{
   "P0":{
      "name":"\n          Tuhina Neogi, MD PhD\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/bmaw00v5wz4n9f7rj0ur.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        650 Albany Street\n       \n        Suite X200, Rheumatology\n       \n        Boston, MA 02118\n        ",
      "phone":"\n      \n     \n      (617) 358-9650\n      ",
      "fax":"",
      "job-title":"\n            Chief of Rheumatology\nProfessor, Medicine and Epidemiology, Boston University School of Medicine and School of Public Health\n          ",
      "summary":" \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        Boston University School of Public Health\n       \n      PhD, Epidemiology, Delta Omega, 2009\n    ",
         "   \n        University of Toronto Faculty of Medicine\n       \n      Class of 1998, MD\n    "
      ],
      "certifications&licences":[
         "   \n      MA State Medical License\n     \n      2003 - 2020\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    "
      ],
      "publications&presentations":[
         "     \n        Relationship Between Serum Urate Concentration and Clinically Evident Incident Gout: An Individual Participant Data Analysis\n       \n      Tuhina Neogi, MD…\n     \n      Emergency Medicine Journal\n      \n    ",
         "     \n        Mortality in Patients with Giant Cell Arteritis: A Cohort Study in UK Primary Care\n       \n      Tuhina Neogi, MD…\n     \n      Arthritis Care &amp; Research\n      \n    ",
         "     \n        Deep learning risk assessment models for predicting progression of radiographic medial joint space loss over a 48-MONTH follow-up period.\n       \n      Guan, B., Liu, F., Haj-Mirzaian, A., Demehri, S., Samsonov, A., Neogi, T., Guermazi, A., Kijowski, R…\n     \n      Osteoarthritis and cartilage\n      2020 Feb 10\n    ",
         "     \n        Flare-ups of osteoarthritis: what do they mean in the short-term and the long-term?\n       \n      Thomas, M. J., Neogi, T.…\n     \n      Osteoarthritis and cartilage\n      2020 Jan 29\n    ",
         "     \n        A tale of two TrkA inhibitor trials: same target, divergent results.\n       \n      Walsh, D. A., Neogi, T.…\n     \n      Osteoarthritis and cartilage\n      2019 Jul 30\n    ",
         "\n        1\n       mention   \n        Thiazide diuretics and risk of knee replacement surgery among patients with knee osteoarthritis: a general population-based cohort study.\n       \n      Wei, J., Neogi, T., Terkeltaub, R., Fenves, A. Z., Zeng, C., Misra, D., Choi, H. K., Lei, G., Zhang,…\n     \n      Osteoarthritis and cartilage\n      2019 Jun 11\n    ",
         "  \n        Cause-Specific\\xa0Mortality\\xa0in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular Related Deaths.\n       \n      Vargas-Santos, A. B.,Neogi, T.,da Rocha Castelar-Pinheiro, G.,Kapetanovic, M. C.,Turkiewicz, A.…\n     \n      \n      2019 Jun 07\n    ",
         "  \n        Acute Flares of Knee Osteoarthritis (the ACT-FLARE Study): Protocol for a Web-Based Case-Crossover Study in Community-Dwelling Adults.\n       \n      Thomas, M. J.,Rathod-Mistry, T.,Harper, S.,Parry, E. L.,Pope, C.,Neogi, T.,Peat, G.…\n     \n      JMIR Res Protoc\n      2019 Apr 23\n    ",
         "  \n        Effect of Dietary and Supplemental Omega-3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares.\n       \n      Zhang, M.,Zhang, Y.,Terkeltaub, R.,Chen, C.,Neogi, T.…\n     \n      \n      2019 Mar 26\n    ",
         "  \n        The association of frontal plane alignment to MRI-defined worsening of patellofemoral osteoarthritis: the MOST study.\n       \n      Macri, E. M., Felson, D. T., Ziegler, M. L., Cooke, T. D., Guermazi, A., Roemer, F. W., Neogi, T., T…\n     \n      Osteoarthritis and cartilage\n      2018 Dec 1\n    ",
         "  \n        Acute flares of knee osteoarthritis in primary care: a feasibility and pilot case-crossover study.\n       \n      Thomas, M. J.,Butler-Walley, S.,Rathod-Mistry, T.,Mayson, Z.,Parry, E. L.,Pope, C.,Neogi, T.,Peat, G…\n     \n      Pilot Feasibility Stud\n      2018 Nov 10\n    ",
         "  \n        Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs.\n       \n      Kraus, V. B.,Simon, L. S.,Katz, J. N.,Neogi, T.,Hunter, D.,Guermazi, A.,Karsdal, M. A.…\n     \n      Osteoarthr. Cartil.\n      2018 Nov 23\n    ",
         "  \n        Urate and Osteoarthritis: Evidence For a Reciprocal Relationship.\n       \n      Neogi, T.,Krasnokutsky, S.,Pillinger, M. H.…\n     \n      Joint Bone Spine\n      2018 Nov 25\n    ",
         "\n        17\n       mentions   \n        Patient education and engagement in treat-to-target gout care.\n       \n      Neogi, T., Dalbeth, N.…\n     \n      Lancet (London, England)\n      2018 Oct 23\n    ",
         "  \n        Meniscal body extrusion and cartilage coverage in middle-aged and elderly without radiographic knee osteoarthritis.\n       \n      Svensson, F.,Felson, D. T.,Zhang, F.,Guermazi, A.,Roemer, F. W.,Niu, J.,Aliabadi, P.,Neogi, T.,Englu…\n     \n      Eur Radiol\n      2018 Oct 04\n    ",
         "  \n        Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.\n       \n      Vargas-Santos, A. B.,Peloquin, C. E.,Zhang, Y.,Neogi, T.…\n     \n      JAMA Intern Med\n      2018 Oct 12\n    ",
         "  \n        Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain.\n       \n      Suri, P.,Palmer, M. R.,Tsepilov, Y. A.,Freidin, M. B.,Boer, C. G.,Yau, M. S.,Evans, D. S.,Gelemanovi…\n     \n      PLoS Genet.\n      2018 Sep 28\n    ",
         "  \n        Response to: 'Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis'.\n       \n      Dubreuil, M., Louie-Gao, Q., Peloquin, C., Choi, H. K., Zhang, Y., Neogi, T.…\n     \n      Annals of the rheumatic diseases\n      2018 Jun 18\n    ",
         "  \n        New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert.\n       \n      Choi, H., Neogi, T., Stamp, L., Dalbeth, N., Terkeltaub, R.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Jun 6\n    ",
         "  \n        Does the intensity of daily walking matter for protecting against the development of a slow gait speed in people with or at high risk of knee osteoarthritis? An observational study.\n       \n      Fenton, S. A., Neogi, T., Dunlop, D., Nevitt, M., Doherty, M., Duda, J. L., Klocke, R., Abhishek, A.…\n     \n      Osteoarthritis and cartilage\n      2018 May 8\n    ",
         "  \n        Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout.\n       \n      FitzGerald, J. D.,Mikuls, T. R.,Neogi, T.,Singh, J. A.,Robbins, M.,Khanna, P. P.,Turner, A. S.,Mysli…\n     \n      Arthritis Care Res (Hoboken)\n      2018 Apr 13\n    ",
         "  \n        Design and Rationale for the Veterans Affairs \"Cooperative Study Program 594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat\" Trial.\n       \n      Timilsina, S.,Brittan, K.,O\\'Dell, J. R.,Brophy, M.,Davis-Karim, A.,Henrie, A. M.,Neogi, T.,Newcomb, …\n     \n      Contemp Clin Trials\n      2018 Mar 30\n    ",
         "  \n        Response to: 'The reference levels of serum urate for clinically evident incident gout' by Chen and Ding.\n       \n      Dalbeth, N., Phipps-Green, A., Frampton, C., Neogi, T., Taylor, W. J., Merriman, T. R.…\n     \n      Annals of the rheumatic diseases\n      2018 Mar 23\n    ",
         "  \n        Response to: 'Bisphosphonates reduce the risk of knee replacement: we need more analyses!' by Li <i>et al</i>.\n       \n      Neogi, T., Li, S., Peloquin, C., Misra, D., Zhang, Y.…\n     \n      Annals of the rheumatic diseases\n      2018 Feb 16\n    ",
         "1\n       citations  \n        1\n       mention   \n        Changes in Pain Sensitization After BariatricÂ\\xa0Surgery.\n       \n      Stefanik, J. J., Felson, D. T., Apovian, C. M., Niu, J., Clancy, M. M., LaValley, M. P., Neogi, T.…\n     \n      Arthritis care & research\n      2018 Jan 10\n    ",
         "  \n        Meloxicam and risk of myocardial infarction: a population-based nested case-control study.\n       \n      Dalal, D.,Dubreuil, M.,Peloquin, C.,Neogi, T.,Zhang, Y.,Choi, H.,Felson, D.…\n     \n      Rheumatol. Int.\n      2017 Oct 17\n    ",
         "\n        1\n       mention   \n        Brief Report: Validation of a Definition of Flare in Patients With Established Gout.\n       \n      Gaffo, A. L., Dalbeth, N., Saag, K. G., Singh, J. A., Rahn, E. J., Mudano, A. S., Chen, Y., Lin, C.,…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Nov 22\n    ",
         "  \n        Structural correlates of pain in osteoarthritis.\n       \n      Neogi, T.…\n     \n      Clinical and experimental rheumatology\n      2017 Oct 3\n    ",
         "  \n        A Cohort Study of Comorbidity in Patients with Granulomatosis with Polyangiitis\n       \n      Tuhina Neogi, MD…\n     \n      Rheumatology\n      2017 Oct 27\n    ",
         "6\n       citations  \n        14\n       mentions \n        1 NEW\n        \n        Management of Gout and Hyperuricemia in CKD.\n       \n      Vargas-Santos, A. B., Neogi, T.…\n     \n      American journal of kidney diseases : the official journal of the National Kidney Foundation\n      2017 May 1\n    ",
         "  \n        The Effect of Widespread Pain on Knee Pain Worsening, Incident Knee Osteoarthritis (OA), and Incident Knee Pain: The Multicenter OA (MOST) Study.\n       \n      Carlesso, L. C.,Niu, J.,Segal, N. A.,Frey-Law, L. A.,Lewis, C. E.,Nevitt, M. C.,Neogi, T.…\n     \n      J. Rheumatol.\n      2017 Mar 03\n    ",
         "  \n        Does knee replacement surgery for osteoarthritis improve survival? The jury is still out.\n       \n      Misra, D.,Lu, N.,Felson, D.,Choi, H. K.,Seeger, J.,Einhorn, T.,Neogi, T.,Zhang, Y.…\n     \n      Ann. Rheum. Dis.\n      2016 May 18\n    ",
         "1\n       citations  \n        2\n       mentions   \n        Gout Classification Criteria: Update and Implications\n       \n      Vargas-Santos, A. B., Taylor, W. J., Neogi, T.…\n     \n      Current Rheumatology Reports\n      2016 Jun 28\n    ",
         "  \n        Synovitis and the risk of knee osteoarthritis: the MOST Study.\n       \n      Felson, D. T.,Niu, J.,Neogi, T.,Goggins, J.,Nevitt, M. C.,Roemer, F.,Torner, J.,Lewis, C. E.,Guermaz…\n     \n      Osteoarthr. Cartil.\n      2015 Oct 04\n    ",
         "  \n        Prospective change in daily walking over 2\\xa0years in older adults with or at risk of knee osteoarthritis: the MOST study.\n       \n      White, D. K.,Tudor-Locke, C.,Zhang, Y.,Niu, J.,Felson, D. T.,Gross, K. D.,Nevitt, M. C.,Lewis, C. E.…\n     \n      Osteoarthr. Cartil.\n      2015 Sep 01\n    ",
         "1\n       citations    \n        Evidence that meniscus damage may be a component of osteoarthritis: the Framingham study.\n       \n      Englund, M., Haugen, I. K., Guermazi, A., Roemer, F. W., Niu, J., Neogi, T., Aliabadi, P., Felson, D…\n     \n      Osteoarthritis and cartilage\n      2015 Sep 1\n    ",
         "5\n       citations    \n        The relation of MRI-detected structural damage in the medial and lateral patellofemoral joint to knee pain: the Multicenter and Framingham Osteoarthritis Studies.\n       \n      Stefanik, J. J., Gross, K. D., Guermazi, A., Felson, D. T., Roemer, F. W., Zhang, Y., Niu, J., Segal…\n     \n      Osteoarthritis and cartilage\n      2015 Jan 13\n    ",
         "3\n       citations    \n        CT imaging for evaluation of calcium crystal deposition in the knee: initial experience from the Multicenter Osteoarthritis (MOST) study.\n       \n      Misra, D., Guermazi, A., Sieren, J. P., Lynch, J., Torner, J., Neogi, T., Felson, D. T.…\n     \n      Osteoarthritis and cartilage\n      2014 Dec 3\n    ",
         "  \n        Examining sex differences in knee pain: the Multicenter Osteoarthritis Study.\n       \n      Glass, N.,Segal, N. A.,Sluka, K. A.,Torner, J. C.,Nevitt, M. C.,Felson, D. T.,Bradley, L. A.,Neogi, …\n     \n      Osteoarthr. Cartil.\n      2014 Jul 08\n    ",
         "  \n        Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation.\n       \n      Misra, D.,Zhang, Y.,Peloquin, C.,Choi, H. K.,Kiel, D. P.,Neogi, T.…\n     \n      Osteoporos Int\n      2014 May 17\n    ",
         "  \n        The Diagnostic Performance of Anterior Knee Pain and Activity-related Pain in Identifying Knees with Structural Damage in the Patellofemoral Joint: The Multicenter Osteoarthritis Study.\n       \n      Stefanik, J. J.,Neogi, T.,Niu, J.,Roemer, F. W.,Segal, N. A.,Lewis, C. E.,Nevitt, M.,Guermazi, A.,Fe…\n     \n      J. Rheumatol.\n      2014 Jun 17\n    ",
         "  \n        Gout and crystal arthropathies.\n       \n      Neogi, T.…\n     \n      Rheumatic diseases clinics of North America\n      2014 Apr 8\n    ",
         "14\n       citations  \n        11\n       mentions \n        3 NEW\n        \n        Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study.\n       \n      Neogi, T., Chen, C. A., Niu, J., Chaisson, C. E., Hunter, D. J., Zhang, Y.…\n     \n      The American journal of medicine\n      2014 Jan 21\n    ",
         "  \n        Does Clinically Important Change in Function After Knee Replacement Guarantee Good Absolute Function? The Multicenter Osteoarthritis Study.\n       \n      Maxwell, J. L.,Felson, D. T.,Niu, J.,Wise, B.,Nevitt, M. C.,Singh, J. A.,Frey-Law, L.,Neogi, T.…\n     \n      J. Rheumatol.\n      2013 Dec 03\n    ",
         "  \n        Increased risk of recurrent gout attacks with hospitalization.\n       \n      Dubreuil M\r\nNeogi T\r\nChen CA\r\nChoi HK\r\nChaisson CE\r\nHunter DJ\r\nZhang Y…\n     \n      Am J Med\n      2013 Dec\r\n\n    ",
         "  \n        High Plasma Levels of Vitamin C and E Are Associated with Incident Radiographic Knee Osteoarthritis.\n       \n      Chaganti, R. K.,Tolstykh, I.,Javaid, M. K.,Neogi, T.,Torner, J.,Curtis, J.,Jacques, P.,Felson, D.,La…\n     \n      Osteoarthr. Cartil.\n      2013 Dec 03\n    ",
         "102\n       citations  \n        103\n       mentions \n        2 NEW\n        \n        The epidemiology and impact of pain in osteoarthritis.\n       \n      Neogi, T.…\n     \n      Osteoarthritis and cartilage\n      2013 Aug 27\n    ",
         "  \n        Contribution of the COMT Val158Met variant to symptomatic knee osteoarthritis.\n       \n      Neogi, T.,Soni, A.,Doherty, S. A.,Laslett, L. L.,Maciewicz, R. A.,Hart, D. J.,Zhang, W.,Muir, K. R.,…\n     \n      Ann. Rheum. Dis.\n      2013 Jul 13\n    ",
         "20\n       citations    \n        Magnetic resonance imaging-based three-dimensional bone shape of the knee predicts onset of knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Neogi, T., Bowes, M. A., Niu, J., De Souza, K. M., Vincent, G. R., Goggins, J., Zhang, Y., Felson, D…\n     \n      Arthritis and rheumatism\n      2013 May 8\n    ",
         "  \n        Vitamin K deficiency is associated with incident knee osteoarthritis.\n       \n      Misra D\r\nBooth SL\r\nTolstykh I\r\nFelson DT\r\nNevitt MC\r\nLewis CE\r\nTorner J\r\nNeogi T…\n     \n      Am J Med\n      2013 Mar\r\n\n    ",
         "201\n       citations  \n        3\n       mentions   \n        Epidemiology of osteoarthritis.\n       \n      Neogi, T., Zhang, Y.…\n     \n      Rheumatic diseases clinics of North America\n      2013 Jan 15\n    ",
         "  \n        Cherry consumption and decreased risk of recurrent gout attacks.\n       \n      Zhang, Y., Neogi, T., Chen, C., Chaisson, C., Hunter, D. J., Choi, H. K.…\n     \n      Arthritis Rheum\n      2012 Dec\n    ",
         "  \n        2012 American College of Rheumatology guidelines for management of gout. Part 2:  therapy and antiinflammatory prophylaxis of acute gouty arthritis.\n       \n      Khanna D\r\nKhanna PP\r\nFitzgerald JD\r\nSingh MK\r\nBae S\r\nNeogi T\r\nPillinger MH\r\nMerill J\r\nLee S\r\nPrakash…\n     \n      Arthritis Care Res (Hoboken)\n      2012 Oct\r\n\n    ",
         "5\n       citations    \n        The non-synonymous SNP, R1150W, in SCN9A is not associated with chronic widespread pain susceptibility.\n       \n      Holliday, K. L., Thomson, W., Neogi, T., Felson, D. T., Wang, K., Wu, F. C., Huhtaniemi, I. T., Bart…\n     \n      Molecular pain\n      2012 Sep 26\n    ",
         "  \n        Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study).\n       \n      Guermazi, A., Niu, J., Hayashi, D., Roemer, F. W., Englund, M., Neogi, T., Aliabadi, P., McLennan, C…\n     \n      BMJ\n      2012\n    ",
         "128\n       citations  \n        5\n       mentions   \n        Clinical practice. Gout.\n       \n      Neogi, T.…\n     \n      The New England journal of medicine\n      2011 Feb 4\n    ",
         "  \n        Osteoarthritis prevention.\n       \n      Neogi, T., Zhang, Y.…\n     \n      Current opinion in rheumatology\n      2011 Jan 6\n    ",
         "11\n       citations    \n        Serum urate is not associated with coronary artery calcification: the NHLBI Family Heart Study.\n       \n      Neogi, T., Terkeltaub, R., Ellison, R. C., Hunt, S. C., Zhang, Y.…\n     \n      The Journal of rheumatology\n      2010 Oct 5\n    ",
         "  \n        Consistency of knee pain: correlates and association with function.\n       \n      Neogi, T., Nevitt, M. C., Yang, M., Curtis, J. R., Torner, J., Felson, D. T.…\n     \n      Osteoarthritis and cartilage\n      2010 Aug 17\n    ",
         "9\n       citations    \n        Cartilage loss occurs in the same subregions as subchondral bone attrition: a within-knee subregion-matched approach from the Multicenter Osteoarthritis Study.\n       \n      Neogi, T., Felson, D., Niu, J., Lynch, J., Nevitt, M., Guermazi, A., Roemer, F., Lewis, C. E., Walla…\n     \n      Arthritis and rheumatism\n      2009 Oct 31\n    ",
         "10\n       citations    \n        Subchondral bone attrition may be a reflection of compartment-specific mechanical load: the MOST Study.\n       \n      Neogi, T., Nevitt, M. C., Niu, J., Sharma, L., Roemer, F., Guermazi, A., Lewis, C. E., Torner, J. C.…\n     \n      Annals of the rheumatic diseases\n      2009 Sep 19\n    ",
         "177\n       citations    \n        Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies.\n       \n      Neogi, T., Felson, D. T., Niu, J., Nevitt, M. C., Lewis, C. E., Aliabadi, P., Sack, B., Torner, J. C…\n     \n      BMJ (Clinical research ed.)\n      2009 Aug 25\n    ",
         "33\n       citations    \n        Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study.\n       \n      Neogi, T., Ellison, R. C., Hunt, S. C., Terkeltaub, R., Felson, D. T., Zhang, Y.…\n     \n      The Journal of rheumatology\n      2008 Nov 18\n    ",
         "18\n       citations    \n        The effect of alendronate on progression of spinal osteophytes and disc-space narrowing.\n       \n      Neogi, T., Nevitt, M. C., Ensrud, K. E., Bauer, D., Felson, D. T.…\n     \n      Annals of the rheumatic diseases\n      2008 Feb 16\n    ",
         "  \n        The association of bone attrition with knee pain and other MRI features of osteoarthritis.\n       \n      Hernández-Molina, G.,Neogi, T.,Hunter, D. J.,Niu, J.,Guermazi, A.,Reichenbach, S.,Roemer, F. W.,McLe…\n     \n      Ann. Rheum. Dis.\n      2008 Jan 01\n    ",
         "1\n       citations    \n        Re: \"Easy SAS calculations for risk or prevalence ratios and differences\".\n       \n      Neogi, T., Zhang, Y.…\n     \n      American journal of epidemiology\n      2006 Jun 7\n    ",
         "18\n       citations    \n        Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: results of two prospective longitudinal magnetic resonance imaging studies.\n       \n      Neogi, T., Nevitt, M., Niu, J., LaValley, M. P., Hunter, D. J., Terkeltaub, R., Carbone, L., Chen, H…\n     \n      Arthritis and rheumatism\n      2006 May 27\n    ",
         "2\n       citations    \n        Low vitamin K status is associated with osteoarthritis in the hand and knee.\n       \n      Neogi, T., Booth, S. L., Zhang, Y. Q., Jacques, P. F., Terkeltaub, R., Aliabadi, P., Felson, D. T.…\n     \n      Arthritis and rheumatism\n      2006 Mar 31\n    ",
         "87\n       citations  \n        1\n       mention   \n        Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study.\n       \n      Neogi, T., Hunter, D. J., Chaisson, C. E., Allensworth-Davies, D., Zhang, Y.…\n     \n      The Journal of rheumatology\n      2005 Nov 4\n    ",
         "  \n        Relationship Between Serum Urate Concentration and Clinically Evident Incident Gout: An Individual Participant Data Analysis\n       \n      Tuhina Neogi, MD…\n     \n      Emergency Medicine Journal\n      \n    ",
         "  \n        Mortality in Patients with Giant Cell Arteritis: A Cohort Study in UK Primary Care\n       \n      Tuhina Neogi, MD…\n     \n      Arthritis Care &amp; Research\n      \n    ",
         "  \n        Deep learning risk assessment models for predicting progression of radiographic medial joint space loss over a 48-MONTH follow-up period.\n       \n      Guan, B., Liu, F., Haj-Mirzaian, A., Demehri, S., Samsonov, A., Neogi, T., Guermazi, A., Kijowski, R…\n     \n      Osteoarthritis and cartilage\n      2020 Feb 10\n    ",
         "  \n        Flare-ups of osteoarthritis: what do they mean in the short-term and the long-term?\n       \n      Thomas, M. J., Neogi, T.…\n     \n      Osteoarthritis and cartilage\n      2020 Jan 29\n    ",
         "  \n        A tale of two TrkA inhibitor trials: same target, divergent results.\n       \n      Walsh, D. A., Neogi, T.…\n     \n      Osteoarthritis and cartilage\n      2019 Jul 30\n    ",
         "\n        1\n       mention   \n        Thiazide diuretics and risk of knee replacement surgery among patients with knee osteoarthritis: a general population-based cohort study.\n       \n      Wei, J., Neogi, T., Terkeltaub, R., Fenves, A. Z., Zeng, C., Misra, D., Choi, H. K., Lei, G., Zhang,…\n     \n      Osteoarthritis and cartilage\n      2019 Jun 11\n    ",
         "  \n        Cause-Specific\\xa0Mortality\\xa0in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular Related Deaths.\n       \n      Vargas-Santos, A. B.,Neogi, T.,da Rocha Castelar-Pinheiro, G.,Kapetanovic, M. C.,Turkiewicz, A.…\n     \n      \n      2019 Jun 07\n    ",
         "  \n        Acute Flares of Knee Osteoarthritis (the ACT-FLARE Study): Protocol for a Web-Based Case-Crossover Study in Community-Dwelling Adults.\n       \n      Thomas, M. J.,Rathod-Mistry, T.,Harper, S.,Parry, E. L.,Pope, C.,Neogi, T.,Peat, G.…\n     \n      JMIR Res Protoc\n      2019 Apr 23\n    ",
         "  \n        Effect of Dietary and Supplemental Omega-3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares.\n       \n      Zhang, M.,Zhang, Y.,Terkeltaub, R.,Chen, C.,Neogi, T.…\n     \n      \n      2019 Mar 26\n    ",
         "  \n        The association of frontal plane alignment to MRI-defined worsening of patellofemoral osteoarthritis: the MOST study.\n       \n      Macri, E. M., Felson, D. T., Ziegler, M. L., Cooke, T. D., Guermazi, A., Roemer, F. W., Neogi, T., T…\n     \n      Osteoarthritis and cartilage\n      2018 Dec 1\n    ",
         "  \n        Acute flares of knee osteoarthritis in primary care: a feasibility and pilot case-crossover study.\n       \n      Thomas, M. J.,Butler-Walley, S.,Rathod-Mistry, T.,Mayson, Z.,Parry, E. L.,Pope, C.,Neogi, T.,Peat, G…\n     \n      Pilot Feasibility Stud\n      2018 Nov 10\n    ",
         "  \n        Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs.\n       \n      Kraus, V. B.,Simon, L. S.,Katz, J. N.,Neogi, T.,Hunter, D.,Guermazi, A.,Karsdal, M. A.…\n     \n      Osteoarthr. Cartil.\n      2018 Nov 23\n    ",
         "  \n        Urate and Osteoarthritis: Evidence For a Reciprocal Relationship.\n       \n      Neogi, T.,Krasnokutsky, S.,Pillinger, M. H.…\n     \n      Joint Bone Spine\n      2018 Nov 25\n    ",
         "\n        17\n       mentions   \n        Patient education and engagement in treat-to-target gout care.\n       \n      Neogi, T., Dalbeth, N.…\n     \n      Lancet (London, England)\n      2018 Oct 23\n    ",
         "  \n        Meniscal body extrusion and cartilage coverage in middle-aged and elderly without radiographic knee osteoarthritis.\n       \n      Svensson, F.,Felson, D. T.,Zhang, F.,Guermazi, A.,Roemer, F. W.,Niu, J.,Aliabadi, P.,Neogi, T.,Englu…\n     \n      Eur Radiol\n      2018 Oct 04\n    ",
         "  \n        Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.\n       \n      Vargas-Santos, A. B.,Peloquin, C. E.,Zhang, Y.,Neogi, T.…\n     \n      JAMA Intern Med\n      2018 Oct 12\n    ",
         "  \n        Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain.\n       \n      Suri, P.,Palmer, M. R.,Tsepilov, Y. A.,Freidin, M. B.,Boer, C. G.,Yau, M. S.,Evans, D. S.,Gelemanovi…\n     \n      PLoS Genet.\n      2018 Sep 28\n    ",
         "  \n        Response to: 'Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis'.\n       \n      Dubreuil, M., Louie-Gao, Q., Peloquin, C., Choi, H. K., Zhang, Y., Neogi, T.…\n     \n      Annals of the rheumatic diseases\n      2018 Jun 18\n    ",
         "  \n        New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert.\n       \n      Choi, H., Neogi, T., Stamp, L., Dalbeth, N., Terkeltaub, R.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Jun 6\n    ",
         "  \n        Does the intensity of daily walking matter for protecting against the development of a slow gait speed in people with or at high risk of knee osteoarthritis? An observational study.\n       \n      Fenton, S. A., Neogi, T., Dunlop, D., Nevitt, M., Doherty, M., Duda, J. L., Klocke, R., Abhishek, A.…\n     \n      Osteoarthritis and cartilage\n      2018 May 8\n    ",
         "  \n        Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout.\n       \n      FitzGerald, J. D.,Mikuls, T. R.,Neogi, T.,Singh, J. A.,Robbins, M.,Khanna, P. P.,Turner, A. S.,Mysli…\n     \n      Arthritis Care Res (Hoboken)\n      2018 Apr 13\n    ",
         "  \n        Design and Rationale for the Veterans Affairs \"Cooperative Study Program 594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat\" Trial.\n       \n      Timilsina, S.,Brittan, K.,O\\'Dell, J. R.,Brophy, M.,Davis-Karim, A.,Henrie, A. M.,Neogi, T.,Newcomb, …\n     \n      Contemp Clin Trials\n      2018 Mar 30\n    ",
         "  \n        Response to: 'The reference levels of serum urate for clinically evident incident gout' by Chen and Ding.\n       \n      Dalbeth, N., Phipps-Green, A., Frampton, C., Neogi, T., Taylor, W. J., Merriman, T. R.…\n     \n      Annals of the rheumatic diseases\n      2018 Mar 23\n    ",
         "  \n        Response to: 'Bisphosphonates reduce the risk of knee replacement: we need more analyses!' by Li <i>et al</i>.\n       \n      Neogi, T., Li, S., Peloquin, C., Misra, D., Zhang, Y.…\n     \n      Annals of the rheumatic diseases\n      2018 Feb 16\n    ",
         "1\n       citations  \n        1\n       mention   \n        Changes in Pain Sensitization After BariatricÂ\\xa0Surgery.\n       \n      Stefanik, J. J., Felson, D. T., Apovian, C. M., Niu, J., Clancy, M. M., LaValley, M. P., Neogi, T.…\n     \n      Arthritis care & research\n      2018 Jan 10\n    ",
         "  \n        Meloxicam and risk of myocardial infarction: a population-based nested case-control study.\n       \n      Dalal, D.,Dubreuil, M.,Peloquin, C.,Neogi, T.,Zhang, Y.,Choi, H.,Felson, D.…\n     \n      Rheumatol. Int.\n      2017 Oct 17\n    ",
         "\n        1\n       mention   \n        Brief Report: Validation of a Definition of Flare in Patients With Established Gout.\n       \n      Gaffo, A. L., Dalbeth, N., Saag, K. G., Singh, J. A., Rahn, E. J., Mudano, A. S., Chen, Y., Lin, C.,…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Nov 22\n    ",
         "  \n        Structural correlates of pain in osteoarthritis.\n       \n      Neogi, T.…\n     \n      Clinical and experimental rheumatology\n      2017 Oct 3\n    ",
         "  \n        A Cohort Study of Comorbidity in Patients with Granulomatosis with Polyangiitis\n       \n      Tuhina Neogi, MD…\n     \n      Rheumatology\n      2017 Oct 27\n    ",
         "6\n       citations  \n        14\n       mentions \n        1 NEW\n        \n        Management of Gout and Hyperuricemia in CKD.\n       \n      Vargas-Santos, A. B., Neogi, T.…\n     \n      American journal of kidney diseases : the official journal of the National Kidney Foundation\n      2017 May 1\n    ",
         "  \n        The Effect of Widespread Pain on Knee Pain Worsening, Incident Knee Osteoarthritis (OA), and Incident Knee Pain: The Multicenter OA (MOST) Study.\n       \n      Carlesso, L. C.,Niu, J.,Segal, N. A.,Frey-Law, L. A.,Lewis, C. E.,Nevitt, M. C.,Neogi, T.…\n     \n      J. Rheumatol.\n      2017 Mar 03\n    ",
         "  \n        Does knee replacement surgery for osteoarthritis improve survival? The jury is still out.\n       \n      Misra, D.,Lu, N.,Felson, D.,Choi, H. K.,Seeger, J.,Einhorn, T.,Neogi, T.,Zhang, Y.…\n     \n      Ann. Rheum. Dis.\n      2016 May 18\n    ",
         "1\n       citations  \n        2\n       mentions   \n        Gout Classification Criteria: Update and Implications\n       \n      Vargas-Santos, A. B., Taylor, W. J., Neogi, T.…\n     \n      Current Rheumatology Reports\n      2016 Jun 28\n    ",
         "  \n        Synovitis and the risk of knee osteoarthritis: the MOST Study.\n       \n      Felson, D. T.,Niu, J.,Neogi, T.,Goggins, J.,Nevitt, M. C.,Roemer, F.,Torner, J.,Lewis, C. E.,Guermaz…\n     \n      Osteoarthr. Cartil.\n      2015 Oct 04\n    ",
         "  \n        Prospective change in daily walking over 2\\xa0years in older adults with or at risk of knee osteoarthritis: the MOST study.\n       \n      White, D. K.,Tudor-Locke, C.,Zhang, Y.,Niu, J.,Felson, D. T.,Gross, K. D.,Nevitt, M. C.,Lewis, C. E.…\n     \n      Osteoarthr. Cartil.\n      2015 Sep 01\n    ",
         "1\n       citations    \n        Evidence that meniscus damage may be a component of osteoarthritis: the Framingham study.\n       \n      Englund, M., Haugen, I. K., Guermazi, A., Roemer, F. W., Niu, J., Neogi, T., Aliabadi, P., Felson, D…\n     \n      Osteoarthritis and cartilage\n      2015 Sep 1\n    ",
         "5\n       citations    \n        The relation of MRI-detected structural damage in the medial and lateral patellofemoral joint to knee pain: the Multicenter and Framingham Osteoarthritis Studies.\n       \n      Stefanik, J. J., Gross, K. D., Guermazi, A., Felson, D. T., Roemer, F. W., Zhang, Y., Niu, J., Segal…\n     \n      Osteoarthritis and cartilage\n      2015 Jan 13\n    ",
         "3\n       citations    \n        CT imaging for evaluation of calcium crystal deposition in the knee: initial experience from the Multicenter Osteoarthritis (MOST) study.\n       \n      Misra, D., Guermazi, A., Sieren, J. P., Lynch, J., Torner, J., Neogi, T., Felson, D. T.…\n     \n      Osteoarthritis and cartilage\n      2014 Dec 3\n    ",
         "  \n        Examining sex differences in knee pain: the Multicenter Osteoarthritis Study.\n       \n      Glass, N.,Segal, N. A.,Sluka, K. A.,Torner, J. C.,Nevitt, M. C.,Felson, D. T.,Bradley, L. A.,Neogi, …\n     \n      Osteoarthr. Cartil.\n      2014 Jul 08\n    ",
         "  \n        Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation.\n       \n      Misra, D.,Zhang, Y.,Peloquin, C.,Choi, H. K.,Kiel, D. P.,Neogi, T.…\n     \n      Osteoporos Int\n      2014 May 17\n    ",
         "  \n        The Diagnostic Performance of Anterior Knee Pain and Activity-related Pain in Identifying Knees with Structural Damage in the Patellofemoral Joint: The Multicenter Osteoarthritis Study.\n       \n      Stefanik, J. J.,Neogi, T.,Niu, J.,Roemer, F. W.,Segal, N. A.,Lewis, C. E.,Nevitt, M.,Guermazi, A.,Fe…\n     \n      J. Rheumatol.\n      2014 Jun 17\n    ",
         "  \n        Gout and crystal arthropathies.\n       \n      Neogi, T.…\n     \n      Rheumatic diseases clinics of North America\n      2014 Apr 8\n    ",
         "14\n       citations  \n        11\n       mentions \n        3 NEW\n        \n        Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study.\n       \n      Neogi, T., Chen, C. A., Niu, J., Chaisson, C. E., Hunter, D. J., Zhang, Y.…\n     \n      The American journal of medicine\n      2014 Jan 21\n    ",
         "  \n        Does Clinically Important Change in Function After Knee Replacement Guarantee Good Absolute Function? The Multicenter Osteoarthritis Study.\n       \n      Maxwell, J. L.,Felson, D. T.,Niu, J.,Wise, B.,Nevitt, M. C.,Singh, J. A.,Frey-Law, L.,Neogi, T.…\n     \n      J. Rheumatol.\n      2013 Dec 03\n    ",
         "  \n        Increased risk of recurrent gout attacks with hospitalization.\n       \n      Dubreuil M\r\nNeogi T\r\nChen CA\r\nChoi HK\r\nChaisson CE\r\nHunter DJ\r\nZhang Y…\n     \n      Am J Med\n      2013 Dec\r\n\n    ",
         "  \n        High Plasma Levels of Vitamin C and E Are Associated with Incident Radiographic Knee Osteoarthritis.\n       \n      Chaganti, R. K.,Tolstykh, I.,Javaid, M. K.,Neogi, T.,Torner, J.,Curtis, J.,Jacques, P.,Felson, D.,La…\n     \n      Osteoarthr. Cartil.\n      2013 Dec 03\n    ",
         "102\n       citations  \n        103\n       mentions \n        2 NEW\n        \n        The epidemiology and impact of pain in osteoarthritis.\n       \n      Neogi, T.…\n     \n      Osteoarthritis and cartilage\n      2013 Aug 27\n    ",
         "  \n        Contribution of the COMT Val158Met variant to symptomatic knee osteoarthritis.\n       \n      Neogi, T.,Soni, A.,Doherty, S. A.,Laslett, L. L.,Maciewicz, R. A.,Hart, D. J.,Zhang, W.,Muir, K. R.,…\n     \n      Ann. Rheum. Dis.\n      2013 Jul 13\n    ",
         "20\n       citations    \n        Magnetic resonance imaging-based three-dimensional bone shape of the knee predicts onset of knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Neogi, T., Bowes, M. A., Niu, J., De Souza, K. M., Vincent, G. R., Goggins, J., Zhang, Y., Felson, D…\n     \n      Arthritis and rheumatism\n      2013 May 8\n    ",
         "  \n        Vitamin K deficiency is associated with incident knee osteoarthritis.\n       \n      Misra D\r\nBooth SL\r\nTolstykh I\r\nFelson DT\r\nNevitt MC\r\nLewis CE\r\nTorner J\r\nNeogi T…\n     \n      Am J Med\n      2013 Mar\r\n\n    "
      ],
      "journals":[

      ],
      "non-journals":[
         "   \n          Management of Gout and Hyperuricemia in CKD\n         \n        American Journal of Kidney Diseases\n       \n"
      ],
      "committees":[
         "  ACR Classification and Response Criteria Subcommittee Co-Chair ",
         "  ACR Quality of Care Committee member ",
         "  FDA Arthritis Advisory Committee Chair ",
         "  IASP Musculoskeletal Pain SIG Board member ",
         "  OARSI Communications Committee member ",
         "  OARSI Annual Congress Planning Committee member "
      ],
      "memberships":[
         "   American College of Rheumatology - ACR Member",
         "   Osteoarthritis Research Society International Member",
         "   International Association for the Study of Pain Member"
      ],
      "clinical-trails":[
         "  Wearable Sensors in Knee OA  \n    Deepak Kumar, PT, PhD and T...\n  "
      ],
      "lectures":[

      ],
      "press-mentions":[
         "   \n        Opioid Prescriptions Linked to Obesity\n       \n      Chiropractic Economics\n       · July 27, 2020  ...urgent need for better pain management approaches and options for millions of Americans,” says Dr. Tuhina Neogi, professor of epidemiology at BUSPH, professor of rheumatology at the Boston University School of M...",
         "   \n        New Studies Link Opioid Prescriptions to Obesity\n       \n      Pharmacy Times\n       · April 10, 2020  ...ment of painful musculoskeletal conditions where little evidence exists to support their use,” said Tuhina Neogi, MD, PhD, professor of epidemiology at BUSPH, professor of rheumatology at the Boston University Sc...",
         "   \n        Researchers Find Opioid Prescriptions Linked to Obesity\n       \n      Medical Xpress\n       · April 02, 2020  ...urgent need for better pain management approaches and options for millions of Americans,\" says Dr. Tuhina Neogi, professor of epidemiology at BUSPH, professor of rheumatology at the Boston University School of M...",
         "   \n        A Role for SGLT2 Inhibition in Gout?\n       \n      RheumNow\n       · December 17, 2019  ...ylaxis with agents that are often contraindicated or poorly tolerated in patients with gout,\" wrote Tuhina Neogi, MD, PhD, chief of rheumatology at Boston University School of Medicine, in an accompanying comment...",
         "   \n        BU Finds Concerns About Other Painkillers Contributed to Opioid Crisis\n       \n      Medical Xpress\n       · December 11, 2019  ...COX-2 inhibitors coming off the market and concerns about NSAID risk,\" says study senior author Dr. Tuhina Neogi, professor of epidemiology at BUSPH, professor of medicine at the Boston University School of Medic...",
         "   \n        Updated Gout Guidelines: Don’t Let Kidney Function Dictate Allopurinol Dosing\n       \n      MDedge\n       · December 09, 2019  ...“we now have more evidence to support it,” said co–lead author, rheumatologist, and epidemiologist Tuhina Neogi, MD, PhD, a professor of medicine at Boston University. She gave a sneak preview of the new guideli...",
         "   \n        ACR Releases Draft Gout Guideline\n       \n      The Rheumatologist\n       · November 20, 2019  ...Neogi Data published after 2012 supported several important changes, said co-principal investigator Tuhina Neogi, MD, PhD, rheumatology section chief and professor of medicine at Boston University School of Medic...",
         "New Gout Guidelines Previewed at ACR 2019\n       \n      Patrick Campbell\n       · November 09, 2019  ...tion recommendations to help them be successful in optimally managing gout in their patients,” said Tuhina Neogi, MD, PhD, one of the co-principal investigators on the treatment guideline. Citing additional evide...",
         "American College of Rheumatology Previews Draft of Updated Gout Treatment Guideline at the 2019 ACR/ARP Annual Meeting\n       \n      Newswise\n       · November 06, 2019  ...recommendations to help them be successful in optimally managing gout in their patients,” said Dr. Tuhina Neogi, one of the co-principal investigators on the treatment guideline. Dr. Neogi will discuss the draft...",
         "Association of Back Pain with All-Cause and Cause-Specific Mortality Among Older Women: A Cohort Study\n       \n      Journal of General Internal Medicine\n       · October 22, 2019  ",
         "LISTEN: Osteoarthritis Master Class with Tuhina Neogi MD, PhD\n       \n      The Curbsiders\n       · October 14, 2019  American College of Rheumatology (ACR) osteoarthritis guidelines author, Dr. Tuhina Neogi (Boston University; @tuhinaneogi) schools us on all things OA, including new understandings of path...",
         "Decoding the Link Between Pain Sensitization and Knee Pain\n       \n      The Health Site\n       · November 01, 2018  ...egree of sensitization had the highest risk of developing persistent knee pain. According to author Tuhina Neogi, MD, PhD, professor of medicine and epidemiology at BUSM and BU School of Public Health, findings s...",
         "Pain Sensitization Increases Risk of Persistent Knee Pain\n       \n      News Medical\n       · October 31, 2018  ...of pain sensitization may be a novel approach to preventing persistent knee pain,\" explained author Tuhina Neogi, MD, PhD, professor of medicine and epidemiology at BUSM and BU School of Public Health. \"Preventin...",
         "Treat-to-Target Strategy in Gout Management Is Effective\n       \n      Boston University\n       · October 19, 2018  ...care strategy was projected to be cost saving by five years. An accompanying Lancet comment led by Tuhina Neogi, MD, PhD, professor of medicine and epidemiology at Boston University Schools of Medicine and Publi...",
         "Association of Chronic Kidney Disease with Allopurinol Use in Gout Treatment\n       \n      JAMA Internal Medicine\n       · October 08, 2018  ...contributed to the ongoing suboptimal treatment of gout. Article Information Corresponding Author: Tuhina Neogi, MD, PhD, FRCPC, Professor of Medicine, Clinical Epidemiology Research and Training Unit, Boston Un...",
         "Study Sees No Link Between Gout Drug, Kidney Disease\n       \n      Drugs.com\n       · October 08, 2018  ...e results will be disseminated to [doctors] taking care of patients with gout,\" study co-author Dr. Tuhina Neogi said in a university news release. She\\'s a rheumatologist and professor of medicine and epidemiolog...",
         "Allopurinol for Gout an Unlikely Contributor to Kidney Disease\n       \n      The Rheumatologist\n       · October 08, 2018  ...y. Gout affects around 4% of Americans and often occurs alongside chronic kidney disease (CKD), Dr. Tuhina Neogi from Boston University School of Medicine and colleagues note in an article online Oct. 8 in JAMA I...",
         "#113 Gout: Uric Acid Targets, Urate Lowering Therapy, and Random Questions\n       \n      The Curbsiders\n       · September 10, 2018  Master the management of gout with tips from expert, Tuhina Neogi MD, PhD, Professor of Medicine at Boston University School of Medicine. Topics include: how to init...",
         "First Ever Osteoarthritis Patient Guidelines Published by CreakyJoints\n       \n      Business Wire\n       · January 15, 2018  ...edicine & Section Chief of Rheumatology, Adirondack Health Systems, Saranac Lake, New York, and Dr. Tuhina Neogi, M.D., Ph. D., Professor of Medicine, Boston University School of Medicine, Professor, Epidemiology...",
         "Battle Erupts over How to Treat Gout, No Longer the ‘Disease of Kings’\n       \n      STAT\n       · January 25, 2017  ...g years, with AstraZeneca, Horizon Pharma, and Takeda as leading vendors. The debate frustrates Dr. Tuhina Neogi, a rheumatologist, epidemiologist, and professor of medicine at Boston University. She understands...",
         "ACP Releases New Gout Guidelines\n       \n      Renal & Urology News\n       · November 04, 2016  ...this may involve therapeutic serum urate-lowering to below 5 mg/dL.” In an accompanying editorial, Tuhina Neogi, MD, PhD, of Boston University School of Medicine and Ted R. Mikuls, MD, MSPH, of the University of...",
         "Two Birds with One Stone in Gout?\n       \n      MedPage Today\n       · March 24, 2016  ...ated with gout attacks and tophi as well as these cardiovascular-metabolic-renal conditions,\" wrote Tuhina Neogi, MD, PhD, of Boston University School of Medicine and Hyon Choi, MD, DPH, of Brigham and Women\\'s Ho...",
         "New Classification System Developed for Gout\n       \n      Medical News Today\n       · September 15, 2015  ...dard expected by the FDA and EMA when evaluating gout clinical trials,\" explained lead investigator Tuhina Neogi, MD, PhD, associate professor of medicine at BUSM and a rheumatologist at Boston Medical Center.",
         "Inflammation Drives Painful Sensitization in Knee Osteoarthritis\n       \n      ScienceDaily\n       · November 16, 2014  ...ients experience is not always what one would expect based upon what is seen on their X-rays,\" said Tuhina Neogi, MD, PhD, FRCPC of Boston University School of Medicine and a lead author on the study. \"In prior w...",
         "Weather Found to Affect Gout Attack Risk\n       \n      Renal & Urology News\n       · July 17, 2014  ...humidity are associated with an elevated risk of a recurrent gout attack, according to researchers. Tuhina Neogi, MD, PhD, of the Boston University School of Medicine, and colleagues evaluated the combined associ...",
         "All Alcohol, Even Wine, Raises Risk of Gout Flare-Ups: Study\n       \n      Reuters: Health\n       · January 31, 2014  ...condition. \"I don\\'t want to sound too dogmatic and say, \\'You must stop drinking,\\'\" lead author Dr. Tuhina Neogi told Reuters Health. But, the Boston University rheumatologist said, \"based on this study, I would..."
      ],
      "hospital-info":[
         "   \n      Section Chief\n      \n    Faculty Practice Foundation Evans Medical Foundation  ·  Boston, MA\n   \n    October 2006 - Present\n   ",
         "   \n        Boston University School of Medicine, Boston University School of Public Health\n       \n      Current Affiliation\n     \n        Boston, MA\n    ",
         "   \n        Boston Medical Center\n       \n      Current Affiliation\n     \n        Boston, MA\n    "
      ],
      "award-info":[
         "   \n      Henry Kunkel Young Investigator Award\n     \n      American College of Rheumatology, 2014\n    ",
         "   \n      OARSI Young Investigator Award\n     \n      OARSI (Osteoarthritis Research Society International)\n    ",
         "   \n      J.V. Satterfield Research Award\n     \n      Arthritis Foundation\n    ",
         "   \n      Robert Dawson Evans Junior Faculty Merit Award\n     \n      Boston University School of Medicine\n    ",
         "   \n      Fellow\n     \n      American College of Rheumatology\n    "
      ],
      "support-grants":[
         "   Bisphosphonate Effects in Knee Osteoarthritis Arthritis Foundation \n      Boston University Medical Campus\n     2014–Present",
         "   Multidisciplinary Clinical Research Center at Boston University (P60 AR47785) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) \n      Boston University Medical Campus\n     2012–Present",
         "   Central Sensitization in Post-Knee Replacement Pain and Relation to OA Pathology (R01 AR062506) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) \n      Boston University Medical Campus\n     2012–Present",
         "   Predictors And Consequences Of Subchondral Bone Attrition In Osteoarthritis (K23AR055127) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Boston University Medical Campus\n     2007–2011"
      ]
   },
   "P1":{
      "name":"\n          Alan J Kivitz, MD\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/l_text:Helvetica_130_bold:AK,co_rgb:FFFFFF,t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/profile-placeholder-registered-1.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        175 Meadowbrook Lane\n        \n        Duncansville, PA 16635\n        ",
      "phone":"\n      \n     \n      (814) 693-0300\n      ",
      "fax":"",
      "job-title":"\n",
      "summary":" \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        Albany Medical Center\n       \n      Fellowship, Rheumatology, 1980 - 1982\n    ",
         "   \n        North Shore-Long Island Jewish Health System\n       \n      Residency, Internal Medicine, 1977 - 1979\n    ",
         "   \n        Albany Medical College\n       \n      Class of 1977\n    "
      ],
      "certifications&licences":[
         "   \n      PA State Medical License\n     \n      1982 - 2020\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Internal Medicine\n    "
      ],
      "publications&presentations":[
         "     \n        Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis.\n       \n      Bergman, M. J., Kivitz, A. J., Pappas, D. A., Kremer, J. M., Zhang, L., Jeter, A., Withers, J. B.…\n     \n      Rheumatology and therapy\n      2020 Aug 17\n    ",
         "     \n        Secukinumab improves signs and symptoms of non-radiographic axial spondyloarthritis: primary results of a randomized controlled phase III study.\n       \n      Deodhar, A., Blanco, R., Dokoupilová, E., Hall, S., Kameda, H., Kivitz, A. J., Poddubnyy, D., van de…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2020 Aug 10\n    ",
         "     \n        A Randomised, Double-Blind Trial to Demonstrate Bioequivalence of GP2013 and Reference Rituximab Combined with Methotrexate in Patients with Active Rheumatoid Arthritis\n       \n      Alan Kivitz, MD…\n     \n      Emergency Medicine Journal\n      \n    ",
         "     \n        Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study.\n       \n      Nash, P., Coates, L. C., Kivitz, A. J., Mease, P. J., Gladman, D. D., Covarrubias-Cobos, J. A., Fitz…\n     \n      Rheumatology and therapy\n      2020 Jun 9\n    ",
         "     \n        Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study.\n       \n      van der Heijde, D., Gensler, L. S., Deodhar, A., Baraliakos, X., Poddubnyy, D., Kivitz, A., Farmer, …\n     \n      Annals of the rheumatic diseases\n      2020 Apr 8\n    ",
         "  \n        Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: Week 54-78 Data From a Randomized, Double-Blind, Phase III Trial.\n       \n      Cohen, S. B., Radominski, S. C., Kameda, H., Kivitz, A. J., Tee, M., Cronenberger, C., Zhang, M., Ha…\n     \n      BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy\n      2020 Jan 16\n    ",
         "  \n        A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.\n       \n      Aranow, C., Cush, J., Bolster, M. B., Striebich, C. C., Dall'era, M., Mackay, M., Olech, E., Frech, …\n     \n      Rheumatology (Oxford, England)\n      2019 Oct 20\n    ",
         "  \n        Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study.\n       \n      Baraliakos, X., Braun, J., Deodhar, A., Poddubnyy, D., Kivitz, A., Tahir, H., Van den Bosch, F., Del…\n     \n      RMD open\n      2019 Oct 1\n    ",
         "  \n        Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment.\n       \n      Genovese, M. C., van der Heijde, D., Lin, Y., St John, G., Wang, S., van Hoogstraten, H., Gómez-Rein…\n     \n      RMD open\n      2019 Aug 28\n    ",
         "\n        1\n       mention \n        1 NEW\n        \n        Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.\n       \n      Genovese, M. C., Greenwald, M. W., Gutierrez-Ureña, S. R., Cardiel, M. H., Poiley, J. E., Zubrzycka-…\n     \n      Rheumatology and therapy\n      2019 Aug 15\n    ",
         "  \n        Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.\n       \n      Fleischmann, R., Genovese, M. C., Lin, Y., St John, G., van der Heijde, D., Wang, S., Gomez-Reino, J…\n     \n      Rheumatology (Oxford, England)\n      2019 Jul 18\n    ",
         "  \n        Efficacy and Safety of Subcutaneous Secukinumab 150Â\\xa0mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study.\n       \n      Kivitz, A. J., Nash, P., Tahir, H., Everding, A., Mann, H., Kaszuba, A., Pellet, P., Widmer, A., Pri…\n     \n      Rheumatology and therapy\n      2019 Jun 23\n    ",
         "  \n        The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.\n       \n      Dakin, P., DiMartino, S. J., Gao, H., Maloney, J., Kivitz, A. J., Schnitzer, T. J., Stahl, N., Yanco…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2019 Jun 18\n    ",
         "\n        3\n       mentions   \n        Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials.\n       \n      Kivitz, A. J., Conaghan, P. G., Cinar, A., Lufkin, J., Kelley, S. D.…\n     \n      Pain and therapy\n      2019 May 9\n    ",
         "  \n        Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.\n       \n      Langworthy, M. J., Conaghan, P. G., Ruane, J. J., Kivitz, A. J., Lufkin, J., Cinar, A., Kelley, S. D…\n     \n      Advances in therapy\n      2019 Apr 11\n    ",
         "\n        4\n       mentions   \n        An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis.\n       \n      Cohen, S., Pablos, J. L., Pavelka, K., Müller, G. A., Matsumoto, A., Kivitz, A., Wang, H., Krishnan,…\n     \n      Arthritis research & therapy\n      2019 Mar 30\n    ",
         "  \n        Evolving treatment paradigms for rheumatoid arthritis: Translating comprehensive patient evaluations into personalized therapy.\n       \n      Calabrese, L. H.,Emery, P.,Kivitz, A. J.,Tesser, JRP.…\n     \n      Semin. Arthritis Rheum.\n      2019 Mar 10\n    ",
         "\n        1\n       mention   \n        Brief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis.\n       \n      Tony, H., Krüger, K., Cohen, S. B., Schulze-Koops, H., Kivitz, A. J., Jeka, S., Vereckei, E., Cen, L…\n     \n      Arthritis care & research\n      2018 Oct 9\n    ",
         "  \n        CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial.\n       \n      Jin, Y., Smith, C., Monteith, D., Brown, R., Camporeale, A., McNearney, T. A., Deeg, M. A., Raddad, …\n     \n      Osteoarthritis and cartilage\n      2018 Sep 22\n    ",
         "  \n        A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.\n       \n      Kivitz, A. J., Cohen, S., Keystone, E., van Vollenhoven, R. F., Haraoui, B., Kaine, J., Fan, H., Con…\n     \n      Seminars in arthritis and rheumatism\n      2018 Sep 5\n    ",
         "\n        1\n       mention \n        1 NEW\n        \n        Efficacy and Safety of Secukinumab 150Â\\xa0mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study.\n       \n      Kivitz, A. J., Wagner, U., Dokoupilova, E., Supronik, J., Martin, R., Talloczy, Z., Richards, H. B.,…\n     \n      Rheumatology and therapy\n      2018 Aug 20\n    ",
         "  \n        Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores.\n       \n      Chernoff, D.,Scott Eastman, P.,Hwang, C. C.,Flake, D. D.,Wang, X.,Kivitz, A.,Curtis, J. R.…\n     \n      Clin. Rheumatol.\n      2018 Aug 31\n    ",
         "  \n        Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis.\n       \n      Strand, V., Michalska, M., Birchwood, C., Pei, J., Tuckwell, K., Finch, R., Kivitz, A. J., Smolen, J…\n     \n      RMD open\n      2018 Jun 30\n    ",
         "2\n       citations  \n        139\n       mentions \n        81 NEW\n        \n        Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial.\n       \n      Burmester, G. R., Kremer, J. M., Van den Bosch, F., Kivitz, A., Bessette, L., Li, Y., Zhou, Y., Othm…\n     \n      Lancet (London, England)\n      2018 Jun 18\n    ",
         "  \n        Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses.\n       \n      Strand, V., Kavanaugh, A., Kivitz, A. J., van der Heijde, D., Kwok, K., Akylbekova, E., Soonasra, A.…\n     \n      Rheumatology and therapy\n      2018 May 16\n    ",
         "\n        4\n       mentions   \n        Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial.\n       \n      Wells, A. F., Edwards, C. J., Kivitz, A. J., Bird, P., Nguyen, D., Paris, M., Teng, L., Aelion, J. A…\n     \n      Rheumatology (Oxford, England)\n      2018 Apr 11\n    ",
         "\n        3\n       mentions   \n        Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2.\n       \n      Marzo-Ortega, H., Sieper, J., Kivitz, A. J., Blanco, R., Cohen, M., Delicha, E., Rohrer, S., Richard…\n     \n      RMD open\n      2018 Feb 13\n    ",
         "  \n        Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.\n       \n      Kivitz, A. J., Olech, E., Borofsky, M. A., Zazueta, B., Navarro-Sarabia, F., Radominski, S. C., Merr…\n     \n      The Journal of rheumatology\n      2017 Dec 17\n    ",
         "  \n        Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).\n       \n      Kraus, V. B., Conaghan, P. G., Aazami, H. A., Mehra, P., Kivitz, A. J., Lufkin, J., Hauben, J., John…\n     \n      Osteoarthritis and cartilage\n      2017 Oct 13\n    ",
         "2\n       citations  \n        2\n       mentions   \n        Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-Î³ monoclonal antibody, in SLE subjects without or with lupus nephritis.\n       \n      Boedigheimer, M. J., Martin, D. A., Amoura, Z., Sánchez-Guerrero, J., Romero-Diaz, J., Kivitz, A. J.…\n     \n      Lupus science & medicine\n      2017 Oct 12\n    ",
         "4\n       citations  \n        1\n       mention   \n        Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis.\n       \n      Fleischmann, R. M., Wagner, F., Kivitz, A. J., Mansikka, H. T., Khan, N., Othman, A. A., Khatri, A.,…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Sep 25\n    ",
         "  \n        Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment.\n       \n      Bessette, L., Khraishi, M., Kivitz, A. J., Kaliyaperumal, A., Grantab, R., Poulin-Costello, M., Isai…\n     \n      Rheumatology and therapy\n      2017 Sep 14\n    ",
         "\n        1\n       mention   \n        Simulating clinical trial visits yields patient insights into study design and recruitment.\n       \n      Lim, S. S., Kivitz, A. J., McKinnell, D., Pierson, M. E., O'Brien, F. S.…\n     \n      Patient preference and adherence\n      2017 Aug 18\n    ",
         "  \n        A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: Results of a 24-week, randomized, controlled, phase 1 study.\n       \n      Yazici, Y.,McAlindon, T. E.,Fleischmann, R.,Gibofsky, A.,Lane, N. E.,Kivitz, A. J.,Skrepnik, N.,Arma…\n     \n      Osteoarthr. Cartil.\n      1900 Jan 01\n    ",
         "  \n        Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study.\n       \n      Burge, D. J.,Eisenman, J.,Byrnes-Blake, K.,Smolak, P.,Lau, K.,Cohen, S. B.,Kivitz, A. J.,Levin, R.,M…\n     \n      Lupus\n      2016 Nov 18\n    ",
         "16\n       citations  \n        20\n       mentions   \n        Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.\n       \n      Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., DeMasi, R., Soma, K., Z…\n     \n      Lancet (London, England)\n      2017 Jun 21\n    ",
         "1\n       citations  \n        2\n       mentions   \n        Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial.\n       \n      Baraliakos, X., Kivitz, A. J., Deodhar, A. A., Braun, J., Wei, J. C., Delicha, E. M., Talloczy, Z., …\n     \n      Clinical and experimental rheumatology\n      2017 May 19\n    ",
         "7\n       citations  \n        4\n       mentions   \n        Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.\n       \n      Genovese, M. C., Greenwald, M., Codding, C., Zubrzycka-Sienkiewicz, A., Kivitz, A. J., Wang, A., Sha…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Jan 25\n    ",
         "8\n       citations    \n        Low immunogenicity of tocilizumab in patients with rheumatoid arthritis.\n       \n      Burmester, G. R., Choy, E., Kivitz, A. J., Ogata, A., Bao, M., Nomura, A., Lacey, S., Pei, J., Reiss…\n     \n      Annals of the rheumatic diseases\n      2016 Dec 23\n    ",
         "  \n        Minocycline-induced hyperpigmentation.\n       \n      Abdelghany, M., Kivitz, A. J.…\n     \n      Cleveland Clinic journal of medicine\n      2016 Dec 13\n    ",
         "4\n       citations  \n        1\n       mention   \n        Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study.\n       \n      Kivitz, A. J., Wallace, T., Olech, E., Borofsky, M., Devenport, J., Pei, J., Michalska, M.…\n     \n      Rheumatology and therapy\n      2016 Oct 18\n    ",
         "5\n       citations  \n        1\n       mention   \n        Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA.\n       \n      Abdallah, H. Y., Hsu, J. C., Lu, P., Fettner, S., Zhang, X., Douglass, W., Bao, M., Rowell, L., Burm…\n     \n      Journal of clinical pharmacology\n      2016 Sep 8\n    ",
         "  \n        Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.\n       \n      Doedens, J. R., Jones, W. D., Hill, K., Mason, M. J., Gersuk, V. H., Mease, P. J., Dall'Era, M., Ara…\n     \n      Journal of immunology (Baltimore, Md. : 1950)\n      2016 Aug 19\n    ",
         "2\n       citations    \n        Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.\n       \n      Bickham, K., Kivitz, A. J., Mehta, A., Frontera, N., Shah, S., Stryszak, P., Popmihajlov, Z., Peloso…\n     \n      BMC musculoskeletal disorders\n      2016 Aug 10\n    ",
         "  \n        Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.\n       \n      Zhu, T., Keirns, J., Howieson, C., Kaibara, A., Goldwater, R., Kivitz, A. J., Chindalore, V., Cohen,…\n     \n      Clinical pharmacology in drug development\n      2016 Jul 14\n    ",
         "7\n       citations  \n        1\n       mention   \n        A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol.\n       \n      Curtis, J. R., Churchill, M., Kivitz, A. J., Samad, A., Gauer, L., Gervitz, L., Koetse, W., Melin, J…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Sep 1\n    ",
         "22\n       citations    \n        Blockade of interferon-Î³ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.\n       \n      Welcher, A. A., Boedigheimer, M., Kivitz, A. J., Amoura, Z., Buyon, J. P., Rudinskaya, A., Latinis, …\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Jul 4\n    ",
         "19\n       citations  \n        1\n       mention   \n        Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial.\n       \n      Kremer, J. M., Kivitz, A. J., Simon-Campos, J. A., Nasonov, E. L., Tony, H., Lee, S., Vlahos, B., Ha…\n     \n      Arthritis research & therapy\n      2015 Apr 19\n    ",
         "7\n       citations  \n        4\n       mentions \n        1 NEW\n        \n        Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.\n       \n      Genovese, M. C., Jarosova, K., Cieślak, D., Alper, J., Kivitz, A. J., Hough, D. R., Maes, P., Pineda…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Mar 18\n    ",
         "41\n       citations  \n        6\n       mentions   \n        Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.\n       \n      Genovese, M. C., Fleischmann, R., Kivitz, A. J., Rell-Bakalarska, M., Martincova, R., Fiore, S., Roh…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Mar 4\n    ",
         "20\n       citations  \n        1\n       mention   \n        A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.\n       \n      Langdahl, B. L., Teglbjærg, C. S., Ho, P., Chapurlat, R., Czerwinski, E., Kendler, D. L., Reginster,…\n     \n      The Journal of clinical endocrinology and metabolism\n      2015 Jan 22\n    ",
         "26\n       citations  \n        1\n       mention   \n        A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritis.\n       \n      Fleischmann, R. M., Damjanov, N. S., Kivitz, A. J., Legedza, A. T., Hoock, T., Kinnman, N.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2014 Nov 12\n    ",
         "  \n        Nearly Pain-Free Self-administration of Subcutaneous Methotrexate With an Autoinjector: Results of a Phase 2 Clinical Trial in Patients With Rheumatoid Arthritis Who Have Functional Limitations.\n       \n      Freundlich, B.,Kivitz, A.,Jaffe, J. S.…\n     \n      J Clin Rheumatol\n      2014 Jul 19\n    ",
         "  \n        Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study.\n       \n      Sundy, J. S.,Schumacher, H. R.,Kivitz, A.,Weinstein, S. P.,Wu, R.,King-Davis, S.,Evans, R. R.…\n     \n      J. Rheumatol.\n      2014 Jul 17\n    ",
         "40\n       citations  \n        1\n       mention   \n        Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.\n       \n      Kivitz, A. J., Olech, E., Borofsky, M., Zazueta, B. M., Navarro-Sarabia, F., Radominski, S. C., Merr…\n     \n      Arthritis care & research\n      2014 Jun 20\n    ",
         "  \n        Response to H Zeidler's comments on the CONCERTO study.\n       \n      Burmester, G. R.,Kivitz, A.,Kupper, H.,Arulmani, U.,Florentinus, S.,Goss, S. L.,Rathmann, S. S.,Flei…\n     \n      Ann. Rheum. Dis.\n      2014 Jun 11\n    ",
         "74\n       citations  \n        2\n       mentions   \n        Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial.\n       \n      Burmester, G., Kivitz, A. J., Kupper, H., Arulmani, U., Florentinus, S., Goss, S. L., Rathmann, S. S…\n     \n      Annals of the rheumatic diseases\n      2014 Feb 20\n    ",
         "4\n       citations    \n        A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.\n       \n      Bar-Or, D., Salottolo, K. M., Loose, H., Phillips, M. J., McGrath, B. E., Wei, N., Borders, J. L., E…\n     \n      PloS one\n      2014 Feb 6\n    ",
         "3\n       citations    \n        Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis.\n       \n      Pachon, J. A., Kivitz, A. J., Heuer, K., Pichlmeier, U.…\n     \n      SAGE open medicine\n      2014 Jan 1\n    ",
         "48\n       citations    \n        Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study.\n       \n      Padhi, D., Allison, M., Kivitz, A. J., Gutierrez, M. J., Stouch, B., Wang, C., Jang, G.…\n     \n      Journal of clinical pharmacology\n      2013 Nov 26\n    ",
         "  \n        Twice daily versus once nightly dosing of pregabalin for fibromyalgia: a double-blind randomized clinical trial of efficacy and safety.\n       \n      Nasser, K. M., Kivitz, A. J., Maricic, M. J., Silver, D. S., Silverman, S. L.…\n     \n      Arthritis care & research\n      2013 Aug 29\n    ",
         "  \n        Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis.\n       \n      Dervieux, T.,Weinblatt, M. E.,Kivitz, A.,Kremer, J. M.…\n     \n      Ann. Rheum. Dis.\n      2013 Jun\n    ",
         "37\n       citations  \n        2\n       mentions   \n        Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.\n       \n      Kivitz, A. J., Gimbel, J. S., Bramson, C., Nemeth, M. A., Keller, D. S., Brown, M. T., West, C. R., …\n     \n      Pain\n      2013 May 1\n    ",
         "53\n       citations  \n        2\n       mentions   \n        A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.\n       \n      Orwoll, E. S., Teglbjærg, C. S., Langdahl, B. L., Chapurlat, R., Czerwinski, E., Kendler, D. L., Reg…\n     \n      The Journal of clinical endocrinology and metabolism\n      2012 Jun 23\n    ",
         "  \n        Tocilizumab has no clinically relevant effects on methotrexate pharmacokinetics in patients with rheumatoid arthritis.\n       \n      Schmitt, C., Kuhn, B., Zhang, X., Kivitz, A., Grange, S.…\n     \n      Int J Clin Pharmacol Ther\n      2012 Mar\n    ",
         "  \n        Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis.\n       \n      Schmitt, C., Kuhn, B., Zhang, X., Kivitz, A. J., Grange, S.…\n     \n      Clin Pharmacol Ther\n      2011 May\n    ",
         "  \n        Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density.\n       \n      Genant, H. K., Engelke, K., Hanley, D. A., Brown, J. P., Omizo, M., Bone, H. G., Kivitz, A. J., Fuer…\n     \n      Bone\n      2010 Jul\n    ",
         "  \n        Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.\n       \n      Schnitzer, T. J., Kivitz, A., Frayssinet, H., Duquesroix, B.…\n     \n      Osteoarthr Cartil\n      2010 May\n    ",
         "  \n        A walking model to assess the onset of analgesia in osteoarthritis knee pain.\n       \n      Peeva, E., Beals, C. R., Bolognese, J. A., Kivitz, A. J., Taber, L., Harman, A., Smugar, S. S., Mosk…\n     \n      Osteoarthr Cartil\n      2010 May\n    ",
         "34\n       citations    \n        Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.\n       \n      Mease, P. J., Wei, N., Fudman, E. J., Kivitz, A. J., Schechtman, J., Trapp, R. G., Hobbs, K. F., Gre…\n     \n      The Journal of rheumatology\n      2009 Dec 25\n    ",
         "1\n       citations    \n        Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial.\n       \n      Koffeman, E. C., Genovese, M. C., Amox, D., Keogh, E., Santana, E., Matteson, E. L., Kavanaugh, A., …\n     \n      Arthritis and rheumatism\n      2009 Oct 31\n    ",
         "54\n       citations \n        1 NEW\n       \n        3\n       mentions   \n        Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.\n       \n      Goldbach-Mansky, R., Wilson, M., Fleischmann, R., Olsen, N. J., Silverfield, J., Kempf, P., Kivitz, …\n     \n      Annals of internal medicine\n      2009 Aug 19\n    ",
         "  \n        Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.\n       \n      van der Heijde, D., Schiff, M. H., Sieper, J., Kivitz, A. J., Wong, R. L., Kupper, H., Dijkmans, B. …\n     \n      Ann Rheum Dis\n      2009 Jun\n    ",
         "  \n        Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.\n       \n      Chevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, …\n     \n      Arthritis Rheum\n      2009 Mar 15\n    ",
         "  \n        Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.\n       \n      Kivitz, A., Fairfax, M., Sheldon, E. A., Xiang, Q., Jones, B. A., Gammaitoni, A. R., Gould, E. M.…\n     \n      Clin Ther\n      2008 Dec 01\n    ",
         "22\n       citations    \n        Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.\n       \n      Lewiecki, E. M., Keaveny, T. M., Kopperdahl, D. L., Genant, H. K., Engelke, K., Fuerst, T., Kivitz, …\n     \n      The Journal of clinical endocrinology and metabolism\n      2008 Oct 9\n    ",
         "  \n        Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.\n       \n      Davis, J. C., van der Heijde, D. M., Braun, J., Dougados, M., Clegg, D. O., Kivitz, A. J., Fleischma…\n     \n      Ann Rheum Dis\n      2008 Mar\n    ",
         "  \n        Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.\n       \n      Mease, P. J., Revicki, D. A., Szechinski, J., Greenwald, M., Kivitz, A., Barile-Fabris, L., Kalsi, J…\n     \n      J Rheumatol\n      2008 Jan\n    ",
         "1\n       citations    \n        A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.\n       \n      Kivitz, A. J., Espinoza, L. R., Sherrer, Y. R., Liu-Dumaw, M., West, C. R.…\n     \n      Seminars in arthritis and rheumatism\n      2007 Jun 16\n    ",
         "1\n       citations    \n        A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.\n       \n      Weisman, M. H., Paulus, H. E., Burch, F. X., Kivitz, A. J., Fierer, J., Dunn, M., Kerr, D. R., Tsuji…\n     \n      Rheumatology (Oxford, England)\n      2007 May 2\n    ",
         "  \n        HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab.\n       \n      Kivitz, A., Segurado, O. G.…\n     \n      Expert Rev Med Devices\n      2007 Mar\n    ",
         "140\n       citations    \n        Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.\n       \n      Kaine, J. L., Kivitz, A. J., Birbara, C., Luo, A. Y.…\n     \n      The Journal of rheumatology\n      2007 Feb 17\n    ",
         "  \n        Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial.\n       \n      Kivitz, A., Cohen, S., Dowd, J. E., Edwards, W., Thakker, S., Wellborne, F. R., Renz, C. L., Segurad…\n     \n      Clin Ther\n      2006 Oct\n    ",
         "  \n        A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.\n       \n      Kivitz, A., Ma, C., Ahdieh, H., Galer, B. S.…\n     \n      Clin Ther\n      2006 Mar\n    ",
         "117\n       citations    \n        Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.\n       \n      Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubens…\n     \n      The Journal of rheumatology\n      2006 Feb 8\n    ",
         "  \n        Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).\n       \n      Emkey, R., Koltun, W., Beusterien, K., Seidman, L., Kivitz, A., Devas, V., Masanauskaite, D.…\n     \n      Curr Med Res Opin\n      2005 Dec\n    ",
         "  \n        Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.\n       \n      Davis, J. C., van der Heijde, D. M., Braun, J., Dougados, M., Cush, J., Clegg, D., Inman, R. D., Kiv…\n     \n      Ann Rheum Dis\n      2005 Nov\n    ",
         "66\n       citations    \n        A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.\n       \n      Bradley, J. D., Dmitrienko, A. A., Kivitz, A. J., Gluck, O. S., Weaver, A. L., Wiesenhutter, C., Mye…\n     \n      The Journal of rheumatology\n      2005 Mar 3\n    ",
         "  \n        The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.\n       \n      Sowers, J. R., White, W. B., Pitt, B., Whelton, A., Simon, L. S., Winer, N., Kivitz, A., van Ingen, …\n     \n      Arch Intern Med\n      2005 Jan 24\n    ",
         "  \n        A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.\n       \n      van Holten, J., Pavelka, K., Vencovsky, J., Stahl, H., Rozman, B., Genovese, M., Kivitz, A. J., Alva…\n     \n      Ann Rheum Dis\n      2005 Jan\n    ",
         "13\n       citations    \n        Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials.\n       \n      Battisti, W. P., Katz, N. P., Weaver, A. L., Matsumoto, A. K., Kivitz, A. J., Polis, A. B., Geba, G.…\n     \n      The journal of pain : official journal of the American Pain Society\n      2004 Nov 24\n    ",
         "32\n       citations    \n        Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.\n       \n      Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubens…\n     \n      Arthritis and rheumatism\n      2004 Jul 13\n    ",
         "  \n        Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.\n       \n      Kivitz, A. J., Nayiager, S., Schimansky, T., Gimona, A., Thurston, H. J., Hawkey, C.…\n     \n      Aliment Pharmacol Ther\n      2004 Jun 1\n    ",
         "4\n       citations    \n        Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.\n       \n      Kivitz, A. J., Greenwald, M. W., Cohen, S. B., Polis, A. B., Najarian, D. K., Dixon, M. E., Moidel, …\n     \n      Journal of the American Geriatrics Society\n      2004 Apr 17\n    ",
         "  \n        Management of postmenopausal osteoporosis.\n       \n      Murphy, F. T., Kivitz, A. J., Sands, E. E.…\n     \n      The Journal of the American Osteopathic Association\n      2003 Nov 19\n    ",
         "17\n       citations    \n        Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.\n       \n      Davis, J. C., Van Der Heijde, D., Braun, J., Dougados, M., Cush, J. J., Clegg, D. O., Kivitz, A. J.,…\n     \n      Arthritis and rheumatism\n      2003 Nov 13\n    ",
         "  \n        A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects.\n       \n      Goldstein, J. L., Kivitz, A. J., Verburg, K. M., Recker, D. P., Palmer, R. C., Kent, J. D.…\n     \n      Aliment Pharmacol Ther\n      2003 Jul 1\n    ",
         "  \n        Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.\n       \n      Kavanaugh, A., Genovese, M., Baughman, J., Kivitz, A., Bulpitt, K., Olsen, N., Weisman, M., Matteson…\n     \n      J Rheumatol\n      2003 Mar\n    ",
         "  \n        Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.\n       \n      Kivitz, A., Eisen, G., Zhao, W. W., Bevirt, T., Recker, D. P.…\n     \n      J Fam Pract\n      2002 Jun\n    ",
         "  \n        Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.\n       \n      Kivitz, A. J., Moskowitz, R. W., Woods, E., Hubbard, R. C., Verburg, K. M., Lefkowith, J. B., Geis, …\n     \n      J Int Med Res\n      2002 Jan 24\n    ",
         "  \n        Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.\n       \n      Simon, L. S., Weaver, A. L., Graham, D. Y., Kivitz, A. J., Lipsky, P. E., Hubbard, R. C., Isakson, P…\n     \n      JAMA\n      1999 Nov 24\n    ",
         "  \n        Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers.\n       \n      Agrawal, N. M., Caldwell, J., Kivitz, A. J., Weaver, A. L., Bocanegra, T. S., Ball, J., Dhadda, S., …\n     \n      Clin Ther\n      1999 Apr\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[

      ],
      "memberships":[
         "   American College of Rheumatology - ACR Fellow",
         "   American College of Physicians - ACP Fellow"
      ],
      "clinical-trails":[
         "  A Study of LY3337641 in Moderate to Severe Rheumatoid Arthritis \n    Start of enrollment: 2016-07-01\n   \n    Call 1-877-CTLILLY (1-877-2...\n  ",
         "  A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis \n    Start of enrollment: 2016-04-01\n   \n    Call 1-877-CTLILLY (1-877-2...\n  ",
         "  Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon \n    Start of enrollment: 2016-02-01\n   \n    Robert Levy, MD\n  ",
         "  A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain \n    Start of enrollment: 2014-07-01\n   \n    Kivitz, A.,Murray, A.,Zewai...\n  ",
         "  Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) \n    Start of enrollment: 2014-06-01\n   \n    Lim, A.,Kivitz, A.,Tejada, ...\n  ",
         "  A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate \n    Start of enrollment: 2014-05-01\n   \n    Finck, B.K.,Hodge, J.\n  ",
         "  A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis \n    Start of enrollment: 2014-02-01\n   \n    Kivitz, A.,Cevera, A.,Clary...\n  ",
         "\n  Edit\n    Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus \n    Start of enrollment: 2014-01-01\n   \n    Mabaquiao, A.,Murray, A.,Je...\n  ",
         "\n  Edit\n    Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With SLE. \n    Start of enrollment: 2013-07-01\n   \n    Cohen, S.B.,Werth, V.P.,Ols...\n  ",
         "\n  Edit\n    A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis \n    Start of enrollment: 2013-06-01\n   \n    Jaffer, A.M.,Miller, K.A.,P...\n  ",
         "\n  Edit\n    Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects \n    Start of enrollment: 2013-05-01\n   \n    Kivitz, A.J.,Pappa, C.,Haza...\n  ",
         "\n  Edit\n    Study of Meloxicam Capsules to Treat Osteoarthritis Pain \n    Start of enrollment: 2013-02-01\n   \n    Kivitz, A.,Essink, B.,Andre...\n  ",
         "\n  Edit\n    A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis \n    Start of enrollment: 2012-04-01\n   \n    Lovell, D.J.\n  ",
         "\n  Edit\n    A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome \n    Start of enrollment: 2011-02-01\n   \n    Kivitz, A.,Lopez, A.,Attall...\n  ",
         "\n  Edit\n    Safety and Efficacy Study of Intramuscular Uricase-PEG 20 \n    Start of enrollment: 2009-12-01\n   \n    Kivitz, A.J.,Fiorino, A.S.,...\n  ",
         "\n  Edit\n    Safety and Efficacy Study of Intravenous Uricase-PEG 20 \n    Start of enrollment: 2009-10-01\n   \n    Kivitz, A.,Fiorino, A.S.\n  ",
         "\n  Edit\n    Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers \n    Start of enrollment: 2009-01-01\n   \n    Kivitz, A.J.,Cryer, B.L.,La...\n  ",
         "\n  Edit\n    Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome \n    Start of enrollment: 2008-02-01\n   \n    Kivitz, A.,Vivino, F.B.,Cha...\n  ",
         "\n  Edit\n    Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee \n    Start of enrollment: 2006-04-01\n   \n    Kivitz, A.,Levy, R.M.\n  ",
         "\n  Edit\n    Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee \n    Start of enrollment: 2006-03-01\n   \n    Kivitz, A.J.,McLain, D.A.,S...\n  ",
         "\n  Edit\n    A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis \n    Start of enrollment: 2005-12-01\n   \n    Fiechtner, J.J.,Genovese, M...\n  ",
         "\n  Edit\n    A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis  \n    Call 1-877-CTLILLY (1-877-2...\n  "
      ],
      "lectures":[

      ],
      "press-mentions":[
         "   \n        Altoona Center: A World-Class Research Facility Few Have Heard Of\n       \n      www.trialsitenews.com\n       · September 23, 2019  ...illy, Amgen, Novartis, and AbbVie just to mention a few big names. ‘A Hidden Secret’ Founded by Dr. Alan Kivitz who himself has over 37 years of experience in clinical research notes that “We are like a hidden s...",
         "   \n        Sarilumab Gets Nod from FDA for RA\n       \n      Rheumatology Network\n       · May 24, 2017  ...s those in the anti-TNF class, and is a welcome new option for patients and their physicians,\" said Alan Kivitz, M.D., in a written statement provided by Sanofi and Regeneron Pharmaceuticals, Inc. Dr. Kivitz is...",
         "   \n        Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs\n       \n      BioNews Feeds\n       · May 23, 2017  ...function, and resulting in significantly less radiographic progression of structural damage of RA,” Alan Kivitz, MD, founder and medical director of the Altoona Center for Clinical Research and Altoona Arthritis...",
         "   \n        Sanofi and Regeneron Announce FDA Approval of Kevzara® (Sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients\n       \n      PharmaLive\n       · May 22, 2017  ...ion, and resulting in significantly less radiographic progression of structural damage of RA,\" said Alan Kivitz, M.D., CPI, Founder and Medical Director of the Altoona Center for Clinical Research and Altoona Ar...",
         "   \n        Peficitinib Shows Dose-Dependent ACR20 Response Rates in RA\n       \n      Rheumatology Advisor\n       · May 22, 2017  "
      ],
      "hospital-info":[
         "   \n      Adult And Pediatric Rheumatology  ·  Duncansville, PA\n       \n    September 2019 - Present\n   ",
         "   \n      Altoona Arthritis and Osteoporosis Center  ·  Duncansville, PA\n       \n    February 2011 - Present\n   ",
         "   \n        James E. Van Zandt Veterans Affairs Medical Center\n       \n      Current Affiliation\n     \n        Altoona, PA\n    ",
         "   \n        UPMC Altoona\n       \n      Current Affiliation\n     \n        Altoona, PA\n    "
      ],
      "award-info":[
         "   \n      Fellow (FACP)\n     \n      American College of Physicians, 2006\n    ",
         "   \n      Fellow (FACR)\n     \n      American College of Rheumatology\n    "
      ],
      "support-grants":[

      ]
   },
   "P2":{
      "name":"\n          Timothy Edward McAlindon, MD\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/myw45ihcqfkmpr8drv9v.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        800 Washington Street\n       \n        Tufts Medical Center\n       \n        Boston, MA 02111\n        ",
      "phone":"\n      \n     \n      (617) 636-5990\n      ",
      "fax":"",
      "job-title":"\n",
      "summary":" \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        University of Southampton Faculty of Medicine\n       \n      Class of 1982\n    "
      ],
      "certifications&licences":[
         "   \n      MA State Medical License\n     \n      1997 - 2022\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Internal Medicine\n    "
      ],
      "publications&presentations":[
         "     \n        Comparative Safety Profile of Hyaluronic Acid Products for Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis\n       \n      Timothy McAlindon, MD…\n     \n      Osteoarthritis and Cartilage\n      \n    ",
         "     \n        A Decline in Walking Speed is Associated with Incident Knee Replacement in Adults with and at Risk for Knee Osteoarthritis.\n       \n      Harkey, M. S., Lapane, K. L., Liu, S., Lo, G. H., McAlindon, T. E., Driban, J. B.…\n     \n      The Journal of rheumatology\n      2020 Jun 17\n    ",
         "     \n        Risk factors and the natural history of accelerated knee osteoarthritis: a narrative review.\n       \n      Driban, J. B., Harkey, M. S., Barbe, M. F., Ward, R. J., MacKay, J. W., Davis, J. E., Lu, B., Price,…\n     \n      BMC musculoskeletal disorders\n      2020 May 31\n    ",
         "     \n        Composite quantitative knee structure metrics predict the development of accelerated knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Harkey, M. S., Davis, J. E., Price, L. L., Ward, R. J., MacKay, J. W., Eaton, C. B., Lo, G. H., Barb…\n     \n      BMC musculoskeletal disorders\n      2020 May 15\n    ",
         "     \n        Effect of vitamin D supplementation on pain and physical function in patients with knee osteoarthritis (OA): an OA Trial Bank protocol for a systematic review and individual patient data (IPD) meta-analysis.\n       \n      Jin, X., Antony, B., Wang, X., Persson, M. S., McAlindon, T., Arden, N. K., Srivastava, S., Srivasta…\n     \n      BMJ open\n      2020 Apr 26\n    ",
         "  \n        Stakeholder engagement in methodological research: Development of a clinical decision support tool.\n       \n      Daudelin, D. H., Ruthazer, R., Kwong, M., Lorenzana, R. C., Hannon, D. J., Kent, D. M., McAlindon, T…\n     \n      Journal of clinical and translational science\n      2020 Apr 22\n    ",
         "  \n        Intra-articular Corticosteroid Injections in the Hip and Knee: Perhaps Not as Dangerous as They Want You to Believe?\n       \n      McAlindon, T. E., Harkey, M. S., Ward, R. J., Hochberg, M. C., Driban, J. B.…\n     \n      Radiology\n      2020 Feb 26\n    ",
         "  \n        Patient-specific reference values for objective physical function tests: data from the Osteoarthritis Initiative.\n       \n      Harkey, M. S., Price, L. L., Reid, K. F., Lo, G. H., Liu, S., Lapane, K. L., Dantas, L. O., McAlindo…\n     \n      Clinical rheumatology\n      2020 Feb 8\n    ",
         "\n        1\n       mention \n        1 NEW\n        \n        The incidence and characteristics of accelerated knee osteoarthritis among women: the Chingford cohort.\n       \n      Driban, J. B., Bannuru, R. R., Eaton, C. B., Spector, T. D., Hart, D. J., McAlindon, T. E., Lu, B., …\n     \n      BMC musculoskeletal disorders\n      2020 Feb 2\n    ",
         "  \n        Dietary Patterns and Progression of Knee Osteoarthritis: Data from the Osteoarthritis Initiative.\n       \n      Xu, C., Marchand, N. E., Driban, J. B., McAlindon, T., Eaton, C. B., Lu, B.…\n     \n      The American journal of clinical nutrition\n      2020 Jan 9\n    ",
         "\n        1\n       mention \n        1 NEW\n        \n        Adults With Incident Accelerated Knee Osteoarthritis Are More Likely to Use Pharmacological Treatment Options and Receive Arthroscopic Knee Surgery: Data From the Osteoarthritis Initiative.\n       \n      Davis, J. E., Harkey, M. S., Liu, S., Lapane, K., Price, L. L., Lu, B., Lo, G. H., Eaton, C. B., Bar…\n     \n      ACR open rheumatology\n      2019 Nov 30\n    ",
         "\n        1\n       mention \n        1 NEW\n        \n        Football Increases Future Risk of Symptomatic Radiographic Knee Osteoarthritis.\n       \n      Lo, G. H., McAlindon, T. E., Kriska, A. M., Price, L. L., Rockette-Wagner, B. J., Mandl, L. A., Eato…\n     \n      Medicine and science in sports and exercise\n      2019 Oct 28\n    ",
         "  \n        Evidence that Swimming May Be Protective of Knee Osteoarthritis: Data from the Osteoarthritis Initiative.\n       \n      Lo, G. H., Ikpeama, U. E., Driban, J. B., Kriska, A. M., McAlindon, T. E., Petersen, N. J., Storti, …\n     \n      PM & R : the journal of injury, function, and rehabilitation\n      2019 Oct 20\n    ",
         "  \n        Reply.\n       \n      Driban, J. B., Harkey, M. S., Ward, R. J., Lo, G. H., MacKay, J. W., McAlindon, T. E.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2019 Oct 1\n    ",
         "  \n        The use of patient-specific equipoise to support shared decision-making for clinical care and enrollment into clinical trials.\n       \n      Selker, H. P., Daudelin, D. H., Ruthazer, R., Kwong, M., Lorenzana, R. C., Hannon, D. J., Wong, J. B…\n     \n      Journal of clinical and translational science\n      2019 Aug 14\n    ",
         "\n        2\n       mentions \n        1 NEW\n        \n        Role of Magnetic Resonance Imaging in Classifying Individuals Who Will Develop Accelerated Radiographic Knee Osteoarthritis.\n       \n      Price, L. L., Harkey, M. S., Ward, R. J., MacKay, J. W., Zhang, M., Pang, J., Davis, J. E., McAlindo…\n     \n      Journal of orthopaedic research : official publication of the Orthopaedic Research Society\n      2019 Jul 13\n    ",
         "\n        1\n       mention   \n        Accelerated knee osteoarthritis is associated with pre-radiographic degeneration of the extensor mechanism and cruciate ligaments: data from the Osteoarthritis Initiative.\n       \n      Davis, J. E., Harkey, M. S., Ward, R. J., MacKay, J. W., Lu, B., Price, L. L., Eaton, C. B., Lo, G. …\n     \n      BMC musculoskeletal disorders\n      2019 Jun 30\n    ",
         "\n        1\n       mention   \n        Early pre-radiographic structural pathology precedes the onset of accelerated knee osteoarthritis.\n       \n      Harkey, M. S., Davis, J. E., Lu, B., Price, L. L., Ward, R. J., MacKay, J. W., Eaton, C. B., Lo, G. …\n     \n      BMC musculoskeletal disorders\n      2019 May 23\n    ",
         "  \n        Duration of Symptom Relief and Early Trajectory of Adverse Events for Oral Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis: A Systematic Review and Meta-Analysis.\n       \n      Osani, M. C., Vaysbrot, E. E., Zhou, M., McAlindon, T. E., Bannuru, R. R.…\n     \n      Arthritis care & research\n      2019 Mar 26\n    ",
         "\n        4\n       mentions   \n        Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative.\n       \n      Zeng, C., Lane, N. E., Hunter, D. J., Wei, J., Choi, H. K., McAlindon, T. E., Li, H., Lu, N., Lei, G…\n     \n      Osteoarthritis and cartilage\n      2019 Feb 1\n    ",
         "\n        1\n       mention   \n        Sample size calculations for detecting disease-modifying osteoarthritis drug effects on the incidence of end-stage knee osteoarthritis in clinical trials: Data from the Osteoarthritis Initiative.\n       \n      Flechsenhar, K., Ried, J. S., Driban, J. B., Price, L. L., McAlindon, T.…\n     \n      Seminars in arthritis and rheumatism\n      2019 Jan 7\n    ",
         "  \n        Accelerated Knee Osteoarthritis Is Characterized by Destabilizing Meniscal Tears and Preradiographic Structural Disease Burden.\n       \n      Driban, J. B., Davis, J. E., Lu, B., Price, L. L., Ward, R. J., MacKay, J. W., Eaton, C. B., Lo, G. …\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Dec 29\n    ",
         "\n        1\n       mention   \n        Diffuse tibiofemoral cartilage change prior to the development of accelerated knee osteoarthritis: Data from the osteoarthritis initiative.\n       \n      Harkey, M. S., Davis, J. E., Lu, B., Price, L. L., Eaton, C. B., Lo, G. H., Barbe, M. F., Ward, R. J…\n     \n      Clinical anatomy (New York, N.Y.)\n      2018 Dec 7\n    ",
         "\n        1\n       mention   \n        Characteristics of Accelerated Hand Osteoarthritis: Data from the Osteoarthritis Initiative.\n       \n      Davis, J. E., Schaefer, L. F., McAlindon, T. E., Eaton, C. B., Roberts, M. B., Haugen, I. K., Smith,…\n     \n      The Journal of rheumatology\n      2018 Dec 7\n    ",
         "  \n        Validation of a new symptom outcome for knee osteoarthritis: the Ambulation Adjusted Score for Knee pain.\n       \n      Lo, G. H., Song, J., McAlindon, T. E., Hawker, G. A., Driban, J. B., Price, L. L., Eaton, C. B., Hoc…\n     \n      Clinical rheumatology\n      2018 Nov 13\n    ",
         "\n        3\n       mentions   \n        Effusion-synovitis and infrapatellar fat pad signal intensity alteration differentiate accelerated knee osteoarthritis.\n       \n      Davis, J. E., Ward, R. J., MacKay, J. W., Lu, B., Price, L. L., McAlindon, T. E., Eaton, C. B., Barb…\n     \n      Rheumatology (Oxford, England)\n      2018 Oct 23\n    ",
         "  \n        Correction to: Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.\n       \n      Arayssi, T., Harfouche, M., Darzi, A., Emadi, S. A., Alnaqbi, K. A., Badsha, H., Balushi, F. A., Dib…\n     \n      Clinical rheumatology\n      2018 Sep 8\n    ",
         "  \n        Incident hand OA is strongly associated with reduced peripheral blood leukocyte telomere length.\n       \n      McAlindon, T., Roberts, M., Driban, J., Schaefer, L., Haugen, I. K., Smith, S. E., Duryea, J., Cunha…\n     \n      Osteoarthritis and cartilage\n      2018 Sep 3\n    ",
         "\n        2\n       mentions   \n        Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.\n       \n      Arayssi, T., Harfouche, M., Darzi, A., Emadi, S. A., Alnaqbi, K. A., Badsha, H., Balushi, F. A., Dib…\n     \n      Clinical rheumatology\n      2018 Aug 12\n    ",
         "\n        2\n       mentions   \n        Longterm Effectiveness of Intraarticular Injections on Patient-reported Symptoms in Knee Osteoarthritis.\n       \n      Liu, S., Dubé, C. E., Eaton, C. B., Driban, J. B., McAlindon, T. E., Lapane, K. L.…\n     \n      The Journal of rheumatology\n      2018 Jun 17\n    ",
         "\n        1\n       mention   \n        Association Between Declining Walking Speed and Increasing Bone Marrow Lesion and Effusion Volume in Individuals with Accelerated Knee Osteoarthritis.\n       \n      Harkey, M. S., Price, L. L., McAlindon, T. E., Davis, J. E., Stout, A. C., Lu, B., Zhang, M., Eaton,…\n     \n      Arthritis care & research\n      2018 Jun 9\n    ",
         "  \n        Two cases of sarcoidosis presenting as longitudinally extensive transverse myelitis.\n       \n      Scott, A. M., Yinh, J., McAlindon, T. E., Kalish, R. A.…\n     \n      Clinical rheumatology\n      2018 May 18\n    ",
         "  \n        Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study.\n       \n      McAlindon, T. E., Schmidt, U., Bugarin, D., Abrams, S., Geib, T., DeGryse, R. E., Kim, K., Schnitzer…\n     \n      Osteoarthritis and cartilage\n      2018 May 13\n    ",
         "  \n        Running does not increase symptoms or structural progression in people with knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Lo, G. H., Musa, S. M., Driban, J. B., Kriska, A. M., McAlindon, T. E., Souza, R. B., Petersen, N. J…\n     \n      Clinical rheumatology\n      2018 May 8\n    ",
         "\n        2\n       mentions   \n        Association of subchondral bone texture on magnetic resonance imaging with radiographic knee osteoarthritis progression: data from the Osteoarthritis Initiative Bone Ancillary Study.\n       \n      MacKay, J. W., Kapoor, G., Driban, J. B., Lo, G. H., McAlindon, T. E., Toms, A. P., McCaskie, A. W.,…\n     \n      European radiology\n      2018 May 4\n    ",
         "1\n       citations  \n        103\n       mentions \n        4 NEW\n        \n        Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial.\n       \n      Wang, C., Schmid, C. H., Fielding, R. A., Harvey, W. F., Reid, K. F., Price, L. L., Driban, J. B., K…\n     \n      BMJ (Clinical research ed.)\n      2018 Mar 23\n    ",
         "  \n        Bioluminescence and second harmonic generation imaging reveal dynamic changes in the inflammatory and collagen landscape in early osteoarthritis.\n       \n      Mingalone, C. K., Liu, Z., Hollander, J. M., Garvey, K. D., Gibson, A. L., Banks, R. E., Zhang, M., …\n     \n      Laboratory investigation; a journal of technical methods and pathology\n      2018 Mar 16\n    ",
         "1\n       citations    \n        Periarticular bone predicts knee osteoarthritis progression: Data from the Osteoarthritis Initiative.\n       \n      Lo, G. H., Schneider, E., Driban, J. B., Price, L. L., Hunter, D. J., Eaton, C. B., Hochberg, M. C.,…\n     \n      Seminars in arthritis and rheumatism\n      2018 Feb 17\n    ",
         "\n        1\n       mention   \n        Adults with incident accelerated knee osteoarthritis are more likely to receive a knee replacement: data from the Osteoarthritis Initiative.\n       \n      Davis, J. E., Liu, S., Lapane, K., Harkey, M. S., Price, L. L., Lu, B., Lo, G. H., Eaton, C. B., Bar…\n     \n      Clinical rheumatology\n      2018 Feb 10\n    ",
         "\n        1\n       mention   \n        Characterizing the distinct structural changes associated with self-reported knee injury among individuals with incident knee osteoarthritis: Data from the osteoarthritis initiative.\n       \n      Davis, J. E., Harkey, M. S., Ward, R. J., Mackay, J. W., Lu, B., Price, L. L., Eaton, C. B., Barbe, …\n     \n      Clinical anatomy (New York, N.Y.)\n      2018 Jan 31\n    ",
         "  \n        Osteoarthritis in 2017: Latest advances in the management of knee OA.\n       \n      McAlindon, T. E., Bannuru, R. R.…\n     \n      Nature reviews. Rheumatology\n      2018 Jan 13\n    ",
         "  \n        Inflammation and glucose homeostasis are associated with specific structural features among adults without knee osteoarthritis: a cross-sectional study from the osteoarthritis initiative.\n       \n      Stout, A. C., Barbe, M. F., Eaton, C. B., Amin, M., Al-Eid, F., Price, L. L., Lu, B., Lo, G. H., Zha…\n     \n      BMC musculoskeletal disorders\n      2018 Jan 7\n    ",
         "  \n        The associations between radiographic hand osteoarthritis definitions and hand pain: data from the osteoarthritis initiative.\n       \n      Schaefer, L. F., McAlindon, T. E., Eaton, C. B., Roberts, M. B., Haugen, I. K., Smith, S. E., Duryea…\n     \n      Rheumatology international\n      2017 Dec 23\n    ",
         "  \n        Are Bisphosphonates Efficacious in Knee Osteoarthritis? A Meta-Analysis of Randomized Controlled Trials.\n       \n      Vaysbrot, E. E.,Osani, M. C.,Musetti, M. C.,McAlindon, T. E.,Bannuru, R. R.…\n     \n      Osteoarthr. Cartil.\n      2017 Dec 10\n    ",
         "\n        4\n       mentions   \n        Association of Vitamin K Status Combined With Vitamin D Status and Lower-Extremity Function: A Prospective Analysis of Two Knee Osteoarthritis Cohorts.\n       \n      Shea, M. K., Loeser, R. F., McAlindon, T. E., Houston, D. K., Kritchevsky, S. B., Booth, S. L.…\n     \n      Arthritis care & research\n      2017 Oct 19\n    ",
         "  \n        Long-Term Intra-Articular Steroid Injections and Knee Cartilage—Reply\n       \n      Timothy McAlindon, MD…\n     \n      JAMA Psychiatry\n      2017 Oct 4\n    ",
         "  \n        Knee Alignment Is Quantitatively Related to Periarticular Bone Morphometry and Density, Especially in Patients With Osteoarthritis.\n       \n      Lo, G. H., Merchant, M. G., Driban, J. B., Duryea, J., Price, L. L., Eaton, C. B., McAlindon, T. E.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Sep 25\n    ",
         "1\n       citations    \n        A single recent injury is a potent risk factor for the development of accelerated knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Davis, J. E., Price, L. L., Lo, G. H., Eaton, C. B., McAlindon, T. E., Lu, B., Barbe, M. F., Driban,…\n     \n      Rheumatology international\n      2017 Aug 24\n    ",
         "2\n       citations    \n        Determination of serum biomarkers in osteoarthritis patients: a previous interventional imaging study revisited.\n       \n      McAlindon, T. E., Bartnik, E., Ried, J. S., Teichert, L., Herrmann, M., Flechsenhar, K.…\n     \n      Journal of biomedical research\n      2017 Aug 16\n    ",
         "1\n       citations    \n        Risk factors can classify individuals who develop accelerated knee osteoarthritis: Data from the osteoarthritis initiative.\n       \n      Driban, J. B., McAlindon, T. E., Amin, M., Price, L. L., Eaton, C. B., Davis, J. E., Lu, B., Lo, G. …\n     \n      Journal of orthopaedic research : official publication of the Orthopaedic Research Society\n      2017 Aug 5\n    ",
         "3\n       citations    \n        Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data meta-analysis from the OA trial bank.\n       \n      Runhaar, J., Rozendaal, R. M., van Middelkoop, M., Bijlsma, H. J., Doherty, M., Dziedzic, K. S., Loh…\n     \n      Annals of the rheumatic diseases\n      2017 Jul 30\n    ",
         "1\n       citations  \n        2\n       mentions   \n        Patterns of intra-articular injection use after initiation of treatment in patients with knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Liu, S., Dubé, C. E., Driban, J. B., McAlindon, T. E., Eaton, C. B., Lapane, K. L.…\n     \n      Osteoarthritis and cartilage\n      2017 Jun 20\n    ",
         "2\n       citations    \n        2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.\n       \n      Buckley, L. M., Guyatt, G. H., Fink, H. A., Cannon, M., Grossman, J. M., Hansen, K. E., Humphrey, M.…\n     \n      Arthritis care & research\n      2017 Jun 7\n    ",
         "2\n       citations  \n        1\n       mention   \n        Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative.\n       \n      Lo, G. H., McAlindon, T. E., Katz, J. N., Driban, J. B., Price, L. L., Eaton, C. B., Petersen, N. J.…\n     \n      Clinical rheumatology\n      2017 Jun 3\n    ",
         "  \n        Development of a clinical prediction algorithm for knee osteoarthritis structural progression in a cohort study: value of adding measurement of subchondral bone density.\n       \n      LaValley, M. P., Lo, G. H., Price, L. L., Driban, J. B., Eaton, C. B., McAlindon, T. E.…\n     \n      Arthritis research & therapy\n      2017 May 18\n    ",
         "  \n        Mindfulness Is Associated With Treatment Response From Nonpharmacologic Exercise Interventions in Knee Osteoarthritis.\n       \n      Lee, A. C., Harvey, W. F., Price, L. L., Han, X., Driban, J. B., Wong, J. B., Chung, M., McAlindon, …\n     \n      Archives of physical medicine and rehabilitation\n      2017 May 17\n    ",
         "  \n        Subjective Crepitus as a Risk Factor for Incident Symptomatic Knee Osteoarthritis: Data From the Osteoarthritis Initiative.\n       \n      Lo, G. H., Strayhorn, M. T., Driban, J. B., Price, L. L., Eaton, C. B., Mcalindon, T. E.…\n     \n      Arthritis care & research\n      2017 May 5\n    ",
         "  \n        Sex differences in the association of skin advanced glycation endproducts with knee osteoarthritis progression.\n       \n      Eaton, C. B., Sayeed, M., Ameernaz, S., Roberts, M. B., Maynard, J. D., Driban, J. B., McAlindon, T.…\n     \n      Arthritis research & therapy\n      2017 Feb 19\n    ",
         "4\n       citations  \n        1\n       mention   \n        Knee symptoms among adults at risk for accelerated knee osteoarthritis: data from the Osteoarthritis Initiative.\n       \n      Davis, J. E., Eaton, C. B., Lo, G. H., Lu, B., Price, L. L., McAlindon, T. E., Barbe, M. F., Driban,…\n     \n      Clinical rheumatology\n      2017 Feb 12\n    ",
         "1\n       citations  \n        2\n       mentions   \n        Factors Associated with the Use of Hyaluronic Acid and Corticosteroid Injections among Patients with Radiographically Confirmed Knee Osteoarthritis: A Retrospective Data Analysis.\n       \n      Lapane, K. L., Liu, S., Dubé, C. E., Driban, J. B., McAlindon, T. E., Eaton, C. B.…\n     \n      Clinical therapeutics\n      2017 Feb 1\n    ",
         "3\n       citations    \n        Glucose homeostasis influences the risk of incident knee osteoarthritis: Data from the osteoarthritis initiative.\n       \n      Driban, J. B., Eaton, C. B., Amin, M., Stout, A. C., Price, L. L., Lu, B., Lo, G. H., McAlindon, T. …\n     \n      Journal of orthopaedic research : official publication of the Orthopaedic Research Society\n      2017 Jan 28\n    ",
         "5\n       citations    \n        Best performing definition of accelerated knee osteoarthritis: data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Stout, A. C., Lo, G. H., Eaton, C. B., Price, L. L., Lu, B., Barbe, M. F., McAlindon,…\n     \n      Therapeutic advances in musculoskeletal disease\n      2016 Oct 11\n    ",
         "4\n       citations  \n        2\n       mentions   \n        Safety of Repeated Injections of Sodium Hyaluronate (SUPARTZ) for Knee Osteoarthritis: A Systematic Review and Meta-Analysis.\n       \n      Bannuru, R. R., Brodie, C. R., Sullivan, M. C., McAlindon, T. E.…\n     \n      Cartilage\n      2016 Oct 1\n    ",
         "3\n       citations    \n        The relationship between meniscal pathology and osteoarthritis depends on the type of meniscal damage visible on magnetic resonance images: data from the Osteoarthritis Initiative.\n       \n      Antony, B., Driban, J. B., Price, L. L., Lo, G. H., Ward, R. J., Nevitt, M., Lynch, J., Eaton, C. B.…\n     \n      Osteoarthritis and cartilage\n      2016 Aug 20\n    ",
         "2\n       citations  \n        1\n       mention   \n        Comparison of self-report and objective measures of physical activity in US adults with osteoarthritis.\n       \n      Liu, S., Eaton, C. B., Driban, J. B., McAlindon, T. E., Lapane, K. L.…\n     \n      Rheumatology international\n      2016 Jul 21\n    ",
         "5\n       citations    \n        Coronal tibial slope is associated with accelerated knee osteoarthritis: data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Stout, A. C., Duryea, J., Lo, G. H., Harvey, W. F., Price, L. L., Ward, R. J., Eaton,…\n     \n      BMC musculoskeletal disorders\n      2016 Jul 20\n    ",
         "1\n       citations    \n        Is There an Association Between a History of Running and Symptomatic Knee Osteoarthritis? A Cross-Sectional Study From the Osteoarthritis Initiative.\n       \n      Lo, G. H., Driban, J. B., Kriska, A. M., McAlindon, T. E., Souza, R. B., Petersen, N. J., Storti, K.…\n     \n      Arthritis care & research\n      2016 Jun 23\n    ",
         "2\n       citations  \n        1\n       mention   \n        Lower leg muscle mass relates to knee pain in patients with knee osteoarthritis.\n       \n      Lee, J., Han, K., McAlindon, T. E., Park, Y. G., Park, S.…\n     \n      International journal of rheumatic diseases\n      2016 Jun 17\n    ",
         "  \n        Dietary Fat Intake and Radiographic Progression of Knee Osteoarthritis: Data From the Osteoarthritis Initiative.\n       \n      Lu, B., Driban, J. B., Xu, C., Lapane, K. L., McAlindon, T. E., Eaton, C. B.…\n     \n      Arthritis care & research\n      2016 Jun 9\n    ",
         "22\n       citations  \n        82\n       mentions \n        3 NEW\n        \n        Comparative Effectiveness of Tai Chi Versus Physical Therapy for Knee Osteoarthritis: A Randomized Trial.\n       \n      Wang, C., Schmid, C. H., Iversen, M. D., Harvey, W. F., Fielding, R. A., Driban, J. B., Price, L. L.…\n     \n      Annals of internal medicine\n      2016 May 18\n    ",
         "1\n       citations  \n        1\n       mention   \n        Defining and evaluating a novel outcome measure representing end-stage knee osteoarthritis: data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Price, L. L., Lynch, J., Nevitt, M. C., Lo, G. H., Eaton, C. B., McAlindon, T. E.…\n     \n      Clinical rheumatology\n      2016 May 18\n    ",
         "5\n       citations    \n        Objectively Measured Physical Activity and Symptoms Change in Knee Osteoarthritis.\n       \n      Liu, S., Driban, J. B., Eaton, C. B., McAlindon, T. E., Harrold, L. R., Lapane, K. L.…\n     \n      The American journal of medicine\n      2016 Feb 5\n    ",
         "10\n       citations  \n        1\n       mention   \n        The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids.\n       \n      van Middelkoop, M., Arden, N. K., Atchia, I., Birrell, F., Chao, J., Rezende, M. U., Lambert, R. G.,…\n     \n      Osteoarthritis and cartilage\n      2016 Feb 3\n    ",
         "\n        1\n       mention   \n        Reply.\n       \n      Lo, G. H., McAlindon, T. E., Driban, J. B., Hawker, G. A., Price, L. L., Song, J., Dunlop, D. D., Ea…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Jan 28\n    ",
         "1\n       citations  \n        1\n       mention   \n        Development of a Rapid Cartilage Damage Quantification Method for the Lateral Tibiofemoral Compartment Using Magnetic Resonance Images: Data from the Osteoarthritis Initiative.\n       \n      Zhang, M., Driban, J. B., Price, L. L., Lo, G. H., Miller, E. L., McAlindon, T. E.…\n     \n      BioMed research international\n      2015 Dec 30\n    ",
         "5\n       citations  \n        1\n       mention   \n        Overweight older adults, particularly after an injury, are at high risk for accelerated knee osteoarthritis: data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Eaton, C. B., Lo, G. H., Price, L. L., Lu, B., Barbe, M. F., McAlindon, T. E.…\n     \n      Clinical rheumatology\n      2015 Dec 22\n    ",
         "8\n       citations    \n        Individuals with incident accelerated knee osteoarthritis have greater pain than those with common knee osteoarthritis progression: data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Price, L. L., Eaton, C. B., Lu, B., Lo, G. H., Lapane, K. L., McAlindon, T. E.…\n     \n      Clinical rheumatology\n      2015 Nov 29\n    ",
         "2\n       citations  \n        1\n       mention   \n        Magnetic Resonance Image Sequence Influences the Relationship between Bone Marrow Lesions Volume and Pain: Data from the Osteoarthritis Initiative.\n       \n      Zhang, M., Driban, J. B., Price, L. L., Lo, G. H., McAlindon, T. E.…\n     \n      BioMed research international\n      2015 Nov 27\n    ",
         "390\n       citations  \n        60\n       mentions \n        2 NEW\n        \n        2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.\n       \n      Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Nov 8\n    ",
         "490\n       citations  \n        7\n       mentions   \n        2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.\n       \n      Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E.…\n     \n      Arthritis care & research\n      2015 Nov 8\n    ",
         "  \n        The relationship between smoking and knee osteoarthritis in the Osteoarthritis Initiative.\n       \n      Dubé, C. E., Liu, S., Driban, J. B., McAlindon, T. E., Eaton, C. B., Lapane, K. L.…\n     \n      Osteoarthritis and cartilage\n      2015 Oct 4\n    ",
         "3\n       citations    \n        Symptom assessment in knee osteoarthritis needs to account for physical activity level.\n       \n      Lo, G. H., McAlindon, T. E., Hawker, G. A., Driban, J. B., Price, L. L., Song, J., Eaton, C. B., Hoc…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Sep 26\n    ",
         "31\n       citations  \n        13\n       mentions   \n        Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials.\n       \n      Bannuru, R. R., McAlindon, T. E., Sullivan, M. C., Wong, J. B., Kent, D. M., Schmid, C. H.…\n     \n      Annals of internal medicine\n      2015 Jul 29\n    ",
         "5\n       citations    \n        Meniscal extrusion or subchondral damage characterize incident accelerated osteoarthritis: Data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Ward, R. J., Eaton, C. B., Lo, G. H., Price, L. L., Lu, B., McAlindon, T. E.…\n     \n      Clinical anatomy (New York, N.Y.)\n      2015 Jul 8\n    ",
         "4\n       citations    \n        Knee Pain and a Prior Injury Are Associated with Increased Risk of a New Knee Injury: Data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Lo, G. H., Eaton, C. B., Price, L. L., Lu, B., McAlindon, T. E.…\n     \n      The Journal of rheumatology\n      2015 Jun 3\n    ",
         "  \n        Reply: To PMID 25369996.\n       \n      Lapane, K. L., Liu, S., Dubé, C. E., Yang, S., Driban, J. B., McAlindon, T. E., Eaton, C. B.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Apr 22\n    ",
         "  \n        Reply: To PMID 25369761.\n       \n      Yang, S., Eaton, C. B., McAlindon, T. E., Lapane, K. L.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Apr 3\n    ",
         "25\n       citations  \n        2\n       mentions   \n        Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis.\n       \n      Bruyère, O., Cooper, C., Arden, N., Branco, J., Brandi, M. L., Herrero-Beaumont, G., Berenbaum, F., …\n     \n      Drugs & aging\n      2015 Feb 24\n    ",
         "8\n       citations  \n        1\n       mention   \n        A novel comparative effectiveness study of Tai Chi versus aerobic exercise for fibromyalgia: study protocol for a randomized controlled trial.\n       \n      Wang, C., McAlindon, T. E., Fielding, R. A., Harvey, W. F., Driban, J. B., Price, L. L., Kalish, R. …\n     \n      Trials\n      2015 Jan 31\n    ",
         "114\n       citations  \n        49\n       mentions   \n        Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.\n       \n      Bannuru, R. R., Schmid, C. H., Kent, D. M., Vaysbrot, E. E., Wong, J. B., McAlindon, T. E.…\n     \n      Annals of internal medicine\n      2015 Jan 7\n    ",
         "  \n        The association between vitamin K status and knee osteoarthritis features in older adults: The Health, Aging and Body Composition Study.\n       \n      Shea, M. K.,Kritchevsky, S. B.,Hsu, F.,Nevitt, M.,Booth, S. L.,Kwoh, C. K.,McAlindon, T. E.,Vermeer,…\n     \n      Osteoarthr. Cartil.\n      2014 Dec 22\n    ",
         "11\n       citations  \n        26\n       mentions   \n        Vitamin D deficiency is associated with progression of knee osteoarthritis.\n       \n      Zhang, F., Driban, J. B., Lo, G. H., Price, L. L., Booth, S. L., Eaton, C. B., Lu, B., Nevitt, M. C.…\n     \n      The Journal of nutrition\n      2014 Nov 21\n    ",
         "9\n       citations  \n        13\n       mentions   \n        Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models.\n       \n      Yang, S., Eaton, C. B., McAlindon, T. E., Lapane, K. L.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2014 Nov 6\n    ",
         "3\n       citations    \n        Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis.\n       \n      Lapane, K. L., Yang, S., Driban, J. B., Liu, S., Dubé, C. E., McAlindon, T. E., Eaton, C. B.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2014 Nov 6\n    ",
         "14\n       citations  \n        5\n       mentions   \n        Assessing the comparative effectiveness of Tai Chi versus physical therapy for knee osteoarthritis: design and rationale for a randomized trial.\n       \n      Wang, C., Iversen, M. D., McAlindon, T. E., Harvey, W. F., Wong, J. B., Fielding, R. A., Driban, J. …\n     \n      BMC complementary and alternative medicine\n      2014 Sep 10\n    ",
         "5\n       citations  \n        1\n       mention   \n        Development of a rapid knee cartilage damage quantification method using magnetic resonance images.\n       \n      Zhang, M., Driban, J. B., Price, L. L., Harper, D., Lo, G. H., Miller, E. L., Ward, R. J., McAlindon…\n     \n      BMC musculoskeletal disorders\n      2014 Aug 8\n    ",
         "1\n       citations    \n        On the use of coupled shape priors for segmentation of magnetic resonance images of the knee.\n       \n      Pang, J., Driban, J. B., McAlindon, T. E., Tamez-Peña, J. G., Fripp, J., Miller, E. L.…\n     \n      IEEE journal of biomedical and health informatics\n      2014 Jul 12\n    ",
         "10\n       citations    \n        Association of knee injuries with accelerated knee osteoarthritis progression: data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Eaton, C. B., Lo, G. H., Ward, R. J., Lu, B., McAlindon, T. E.…\n     \n      Arthritis care & research\n      2014 May 2\n    ",
         "  \n        Response to Letter to the Editor entitled \"Comments on \\'OARSI guidelines for the non-surgical management of knee osteoarthritis\\'\".\n       \n      McAlindon, T. E., Bannuru, R. R., Sullivan, M. C., Arden, N. K., Berenbaum, F., Bierma-Zeinstra, S. …\n     \n      Osteoarthritis and cartilage\n      2014 Apr 20\n    ",
         "  \n        Milk consumption and progression of medial tibiofemoral knee osteoarthritis: data from the Osteoarthritis Initiative.\n       \n      Lu, B., Driban, J. B., Duryea, J., McAlindon, T. E., Lapane, K. L., Eaton, C. B.…\n     \n      Arthritis care & research\n      2014 Apr 8\n    ",
         "473\n       citations  \n        27\n       mentions \n        2 NEW\n        \n        OARSI guidelines for the non-surgical management of knee osteoarthritis.\n       \n      McAlindon, T. E., Bannuru, R. R., Sullivan, M. C., Arden, N. K., Berenbaum, F., Bierma-Zeinstra, S. …\n     \n      Osteoarthritis and cartilage\n      2014 Jan 28\n    ",
         "5\n       citations    \n        Bone marrow lesion volume reduction is not associated with improvement of other periarticular bone measures: data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Lo, G. H., Price, L. L., Pang, J., Miller, E. L., Ward, R. J., Hunter, D. J., Eaton, …\n     \n      Arthritis research & therapy\n      2014 Jan 17\n    ",
         "37\n       citations  \n        3\n       mentions   \n        Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis.\n       \n      Bannuru, R. R., Vaysbrot, E. E., Sullivan, M. C., McAlindon, T. E.…\n     \n      Seminars in arthritis and rheumatism\n      2013 Nov 13\n    ",
         "6\n       citations    \n        Longitudinal use of complementary and alternative medicine among older adults with radiographic knee osteoarthritis.\n       \n      Yang, S., Dubé, C. E., Eaton, C. B., McAlindon, T. E., Lapane, K. L.…\n     \n      Clinical therapeutics\n      2013 Oct 23\n    ",
         "  \n        CAM use among overweight and obese persons with radiographic knee osteoarthritis.\n       \n      Lapane, K. L., Yang, S., Jawahar, R., McAlindon, T. E., Eaton, C. B.…\n     \n      BMC complementary and alternative medicine\n      2013 Oct 1\n    ",
         "20\n       citations    \n        Evaluation of bone marrow lesion volume as a knee osteoarthritis biomarker--longitudinal relationships with pain and structural changes: data from the Osteoarthritis Initiative.\n       \n      Driban, J. B., Price, L. L., Lo, G. H., Pang, J., Hunter, D. J., Miller, E. L., Ward, R. J., Eaton, …\n     \n      Arthritis research & therapy\n      2013 Sep 12\n    ",
         "12\n       citations  \n        1\n       mention   \n        Individual patient data meta-analysis of trials investigating the effectiveness of intra-articular glucocorticoid injections in patients with knee or hip osteoarthritis: an OA Trial Bank protocol for a systematic review.\n       \n      van Middelkoop, M., Dziedzic, K. S., Doherty, M., Zhang, W., Bijlsma, J. W., McAlindon, T. E., Lohma…\n     \n      Systematic reviews\n      2013 Jul 9\n    ",
         "  \n        Vitamin D supplementation in patients with osteoarthritis--reply.\n       \n      McAlindon, T. E., LaValley, M. P., Dawson-Hughes, B.…\n     \n      JAMA\n      2013 Apr 18\n    ",
         "7\n       citations  \n        2\n       mentions   \n        Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities.\n       \n      Henrotin, Y., Chevalier, X., Herrero-Beaumont, G., McAlindon, T. E., Mobasheri, A., Pavelka, K., Sch…\n     \n      BMC research notes\n      2013 Mar 28\n    ",
         "  \n        Relationship of bone mineral density to progression of knee osteoarthritis.\n       \n      Lee, J. Y., Harvey, W. F., Price, L. L., Paulus, J. K., Dawson-Hughes, B., McAlindon, T. E.…\n     \n      Arthritis and rheumatism\n      2013 Mar 16\n    ",
         "2\n       citations    \n        Osteoarthritis Research Society International (OARSI) Classification and Guidelines.\n       \n      McAlindon, T. E.…\n     \n      HSS journal : the musculoskeletal journal of Hospital for Special Surgery\n      2013 Feb 2\n    ",
         "61\n       citations  \n        12\n       mentions   \n        Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial.\n       \n      McAlindon, T. E., LaValley, M. P., Schneider, E., Nuite, M., Lee, J., Price, L. L., Lo, G., Dawson-H…\n     \n      JAMA\n      2013 Jan 10\n    ",
         "7\n       citations    \n        Quantification of bone marrow lesion volume and volume change using semi-automated segmentation: data from the osteoarthritis initiative.\n       \n      Pang, J., Driban, J. B., Destenaves, G., Miller, E. L., Lo, G. H., Ward, R. J., Price, L. L., Lynch,…\n     \n      BMC musculoskeletal disorders\n      2013 Jan 4\n    ",
         "  \n        Soft drink intake and progression of radiographic knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Lu, B.,Ahmad, O.,Zhang, F. F.,Driban, J. B.,Duryea, J.,Lapane, K. L.,McAlindon, T.,Eaton, C. B.…\n     \n      BMJ Open\n      2013\n    ",
         "  \n        The Influence of Tai Chi Exercise on Proprioception in Patients with Knee Osteoarthritis: Results from a Pilot Randomized Controlled Trial.\n       \n      Schmid, A., McAlindon, T. E., Schmid, C. H., Wang, C.…\n     \n      International journal of integrative medicine\n      2013 Jan 1\n    ",
         "  \n        American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice.\n       \n      McAlindon, T. E., Kissin, E. Y., Nazarian, L. N., Ranganath, V. K., Prakash, S., Taylor, M., Bannuru…\n     \n      Arthritis care & research\n      2012 Nov 1\n    ",
         "19\n       citations    \n        Osteoarthritis: Is viscosupplementation really so unsafe for knee OA?\n       \n      McAlindon, T. E., Bannuru, R. R.…\n     \n      Nature reviews. Rheumatology\n      2012 Sep 12\n    ",
         "5\n       citations    \n        Gender-specific correlates of complementary and alternative medicine use for knee osteoarthritis.\n       \n      Jawahar, R., Yang, S., Eaton, C. B., McAlindon, T. E., Lapane, K. L.…\n     \n      Journal of women's health (2002)\n      2012 Sep 6\n    ",
         "3\n       citations    \n        Racial differences in symptom management approaches among persons with radiographic knee osteoarthritis.\n       \n      Yang, S., Jawahar, R., McAlindon, T. E., Eaton, C. B., Lapane, K. L.…\n     \n      BMC complementary and alternative medicine\n      2012 Jul 10\n    ",
         "  \n        Cross-sectional DXA and MR measures of tibial periarticular bone associate with radiographic knee osteoarthritis severity.\n       \n      Lo, G. H.,Tassinari, A. M.,Driban, J. B.,Price, L. L.,Schneider, E.,Majumdar, S.,McAlindon, T. E.…\n     \n      Osteoarthr. Cartil.\n      2012 Jul\n    ",
         "1\n       citations    \n        A 3D system for culturing human articular chondrocytes in synovial fluid.\n       \n      Brand, J. A., McAlindon, T. E., Zeng, L.…\n     \n      Journal of visualized experiments : JoVE\n      2012 Feb 9\n    ",
         "13\n       citations    \n        Associations of varus thrust and alignment with pain in knee osteoarthritis.\n       \n      Lo, G. H., Harvey, W. F., McAlindon, T. E.…\n     \n      Arthritis and rheumatism\n      2012 Feb 7\n    ",
         "4\n       citations    \n        Osteoarthritis year 2011 in review: clinical.\n       \n      McAlindon, T. E., Driban, J. B., Lo, G. H.…\n     \n      Osteoarthritis and cartilage\n      2012 Jan 24\n    ",
         "  \n        Use of complementary and alternative medicine among patients with radiographic-confirmed knee osteoarthritis.\n       \n      Lapane, K. L., Sands, M. R., Yang, S., McAlindon, T. E., Eaton, C. B.…\n     \n      Osteoarthr Cartil\n      2012 Jan\n    ",
         "9\n       citations    \n        Quantitative bone marrow lesion size in osteoarthritic knees correlates with cartilage damage and predicts longitudinal cartilage loss.\n       \n      Driban, J. B., Lo, G. H., Lee, J., Ward, R. J., Miller, E. L., Pang, J., Price, L. L., McAlindon, T.…\n     \n      BMC musculoskeletal disorders\n      2011 Oct 4\n    ",
         "  \n        Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis.\n       \n      Bannuru, R. R., Natov, N. S., Dasi, U. R., Schmid, C. H., McAlindon, T. E.…\n     \n      Osteoarthr Cartil\n      2011 Jun\n    ",
         "  \n        Comparison of BLOKS and WORMS scoring systems part II. Longitudinal assessment of knee MRIs for osteoarthritis and suggested approach based on their performance: data from the Osteoarthritis Initiative.\n       \n      Felson, D. T., Lynch, J., Guermazi, A., Roemer, F. W., Niu, J., McAlindon, T., Nevitt, M. C.…\n     \n      Osteoarthr Cartil\n      2010 Nov\n    ",
         "38\n       citations    \n        Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis.\n       \n      Hunter, D. J., Pike, M. C., Jonas, B. L., Kissin, E. Y., Krop, J., McAlindon, T. E.…\n     \n      BMC musculoskeletal disorders\n      2010 Oct 12\n    ",
         "164\n       citations  \n        43\n       mentions   \n        A randomized trial of tai chi for fibromyalgia.\n       \n      Wang, C., Schmid, C. H., Rones, R., Kalish, R. A., Yinh, J., Goldenberg, D. L., Lee, Y., McAlindon, …\n     \n      The New England journal of medicine\n      2010 Sep 8\n    ",
         "10\n       citations    \n        Magnetic resonance imaging evaluation of weight-bearing subchondral trabecular bone in the knee.\n       \n      Schneider, E., Lo, G. H., Sloane, G., Fanella, L., Hunter, D. J., Eaton, C. B., McAlindon, T. E.…\n     \n      Skeletal radiology\n      2010 May 8\n    ",
         "  \n        Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus.\n       \n      Wang, J., Nuite, M., McAlindon, T. E.…\n     \n      Lupus\n      2010 May\n    ",
         "  \n        OARSI recommendations for the management of hip and knee osteoarthritis: the semantics of differences and changes.\n       \n      McAlindon, T. E., Bannuru, R. R.…\n     \n      Osteoarthr Cartil\n      2010 Apr\n    ",
         "123\n       citations  \n        2\n       mentions   \n        Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis.\n       \n      Bannuru, R. R., Natov, N. S., Obadan, I. E., Price, L. L., Schmid, C. H., McAlindon, T. E.…\n     \n      Arthritis and rheumatism\n      2009 Dec 2\n    ",
         "  \n        Bone marrow lesions and joint effusion are strongly and independently associated with weight-bearing pain in knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Lo, G. H., McAlindon, T. E., Niu, J., Zhang, Y., Beals, C., Dabrowski, C., Le Graverand, M. P., Hunt…\n     \n      Osteoarthr Cartil\n      2009 Dec 01\n    ",
         "92\n       citations  \n        13\n       mentions   \n        Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial.\n       \n      Wang, C., Schmid, C. H., Hibberd, P. L., Kalish, R. A., Roubenoff, R., Rones, R., McAlindon, T. E.…\n     \n      Arthritis and rheumatism\n      2009 Oct 31\n    ",
         "  \n        Strong association of MRI meniscal derangement and bone marrow lesions in knee osteoarthritis: data from the osteoarthritis initiative.\n       \n      Lo, G. H., Hunter, D. J., Nevitt, M., Lynch, J., McAlindon, T. E.…\n     \n      Osteoarthr Cartil\n      2009 Jun 01\n    ",
         "  \n        Alcohol consumption is not protective for systemic lupus erythematosus.\n       \n      Wang, J., Kay, A. B., Fletcher, J., Formica, M. K., McAlindon, T. E.…\n     \n      Ann Rheum Dis\n      2009 Mar\n    ",
         "22\n       citations  \n        1\n       mention   \n        Acupuncture for pain relief in patients with rheumatoid arthritis: a systematic review.\n       \n      Wang, C., de Pablo, P., Chen, X., Schmid, C. H., McAlindon, T. E.…\n     \n      Arthritis and rheumatism\n      2008 Sep 2\n    ",
         "  \n        Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis.\n       \n      Emrani, P. S., Katz, J. N., Kessler, C. L., Reichmann, W. M., Wright, E. A., McAlindon, T. E., Losin…\n     \n      Osteoarthr Cartil\n      2008 Aug\n    ",
         "15\n       citations  \n        1\n       mention   \n        Tai Chi for treating knee osteoarthritis: designing a long-term follow up randomized controlled trial.\n       \n      Wang, C., Schmid, C. H., Hibberd, P. L., Kalish, R. A., Roubenoff, R., Rones, R., Okparavero, A., Mc…\n     \n      BMC musculoskeletal disorders\n      2008 Jul 31\n    ",
         "  \n        2007 OARSI recommendations for the management of hip and knee osteoarthritis: towards consensus?\n       \n      McAlindon, T., Zucker, N. V., Zucker, M. O.…\n     \n      Osteoarthr Cartil\n      2008 Jun\n    ",
         "  \n        Meniscal damage associated with increased local subchondral bone mineral density: a Framingham study.\n       \n      Lo, G. H., Niu, J., McLennan, C. E., Kiel, D. P., McLean, R. R., Guermazi, A., Genant, H. K., McAlin…\n     \n      Osteoarthr Cartil\n      2008 Feb\n    ",
         "134\n       citations    \n        Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population.\n       \n      de Pablo, P., Dietrich, T., McAlindon, T. E.…\n     \n      The Journal of rheumatology\n      2007 Dec 1\n    ",
         "  \n        Is treatment with chondroitin efficacious for osteoarthritis?\n       \n      McAlindon, T. E.…\n     \n      Nat Clin Pract Rheumatol\n      2007 Nov\n    ",
         "82\n       citations  \n        8\n       mentions \n        2 NEW\n        \n        Glucosamine for pain in osteoarthritis: why do trial results differ?\n       \n      Vlad, S. C., LaValley, M. P., McAlindon, T. E., Felson, D. T.…\n     \n      Arthritis and rheumatism\n      2007 Jun 30\n    ",
         "  \n        Changes in barometric pressure and ambient temperature influence osteoarthritis pain.\n       \n      McAlindon, T., Formica, M., Schmid, C. H., Fletcher, J.…\n     \n      Am J Med\n      2007 May\n    ",
         "  \n        Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis.\n       \n      Biggee, B. A., Blinn, C. M., Nuite, M., Silbert, J. E., McAlindon, T. E.…\n     \n      Ann Rheum Dis\n      2007 Feb\n    ",
         "1\n       citations    \n        Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury lupus project.\n       \n      Karlson, E. W., Watts, J., Signorovitch, J., Bonetti, M., Wright, E. A., Cooper, G. S., McAlindon, T…\n     \n      Arthritis and rheumatism\n      2006 Dec 30\n    ",
         "1\n       citations    \n        Small vessel vasculitis in a patient with botryomycosis.\n       \n      Snowden, M. J., McAlindon, T. E., Morosan, C. G., Lo, G. H.…\n     \n      The Journal of rheumatology\n      2006 Dec 5\n    ",
         "5\n       citations    \n        Alcohol consumption as a trigger of recurrent gout attacks.\n       \n      Zhang, Y., Woods, R., Chaisson, C. E., Neogi, T., Niu, J., McAlindon, T. E., Hunter, D. J.…\n     \n      The American journal of medicine\n      2006 Sep 2\n    ",
         "  \n        Sulphate and osteoarthritis: decrease of serum sulphate levels by an additional 3-h fast and a 3-h glucose tolerance test after an overnight fast.\n       \n      Blinn, C. M., Biggee, B. A., McAlindon, T. E., Nuite, M., Silbert, J. E.…\n     \n      Ann Rheum Dis\n      2006 Sep\n    ",
         "16\n       citations    \n        Nutraceuticals: do they work and when should we use them?\n       \n      McAlindon, T. E.…\n     \n      Bailliere's best practice & research. Clinical rheumatology\n      2006 Feb 18\n    ",
         "  \n        Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness.\n       \n      Biggee, B. A., Blinn, C. M., McAlindon, T. E., Nuite, M., Silbert, J. E.…\n     \n      Ann Rheum Dis\n      2006 Feb\n    ",
         "  \n        High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women.\n       \n      Karlson, E. W., Costenbader, K. H., McAlindon, T. E., Massarotti, E. M., Fitzgerald, L. M., Jajoo, R…\n     \n      Lupus\n      2005\n    ",
         "4\n       citations    \n        Considerations in the treatment of early osteoarthritis.\n       \n      Arabelovic, S., McAlindon, T. E.…\n     \n      Current rheumatology reports\n      2005 Mar 12\n    ",
         "  \n        Glucosamine for osteoarthritis: part I, review of the clinical evidence.\n       \n      Biggee, B. A., McAlindon, T.…\n     \n      Med Health R I\n      2004 Jun\n    ",
         "  \n        Glucosamine for osteoarthritis: part II, biologic and metabolic controversies.\n       \n      Biggee, B. A., McAlindon, T.…\n     \n      Med Health R I\n      2004 Jun\n    ",
         "9\n       citations    \n        Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.\n       \n      Formica, M., Kabbara, K., Clark, R. A., McAlindon, T. E.…\n     \n      Journal of medical Internet research\n      2004 Apr 28\n    ",
         "192\n       citations  \n        1\n       mention   \n        Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis.\n       \n      Lo, G. H., LaValley, M. P., McAlindon, T. E., Felson, D. T.…\n     \n      JAMA\n      2003 Dec 18\n    ",
         "  \n        Assessment of strategies for identifying diagnosed cases of systemic lupus erythematosus through self-report.\n       \n      McAlindon, T. E., Formica, M., Palmer, J. R., Lafyatis, R., Rosenberg, L.…\n     \n      Lupus\n      2003\n    ",
         "  \n        Why are clinical trials of glucosamine no longer uniformly positive?\n       \n      McAlindon, T.…\n     \n      Rheum Dis Clin North Am\n      2003 Nov\n    ",
         "47\n       citations    \n        Smoking, alcohol consumption, and risk of systemic lupus erythematosus in the Black Women's Health Study.\n       \n      Formica, M. K., Palmer, J. R., Rosenberg, L., McAlindon, T. E.…\n     \n      The Journal of rheumatology\n      2003 Jun 5\n    ",
         "  \n        Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity.\n       \n      McAlindon, T. E., Gulin, J., Chen, T., Klug, T., Lahita, R., Nuite, M.…\n     \n      Lupus\n      2001\n    ",
         "  \n        Absence of linkage or association for osteoarthritis with the vitamin D receptor/type II collagen locus: the Framingham Osteoarthritis Study.\n       \n      Baldwin, C. T., Cupples, L. A., Joost, O., Demissie, S., Chaisson, C., Mcalindon, T., Myers, R. H., …\n     \n      J Rheumatol\n      2002 Jan\n    ",
         "  \n        Microchimerism in a female patient with systemic lupus erythematosus.\n       \n      Johnson, K. L., McAlindon, T. E., Mulcahy, E., Bianchi, D. W.…\n     \n      Arthritis Rheum\n      2001 Sep\n    ",
         "  \n        Glucosamine and chondroitin for osteoarthritis?\n       \n      McAlindon, T.…\n     \n      Bull Rheum Dis\n      2001 Jul\n    ",
         "  \n        Problems in the development and validation of questionnaire-based screening instruments for ascertaining cases with symptomatic knee osteoarthritis: the Framingham Study.\n       \n      LaValley, M., McAlindon, T. E., Evans, S., Chaisson, C. E., Felson, D. T.…\n     \n      Arthritis Rheum\n      2001 May\n    ",
         "  \n        Glusoamine for osteoarthritis: dawn of a new era?\n       \n      McAlindon, T.…\n     \n      Lancet\n      2001 Jan 27\n    ",
         "  \n        The validity of different definitions of radiographic worsening for longitudinal studies of knee osteoarthritis.\n       \n      LaValley, M. P., McAlindon, T. E., Chaisson, C. E., Levy, D., Felson, D. T.…\n     \n      J Clin Epidemiol\n      2001 Jan\n    ",
         "  \n        Osteoarthritis: new insights. Part 2: treatment approaches.\n       \n      Felson, D. T., Lawrence, R. C., Hochberg, M. C., McAlindon, T., Dieppe, P. A., Minor, M. A., Blair, …\n     \n      Ann Intern Med\n      2000 Nov 7\n    ",
         "  \n        Osteoarthritis: new insights. Part 1: the disease and its risk factors.\n       \n      Felson, D. T., Lawrence, R. C., Dieppe, P. A., Hirsch, R., Helmick, C. G., Jordan, J. M., Kington, R…\n     \n      Ann Intern Med\n      2000 Oct 17\n    ",
         "  \n        Exercise for knee osteoarthritis.\n       \n      Baker, K., McAlindon, T.…\n     \n      Curr Opin Rheumatol\n      2000 Sep\n    ",
         "  \n        Glucosamine and chondroitin for osteoarthritis: to recommend or not to recommend?\n       \n      Felson, D. T., McAlindon, T. E.…\n     \n      Arthritis Care Res\n      2000 Aug\n    ",
         "  \n        In vitro and in vivo spin echo diffusion imaging characteristics of synovial fluid: potential non-invasive differentiation of inflammatory and degenerative arthritis.\n       \n      Eustace, S., DiMasi, M., Adams, J., Ward, R., Caruthers, S., McAlindon, T.…\n     \n      Skeletal Radiol\n      2000 Jun\n    ",
         "  \n        Risk factors for the incidence and progression of radiographic knee osteoarthritis.\n       \n      Cooper, C., Snow, S., McAlindon, T. E., Kellingray, S., Stuart, B., Coggon, D., Dieppe, P. A.…\n     \n      Arthritis Rheum\n      2000 May\n    ",
         "  \n        Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study.\n       \n      Zhang, Y., Hannan, M. T., Chaisson, C. E., McAlindon, T. E., Evans, S. R., Aliabadi, P., Levy, D., F…\n     \n      J Rheumatol\n      2000 Apr\n    ",
         "  \n        Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis.\n       \n      McAlindon, T. E., LaValley, M. P., Gulin, J. P., Felson, D. T.…\n     \n      JAMA\n      2000 Mar 15\n    ",
         "  \n        Update on the epidemiology of systemic lupus erythematosus: new spins on old ideas.\n       \n      McAlindon, T.…\n     \n      Curr Opin Rheumatol\n      2000 Mar\n    ",
         "  \n        Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis.\n       \n      Adams, J. G., McAlindon, T., Dimasi, M., Carey, J., Eustace, S.…\n     \n      Clin Radiol\n      1999 Aug\n    ",
         "  \n        Regional musculoskeletal pain. The knee.\n       \n      McAlindon, T. E.…\n     \n      Baillieres Best Pract Res Clin Rheumatol\n      1999 Jun\n    ",
         "  \n        Level of physical activity and the risk of radiographic and symptomatic knee osteoarthritis in the elderly: the Framingham study.\n       \n      McAlindon, T. E., Wilson, P. W., Aliabadi, P., Weissman, B., Felson, D. T.…\n     \n      Am J Med\n      1999 Feb\n    ",
         "  \n        Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study.\n       \n      Zhang, Y., McAlindon, T. E., Hannan, M. T., Chaisson, C. E., Klein, R., Wilson, P. W., Felson, D. T.…\n     \n      Arthritis Rheum\n      1998 Oct\n    ",
         "  \n        Longitudinal analysis of the relationship between serum insulin-like growth factor-I and radiographic knee osteoarthritis.\n       \n      Fraenkel, L., Zhang, Y., Trippel, S. B., McAlindon, T. E., LaValley, M. P., Assif, A., Adams, K. E.,…\n     \n      Osteoarthr Cartil\n      1998 Sep\n    ",
         "  \n        The association of peripheral monocyte derived interleukin 1beta (IL-1beta), IL-1 receptor antagonist, and tumor necrosis factor-alpha with osteoarthritis in the elderly.\n       \n      Fraenkel, L., Roubenoff, R., LaValley, M., McAlindon, T., Chaisson, C., Evans, S., Harris, T., Dinar…\n     \n      J Rheumatol\n      1998 Sep\n    ",
         "  \n        Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study.\n       \n      Felson, D. T., Couropmitree, N. N., Chaisson, C. E., Hannan, M. T., Zhang, Y., McAlindon, T. E., LaV…\n     \n      Arthritis Rheum\n      1998 Jun\n    ",
         "  \n        Disc degeneration/back pain and calcification of the abdominal aorta. A 25-year follow-up study in Framingham.\n       \n      Kauppila, L. I., McAlindon, T., Evans, S., Wilson, P. W., Kiel, D., Felson, D. T.…\n     \n      Spine (Phila Pa 1976)\n      1997 Jul 15\n    ",
         "  \n        Radiographic hand osteoarthritis: incidence, patterns, and influence of pre-existing disease in a population based sample.\n       \n      Chaisson, C. E., Zhang, Y., McAlindon, T. E., Hannan, M. T., Aliabadi, P., Naimark, A., Levy, D., Fe…\n     \n      J Rheumatol\n      1997 Jul\n    ",
         "  \n        Defining radiographic osteoarthritis for the whole knee.\n       \n      Felson, D. T., McAlindon, T. E., Anderson, J. J., Naimark, A., Weissman, B. W., Aliabadi, P., Evans,…\n     \n      Osteoarthr Cartil\n      1997 Jul\n    ",
         "  \n        Nutrition: risk factors for osteoarthritis.\n       \n      McAlindon, T., Felson, D. T.…\n     \n      Ann Rheum Dis\n      1997 Jul\n    ",
         "  \n        Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study.\n       \n      Lloyd, M. E., Hart, D. J., Nandra, D., McAlindon, T. E., Wheeler, M., Doyle, D. V., Spector, T. D.…\n     \n      Ann Rheum Dis\n      1996 Dec\n    ",
         "  \n        Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study.\n       \n      McAlindon, T. E., Felson, D. T., Zhang, Y., Hannan, M. T., Aliabadi, P., Weissman, B., Rush, D., Wil…\n     \n      Ann Intern Med\n      1996 Sep 1\n    ",
         "  \n        Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?\n       \n      McAlindon, T. E., Jacques, P., Zhang, Y., Hannan, M. T., Aliabadi, P., Weissman, B., Rush, D., Levy,…\n     \n      Arthritis Rheum\n      1996 Apr\n    ",
         "  \n        Lack of association between thyroid status and chondrocalcinosis or osteoarthritis: the Framingham Osteoarthritis Study.\n       \n      Chaisson, C. E., McAlindon, T. E., Felson, D. T., Naimark, A., Wilson, P. W., Sawin, C. T.…\n     \n      J Rheumatol\n      1996 Apr\n    ",
         "  \n        Are risk factors for patellofemoral and tibiofemoral knee osteoarthritis different?\n       \n      McAlindon, T., Zhang, Y., Hannan, M., Naimark, A., Weissman, B., Castelli, W., Felson, D.…\n     \n      J Rheumatol\n      1996 Feb\n    ",
         "  \n        Occupational activity and osteoarthritis of the knee.\n       \n      Cooper, C., McAlindon, T., Coggon, D., Egger, P., Dieppe, P.…\n     \n      Ann Rheum Dis\n      1994 Feb\n    ",
         "  \n        Mechanical and constitutional risk factors for symptomatic knee osteoarthritis: differences between medial tibiofemoral and patellofemoral disease.\n       \n      Cooper, C., McAlindon, T., Snow, S., Vines, K., Young, P., Kirwan, J., Dieppe, P.…\n     \n      J Rheumatol\n      1994 Feb\n    ",
         "  \n        Transient regional osteoporosis presenting as a septic arthritis.\n       \n      McAlindon, T. E., Ward, S. A., MacFarlane, D., Mathews, J. A.…\n     \n      Postgrad Med J\n      1993 Nov\n    ",
         "  \n        Environmental factors predicting nephritis in systemic lupus erythematosus.\n       \n      McAlindon, T., Giannotta, L., Taub, N., D'Cruz, D., Hughes, G.…\n     \n      Ann Rheum Dis\n      1993 Oct\n    ",
         "  \n        Radiographic assessment of patellofemoral osteoarthritis.\n       \n      Jones, A. C., Ledingham, J., McAlindon, T., Regan, M., Hart, D., MacMillan, P. J., Doherty, M.…\n     \n      Ann Rheum Dis\n      1993 Sep\n    ",
         "  \n        Possible danger of cold water.\n       \n      Hanson, J. H., McAlindon, T. E.…\n     \n      Br J Rheumatol\n      1993 Jun\n    ",
         "  \n        Determinants of disability in osteoarthritis of the knee.\n       \n      McAlindon, T. E., Cooper, C., Kirwan, J. R., Dieppe, P. A.…\n     \n      Ann Rheum Dis\n      1993 Apr\n    ",
         "  \n        Levels of insulin related growth factor 1 in osteoarthritis of the knee.\n       \n      McAlindon, T. E., Teale, J. D., Dieppe, P. A.…\n     \n      Ann Rheum Dis\n      1993 Mar\n    ",
         "  \n        Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint.\n       \n      McAlindon, T. E., Snow, S., Cooper, C., Dieppe, P. A.…\n     \n      Ann Rheum Dis\n      1992 Jul\n    ",
         "  \n        Knee pain and disability in the community.\n       \n      McAlindon, T. E., Cooper, C., Kirwan, J. R., Dieppe, P. A.…\n     \n      Br J Rheumatol\n      1992 Mar\n    ",
         "  \n        Radiographic assessment of the knee joint in osteoarthritis.\n       \n      Cooper, C., Cushnaghan, J., Kirwan, J. R., Dieppe, P. A., Rogers, J., McAlindon, T., McCrae, F.…\n     \n      Ann Rheum Dis\n      1992 Jan\n    ",
         "  \n        Magnetic resonance imaging in osteoarthritis of the knee: correlation with radiographic and scintigraphic findings.\n       \n      McAlindon, T. E., Watt, I., McCrae, F., Goddard, P., Dieppe, P. A.…\n     \n      Ann Rheum Dis\n      1991 Jan\n    ",
         "  \n        The medical management of osteoarthritis of the knee: an inflammatory issue?\n       \n      McAlindon, T., Dieppe, P.…\n     \n      Br J Rheumatol\n      1990 Dec\n    ",
         "  \n        Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy.\n       \n      Seegmiller, J. E., Dixon, R. M., Kemp, G. J., Angus, P. W., McAlindon, T. E., Dieppe, P., Rajagopala…\n     \n      Proc Natl Acad Sci U S A\n      1990 Nov\n    ",
         "  \n        Clinical assessment of osteoarthritis of the knee.\n       \n      Cushnaghan, J., Cooper, C., Dieppe, P., Kirwan, J., McAlindon, T., McCrae, F.…\n     \n      Ann Rheum Dis\n      1990 Oct\n    ",
         "  \n        An aberration of fructose metabolism in familial gout identified by 31P magnetic resonance spectroscopy of the liver.\n       \n      Seegmiller, J. E., Dixon, R. M., Kemp, G. J., Angus, P. W., McAlindon, T. E., Dieppe, P., Rajagopala…\n     \n      Trans Assoc Am Physicians\n      1990\n    ",
         "  \n        Osteoarthritis: definitions and criteria.\n       \n      McAlindon, T., Dieppe, P.…\n     \n      Ann Rheum Dis\n      1989 Jul\n    ",
         "  \n        Mononeuritis multiplex and occipital infarction complicating giant cell arteritis.\n       \n      McAlindon, T. E., Ferguson, I. T.…\n     \n      Br J Rheumatol\n      1989 Jun\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[

      ],
      "memberships":[
         "   American College of Rheumatology - ACR Fellow"
      ],
      "clinical-trails":[
         "  Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee \n    Start of enrollment: 2014-06-01\n   \n    Cohen-Gadol, S.,Rubino, J.,...\n  ",
         "  Effect of Steroid Injections in a Knee With Osteoarthritis \n    Start of enrollment: 2011-03-01\n   \n    McAlindon, T.E.\n  ",
         "  A Placebo-Controlled Study of Collagen Hydrolysate in Subjects With Knee Osteoarthritis (OA) \n    Start of enrollment: 2007-03-01\n   \n    McAlindon, T.E.\n  ",
         "  Trial of Vitamin D to Reduce the Progression of Knee Osteoarthritis: A Double-Blind, Placebo-Controlled Once Daily Dosing Regimen \n    Start of enrollment: 2006-03-01\n   \n    McAlindon, T.E.\n  "
      ],
      "lectures":[

      ],
      "press-mentions":[
         "   \n        30+ Things Doctors Wish You Knew About Arthritis\n       \n      Reader's Digest\n       · June 08, 2020  ...after surgery. Cortisone injections don’t help in the long-term “A single shot can ease pain,” says Timothy McAlindon, MD, MPH, chief of rheumatology at Tufts Medical Center. But the relief is typically only temporary...",
         "   \n        Efficacy and Effectiveness Too Trials: Clinical Trial Designs to Generate Evidence on Efficacy and on Effectiveness in Wide Practice\n       \n      Clinical Pharmacology and Therapeutics\n       · February 12, 2019  ...is work and manuscript preparation by Giuliana Green, Sheeona Gorman, PhD; William Harvey, MD, MSc; Timothy McAlindon, MD, MPH; Hanneke Parkinson, Elizabeth Patchen, and Margaret Towne, MSc, without which we would not...",
         "   \n        A Myth That Won’t Die: Why Patients Blame the Weather for Their Aching Joints\n       \n      STAT\n       · January 13, 2017  ...body with arthritis does have the conviction that the weather influences their condition,” said Dr. Timothy McAlindon, the chief of the division of rheumatology at Tufts Medical Center in Boston. Same goes for patient..."
      ],
      "hospital-info":[
         "   \n      Pratt Medical Group Rheumatology  ·  Boston, MA\n       \n    September 2011 - Present\n   ",
         "   \n        Tufts Medical Center\n       \n      Current Affiliation\n     \n        Boston, MA\n    ",
         "   \n        Tufts Medical Center\n       \n      Current Affiliation\n     \n        Boston, MA\n    "
      ],
      "award-info":[
         "   \n      Fellow (FACR)\n     \n      American College of Rheumatology\n    ",
         "   \n      America's Top Doctors\n     \n      Castle Connolly, 2013-2014\n    ",
         "   \n      Boston Magazine\n     \n      Castle Connolly, 2012-2013\n    ",
         "   \n      CMS Meaningful Use Stage 1 Certification\n     \n      eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013\n    "
      ],
      "support-grants":[
         "   Effect Of Intra-Articular Steroids On Structural Progression Of Knee OA: An RCT (R01AR057802) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Tufts Medical Center\n     2010–2011",
         "   The Role Of Bone In Osteoarthritis Progression (R01AR054938) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Tufts Medical Center\n     2007–2011",
         "   Trial Of Vitamin D To Reduce Progression Of Knee OA (R01AR051361) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Tufts Medical Center\n     2005–2008",
         "   Research Training In Rheumatology At New England Medical (T32AR007570) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Tufts Medical Center\n     2002–2005",
         "   Trial Of Vitamin D To Reduce Progression Of Knee OA (R55AR051361) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Tufts Medical Center\n     2004",
         "   Case Control Studies Of RARE Diseases Over The Internet (P60AR047785) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Boston University Medical Campus\n     2001–2002",
         "   Feasibility Of Internet-Based Trials For Osteoarthritis (R01LM006856) National Library Of Medicine \n      Boston University Medical Campus\n     1999–2001",
         "   Investigate Efficacy, Tolerability, &Safety Of BAY 12 9566 (M01RR000533) National Center For Research Resources \n      Boston University Medical Campus\n     1999–2001",
         "   Indole 3 Carbinol In Therapy Of Systemic Lupus Erythematosus (M01RR000533) National Center For Research Resources \n      Boston University Medical Campus\n     1999–2001",
         "   Treatment Of Patients With Mild To Moderate Osteoarthritis Of The Knee (M01RR000533) National Center For Research Resources \n      Boston University Medical Campus\n     1998–2000",
         "   Epidemiologic Study Of SLE Among African American Women (P60AR020613) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Boston University Medical Campus\n     1997–2000"
      ]
   },
   "P3":{
      "name":"\n          Roy Mitchel Fleischmann, MD\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/scthd1aeq8r4c0zchhti.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        8144 Walnut Hill Ln\n       \n        Suite 800\n       \n        Dallas, TX 75231\n        ",
      "phone":"\n      \n     \n      (214) 540-0700\n      ",
      "fax":"",
      "job-title":"\n            Clinical Professor of Medicine, University Tex SW Dallas\n          ",
      "summary":" \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        Mount Sinai School of Medicine\n       \n      Residency, Internal Medicine, 1971 - 1972\n    ",
         "   \n        Maimonides Medical Center\n       \n      Residency, Internal Medicine, 1969 - 1971\n    ",
         "   \n        State University of New York Downstate Medical Center College of Medicine\n       \n      Class of 1969\n    "
      ],
      "certifications&licences":[
         "   \n      TX State Medical License\n     \n      1975 - 2022\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Internal Medicine\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    "
      ],
      "publications&presentations":[
         "     \n        EULAR PsA management recommendations 2019: can the recommendations be improved?\n       \n      Fleischmann, R. M.…\n     \n      Annals of the rheumatic diseases\n      2020 May 22\n    ",
         "     \n        Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial.\n       \n      Fleischmann, R., Furst, D. E., Connolly-Strong, E., Liu, J., Zhu, J., Brasington, R.…\n     \n      Rheumatology and therapy\n      2020 Mar 19\n    ",
         "     \n        Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE).\n       \n      Fleischmann, R., Weinblatt, M., Ahmad, H., Maldonado, M. A., Alemao, E., Ye, J., Schiff, M.…\n     \n      Rheumatology and therapy\n      2019 Oct 24\n    ",
         "   \n        2\n       mentions \n        1 NEW\n        \n        Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response.\n       \n      Fleischmann, R. M., Genovese, M. C., Enejosa, J. V., Mysler, E., Bessette, L., Peterfy, C., Durez, P…\n     \n      Annals of the rheumatic diseases\n      2019 Aug 1\n    ",
         "     \n        Dr. Fleischmann replies.\n       \n      Fleischmann, R.…\n     \n      The Journal of rheumatology\n      2019 Jul 17\n    ",
         "  \n        Value of the Multibiomarker Disease Activity Score to Predict Remission in RA: What Does the Evidence Show?\n       \n      Fleischmann, R.…\n     \n      The Journal of rheumatology\n      2019 May 3\n    ",
         "\n        3\n       mentions   \n        A Phase II Trial of Lutikizumab, an Anti-Interleukin-1Î±/Î² Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.\n       \n      Fleischmann, R. M., Bliddal, H., Blanco, F. J., Schnitzer, T. J., Peterfy, C., Chen, S., Wang, L., F…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2019 Jan 18\n    ",
         "  \n        A Summary of 2018 and What Lies Ahead for Rheumatology and Therapy in 2019.\n       \n      Fleischmann, R.…\n     \n      Rheumatology and therapy\n      2019 Jan 7\n    ",
         "  \n        Tofacitinib in Combination with Methotrexate in Patients with Rheumatoid Arthritis: Clinical Efficacy, Radiographic and Safety Outcomes from the 24-Month Phase 3 ORAL Scan Study.\n       \n      van der Heijde, D.,Strand, V.,Tanaka, Y.,Keystone, E.,Kremer, J.,Zerbini, CAF.,Cardiel, M. H.,Stanle…\n     \n      \n      2019 Jan 23\n    ",
         "\n        16\n       mentions   \n        Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.\n       \n      Kloppenburg, M., Peterfy, C., Haugen, I. K., Kroon, F., Chen, S., Wang, L., Liu, W., Levy, G., Fleis…\n     \n      Annals of the rheumatic diseases\n      2018 Dec 16\n    ",
         "  \n        Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies.\n       \n      Nash, P.,Coates, L. C.,Fleischmann, R.,Papp, K. A.,Gomez-Reino, J. J.,Kanik, K. S.,Wang, C.,Wu, J.,M…\n     \n      Rheumatol Ther\n      2018 Nov 11\n    ",
         "  \n        Distinguishing rheumatoid arthritis from psoriatic arthritis.\n       \n      Merola, J. F.,Espinoza, L. R.,Fleischmann, R.…\n     \n      RMD Open\n      2018 Sep 01\n    ",
         "\n        17\n       mentions \n        17 NEW\n        \n        A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (HumiraÂ®) in the treatment of active rheumatoid arthritis.\n       \n      Fleischmann, R. M., Alten, R., Pileckyte, M., Lobello, K., Hua, S. Y., Cronenberger, C., Alvarez, D.…\n     \n      Arthritis research & therapy\n      2018 Aug 17\n    ",
         "  \n        Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study.\n       \n      van der Heijde, D.,Durez, P.,Schett, G.,Naredo, E.,Østergaard, M.,Meszaros, G.,De Leonardis, F.,de l…\n     \n      Clin. Rheumatol.\n      2018 Aug 06\n    ",
         "  \n        A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.\n       \n      Kivitz, A. J.,Cohen, S.,Keystone, E.,van Vollenhoven, R. F.,Haraoui, B.,Kaine, J.,Fan, H.,Connell, C…\n     \n      Semin. Arthritis Rheum.\n      2018 Sep 05\n    ",
         "2\n       citations  \n        46\n       mentions \n        39 NEW\n        \n        Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.\n       \n      Genovese, M. C., Fleischmann, R., Combe, B., Hall, S., Rubbert-Roth, A., Zhang, Y., Zhou, Y., Mohame…\n     \n      Lancet (London, England)\n      2018 Jun 18\n    ",
         "2\n       citations    \n        Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study.\n       \n      Fleischmann, R., Winkle, P., Miner, J. N., Yan, X., Hicks, L., Valdez, S., Hall, J., Liu, S., Shen, …\n     \n      RMD open\n      2018 Mar 14\n    ",
         "\n        1\n       mention   \n        Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis.\n       \n      Cohen, S., Curtis, J. R., DeMasi, R., Chen, Y., Fan, H., Soonasra, A., Fleischmann, R.…\n     \n      Rheumatology and therapy\n      2018 Feb 23\n    ",
         "1\n       citations    \n        Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies.\n       \n      Fleischmann, R., Wollenhaupt, J., Takiya, L., Maniccia, A., Kwok, K., Wang, L., van Vollenhoven, R. …\n     \n      RMD open\n      2018 Feb 13\n    ",
         "1\n       citations    \n        Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis.\n       \n      Fleischmann, R., Wollenhaupt, J., Cohen, S. B., Wang, L., Fan, H., Bandi, V., Andrews, J., Takiya, L…\n     \n      Rheumatology and therapy\n      2018 Feb 9\n    ",
         "1\n       citations  \n        7\n       mentions   \n        Editorial: The American College of Rheumatology White Paper on Biosimilars: It Isn't All White-There Is Some Gray and Black.\n       \n      Fleischmann, R.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Feb 8\n    ",
         "  \n        Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus.\n       \n      Lu, P.,Fleischmann, R.,Curtis, C.,Ignatenko, S.,Clarke, S. H.,Desai, M.,Wong, S. L.,Grebe, K. M.,Bla…\n     \n      Lupus\n      2017 Jul 12\n    ",
         "3\n       citations  \n        5\n       mentions   \n        Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.\n       \n      Kavanaugh, A., van Vollenhoven, R. F., Fleischmann, R., Emery, P., Sainsbury, I., Florentinus, S., C…\n     \n      Annals of the rheumatic diseases\n      2017 Nov 18\n    ",
         "  \n        Therapy: Biosimilars in Rheumatology — Why, How and When in 2017\n       \n      Fleischmann, R.…\n     \n      Nature\n      2017 Nov 04\n    ",
         "1\n       citations    \n        Tofacitinib in the treatment of active rheumatoid arthritis in adults.\n       \n      Fleischmann, R.…\n     \n      Immunotherapy\n      2017 Oct 19\n    ",
         "4\n       citations  \n        1\n       mention   \n        Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis.\n       \n      Fleischmann, R. M., Wagner, F., Kivitz, A. J., Mansikka, H. T., Khan, N., Othman, A. A., Khatri, A.,…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Sep 25\n    ",
         "4\n       citations  \n        2\n       mentions   \n        Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.\n       \n      Schiff, M., Takeuchi, T., Fleischmann, R., Gaich, C. L., DeLozier, A. M., Schlichting, D., Kuo, W., …\n     \n      Arthritis research & therapy\n      2017 Sep 20\n    ",
         "2\n       citations    \n        A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate.\n       \n      Fleischmann, R.…\n     \n      Expert opinion on pharmacotherapy\n      2017 Aug 23\n    ",
         "  \n        A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: Results of a 24-week, randomized, controlled, phase 1 study.\n       \n      Yazici, Y.,McAlindon, T. E.,Fleischmann, R.,Gibofsky, A.,Lane, N. E.,Kivitz, A. J.,Skrepnik, N.,Arma…\n     \n      Osteoarthr. Cartil.\n      1900 Jan 01\n    ",
         "16\n       citations  \n        20\n       mentions   \n        Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.\n       \n      Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., DeMasi, R., Soma, K., Z…\n     \n      Lancet (London, England)\n      2017 Jun 21\n    ",
         "1\n       citations    \n        Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients.\n       \n      Fleischmann, R. F., van Vollenhoven, R. F., Vencovský, J., Alten, R., Davies, O., Mountian, I., de L…\n     \n      Rheumatology and therapy\n      2017 Mar 30\n    ",
         "2\n       citations    \n        DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable.\n       \n      Fleischmann, R. M., van der Heijde, D., Gardiner, P. V., Szumski, A., Marshall, L., Bananis, E.…\n     \n      RMD open\n      2017 Mar 4\n    ",
         "  \n        Interleukin-6 inhibition for rheumatoid arthritis.\n       \n      Fleischmann, R.…\n     \n      Lancet (London, England)\n      2017 Feb 22\n    ",
         "3\n       citations    \n        Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis.\n       \n      Fleischmann, R., Tongbram, V., van Vollenhoven, R. F., Tang, D. H., Chung, J., Collier, D. H., Urs, …\n     \n      RMD open\n      2017 Jan 27\n    ",
         "1\n       citations  \n        12\n       mentions   \n        Reply.\n       \n      Fleischmann, R., Connolly, S. E., Maldonado, M. A., Schiff, M.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Dec 20\n    ",
         "22\n       citations  \n        168\n       mentions   \n        Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.\n       \n      Fleischmann, R., van Adelsberg, J., Lin, Y., da Rocha Castelar-Pinheiro, G., Brzezicki, J., Hrycaj, …\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Nov 20\n    ",
         "15\n       citations  \n        10\n       mentions   \n        Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.\n       \n      Smolen, J. S., Burmester, G., Combe, B., Curtis, J. R., Hall, S., Haraoui, B., van Vollenhoven, R. F…\n     \n      Lancet (London, England)\n      2016 Nov 20\n    ",
         "\n        1\n       mention   \n        Reply to Letter to the Editor.\n       \n      Fleischmann, R., Connolly, S. E., Maldonado, M. A., Schiff, M.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Nov 5\n    ",
         "  \n        Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.\n       \n      Kay, J., Fleischmann, R., Keystone, E. C., Hsia, E. C., Hsu, B., Zhou, Y., Goldstein, N., Braun, J.…\n     \n      The Journal of rheumatology\n      2016 Nov 3\n    ",
         "6\n       citations  \n        1\n       mention   \n        Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial.\n       \n      Strand, V., Lee, E. B., Fleischmann, R., Alten, R. E., Koncz, T., Zwillich, S. H., Gruben, D., Wilki…\n     \n      RMD open\n      2016 Oct 19\n    ",
         "  \n        Living with Psoriatic Arthritis: A Patient's and Physician's Perspective.\n       \n      Simmons, A., Fleischmann, R.…\n     \n      Rheumatology and therapy\n      2016 Oct 18\n    ",
         "  \n        Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.\n       \n      Doedens, J. R., Jones, W. D., Hill, K., Mason, M. J., Gersuk, V. H., Mease, P. J., Dall'Era, M., Ara…\n     \n      Journal of immunology (Baltimore, Md. : 1950)\n      2016 Aug 19\n    ",
         "4\n       citations  \n        1\n       mention   \n        Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis.\n       \n      Fleischmann, R. M., Huizinga, T. W., Kavanaugh, A. F., Wilkinson, B., Kwok, K., DeMasi, R., van Voll…\n     \n      RMD open\n      2016 Aug 6\n    ",
         "16\n       citations  \n        1\n       mention   \n        A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial.\n       \n      Cutolo, M., Myerson, G. E., Fleischmann, R. M., Lioté, F., Díaz-González, F., Van den Bosch, F., Mar…\n     \n      The Journal of rheumatology\n      2016 Jul 17\n    ",
         "6\n       citations  \n        3\n       mentions \n        2 NEW\n        \n        Brief Report: Estimating Disease Activity Using Multi-Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab.\n       \n      Fleischmann, R., Connolly, S. E., Maldonado, M. A., Schiff, M.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Apr 26\n    ",
         "5\n       citations    \n        Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.\n       \n      Kremer, J. M., Blanco, R., Halland, A., Brzosko, M., Burgos-Vargas, R., Mela, C. M., Rowell, L., Fle…\n     \n      Clinical and experimental rheumatology\n      2016 Apr 19\n    ",
         "  \n        Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus.\n       \n      Witcher, J.,Fleischmann, R.,Chindalore, V. L.,Hansen, R. J.,Hu, L.,Radtke, D.,Voelker, J.,Gomez, E.,…\n     \n      Br J Clin Pharmacol\n      2015 Dec 10\n    ",
         "13\n       citations    \n        Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.\n       \n      Cohen, S. B., Koenig, A., Wang, L., Kwok, K., Mebus, C. A., Riese, R. J., Fleischmann, R. M.…\n     \n      Clinical and experimental rheumatology\n      2015 Nov 18\n    ",
         "11\n       citations  \n        1\n       mention   \n        Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs.\n       \n      Strand, V., Kremer, J. M., Wallenstein, G., Kanik, K. S., Connell, C. A., Gruben, D., Zwillich, S. H…\n     \n      Arthritis research & therapy\n      2015 Nov 5\n    ",
         "2\n       citations    \n        Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis.\n       \n      Fleischmann, R., Weinblatt, M. E., Schiff, M., Khanna, D., Maldonado, M. A., Nadkarni, A., Furst, D.…\n     \n      Arthritis care & research\n      2015 Oct 17\n    ",
         "1\n       citations    \n        Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial.\n       \n      Emery, P., Fleischmann, R. M., Strusberg, I., Durez, P., Nash, P., Amante, E. J., Churchill, M., Par…\n     \n      Arthritis care & research\n      2015 Oct 17\n    ",
         "28\n       citations  \n        2\n       mentions   \n        Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial.\n       \n      Sokolove, J., Schiff, M., Fleischmann, R., Weinblatt, M. E., Connolly, S. E., Johnsen, A., Zhu, J., …\n     \n      Annals of the rheumatic diseases\n      2015 Sep 12\n    ",
         "16\n       citations  \n        2\n       mentions   \n        Efficacy and Safety of Tofacitinib Following Inadequate Response to Conventional Synthetic or Biological Disease-Modifying Antirheumatic Drugs\n       \n      Roy Fleischmann, MD…\n     \n      Emergency Medicine Journal\n      2015 Aug 16\n    ",
         "3\n       citations  \n        1\n       mention   \n        Rheumatoid arthritis: Developing new oral targeted therapies for RA can be challenging.\n       \n      Fleischmann, R. M.…\n     \n      Nature reviews. Rheumatology\n      2014 Nov 12\n    ",
         "26\n       citations  \n        1\n       mention   \n        A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritis.\n       \n      Fleischmann, R. M., Damjanov, N. S., Kivitz, A. J., Legedza, A. T., Hoock, T., Kinnman, N.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2014 Nov 12\n    ",
         "  \n        Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study.\n       \n      Fleischmann, R.,Goldman, J. A.,Leirisalo-Repo, M.,Zanetakis, E.,El-Kadi, H.,Kellner, H.,Bolce, R.,De…\n     \n      Curr Med Res Opin\n      2014 Jul 23\n    ",
         "1\n       citations    \n        Response to: 'Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry' by Favalli et al.\n       \n      Fleischmann, R., Bananis, E.…\n     \n      Annals of the rheumatic diseases\n      2014 Oct 19\n    ",
         "20\n       citations  \n        1\n       mention   \n        How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?\n       \n      Fleischmann, R., van der Heijde, D., Koenig, A. S., Pedersen, R., Szumski, A., Marshall, L., Bananis…\n     \n      Annals of the rheumatic diseases\n      2014 Aug 22\n    ",
         "1\n       citations    \n        Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.\n       \n      Landewé, R. B., Smolen, J. S., Weinblatt, M. E., Emery, P., Dougados, M., Fleischmann, R., Aletaha, …\n     \n      Annals of the rheumatic diseases\n      2014 Aug 13\n    ",
         "6\n       citations    \n        Efficacy of golimumab plus methotrexate in methotrexate-naÃ¯ve patients with severe active rheumatoid arthritis.\n       \n      Emery, P., Fleischmann, R. M., Hsia, E. C., Xu, S., Zhou, Y., Baker, D.…\n     \n      Clinical rheumatology\n      2014 Jul 10\n    ",
         "1\n       citations    \n        Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.\n       \n      Fleischmann, R., Koenig, A. S., Szumski, A., Nab, H. W., Marshall, L., Bananis, E.…\n     \n      Rheumatology (Oxford, England)\n      2014 Jun 8\n    ",
         "  \n        Is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?\n       \n      Fleischmann, R., Yazici, Y.…\n     \n      Annals of the rheumatic diseases\n      2014 Jun 5\n    ",
         "39\n       citations  \n        4\n       mentions   \n        Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study.\n       \n      Genovese, M. C., Fleischmann, R., Furst, D. E., Janssen, N., Carter, J. D., Dasgupta, B., Bryson, J.…\n     \n      Annals of the rheumatic diseases\n      2014 Mar 20\n    ",
         "74\n       citations  \n        2\n       mentions   \n        Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial.\n       \n      Burmester, G., Kivitz, A. J., Kupper, H., Arulmani, U., Florentinus, S., Goss, S. L., Rathmann, S. S…\n     \n      Annals of the rheumatic diseases\n      2014 Feb 20\n    ",
         "27\n       citations  \n        2\n       mentions   \n        Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.\n       \n      Kay, J., Fleischmann, R., Keystone, E. C., Hsia, E. C., Hsu, B., Mack, M., Goldstein, N., Braun, J.,…\n     \n      Annals of the rheumatic diseases\n      2013 Dec 18\n    ",
         "45\n       citations  \n        2\n       mentions   \n        Sarilumab, a fully human monoclonal antibody against IL-6RÎ± in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.\n       \n      Huizinga, T. W., Fleischmann, R. M., Jasson, M., Radin, A. R., van Adelsberg, J., Fiore, S., Huang, …\n     \n      Annals of the rheumatic diseases\n      2013 Dec 4\n    ",
         "93\n       citations  \n        7\n       mentions   \n        Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial.\n       \n      Smolen, J. S., Emery, P., Fleischmann, R., van Vollenhoven, R. F., Pavelka, K., Durez, P., Guérette,…\n     \n      Lancet (London, England)\n      2013 Oct 31\n    ",
         "79\n       citations  \n        3\n       mentions   \n        Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial.\n       \n      Schiff, M., Weinblatt, M. E., Valente, R., van der Heijde, D., Citera, G., Elegbe, A., Maldonado, M.…\n     \n      Annals of the rheumatic diseases\n      2013 Aug 22\n    ",
         "  \n        Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).\n       \n      Mease, P. J.,Fleischmann, R.,Deodhar, A. A.,Wollenhaupt, J.,Khraishi, M.,Kielar, D.,Woltering, F.,St…\n     \n      Ann. Rheum. Dis.\n      2013 Aug 28\n    ",
         "4\n       citations    \n        Golimumab, a human antiâ\\x80\\x93tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function findings of a phase III, multicenter, randomized, double-blind, placebo-controlled study.\n       \n      Emery, P., Fleischmann, R. M., Doyle, M. K., Strusberg, I., Durez, P., Nash, P., Amante, E., Churchi…\n     \n      Arthritis care & research\n      2013 Jul 19\n    ",
         "  \n        Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.\n       \n      Furst, D. E.,Keystone, E. C.,So, A. K.,Braun, J.,Breedveld, F. C.,Burmester, G. R.,De Benedetti, F.,…\n     \n      Ann. Rheum. Dis.\n      2013 Apr\n    ",
         "5\n       citations    \n        Evaluation of serum biomarkers associated with radiographic progression in methotrexate-naive rheumatoid arthritis patients treated with methotrexate or golimumab.\n       \n      Wagner, C., Chen, D., Fan, H., Hsia, E. C., Mack, M., Emery, P., Fleischmann, R. M.…\n     \n      The Journal of rheumatology\n      2013 Mar 5\n    ",
         "23\n       citations  \n        1\n       mention   \n        Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results.\n       \n      Fleischmann, R. M., Halland, A., Brzosko, M., Burgos-Vargas, R., Mela, C., Vernon, E., Kremer, J. M.…\n     \n      The Journal of rheumatology\n      2013 Jan 17\n    ",
         "3\n       citations    \n        Effects of golimumab, an anti-tumour necrosis factor-Î± human monoclonal antibody, on lipids and markers of inflammation.\n       \n      Kirkham, B. W., Wasko, M. C., Hsia, E. C., Fleischmann, R. M., Genovese, M. C., Matteson, E. L., Liu…\n     \n      Annals of the rheumatic diseases\n      2013 Jan 10\n    ",
         "  \n        Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study.\n       \n      Weinblatt, M. E.,Schiff, M.,Valente, R.,van der Heijde, D.,Citera, G.,Zhao, C.,Maldonado, M.,Fleisch…\n     \n      Arthritis Rheum\n      2013 Jan\n    ",
         "2\n       citations    \n        Should we be morbid about comorbidities in the rheumatic diseases?\n       \n      Elewaut, D., Goodson, N. J., Fleischmann, R.…\n     \n      Rheumatology (Oxford, England)\n      2012 Dec 15\n    ",
         "99\n       citations  \n        3\n       mentions   \n        Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients.\n       \n      van Vollenhoven, R. F., Emery, P., Bingham, C. O., Keystone, E. C., Fleischmann, R. M., Furst, D. E.…\n     \n      Annals of the rheumatic diseases\n      2012 Nov 9\n    ",
         "6\n       citations    \n        Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial.\n       \n      Fleischmann, R., Kavanaugh, A., Smolen, J.…\n     \n      Rheumatology (Oxford, England)\n      2012 Oct 17\n    ",
         "278\n       citations \n        2 NEW\n       \n        5\n       mentions   \n        Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.\n       \n      Fleischmann, R., Kremer, J. M., Cush, J. J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Grub…\n     \n      The New England journal of medicine\n      2012 Aug 10\n    ",
         "53\n       citations  \n        2\n       mentions   \n        Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.\n       \n      Curtis, J. R., van der Helm-van Mil, A. H., Knevel, R., Huizinga, T. W., Haney, D. J., Shen, Y., Ram…\n     \n      Arthritis care & research\n      2012 Jun 28\n    ",
         "91\n       citations  \n        2\n       mentions   \n        Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study.\n       \n      Kavanaugh, A., Fleischmann, R. M., Emery, P., Kupper, H., Redden, L., Guerette, B., Santra, S., Smol…\n     \n      Annals of the rheumatic diseases\n      2012 May 9\n    ",
         "24\n       citations  \n        2\n       mentions \n        2 NEW\n        \n        Novel small-molecular therapeutics for rheumatoid arthritis.\n       \n      Fleischmann, R.…\n     \n      Current opinion in rheumatology\n      2012 Feb 24\n    ",
         "24\n       citations  \n        2\n       mentions   \n        Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial.\n       \n      Stohl, W., Gomez-Reino, J. J., Olech, E., Dudler, J., Fleischmann, R. M., Zerbini, C. A., Ashrafzade…\n     \n      Annals of the rheumatic diseases\n      2012 Feb 7\n    ",
         "7\n       citations    \n        Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.\n       \n      Østergaard, M., Emery, P., Conaghan, P. G., Fleischmann, R., Hsia, E. C., Xu, W., Rahman, M. U.…\n     \n      Arthritis and rheumatism\n      2011 Dec 1\n    ",
         "1\n       citations    \n        Safe and well tolerated.\n       \n      Fleischmann, R., Goodson, N. J., Elewaut, D.…\n     \n      Rheumatology (Oxford, England)\n      2011 Oct 14\n    ",
         "16\n       citations    \n        Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.\n       \n      Rigby, W. F., Ferraccioli, G., Greenwald, M., Zazueta-Montiel, B., Fleischmann, R., Wassenberg, S., …\n     \n      Arthritis care & research\n      2011 May 11\n    ",
         "23\n       citations  \n        1\n       mention   \n        Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trial.\n       \n      Keystone, E. C., Curtis, J. R., Fleischmann, R. M., Furst, D. E., Khanna, D., Smolen, J. S., Mease, …\n     \n      The Journal of rheumatology\n      2011 Mar 3\n    ",
         "4\n       citations    \n        Don't forget traditional DMARDs.\n       \n      Fleischmann, R.…\n     \n      Rheumatology (Oxford, England)\n      2011 Feb 23\n    ",
         "10\n       citations    \n        The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.\n       \n      Emery, P., Fleischmann, R., van der Heijde, D., Keystone, E. C., Genovese, M. C., Conaghan, P. G., H…\n     \n      Arthritis and rheumatism\n      2011 Feb 10\n    ",
         "6\n       citations    \n        The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis.\n       \n      Fleischmann, R.…\n     \n      Expert opinion on biological therapy\n      2010 Mar 17\n    ",
         "34\n       citations    \n        Kinase inhibitors: a new approach to rheumatoid arthritis treatment.\n       \n      Cohen, S. N., Fleischmann, R.…\n     \n      Current opinion in rheumatology\n      2010 Feb 19\n    ",
         "9\n       citations    \n        Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials.\n       \n      van Vollenhoven, R. F., Emery, P., Bingham, C. O., Keystone, E. C., Fleischmann, R., Furst, D. E., M…\n     \n      The Journal of rheumatology\n      2010 Jan 30\n    ",
         "27\n       citations    \n        Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.\n       \n      Emery, P., Fleischmann, R. M., Moreland, L. W., Hsia, E. C., Strusberg, I., Durez, P., Nash, P., Ama…\n     \n      Arthritis and rheumatism\n      2009 Aug 1\n    ",
         "8\n       citations    \n        Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.\n       \n      Cohen, S. B., Cohen, M. D., Cush, J. J., Fleischmann, R. M., Mease, P. J., Schiff, M. H., Simon, L. …\n     \n      The Journal of rheumatology. Supplement\n      2009 Feb 6\n    ",
         "161\n       citations  \n        1\n       mention   \n        Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.\n       \n      Fleischmann, R., Vencovsky, J., van Vollenhoven, R. F., Borenstein, D., Box, J., Coteur, G., Goel, N…\n     \n      Annals of the rheumatic diseases\n      2008 Nov 19\n    ",
         "  \n        Clinical studies can be performed in an ethical manner.\n       \n      Fleischmann, R.…\n     \n      Nature clinical practice. Rheumatology\n      2008 Jul 1\n    ",
         "33\n       citations    \n        Safety of biologic therapy in rheumatoid arthritis and other autoimmune diseases: focus on rituximab.\n       \n      Fleischmann, R. M.…\n     \n      Seminars in arthritis and rheumatism\n      2008 Mar 14\n    ",
         "10\n       citations    \n        Comparison of the efficacy of biologic therapy for rheumatoid arthritis: can the clinical trials be accurately compared?\n       \n      Fleischmann, R. M.…\n     \n      Rheumatic diseases clinics of North America\n      2007 Apr 7\n    ",
         "1\n       citations  \n        1\n       mention   \n        Primer: establishing a clinical trial unit - regulations and infrastructure.\n       \n      Fleischmann, R.…\n     \n      Nature clinical practice. Rheumatology\n      2007 Mar 31\n    ",
         "19\n       citations    \n        Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.\n       \n      Fleischmann, R., Iqbal, I.…\n     \n      Drugs & aging\n      2007 Mar 17\n    ",
         "7\n       citations    \n        Anakinra in the treatment of rheumatic disease.\n       \n      Fleischmann, R.…\n     \n      Expert review of clinical immunology\n      2006 May 1\n    ",
         "64\n       citations    \n        Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.\n       \n      Bathon, J. M., Fleischmann, R. M., Van der Heijde, D., Tesser, J. R., Peloso, P. M., Chon, Y., White…\n     \n      The Journal of rheumatology\n      2006 Feb 9\n    ",
         "6\n       citations    \n        Tacrolimus in rheumatoid arthritis.\n       \n      Fleischmann, R., Iqbal, I., Stern, R. L.…\n     \n      Expert opinion on pharmacotherapy\n      2005 Dec 24\n    ",
         "81\n       citations    \n        Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.\n       \n      Genovese, M. C., Bathon, J. M., Fleischmann, R. M., Moreland, L. W., Martin, R. W., Whitmore, J. B.,…\n     \n      The Journal of rheumatology\n      2005 Jul 5\n    ",
         "7\n       citations    \n        Is there a need for new therapies for rheumatoid arthritis?\n       \n      Fleischmann, R. M.…\n     \n      The Journal of rheumatology. Supplement\n      2005 Feb 5\n    ",
         "33\n       citations    \n        Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.\n       \n      Fleischmann, R., Stern, R., Iqbal, I.…\n     \n      Expert opinion on biological therapy\n      2004 Jul 23\n    ",
         "14\n       citations    \n        Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?\n       \n      Schwartzman, S., Fleischmann, R., Morgan, G. J.…\n     \n      Arthritis research & therapy\n      2004 Jul 2\n    ",
         "2\n       citations    \n        Does safety make a difference in selecting the right TNF antagonist?\n       \n      Fleischmann, R., Yocum, D. E.…\n     \n      Arthritis research & therapy\n      2004 Jul 2\n    ",
         "332\n       citations    \n        Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).\n       \n      Furst, D. E., Schiff, M. H., Fleischmann, R. M., Strand, V., Birbara, C. A., Compagnone, D., Fischko…\n     \n      The Journal of rheumatology\n      2004 Jan 14\n    ",
         "7\n       citations    \n        Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis.\n       \n      Fleischmann, R.…\n     \n      Expert opinion on drug safety\n      2003 Aug 9\n    ",
         "2\n       citations    \n        Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.\n       \n      Kremer, J. M., Weinblatt, M. E., Bankhurst, A. D., Bulpitt, K. J., Fleischmann, R. M., Jackson, C. G…\n     \n      Arthritis and rheumatism\n      2003 Jun 10\n    ",
         "137\n       citations    \n        Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.\n       \n      Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G., Tesser, J., Modafferi…\n     \n      Arthritis and rheumatism\n      2003 Apr 11\n    ",
         "44\n       citations    \n        Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.\n       \n      Fleischmann, R. M., Baumgartner, S. W., Tindall, E. A., Weaver, A. L., Moreland, L. W., Schiff, M. H…\n     \n      The Journal of rheumatology\n      2003 Apr 3\n    ",
         "8\n       citations    \n        Examining the efficacy of biologic therapy: are there real differences?\n       \n      Fleischmann, R. M.…\n     \n      The Journal of rheumatology. Supplement\n      2002 Sep 19\n    ",
         "38\n       citations    \n        Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.\n       \n      Fleischmann, R., Iqbal, I., Nandeshwar, P., Quiceno, A.…\n     \n      Drug safety\n      2002 Apr 12\n    ",
         "  \n        EULAR PsA management recommendations 2019: can the recommendations be improved?\n       \n      Fleischmann, R. M.…\n     \n      Annals of the rheumatic diseases\n      2020 May 22\n    ",
         "  \n        Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial.\n       \n      Fleischmann, R., Furst, D. E., Connolly-Strong, E., Liu, J., Zhu, J., Brasington, R.…\n     \n      Rheumatology and therapy\n      2020 Mar 19\n    ",
         "  \n        Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE).\n       \n      Fleischmann, R., Weinblatt, M., Ahmad, H., Maldonado, M. A., Alemao, E., Ye, J., Schiff, M.…\n     \n      Rheumatology and therapy\n      2019 Oct 24\n    ",
         "\n        2\n       mentions \n        1 NEW\n        \n        Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response.\n       \n      Fleischmann, R. M., Genovese, M. C., Enejosa, J. V., Mysler, E., Bessette, L., Peterfy, C., Durez, P…\n     \n      Annals of the rheumatic diseases\n      2019 Aug 1\n    ",
         "  \n        Dr. Fleischmann replies.\n       \n      Fleischmann, R.…\n     \n      The Journal of rheumatology\n      2019 Jul 17\n    ",
         "  \n        Value of the Multibiomarker Disease Activity Score to Predict Remission in RA: What Does the Evidence Show?\n       \n      Fleischmann, R.…\n     \n      The Journal of rheumatology\n      2019 May 3\n    ",
         "\n        3\n       mentions   \n        A Phase II Trial of Lutikizumab, an Anti-Interleukin-1Î±/Î² Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.\n       \n      Fleischmann, R. M., Bliddal, H., Blanco, F. J., Schnitzer, T. J., Peterfy, C., Chen, S., Wang, L., F…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2019 Jan 18\n    ",
         "  \n        A Summary of 2018 and What Lies Ahead for Rheumatology and Therapy in 2019.\n       \n      Fleischmann, R.…\n     \n      Rheumatology and therapy\n      2019 Jan 7\n    ",
         "  \n        Tofacitinib in Combination with Methotrexate in Patients with Rheumatoid Arthritis: Clinical Efficacy, Radiographic and Safety Outcomes from the 24-Month Phase 3 ORAL Scan Study.\n       \n      van der Heijde, D.,Strand, V.,Tanaka, Y.,Keystone, E.,Kremer, J.,Zerbini, CAF.,Cardiel, M. H.,Stanle…\n     \n      \n      2019 Jan 23\n    ",
         "\n        16\n       mentions   \n        Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.\n       \n      Kloppenburg, M., Peterfy, C., Haugen, I. K., Kroon, F., Chen, S., Wang, L., Liu, W., Levy, G., Fleis…\n     \n      Annals of the rheumatic diseases\n      2018 Dec 16\n    ",
         "  \n        Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies.\n       \n      Nash, P.,Coates, L. C.,Fleischmann, R.,Papp, K. A.,Gomez-Reino, J. J.,Kanik, K. S.,Wang, C.,Wu, J.,M…\n     \n      Rheumatol Ther\n      2018 Nov 11\n    ",
         "  \n        Distinguishing rheumatoid arthritis from psoriatic arthritis.\n       \n      Merola, J. F.,Espinoza, L. R.,Fleischmann, R.…\n     \n      RMD Open\n      2018 Sep 01\n    ",
         "\n        17\n       mentions \n        17 NEW\n        \n        A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (HumiraÂ®) in the treatment of active rheumatoid arthritis.\n       \n      Fleischmann, R. M., Alten, R., Pileckyte, M., Lobello, K., Hua, S. Y., Cronenberger, C., Alvarez, D.…\n     \n      Arthritis research & therapy\n      2018 Aug 17\n    ",
         "  \n        Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study.\n       \n      van der Heijde, D.,Durez, P.,Schett, G.,Naredo, E.,Østergaard, M.,Meszaros, G.,De Leonardis, F.,de l…\n     \n      Clin. Rheumatol.\n      2018 Aug 06\n    ",
         "  \n        A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.\n       \n      Kivitz, A. J.,Cohen, S.,Keystone, E.,van Vollenhoven, R. F.,Haraoui, B.,Kaine, J.,Fan, H.,Connell, C…\n     \n      Semin. Arthritis Rheum.\n      2018 Sep 05\n    ",
         "2\n       citations  \n        46\n       mentions \n        39 NEW\n        \n        Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.\n       \n      Genovese, M. C., Fleischmann, R., Combe, B., Hall, S., Rubbert-Roth, A., Zhang, Y., Zhou, Y., Mohame…\n     \n      Lancet (London, England)\n      2018 Jun 18\n    ",
         "2\n       citations    \n        Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study.\n       \n      Fleischmann, R., Winkle, P., Miner, J. N., Yan, X., Hicks, L., Valdez, S., Hall, J., Liu, S., Shen, …\n     \n      RMD open\n      2018 Mar 14\n    ",
         "\n        1\n       mention   \n        Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis.\n       \n      Cohen, S., Curtis, J. R., DeMasi, R., Chen, Y., Fan, H., Soonasra, A., Fleischmann, R.…\n     \n      Rheumatology and therapy\n      2018 Feb 23\n    ",
         "1\n       citations    \n        Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies.\n       \n      Fleischmann, R., Wollenhaupt, J., Takiya, L., Maniccia, A., Kwok, K., Wang, L., van Vollenhoven, R. …\n     \n      RMD open\n      2018 Feb 13\n    ",
         "1\n       citations    \n        Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis.\n       \n      Fleischmann, R., Wollenhaupt, J., Cohen, S. B., Wang, L., Fan, H., Bandi, V., Andrews, J., Takiya, L…\n     \n      Rheumatology and therapy\n      2018 Feb 9\n    ",
         "1\n       citations  \n        7\n       mentions   \n        Editorial: The American College of Rheumatology White Paper on Biosimilars: It Isn't All White-There Is Some Gray and Black.\n       \n      Fleischmann, R.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Feb 8\n    ",
         "  \n        Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus.\n       \n      Lu, P.,Fleischmann, R.,Curtis, C.,Ignatenko, S.,Clarke, S. H.,Desai, M.,Wong, S. L.,Grebe, K. M.,Bla…\n     \n      Lupus\n      2017 Jul 12\n    ",
         "3\n       citations  \n        5\n       mentions   \n        Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.\n       \n      Kavanaugh, A., van Vollenhoven, R. F., Fleischmann, R., Emery, P., Sainsbury, I., Florentinus, S., C…\n     \n      Annals of the rheumatic diseases\n      2017 Nov 18\n    ",
         "  \n        Therapy: Biosimilars in Rheumatology — Why, How and When in 2017\n       \n      Fleischmann, R.…\n     \n      Nature\n      2017 Nov 04\n    ",
         "1\n       citations    \n        Tofacitinib in the treatment of active rheumatoid arthritis in adults.\n       \n      Fleischmann, R.…\n     \n      Immunotherapy\n      2017 Oct 19\n    ",
         "4\n       citations  \n        1\n       mention   \n        Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis.\n       \n      Fleischmann, R. M., Wagner, F., Kivitz, A. J., Mansikka, H. T., Khan, N., Othman, A. A., Khatri, A.,…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Sep 25\n    ",
         "4\n       citations  \n        2\n       mentions   \n        Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.\n       \n      Schiff, M., Takeuchi, T., Fleischmann, R., Gaich, C. L., DeLozier, A. M., Schlichting, D., Kuo, W., …\n     \n      Arthritis research & therapy\n      2017 Sep 20\n    ",
         "2\n       citations    \n        A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate.\n       \n      Fleischmann, R.…\n     \n      Expert opinion on pharmacotherapy\n      2017 Aug 23\n    ",
         "  \n        A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: Results of a 24-week, randomized, controlled, phase 1 study.\n       \n      Yazici, Y.,McAlindon, T. E.,Fleischmann, R.,Gibofsky, A.,Lane, N. E.,Kivitz, A. J.,Skrepnik, N.,Arma…\n     \n      Osteoarthr. Cartil.\n      1900 Jan 01\n    ",
         "16\n       citations  \n        20\n       mentions   \n        Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.\n       \n      Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., DeMasi, R., Soma, K., Z…\n     \n      Lancet (London, England)\n      2017 Jun 21\n    ",
         "1\n       citations    \n        Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients.\n       \n      Fleischmann, R. F., van Vollenhoven, R. F., Vencovský, J., Alten, R., Davies, O., Mountian, I., de L…\n     \n      Rheumatology and therapy\n      2017 Mar 30\n    ",
         "2\n       citations    \n        DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable.\n       \n      Fleischmann, R. M., van der Heijde, D., Gardiner, P. V., Szumski, A., Marshall, L., Bananis, E.…\n     \n      RMD open\n      2017 Mar 4\n    ",
         "  \n        Interleukin-6 inhibition for rheumatoid arthritis.\n       \n      Fleischmann, R.…\n     \n      Lancet (London, England)\n      2017 Feb 22\n    ",
         "3\n       citations    \n        Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis.\n       \n      Fleischmann, R., Tongbram, V., van Vollenhoven, R. F., Tang, D. H., Chung, J., Collier, D. H., Urs, …\n     \n      RMD open\n      2017 Jan 27\n    ",
         "1\n       citations  \n        12\n       mentions   \n        Reply.\n       \n      Fleischmann, R., Connolly, S. E., Maldonado, M. A., Schiff, M.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Dec 20\n    ",
         "22\n       citations  \n        168\n       mentions   \n        Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.\n       \n      Fleischmann, R., van Adelsberg, J., Lin, Y., da Rocha Castelar-Pinheiro, G., Brzezicki, J., Hrycaj, …\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Nov 20\n    ",
         "15\n       citations  \n        10\n       mentions   \n        Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.\n       \n      Smolen, J. S., Burmester, G., Combe, B., Curtis, J. R., Hall, S., Haraoui, B., van Vollenhoven, R. F…\n     \n      Lancet (London, England)\n      2016 Nov 20\n    ",
         "\n        1\n       mention   \n        Reply to Letter to the Editor.\n       \n      Fleischmann, R., Connolly, S. E., Maldonado, M. A., Schiff, M.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Nov 5\n    ",
         "  \n        Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.\n       \n      Kay, J., Fleischmann, R., Keystone, E. C., Hsia, E. C., Hsu, B., Zhou, Y., Goldstein, N., Braun, J.…\n     \n      The Journal of rheumatology\n      2016 Nov 3\n    ",
         "6\n       citations  \n        1\n       mention   \n        Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial.\n       \n      Strand, V., Lee, E. B., Fleischmann, R., Alten, R. E., Koncz, T., Zwillich, S. H., Gruben, D., Wilki…\n     \n      RMD open\n      2016 Oct 19\n    ",
         "  \n        Living with Psoriatic Arthritis: A Patient's and Physician's Perspective.\n       \n      Simmons, A., Fleischmann, R.…\n     \n      Rheumatology and therapy\n      2016 Oct 18\n    ",
         "  \n        Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.\n       \n      Doedens, J. R., Jones, W. D., Hill, K., Mason, M. J., Gersuk, V. H., Mease, P. J., Dall'Era, M., Ara…\n     \n      Journal of immunology (Baltimore, Md. : 1950)\n      2016 Aug 19\n    ",
         "4\n       citations  \n        1\n       mention   \n        Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis.\n       \n      Fleischmann, R. M., Huizinga, T. W., Kavanaugh, A. F., Wilkinson, B., Kwok, K., DeMasi, R., van Voll…\n     \n      RMD open\n      2016 Aug 6\n    ",
         "16\n       citations  \n        1\n       mention   \n        A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial.\n       \n      Cutolo, M., Myerson, G. E., Fleischmann, R. M., Lioté, F., Díaz-González, F., Van den Bosch, F., Mar…\n     \n      The Journal of rheumatology\n      2016 Jul 17\n    ",
         "6\n       citations  \n        3\n       mentions \n        2 NEW\n        \n        Brief Report: Estimating Disease Activity Using Multi-Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab.\n       \n      Fleischmann, R., Connolly, S. E., Maldonado, M. A., Schiff, M.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Apr 26\n    ",
         "5\n       citations    \n        Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.\n       \n      Kremer, J. M., Blanco, R., Halland, A., Brzosko, M., Burgos-Vargas, R., Mela, C. M., Rowell, L., Fle…\n     \n      Clinical and experimental rheumatology\n      2016 Apr 19\n    ",
         "  \n        Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus.\n       \n      Witcher, J.,Fleischmann, R.,Chindalore, V. L.,Hansen, R. J.,Hu, L.,Radtke, D.,Voelker, J.,Gomez, E.,…\n     \n      Br J Clin Pharmacol\n      2015 Dec 10\n    ",
         "13\n       citations    \n        Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.\n       \n      Cohen, S. B., Koenig, A., Wang, L., Kwok, K., Mebus, C. A., Riese, R. J., Fleischmann, R. M.…\n     \n      Clinical and experimental rheumatology\n      2015 Nov 18\n    ",
         "11\n       citations  \n        1\n       mention   \n        Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs.\n       \n      Strand, V., Kremer, J. M., Wallenstein, G., Kanik, K. S., Connell, C. A., Gruben, D., Zwillich, S. H…\n     \n      Arthritis research & therapy\n      2015 Nov 5\n    ",
         "2\n       citations    \n        Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis.\n       \n      Fleischmann, R., Weinblatt, M. E., Schiff, M., Khanna, D., Maldonado, M. A., Nadkarni, A., Furst, D.…\n     \n      Arthritis care & research\n      2015 Oct 17\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[

      ],
      "memberships":[
         "   American College of Rheumatology - ACR Member",
         "   American College of Radiology - ACR Master Member"
      ],
      "clinical-trails":[
         "  A Study of LY3337641 in Moderate to Severe Rheumatoid Arthritis \n    Start of enrollment: 2016-07-01\n   \n    Call 1-877-CTLILLY (1-877-2...\n  ",
         "  A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis \n    Start of enrollment: 2013-06-01\n   \n    Jaffer, A.M.,Miller, K.A.,P...\n  ",
         "  ETEC Logistics Trial (TREK) \n    Start of enrollment: 2006-05-01\n   \n    Roesch, B.G.,Smith, C.A.,Sc...\n  ",
         "  Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)  \n    Roy Fleischmann, MD MACR\n  "
      ],
      "lectures":[

      ],
      "press-mentions":[
         "   \n        Third Pivotal Phase 3 Study Shows Rinvoq plus Topical Corticosteroids Improves Skin and Itch Symptoms in Atopic Dermatitis\n       \n      Practical Dermatology\n       · August 04, 2020  ",
         "   \n        JAK Inhibitor Succeeds as Monotherapy in Rheumatoid Arthritis\n       \n      MedPage Today\n       · July 08, 2020  ...risk factors for radiographic progression. JAK Inhibitors in Perspective Asked for his perspective, Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center in Dallas, pointed to the superiority o...",
         "   \n        Efficacy and Safety of Sarilumab in Combination with csDMARDs or as Monotherapy in Subpopulations of Patients with Moderately to Severely Active Rheumatoid Arthritis in Three Phase III Randomized, Controlled Studies\n       \n      Arthritis Research & Therapy\n       · June 10, 2020  ",
         "   \n        Effective Osteoarthritis Therapy Remains Elusive\n       \n      MDedge\n       · March 06, 2020  ...ry is great. Let’s face it: It’s the only disease-modifying treatment for OA,” Dr. Bugbee declared. Roy Fleischmann, MD, rose from the audience to assert that “the biggest need in rheumatology right now is a medicat...",
         "   \n        MBDA: A Valuable Tool for Medical Decision Making\n       \n      The Journal of Rheumatology\n       · December 01, 2019  ",
         "   \n        RA Q&A with the Investigator\n       \n      Rheumatology Network\n       · September 05, 2019  ",
         "   \n        FDA Approves New Rheumatoid Arthritis Medication for People Who Haven’t Responded to Standard Treatment\n       \n      Everyday Health\n       · August 19, 2019  ",
         "FDA Approves Rinvoq for Methotrexate-Refractory RA\n       \n      weatherherald.com\n       · August 16, 2019  ",
         "FDA Approves Upadacitinib for Moderate-to-Severe Rheumatoid Arthritis\n       \n      weatherherald.com\n       · August 16, 2019  ",
         "FDA Approves Upadacitinib for Inadequately Treated Rheumatoid Arthritis\n       \n      weatherherald.com\n       · August 16, 2019  ",
         "Upadacitinib Outperforms Adalimumab in Methotrexate-Refractory RA\n       \n      Healio\n       · July 29, 2019  ",
         "Upadacitinib vs Adalimumab in RA\n       \n      Rheumatology Network\n       · July 24, 2019  ...inhibited radiographic progression as compared to placebo, wrote the study authors who were led by Roy Fleischmann, M.D., of the University of Texas Southwestern Medical Center in Dallas. \"In this population of met...",
         "Filgotinib Fares Well in RA Trial of Inadequate Methotrexate Responders\n       \n      MDedge\n       · July 22, 2019  ",
         "Safety Consistent for Sarilumab in RA\n       \n      MedPage Today\n       · July 18, 2019  ...4 and 6.7 per 100 patient-years for combination therapy and monotherapy, respectively, according to Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center in Dallas, and colleagues. And the inci...",
         "MBDA: A Valuable Tool for Medical Decision Making\n       \n      Journal of Rheumatology\n       · July 15, 2019  I read with interest the editorial by Dr. Roy Fleischmann on the limitations of the multibiomarker disease activity test (MBDA) in the management of rheumato...",
         "Prepare for Deluge of JAK Inhibitors for RA\n       \n      MDedge\n       · May 22, 2019  ",
         "Targeting IL-1 Fails in Knee OA\n       \n      MedPage Today\n       · January 23, 2019  ",
         "Doubling down on IL-17 in Psoriatic Arthritis\n       \n      RheumNow\n       · October 31, 2018  ...patients at week 12 and in up to 85% of patients at week 48. \"These results are astonishing,\" said Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center in Dallas, who was not involved in the...",
         "\\'These Results Are Astonishing\\': What We Heard at ACR 2018\n       \n      RheumNow\n       · October 29, 2018  ...Evzio). ******************************************************* \"These results are astonishing.\" -- Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center in Dallas, on the outcomes of a phase I...",
         "New JAK1 Agent Beats Humira in Rheumatoid Arthritis\n       \n      MedPage Today\n       · October 22, 2018  ...r week, and by 36.4% of those given placebo (P<0.001 for upadacitinib versus placebo), according to Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center in Dallas. In addition, the proportions...",
         "ACR Issues New Position Statement on the Use of Biosimilars\n       \n      Monthly Prescribing Reference\n       ...effective in every patient nor has it been demonstrated that extrapolation is effective.\" said Dr. Roy Fleischmann from the University of Texas Southwestern Medical Center and Metroplex Clinical Research in Dallas...",
         "New Position Statement for Use of Biosimilars to Treat Rheumatic Diseases\n       \n      Science Newsline\n       · February 07, 2018  ...zed at a lower cost to the individual patient,\" the authors wrote. An accompanying editorial by Dr. Roy Fleischmann, of the University of Texas Southwestern Medical Center and Metroplex Clinical Research Center in D...",
         "2018: What\\'s Next in Rheumatology?\n       \n      MedPage Today\n       · January 04, 2018  ...bate\" held at the annual meeting of the American College of Rheumatology in November, where speaker Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center in Dallas, argued that currently, biosi...",
         "Debate at ACR: Is There a Rationale for Prescribing Biosimilars?\n       \n      MedPage Today\n       · November 06, 2017  ...g the monopolies held by makers of originator drugs can't help but drive prices down. His opponent, Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center in Dallas, sought with some success to...",
         "Biosimilars Take Center Stage at 2017 ACR/ARHP Annual Meeting\n       \n      PressReleasePoint\n       · September 06, 2017  ...perspectives of Dr. Jonathan Kay, Professor of Medicine at the University of Massachusetts, and Dr. Roy Fleischmann, Clinical Professor at the University of Texas Southwestern Medical Center. Dr. Daniel Furst, a mem...",
         "In Rheumatoid Arthritis, Combination Therapy More Favorable Than Tofacitinib Monotherapy\n       \n      Rheumatology Advisor\n       · July 12, 2017  ...Tofacitinib monotherapy did not achieve statistical non-inferiority to either combination regimen,” Roy Fleischmann, MD, from the University of Texas Southwestern Medical Center and Metroplex Clinical Research Cente...",
         "Tofacitinib Goes Head-to-Head with Adalimumab in Rheumatoid Arthritis Study\n       \n      Monthly Prescribing Reference\n       ...ily group, and in 43.8% of the Humira 40mg every other week + methotrexate group. Study author, Dr. Roy Fleischmann, stated, \"Although Xeljanz monotherapy did not demonstrate non-inferiority to either combination ar...",
         "Pfizer Announces Results from XELJANZ\n       \n      Business Wire\n       · June 16, 2017  ...tion with methotrexate provided similar ACR50 response rates to Humira plus methotrexate,” said Dr. Roy Fleischmann, study author and clinical professor in the Department of Internal Medicine at the University of Te...",
         "FDA Says \\'No\\' to Baricitinib for Rheumatoid Arthritis\n       \n      MedPage Today\n       · April 17, 2017  ...eatinine. \"I am surprised, but am not privy to the reason why [baricitinib was not approved],\" said Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center in Dallas, who has been involved in cli...",
         "A Novel Use of Sirukumab in Patients with Active RA\n       \n      Rheumatology Network\n       · March 01, 2017  ...targeting the IL-6 cytokine, in patients with rheumatoid arthritis,” wrote Aletaha and colleagues. Roy Fleischmann, M.D., from the University of Texas Southwestern Medical Center provided a commentary on the findin...",
         "Baricitinib Scores High in Phase III\n       \n      MedPage Today\n       · February 15, 2017  ...perior to adalimumab,\" they stated. The trial, known as RA-BEAM, is \"an important study,\" commented Roy Fleischmann, MD, of Metroplex Clinical Research Center and the University of Texas Southwestern Medical Center...",
         "TNFi-Methotrexate Combo Increases Odds of Achieving ACR70 in RA\n       \n      Rheumatology Network\n       · February 15, 2017  ...s the American College of Rheumatology’s 70 percent response criteria (ACR70) at six months. Led by Roy Fleischmann, M.D., of the University of Texas Southwestern Medical Center, the primary goal of this study was t...",
         "Sarilumab Effective in RA After Failure of Anti-TNF Therapy\n       \n      MedPage Today\n       · November 26, 2016  ...arilumab is an effective medication in the TNFi population in many patients,\" said the lead author, Roy Fleischmann, MD, of the University of Texas Southwestern Medical Center and medical director of the Metroplex C...",
         "Pfizer Research Advances Body of Evidence for Tofacitinib Citrate (XELJANZ®) Providing Clinicians with Additional Information for the Treatment of Moderate to Severe RA\n       \n      Business Wire\n       · June 08, 2016  ...physicians on treatment approaches for tofacitinib citrate in rheumatoid arthritis (RA),” said Dr. Roy Fleischmann, clinical professor in the Department of Internal Medicine at the University of Texas Southwestern...",
         "Rheumatology Associates Hires Padmapriya Sivaraman, MD and Expands to Additional Office in North Richland Hills\n       \n      PRWeb\n       · April 12, 2016  ...family recently moved to Texas from Cleveland, Ohio. Rheumatology Associates was founded in 1975 by Roy Fleischmann, M.D. Our group provides care to patients throughout the Dallas/Fort Worth metroplex with convenien..."
      ],
      "hospital-info":[
         "   \n        Medical City Dallas\n       \n      Current Affiliation\n     \n        Dallas, TX\n    ",
         "   \n        Baylor Scott & White Medical Center-Irving\n       \n      Current Affiliation\n     \n        Irving, TX\n    ",
         "   \n        Medical City Plano\n       \n      Current Affiliation\n     \n        Plano, TX\n    ",
         "   \n        University of Texas Southwestern Medical Center\n       \n      Current Affiliation\n     \n        Dallas, TX\n    ",
         "   \n        Texas Health Presbyterian Hospital Dallas\n       \n      Current Affiliation\n     \n        Dallas, TX\n    "
      ],
      "award-info":[
         "   \n      Regional Top Doctor\n     \n      Castle Connolly, 2014\n    ",
         "   \n      Super Doctor\n     \n      SuperDoctors.com\n    "
      ],
      "support-grants":[

      ]
   },
   "P4":{
      "name":"\n          Margrit Wiesendanger, MD PhD\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/wqwmz18ur95zcod6lssh.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        Mount Sinai FPA\n       \n        5 East 98th Street\n       \n        New York, NY 10029\n        ",
      "phone":"\n      \n     \n      (212) 241-1671\n      ",
      "fax":"",
      "job-title":"\n            Associate Professor of Medicine and Program Director, Division of Rheumatology, Icahn School of Medicine at Mount Sinai\n          ",
      "summary":" \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        New York Presbyterian Hospital\n       \n      Fellowship, Rheumatology, 2005 - 2008\n    ",
         "   \n        New York Presbyterian Hospital\n       \n      Residency, Internal Medicine, 2000 - 2003\n    ",
         "   \n        Albert Einstein College of Medicine\n       \n      Class of 2000\n    "
      ],
      "certifications&licences":[
         "   \n      NY State Medical License\n     \n      2001 - 2021\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Internal Medicine\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    "
      ],
      "publications&presentations":[
         "     \n        Immunologic characteristics of intrarenal T cells: trafficking of expanded CD8+ T cell β-chain clonotypes in progressive lupus nephritis.\n       \n      Winchester, R., Wiesendanger, M., Zhang, H. Z., Steshenko, V., Peterson, K., Geraldino-Pardilla, L.,…\n     \n      Arthritis Rheum\n      2012 May\n    ",
         "     \n        Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis.\n       \n      Winchester, R., Wiesendanger, M., O'Brien, W., Zhang, H. Z., Maurer, M. S., Gillam, L. D., Schwartz,…\n     \n      J Immunol\n      2011 Jul 15\n    ",
         "     \n        Novel therapeutics for systemic lupus erythematosus.\n       \n      Wiesendanger, M., Stanevsky, A., Kovsky, S., Diamond, B.…\n     \n      Curr Opin Rheumatol\n      2006 May\n    ",
         "     \n        The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis.\n       \n      Iruretagoyena, M. I., Wiesendanger, M., Kalergis, A. M.…\n     \n      Curr Pharm Des\n      2006\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[
         "  Ambulatory Care Network Quality and Patient Safety Committee Physician IT Liaison 2014 - 2015"
      ],
      "memberships":[
         "   Alpha Omega Alpha Honor Medical Society - AOA Member",
         "   American College of Rheumatology - ACR Fellow",
         "   American College of Physicians - ACP Fellow"
      ],
      "clinical-trails":[

      ],
      "lectures":[

      ],
      "press-mentions":[

      ],
      "hospital-info":[
         "   \n      Associate Professor of Medicine\n      \n    Icahn School of Medicine at Mount Sinai  ·  New York, NY\n   \n    February 2020 - Present\n   ",
         "   \n      Assistant Professor of Medicine\n      \n    Icahn School of Medicine at Mount Sinai  ·  New York, NY\n   \n    January 2015 - January 2020\n   ",
         "\n  Edit\n     \n      Rheumatology Division Of Mount Sinai  ·  New York, NY\n       \n    September 2016 - Present\n   ",
         "   \n        Mount Sinai Hospital\n       \n      Current Affiliation\n     \n        New York, NY\n    ",
         "   \n        Mount Sinai Queens\n       \n      Current Affiliation\n     \n        Astoria, NY\n    ",
         "   \n        Mount Sinai Beth Israel\n       \n      Current Affiliation\n     \n        New York, NY\n    ",
         "   \n        Mount Sinai West\n       \n      Current Affiliation\n     \n        New York, NY\n    ",
         "   \n        Mount Sinai Brooklyn\n       \n      Current Affiliation\n     \n        Brooklyn, NY\n    ",
         "Mount Sinai Morningside\n       \n      Current Affiliation\n     \n        New York, NY\n    ",
         "Columbia University Medical Center\n       \n      Former Affiliation\n     \n        New York, NY\n    ",
         "New York-Presbyterian Hospital\n       \n      Former Affiliation\n     \n        New York, NY\n    "
      ],
      "award-info":[
         "   \n      Fellow\n     \n      American College of Physicians, 2011\n    ",
         "   \n      Patient-Centered Medical Home Recognition Program\n     \n      National Committee for Quality Assurance, 2013-2016\n    ",
         "   \n      Fellow\n     \n      American College of Rheumatology\n    "
      ],
      "support-grants":[

      ]
   },
   "P5":{
      "name":"\n          Jose U Scher, MD\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/l_text:Helvetica_130_bold:JS,co_rgb:FFFFFF,t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/profile-placeholder-registered-5.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        333 East 38th Street\n       \n        4th Floor\n       \n        New York, NY 10016\n        ",
      "phone":"\n      \n     \n      (646) 501-7400\n      ",
      "fax":"",
      "job-title":"\n            Director, Arthritis Clinic. NYU-Hospital for Joint Diseases\n          ",
      "summary":" \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        NYU School of Medicine\n       \n      Fellowship, Rheumatology, 2007 - 2009\n    ",
         "   \n        NYU School of Medicine\n       \n      Residency, Internal Medicine, 2004 - 2007\n    ",
         "   \n        Maimonides University Faculty of Medicine\n       \n      Class of 2000\n    "
      ],
      "certifications&licences":[
         "   \n      NY State Medical License\n     \n      2009 - 2020\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    "
      ],
      "publications&presentations":[
         "     \n        The microbiome in rheumatology: Where are we and where should we go?\n       \n      Manasson, J., Blank, R. B., Scher, J. U.…\n     \n      Annals of the rheumatic diseases\n      2020 Apr 26\n    ",
         "     \n        Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study.\n       \n      Hudesman, D. P., Chakravarty, S. D., Emond, B., Ellis, L. A., Lefebvre, P., Sadik, K., Scher, J. U.…\n     \n      BMC rheumatology\n      2020 Apr 9\n    ",
         "     \n        Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response.\n       \n      Scher, J. U., Nayak, R. R., Ubeda, C., Turnbaugh, P. J., Abramson, S. B.…\n     \n      Nature reviews. Rheumatology\n      2020 Mar 12\n    ",
         "     \n        Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1.\n       \n      Garshick, M. S., Tawil, M., Barrett, T. J., Salud-Gnilo, C. M., Eppler, M., Lee, A., Scher, J. U., N…\n     \n      Arteriosclerosis, thrombosis, and vascular biology\n      2020 Mar 7\n    ",
         "     \n        Interleukin 1 receptor antagonist (<i>IL1RN</i>) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease.\n       \n      Attur, M., Zhou, H., Samuels, J., Krasnokutsky, S., Yau, M., Scher, J. U., Doherty, M., Wilson, A. G…\n     \n      Annals of the rheumatic diseases\n      2019 Dec 20\n    ",
         "  \n        Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry.\n       \n      Kavanaugh, A., Papp, K., Gottlieb, A. B., de Jong, E. M., Chakravarty, S. D., Kafka, S., Langholff, …\n     \n      BMC rheumatology\n      2019 Mar 20\n    ",
         "\n        6\n       mentions   \n        Inflammasome Signaling and Impaired Vascular Health in Psoriasis.\n       \n      Garshick, M. S., Barrett, T. J., Wechter, T., Azarchi, S., Scher, J. U., Neimann, A., Katz, S., Fuen…\n     \n      Arteriosclerosis, thrombosis, and vascular biology\n      2019 Feb 15\n    ",
         "\n        8\n       mentions \n        2 NEW\n        \n        Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition.\n       \n      Scher, J. U., Ogdie, A., Merola, J. F., Ritchlin, C.…\n     \n      Nature reviews. Rheumatology\n      2019 Feb 12\n    ",
         "\n        7\n       mentions \n        2 NEW\n        \n        Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.\n       \n      Singh, J. A., Guyatt, G., Ogdie, A., Gladman, D. D., Deal, C., Deodhar, A., Dubreuil, M., Dunham, J.…\n     \n      Arthritis care & research\n      2018 Dec 1\n    ",
         "  \n        Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.\n       \n      Singh, J. A., Guyatt, G., Ogdie, A., Gladman, D. D., Deal, C., Deodhar, A., Dubreuil, M., Dunham, J.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Dec 1\n    ",
         "  \n        Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics.\n       \n      Haberman, R., Perez-Chada, L. M., Merola, J. F., Scher, J., Ogdie, A., Reddy, S. M.…\n     \n      Current rheumatology reports\n      2018 Oct 28\n    ",
         "  \n        Microbiota-Dependent Involvement of Th17 Cells in Murine Models of Inflammatory Arthritis.\n       \n      Evans-Marin, H., Rogier, R., Koralov, S. B., Manasson, J., Roeleveld, D., van der Kraan, P. M., Sche…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Jul 6\n    ",
         "  \n        The Microbiome in Psoriasis and Psoriatic Arthritis: Joints.\n       \n      Scher, J. U.…\n     \n      The Journal of rheumatology. Supplement\n      2018 Jun 3\n    ",
         "1\n       citations    \n        Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis.\n       \n      Yang, L., Fanok, M. H., Mediero-Munoz, A., Fogli, L. K., Corciulo, C., Abdollahi, S., Cronstein, B. …\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Feb 14\n    ",
         "4\n       citations  \n        71\n       mentions \n        27 NEW\n        \n        The role of the gut microbiome in systemic inflammatory disease.\n       \n      Clemente, J. C., Manasson, J., Scher, J. U.…\n     \n      BMJ (Clinical research ed.)\n      2018 Jan 10\n    ",
         "\n        3\n       mentions   \n        Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis.\n       \n      Rogier, R., Evans-Marin, H., Manasson, J., van der Kraan, P. M., Walgreen, B., Helsen, M. M., van de…\n     \n      Scientific reports\n      2017 Nov 17\n    ",
         "  \n        Potential risk factors for reactive arthritis and persistence of symptoms at 2Â\\xa0years: a case-control study with longitudinal follow-up.\n       \n      Ferrer, H. R., Azan, A., Iraheta, I., Von Feldt, J. M., Espinoza, L. R., Manasson, J., Scher, J. U.,…\n     \n      Clinical rheumatology\n      2017 Nov 16\n    ",
         "1\n       citations  \n        1\n       mention   \n        Human microbiome, infections, and rheumatic disease.\n       \n      Caminer, A. C., Haberman, R., Scher, J. U.…\n     \n      Clinical rheumatology\n      2017 Nov 5\n    ",
         "3\n       citations  \n        4\n       mentions   \n        Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis.\n       \n      Manasson, J., Shen, N., Ferrer, H. R., Ubeda, C., Iraheta, I., Heguy, A., Von Feldt, J. M., Espinoza…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Oct 27\n    ",
         "  \n        The 2018 landscape of RA, PsA, and SpA pathogenesis.\n       \n      Scher, J. U.…\n     \n      Current opinion in rheumatology\n      2017 Oct 17\n    ",
         "2\n       citations    \n        Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.\n       \n      Rogier, R., Ederveen, T. H., Boekhorst, J., Wopereis, H., Scher, J. U., Manasson, J., Frambach, S. J…\n     \n      Microbiome\n      2017 Jun 25\n    ",
         "2\n       citations    \n        Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.\n       \n      Okhovat, J., Ogdie, A., Reddy, S. M., Rosen, C. F., Scher, J. U., Merola, J. F.…\n     \n      The Journal of rheumatology\n      2017 May 4\n    ",
         "14\n       citations  \n        1\n       mention   \n        The lung microbiota in early rheumatoid arthritis and autoimmunity.\n       \n      Scher, J. U., Joshua, V., Artacho, A., Abdollahi-Roodsaz, S., Öckinger, J., Kullberg, S., Sköld, M.,…\n     \n      Microbiome\n      2016 Nov 20\n    ",
         "13\n       citations  \n        7\n       mentions   \n        The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.\n       \n      Abdollahi-Roodsaz, S., Abramson, S. B., Scher, J. U.…\n     \n      Nature reviews. Rheumatology\n      2016 Jun 4\n    ",
         "37\n       citations  \n        2\n       mentions   \n        Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.\n       \n      Scher, J. U., Littman, D. R., Abramson, S. B.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Sep 4\n    ",
         "  \n        Reply: To PMID 25319745.\n       \n      Scher, J. U., Reddy, S., Ubeda, C., Neimann, A., Abramson, S. B.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Apr 22\n    ",
         "  \n        Erratum to: Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis.\n       \n      Peled, M., Strazza, M., Azoulay-Alfaguter, I., Silverman, G. J., Scher, J. U., Mor, A.…\n     \n      Inflammation\n      2015 Apr 8\n    ",
         "1\n       citations  \n        3\n       mentions   \n        Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease.\n       \n      Scher, J. U.…\n     \n      The Journal of rheumatology\n      2015 Mar 3\n    ",
         "7\n       citations    \n        Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.\n       \n      Manasson, J., Scher, J. U.…\n     \n      Current rheumatology reports\n      2015 Feb 11\n    ",
         "16\n       citations  \n        1\n       mention   \n        Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.\n       \n      Catrina, A. I., Deane, K. D., Scher, J. U.…\n     \n      Rheumatology (Oxford, England)\n      2014 Dec 30\n    ",
         "30\n       citations  \n        6\n       mentions   \n        Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism.\n       \n      Zanin-Zhorov, A., Weiss, J. M., Nyuydzefe, M. S., Chen, W., Scher, J. U., Mo, R., Depoil, D., Rao, N…\n     \n      Proceedings of the National Academy of Sciences of the United States of America\n      2014 Nov 12\n    ",
         "92\n       citations  \n        29\n       mentions \n        2 NEW\n        \n        Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.\n       \n      Scher, J. U., Ubeda, C., Artacho, A., Attur, M., Isaac, S., Reddy, S. M., Marmon, S., Neimann, A., B…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2014 Oct 17\n    ",
         "3\n       citations    \n        Biomarkers in psoriatic arthritis: recent progress.\n       \n      Chandran, V., Scher, J. U.…\n     \n      Current rheumatology reports\n      2014 Sep 15\n    ",
         "20\n       citations    \n        Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?\n       \n      Scher, J. U., Bretz, W. A., Abramson, S. B.…\n     \n      Current opinion in rheumatology\n      2014 May 9\n    ",
         "49\n       citations  \n        2\n       mentions   \n        Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity.\n       \n      Brusca, S. B., Abramson, S. B., Scher, J. U.…\n     \n      Current opinion in rheumatology\n      2013 Nov 20\n    ",
         "10\n       citations  \n        1\n       mention   \n        Periodontal disease, Porphyromonas gingivalis, and rheumatoid arthritis: what triggers autoimmunity and clinical disease?\n       \n      Scher, J. U., Abramson, S. B.…\n     \n      Arthritis research & therapy\n      2013 Nov 16\n    ",
         "293\n       citations  \n        49\n       mentions \n        2 NEW\n        \n        Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.\n       \n      Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C. M., Rostron, T., Ceru…\n     \n      eLife\n      2013 Nov 7\n    ",
         "6\n       citations    \n        Monotherapy in rheumatoid arthritis.\n       \n      Scher, J. U.…\n     \n      Bulletin of the Hospital for Joint Disease (2013)\n      2013 Oct 25\n    ",
         "130\n       citations  \n        1\n       mention   \n        Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis.\n       \n      Scher, J. U., Ubeda, C., Equinda, M., Khanin, R., Buischi, Y., Viale, A., Lipuma, L., Attur, M., Pil…\n     \n      Arthritis and rheumatism\n      2012 May 12\n    ",
         "18\n       citations    \n        Rheumatoid arthritis and periodontitis: a possible link via \"citation\".\n       \n      Rosenstein, E. D., Scher, J. U., Bretz, W. A., Weissmann, G.…\n     \n      Anaerobe\n      2011 Oct 25\n    ",
         "120\n       citations  \n        14\n       mentions   \n        The microbiome and rheumatoid arthritis.\n       \n      Scher, J. U., Abramson, S. B.…\n     \n      Nature reviews. Rheumatology\n      2011 Aug 25\n    ",
         "57\n       citations  \n        1\n       mention   \n        The anti-inflammatory effects of prostaglandins.\n       \n      Scher, J. U., Pillinger, M. H.…\n     \n      Journal of investigative medicine : the official publication of the American Federation for Clinical Research\n      2009 Feb 26\n    ",
         "1\n       citations    \n        Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation.\n       \n      Pillinger, M. H., Marjanovic, N., Kim, S., Lee, Y., Scher, J. U., Roper, J., Abeles, A. M., Izmirly,…\n     \n      The Journal of biological chemistry\n      2007 May 4\n    ",
         "97\n       citations    \n        15d-PGJ2: the anti-inflammatory prostaglandin?\n       \n      Scher, J. U., Pillinger, M. H.…\n     \n      Clinical immunology (Orlando, Fla.)\n      2005 Jan 11\n    ",
         "  \n        The microbiome in rheumatology: Where are we and where should we go?\n       \n      Manasson, J., Blank, R. B., Scher, J. U.…\n     \n      Annals of the rheumatic diseases\n      2020 Apr 26\n    ",
         "  \n        Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study.\n       \n      Hudesman, D. P., Chakravarty, S. D., Emond, B., Ellis, L. A., Lefebvre, P., Sadik, K., Scher, J. U.…\n     \n      BMC rheumatology\n      2020 Apr 9\n    ",
         "  \n        Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response.\n       \n      Scher, J. U., Nayak, R. R., Ubeda, C., Turnbaugh, P. J., Abramson, S. B.…\n     \n      Nature reviews. Rheumatology\n      2020 Mar 12\n    ",
         "  \n        Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1.\n       \n      Garshick, M. S., Tawil, M., Barrett, T. J., Salud-Gnilo, C. M., Eppler, M., Lee, A., Scher, J. U., N…\n     \n      Arteriosclerosis, thrombosis, and vascular biology\n      2020 Mar 7\n    ",
         "  \n        Interleukin 1 receptor antagonist (<i>IL1RN</i>) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease.\n       \n      Attur, M., Zhou, H., Samuels, J., Krasnokutsky, S., Yau, M., Scher, J. U., Doherty, M., Wilson, A. G…\n     \n      Annals of the rheumatic diseases\n      2019 Dec 20\n    ",
         "  \n        Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry.\n       \n      Kavanaugh, A., Papp, K., Gottlieb, A. B., de Jong, E. M., Chakravarty, S. D., Kafka, S., Langholff, …\n     \n      BMC rheumatology\n      2019 Mar 20\n    ",
         "\n        6\n       mentions   \n        Inflammasome Signaling and Impaired Vascular Health in Psoriasis.\n       \n      Garshick, M. S., Barrett, T. J., Wechter, T., Azarchi, S., Scher, J. U., Neimann, A., Katz, S., Fuen…\n     \n      Arteriosclerosis, thrombosis, and vascular biology\n      2019 Feb 15\n    ",
         "\n        8\n       mentions \n        2 NEW\n        \n        Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition.\n       \n      Scher, J. U., Ogdie, A., Merola, J. F., Ritchlin, C.…\n     \n      Nature reviews. Rheumatology\n      2019 Feb 12\n    ",
         "\n        7\n       mentions \n        2 NEW\n        \n        Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.\n       \n      Singh, J. A., Guyatt, G., Ogdie, A., Gladman, D. D., Deal, C., Deodhar, A., Dubreuil, M., Dunham, J.…\n     \n      Arthritis care & research\n      2018 Dec 1\n    ",
         "  \n        Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.\n       \n      Singh, J. A., Guyatt, G., Ogdie, A., Gladman, D. D., Deal, C., Deodhar, A., Dubreuil, M., Dunham, J.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Dec 1\n    ",
         "  \n        Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics.\n       \n      Haberman, R., Perez-Chada, L. M., Merola, J. F., Scher, J., Ogdie, A., Reddy, S. M.…\n     \n      Current rheumatology reports\n      2018 Oct 28\n    ",
         "  \n        Microbiota-Dependent Involvement of Th17 Cells in Murine Models of Inflammatory Arthritis.\n       \n      Evans-Marin, H., Rogier, R., Koralov, S. B., Manasson, J., Roeleveld, D., van der Kraan, P. M., Sche…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Jul 6\n    ",
         "  \n        The Microbiome in Psoriasis and Psoriatic Arthritis: Joints.\n       \n      Scher, J. U.…\n     \n      The Journal of rheumatology. Supplement\n      2018 Jun 3\n    ",
         "1\n       citations    \n        Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis.\n       \n      Yang, L., Fanok, M. H., Mediero-Munoz, A., Fogli, L. K., Corciulo, C., Abdollahi, S., Cronstein, B. …\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2018 Feb 14\n    ",
         "4\n       citations  \n        71\n       mentions \n        27 NEW\n        \n        The role of the gut microbiome in systemic inflammatory disease.\n       \n      Clemente, J. C., Manasson, J., Scher, J. U.…\n     \n      BMJ (Clinical research ed.)\n      2018 Jan 10\n    ",
         "\n        3\n       mentions   \n        Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis.\n       \n      Rogier, R., Evans-Marin, H., Manasson, J., van der Kraan, P. M., Walgreen, B., Helsen, M. M., van de…\n     \n      Scientific reports\n      2017 Nov 17\n    ",
         "  \n        Potential risk factors for reactive arthritis and persistence of symptoms at 2Â\\xa0years: a case-control study with longitudinal follow-up.\n       \n      Ferrer, H. R., Azan, A., Iraheta, I., Von Feldt, J. M., Espinoza, L. R., Manasson, J., Scher, J. U.,…\n     \n      Clinical rheumatology\n      2017 Nov 16\n    ",
         "1\n       citations  \n        1\n       mention   \n        Human microbiome, infections, and rheumatic disease.\n       \n      Caminer, A. C., Haberman, R., Scher, J. U.…\n     \n      Clinical rheumatology\n      2017 Nov 5\n    ",
         "3\n       citations  \n        4\n       mentions   \n        Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis.\n       \n      Manasson, J., Shen, N., Ferrer, H. R., Ubeda, C., Iraheta, I., Heguy, A., Von Feldt, J. M., Espinoza…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2017 Oct 27\n    ",
         "  \n        The 2018 landscape of RA, PsA, and SpA pathogenesis.\n       \n      Scher, J. U.…\n     \n      Current opinion in rheumatology\n      2017 Oct 17\n    ",
         "2\n       citations    \n        Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.\n       \n      Rogier, R., Ederveen, T. H., Boekhorst, J., Wopereis, H., Scher, J. U., Manasson, J., Frambach, S. J…\n     \n      Microbiome\n      2017 Jun 25\n    ",
         "2\n       citations    \n        Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.\n       \n      Okhovat, J., Ogdie, A., Reddy, S. M., Rosen, C. F., Scher, J. U., Merola, J. F.…\n     \n      The Journal of rheumatology\n      2017 May 4\n    ",
         "14\n       citations  \n        1\n       mention   \n        The lung microbiota in early rheumatoid arthritis and autoimmunity.\n       \n      Scher, J. U., Joshua, V., Artacho, A., Abdollahi-Roodsaz, S., Öckinger, J., Kullberg, S., Sköld, M.,…\n     \n      Microbiome\n      2016 Nov 20\n    ",
         "13\n       citations  \n        7\n       mentions   \n        The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.\n       \n      Abdollahi-Roodsaz, S., Abramson, S. B., Scher, J. U.…\n     \n      Nature reviews. Rheumatology\n      2016 Jun 4\n    ",
         "37\n       citations  \n        2\n       mentions   \n        Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.\n       \n      Scher, J. U., Littman, D. R., Abramson, S. B.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Sep 4\n    ",
         "  \n        Reply: To PMID 25319745.\n       \n      Scher, J. U., Reddy, S., Ubeda, C., Neimann, A., Abramson, S. B.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Apr 22\n    ",
         "  \n        Erratum to: Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis.\n       \n      Peled, M., Strazza, M., Azoulay-Alfaguter, I., Silverman, G. J., Scher, J. U., Mor, A.…\n     \n      Inflammation\n      2015 Apr 8\n    ",
         "1\n       citations  \n        3\n       mentions   \n        Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease.\n       \n      Scher, J. U.…\n     \n      The Journal of rheumatology\n      2015 Mar 3\n    ",
         "7\n       citations    \n        Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.\n       \n      Manasson, J., Scher, J. U.…\n     \n      Current rheumatology reports\n      2015 Feb 11\n    ",
         "16\n       citations  \n        1\n       mention   \n        Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.\n       \n      Catrina, A. I., Deane, K. D., Scher, J. U.…\n     \n      Rheumatology (Oxford, England)\n      2014 Dec 30\n    ",
         "30\n       citations  \n        6\n       mentions   \n        Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism.\n       \n      Zanin-Zhorov, A., Weiss, J. M., Nyuydzefe, M. S., Chen, W., Scher, J. U., Mo, R., Depoil, D., Rao, N…\n     \n      Proceedings of the National Academy of Sciences of the United States of America\n      2014 Nov 12\n    ",
         "92\n       citations  \n        29\n       mentions \n        2 NEW\n        \n        Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.\n       \n      Scher, J. U., Ubeda, C., Artacho, A., Attur, M., Isaac, S., Reddy, S. M., Marmon, S., Neimann, A., B…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2014 Oct 17\n    ",
         "3\n       citations    \n        Biomarkers in psoriatic arthritis: recent progress.\n       \n      Chandran, V., Scher, J. U.…\n     \n      Current rheumatology reports\n      2014 Sep 15\n    ",
         "20\n       citations    \n        Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?\n       \n      Scher, J. U., Bretz, W. A., Abramson, S. B.…\n     \n      Current opinion in rheumatology\n      2014 May 9\n    ",
         "49\n       citations  \n        2\n       mentions   \n        Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity.\n       \n      Brusca, S. B., Abramson, S. B., Scher, J. U.…\n     \n      Current opinion in rheumatology\n      2013 Nov 20\n    ",
         "10\n       citations  \n        1\n       mention   \n        Periodontal disease, Porphyromonas gingivalis, and rheumatoid arthritis: what triggers autoimmunity and clinical disease?\n       \n      Scher, J. U., Abramson, S. B.…\n     \n      Arthritis research & therapy\n      2013 Nov 16\n    ",
         "293\n       citations  \n        49\n       mentions \n        2 NEW\n        \n        Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.\n       \n      Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C. M., Rostron, T., Ceru…\n     \n      eLife\n      2013 Nov 7\n    ",
         "6\n       citations    \n        Monotherapy in rheumatoid arthritis.\n       \n      Scher, J. U.…\n     \n      Bulletin of the Hospital for Joint Disease (2013)\n      2013 Oct 25\n    ",
         "130\n       citations  \n        1\n       mention   \n        Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis.\n       \n      Scher, J. U., Ubeda, C., Equinda, M., Khanin, R., Buischi, Y., Viale, A., Lipuma, L., Attur, M., Pil…\n     \n      Arthritis and rheumatism\n      2012 May 12\n    ",
         "18\n       citations    \n        Rheumatoid arthritis and periodontitis: a possible link via \"citation\".\n       \n      Rosenstein, E. D., Scher, J. U., Bretz, W. A., Weissmann, G.…\n     \n      Anaerobe\n      2011 Oct 25\n    ",
         "120\n       citations  \n        14\n       mentions   \n        The microbiome and rheumatoid arthritis.\n       \n      Scher, J. U., Abramson, S. B.…\n     \n      Nature reviews. Rheumatology\n      2011 Aug 25\n    ",
         "57\n       citations  \n        1\n       mention   \n        The anti-inflammatory effects of prostaglandins.\n       \n      Scher, J. U., Pillinger, M. H.…\n     \n      Journal of investigative medicine : the official publication of the American Federation for Clinical Research\n      2009 Feb 26\n    ",
         "1\n       citations    \n        Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation.\n       \n      Pillinger, M. H., Marjanovic, N., Kim, S., Lee, Y., Scher, J. U., Roper, J., Abeles, A. M., Izmirly,…\n     \n      The Journal of biological chemistry\n      2007 May 4\n    ",
         "97\n       citations    \n        15d-PGJ2: the anti-inflammatory prostaglandin?\n       \n      Scher, J. U., Pillinger, M. H.…\n     \n      Clinical immunology (Orlando, Fla.)\n      2005 Jan 11\n    ",
         "  \n        Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function.\n       \n      Zanin-Zhorov, A., Lin, J., Scher, J., Kumari, S., Blair, D., Hippen, K. L., Blazar, B. R., Abramson,…\n     \n      Proc Natl Acad Sci U S A\n      2012 Jan 31\n    ",
         "  \n        Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.\n       \n      Rand, J. H., Wu, X. X., Andree, H. A., Lockwood, C. J., Guller, S., Scher, J., Harpel, P. C.…\n     \n      N Engl J Med\n      1997 Jul 17\n    ",
         "  \n        Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.\n       \n      Rand, J. H., Wu, X. X., Guller, S., Scher, J., Andree, H. A., Lockwood, C. J.…\n     \n      Am J Obstet Gynecol\n      1997 Oct\n    ",
         "  \n        Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.\n       \n      Rand, J. H., Wu, X. X., Guller, S., Gil, J., Guha, A., Scher, J., Lockwood, C. J.…\n     \n      Am J Obstet Gynecol\n      1994 Dec\n    ",
         "  \n        Prothrombin activation fragment (F1.2) is increased in pregnant patients with antiphospholipid antibodies.\n       \n      Zangari, M., Lockwood, C. J., Scher, J., Rand, J. H.…\n     \n      Thromb Res\n      1997 Feb 1\n    ",
         "  \n        Correlation between karyotype and ultrasound findings in patients with failed early pregnancy.\n       \n      Goldstein, S. R., Kerenyi, T., Scher, J., Papp, C.…\n     \n      Ultrasound Obstet Gynecol\n      1996 Nov\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[

      ],
      "memberships":[

      ],
      "clinical-trails":[
         "  Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) \n    Start of enrollment: 2010-01-01\n   \n    Abramson, S.B.,Rivera, S.,S...\n  ",
         "  Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis  \n    Jose Scher, MD\n  "
      ],
      "lectures":[

      ],
      "press-mentions":[
         "   \n        \u200b\u200b\u200b\u200b\u200b\u200b\u200bBiologic, JAK Inhibitor Use May Not Be Linked to Worse COVID-19 Outcomes\n       \n      medwireNews\n       · April 05, 2020  ...JAK inhibitors (50 vs 76%) but the between-group difference did not reach statistical significance. Jose Scher and colleagues from New York University note that these findings were consistent when they restrict...",
         "   \n        The 2019 ACR Award Winners & Distinguished Fellows\n       \n      The Rheumatologist\n       · December 18, 2019  ...ant in 2019. For the past two years, she has researched psoriatic arthritis under the mentorship of Jose Scher, MD, assistant professor, director of NYU Langone Health’s Psoriatic Arthritis Center. While honing...",
         "   \n        National Psoriasis Foundation Awards $2.8 Million in Research Grants and Fellowships\n       \n      Bioengineering\n       · July 12, 2019  ...Paine, Ph.D. University of Rochester, Siba Raychaudhuri, M.D. University of California, Davis, and Jose Scher, M.D. New York University School of Medicine. This grant is not possible without significant suppor...",
         "   \n        The Microbiome: A Predictor of Response?\n       \n      The Rheumatologist\n       · June 12, 2019  ...p predict response to medication and may be manipulated to improve how well a treatment works, said Jose Scher, MD, at the 2019 ACR State-of-the-Art Clinical Symposium, held April 5–7. “We can truly exploit or...",
         "   \n        PsA Patients See Benefit from Cosentyx\n       \n      MedPage Today\n       · May 18, 2016  ...ace of newer biologics such as secukinumab in the treatment of psoriatic arthritis was addressed by Jose Scher, MD, of NYU Langone Medical Center in New York City. \"The question is, are these drugs that will ta...",
         "   \n        The Human Body\\'s Complicated Relationship with Fungi\n       \n      NPR\n       · April 16, 2016  ...to individual patients. However as New York University rheumatologist and microbiome researcher Dr Jose Scher, points out, probiotic research — especially the area involving fungi — is in its adolescence. \"All...",
         "   \n        Mouth Bacteria a Risk Factor of Rheumatoid Arthritis\n       \n      SBWire\n       · January 19, 2016  ...cumstances that can turn this into auto inflammatory disorders, which include rheumatoid arthritis. Jose Scher, M.D., the director of the Microbiome center for Rheumatology and Autoimmunity at the Langone Medic...",
         "Excess Weight Loss May Benefit Patients Due to Reductions in Inflammation\n       \n      Medical Xpress\n       · November 08, 2015  ",
         "Gut Bacteria Linked with Rheumatoid Arthritis in New Study\n       \n      www.huffpost.com\n       · November 06, 2013  ",
         "Intestinal Bacteria Linked to Rheumatoid Arthritis\n       \n      News Medical\n       · November 06, 2013  "
      ],
      "hospital-info":[
         "   \n      NYU School Of Medicine Professional Services  ·  New York, NY\n       \n    January 2013 - Present\n   ",
         "   \n        NYU Langone Orthopedic Hospital\n       \n      Current Affiliation\n     \n        New York, NY\n    ",
         "   \n        NYU Langone Hospitals\n       \n      Current Affiliation\n     \n        New York, NY\n    ",
         "   \n        NYC Health + Hospitals / Coney Island\n       \n      Former Affiliation\n     \n        Brooklyn, NY\n    "
      ],
      "award-info":[
         "   \n      CMS Meaningful Use Stage 1 Certification\n     \n      EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013\n    ",
         "   \n      Fellow\n     \n      American College of Rheumatology\n    "
      ],
      "support-grants":[

      ]
   },
   "P6":{
      "name":"\n          John Steuart Richards, MD\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/l_text:Helvetica_130_bold:JR,co_rgb:FFFFFF,t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/profile-placeholder-registered-3.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        3601 Fifth Avenue\n       \n        Suite 3b Falk Medical Building\n       \n        Pittsburgh, PA 15213\n        ",
      "phone":"\n      \n     \n      (412) 647-6700\n      ",
      "fax":"",
      "job-title":"\n            Associate Professor, Medicine, Georgetown University School of Medicine\n          ",
      "summary":" \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        Georgetown University Hospital\n       \n      Fellowship, Rheumatology, 1995 - 1997\n    ",
         "   \n        University of the West Indies Faculty of Medical Sciences\n       \n      Class of 1988\n    "
      ],
      "certifications&licences":[
         "   \n      PA State Medical License\n     \n      2015 - 2020\n    ",
         "   \n      MD State Medical License\n     \n      2012 - 2017\n    ",
         "   \n      DC State Medical License\n     \n      2000 - 2020\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Internal Medicine\n    "
      ],
      "publications&presentations":[
         "     \n        Validation of disease activity and functional status questionnaires in spondyloarthritis.\n       \n      Quinzanos, I.,Luong, P. T.,Bobba, S.,Richards, J. S.,Majithia, V.,Davis, L. A.,Caplan, L.…\n     \n      Clin. Exp. Rheumatol.\n      2015 Feb 11\n    ",
         "     \n        Measuring physician adherence with gout quality indicators: a role for natural language processing.\n       \n      Kerr, G. S.,Richards, J. S.,Nunziato, C. A.,Patterson, O. V.,DuVall, S. L.,Aujero, M.,Maron, D.,Amdu…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Jul 23\n    ",
         "     \n        Disease characteristics and treatment patterns in veterans with rheumatoid arthritis and concomitant hepatitis C infection.\n       \n      Patel, R.,Mikuls, T.,Richards, J. S.,Kerr, G.,Cannon, G.,Baker, J. F.…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Sep 05\n    ",
         "     \n        Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: Pharmacologic implications.\n       \n      Kerr, G.,Aujero, M.,Richards, J.,Sayles, H.,Davis, L.,Cannon, G.,Caplan, L.,Michaud, K.,Mikuls, T.…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Apr 03\n    ",
         "     \n        Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis.\n       \n      Davis, L. A.,Whitfield, E.,Cannon, G. W.,Wolff, R. K.,Johnson, D. S.,Reimold, A. M.,Kerr, G. S.,Rich…\n     \n      Rheumatology (Oxford)\n      2014 Feb 04\n    ",
         "  \n        Cardiovascular Events Are Not Associated with MTHFR Polymorphisms, But Are Associated with Methotrexate Use and Traditional Risk Factors in US Veterans with Rheumatoid Arthritis.\n       \n      Davis, L. A.,Cannon, G. W.,Pointer, L. F.,Haverhals, L. M.,Wolff, R. K.,Mikuls, T. R.,Reimold, A. M.…\n     \n      J. Rheumatol.\n      2013 Jun\n    ",
         "  \n        Validation of the Osteoporosis Self-Assessment Tool in US Male Veterans.\n       \n      Richards, J. S.,Lazzari, A. A.,Teves Qualler, D. A.,Desale, S.,Howard, R.,Kerr, G. S.…\n     \n      J Clin Densitom\n      2013 Mar 12\n    ",
         "  \n        Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis.\n       \n      Richards, J. S.,Cannon, G. W.,Hayden, C. L.,Amdur, R. L.,Lazaro, D.,Mikuls, T. R.,Reimold, A. M.,Cap…\n     \n      Arthritis Care Res (Hoboken)\n      2012 Jun 29\n    ",
         "  \n        Collaborative learning and technology skills development: evaluation of an online annual grantee meeting.\n       \n      Richards, J.,Edwards, K.,Lackey, M.,Wallace, L.,Calleson, J.,Barber, C.,Long, T.,Lin, S.,Farel, A.…\n     \n      Matern Child Health J\n      2011 Oct 20\n    ",
         "  \n        Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.\n       \n      Cannon GW, Mikuls TR, Hayden CL, Ying J, Curtis JR, Reimold AM, Caplan L, Kerr GS, Richards JS, John…\n     \n      Arthritis Care Res (Hoboken)\n      2011-12-01\n    ",
         "  \n        Odontoid erosions in rheumatoid arthritis: utility of the open mouth view.\n       \n      Richards, J. S.,Kerr, G. S.,Nashel, D. J.…\n     \n      J Clin Rheumatol\n      2000 Dec 01\n    ",
         "  \n        Treating type 2 diabetes. Important findings should not be published in two journals.\n       \n      Richards J…\n     \n      BMJ\n      1999-03-06\n    ",
         "  \n        Screening for Down's syndrome.\n       \n      Parsons L, Richards J, Garlick R…\n     \n      BMJ\n      1992-11-14\n    ",
         "  \n        Quality of drinking water.\n       \n      Richards J, Stokely D, Hipgrave P…\n     \n      BMJ\n      1992-02-29\n    ",
         "  \n        Set menus and clinical freedom.\n       \n      Kinnersley P, Owen P, Wilkinson C, Richards J…\n     \n      BMJ\n      1991-10-05\n    ",
         "  \n        Innovation in general practice.\n       \n      Owen P, Richards J…\n     \n      BMJ\n      1988-08-06\n    ",
         "  \n        Validation of disease activity and functional status questionnaires in spondyloarthritis.\n       \n      Quinzanos, I.,Luong, P. T.,Bobba, S.,Richards, J. S.,Majithia, V.,Davis, L. A.,Caplan, L.…\n     \n      Clin. Exp. Rheumatol.\n      2015 Feb 11\n    ",
         "  \n        Measuring physician adherence with gout quality indicators: a role for natural language processing.\n       \n      Kerr, G. S.,Richards, J. S.,Nunziato, C. A.,Patterson, O. V.,DuVall, S. L.,Aujero, M.,Maron, D.,Amdu…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Jul 23\n    ",
         "  \n        Disease characteristics and treatment patterns in veterans with rheumatoid arthritis and concomitant hepatitis C infection.\n       \n      Patel, R.,Mikuls, T.,Richards, J. S.,Kerr, G.,Cannon, G.,Baker, J. F.…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Sep 05\n    ",
         "  \n        Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: Pharmacologic implications.\n       \n      Kerr, G.,Aujero, M.,Richards, J.,Sayles, H.,Davis, L.,Cannon, G.,Caplan, L.,Michaud, K.,Mikuls, T.…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Apr 03\n    ",
         "  \n        Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis.\n       \n      Davis, L. A.,Whitfield, E.,Cannon, G. W.,Wolff, R. K.,Johnson, D. S.,Reimold, A. M.,Kerr, G. S.,Rich…\n     \n      Rheumatology (Oxford)\n      2014 Feb 04\n    ",
         "  \n        Cardiovascular Events Are Not Associated with MTHFR Polymorphisms, But Are Associated with Methotrexate Use and Traditional Risk Factors in US Veterans with Rheumatoid Arthritis.\n       \n      Davis, L. A.,Cannon, G. W.,Pointer, L. F.,Haverhals, L. M.,Wolff, R. K.,Mikuls, T. R.,Reimold, A. M.…\n     \n      J. Rheumatol.\n      2013 Jun\n    ",
         "  \n        Validation of the Osteoporosis Self-Assessment Tool in US Male Veterans.\n       \n      Richards, J. S.,Lazzari, A. A.,Teves Qualler, D. A.,Desale, S.,Howard, R.,Kerr, G. S.…\n     \n      J Clin Densitom\n      2013 Mar 12\n    ",
         "  \n        Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis.\n       \n      Richards, J. S.,Cannon, G. W.,Hayden, C. L.,Amdur, R. L.,Lazaro, D.,Mikuls, T. R.,Reimold, A. M.,Cap…\n     \n      Arthritis Care Res (Hoboken)\n      2012 Jun 29\n    ",
         "  \n        Collaborative learning and technology skills development: evaluation of an online annual grantee meeting.\n       \n      Richards, J.,Edwards, K.,Lackey, M.,Wallace, L.,Calleson, J.,Barber, C.,Long, T.,Lin, S.,Farel, A.…\n     \n      Matern Child Health J\n      2011 Oct 20\n    ",
         "  \n        Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.\n       \n      Cannon GW, Mikuls TR, Hayden CL, Ying J, Curtis JR, Reimold AM, Caplan L, Kerr GS, Richards JS, John…\n     \n      Arthritis Care Res (Hoboken)\n      2011-12-01\n    ",
         "  \n        Odontoid erosions in rheumatoid arthritis: utility of the open mouth view.\n       \n      Richards, J. S.,Kerr, G. S.,Nashel, D. J.…\n     \n      J Clin Rheumatol\n      2000 Dec 01\n    ",
         "  \n        Treating type 2 diabetes. Important findings should not be published in two journals.\n       \n      Richards J…\n     \n      BMJ\n      1999-03-06\n    ",
         "  \n        Screening for Down's syndrome.\n       \n      Parsons L, Richards J, Garlick R…\n     \n      BMJ\n      1992-11-14\n    ",
         "  \n        Quality of drinking water.\n       \n      Richards J, Stokely D, Hipgrave P…\n     \n      BMJ\n      1992-02-29\n    ",
         "  \n        Set menus and clinical freedom.\n       \n      Kinnersley P, Owen P, Wilkinson C, Richards J…\n     \n      BMJ\n      1991-10-05\n    ",
         "  \n        Innovation in general practice.\n       \n      Owen P, Richards J…\n     \n      BMJ\n      1988-08-06\n    ",
         "  \n        How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease.\n       \n      Richards, J. S.,Dowell, S. M.,Quinones, M. E.,Kerr, G. S.…\n     \n      BMJ\n      2015 Aug 19\n    ",
         "  \n        Dual-energy X-ray absorptiometry and evaluation of the osteoporosis self-assessment tool in men with rheumatoid arthritis.\n       \n      Richards, J. S.,Peng, J.,Amdur, R. L.,Mikuls, T. R.,Hooker, R. S.,Michaud, K.,Reimold, A. M.,Cannon,…\n     \n      J Clin Densitom\n      2009 Sep 25\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[

      ],
      "memberships":[
         "   American College of Physicians - ACP Member",
         "   American College of Rheumatology - ACR Fellow"
      ],
      "clinical-trails":[

      ],
      "lectures":[

      ],
      "press-mentions":[

      ],
      "hospital-info":[
         "   \n        Washington DC Veterans Affairs Medical Center\n       \n      Current Affiliation\n     \n        Washington, DC\n    ",
         "   \n        UPMC Magee-Womens Hospital\n       \n      Current Affiliation\n     \n        Pittsburgh, PA\n    ",
         "   \n        UPMC Presbyterian\n       \n      Current Affiliation\n     \n        Pittsburgh, PA\n    "
      ],
      "award-info":[
         "   \n      Fellow (FACR)\n     \n      American College of Rheumatology\n    "
      ],
      "support-grants":[

      ]
   },
   "P7":{
      "name":"\n          John M. Davis III, MD MS\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/yunta7rm0dwd87opkelq.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        200 1st St SW\n        \n        Rochester, MN 55905\n        ",
      "phone":"\n      \n     \n      (507) 284-4277\n      ",
      "fax":"",
      "job-title":"\n            Associate Professor of Medicine, Mayo Clinic College of Medicine\n          ",
      "summary":" \n        Dr. John M. Davis is a rheumatologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice 17 years. He specializes in crystal related, rheumatoid arthritis & related, and spondyloarthropathy and is experienced in ultrasonography, cardiovascular pathology, and decision making.\n       \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        Mayo Graduate School\n       \n      MS, Clinical and Translational Science, 2008 - 2014\n    ",
         "   \n        Mayo School of Graduate Medical Education\n       \n      Fellowship, Rheumatology, 2003 - 2006\n    ",
         "   \n        Mayo School of Graduate Medical Education\n       \n      Residency, Internal Medicine, 2000 - 2003\n    ",
         "   \n        University of Missouri-Columbia School of Medicine\n       \n      Class of 2000\n    "
      ],
      "certifications&licences":[
         "   \n      TN State Medical License\n     \n      2019 - 2021\n    ",
         "   \n      MN State Medical License\n     \n      2001 - 2020\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Internal Medicine\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    ",
         "   \n      American College of Rheumatology\n     \n      Rheumatology Musculoskeletal Ultrasound (RhMSUS)\n    "
      ],
      "publications&presentations":[
         "     \n        Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation.\n       \n      Davis, J. M., Crowson, C. S., Knutson, K. L., Achenbach, S. J., Strausbauch, M. A., Therneau, T. M.,…\n     \n      Clinical immunology (Orlando, Fla.)\n      2020 Jan 12\n    ",
         "   \n        3\n       mentions \n        3 NEW\n        \n        Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity.\n       \n      Coffey, C. M., Crowson, C. S., Myasoedova, E., Matteson, E. L., Davis, J. M.…\n     \n      Mayo Clinic proceedings\n      2019 Oct 18\n    ",
         "   \n        1\n       mention   \n        Rheumatoid Arthritis: A Severe Disease That Preventive Approaches Would Greatly Benefit.\n       \n      Davis, J. M.…\n     \n      Clinical therapeutics\n      2019 Jun 15\n    ",
         "  \n        2\n       citations    \n        \"Like No One Is Listening to Me\": A Qualitative Study of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis.\n       \n      Kvrgic, Z., Asiedu, G. B., Crowson, C. S., Ridgeway, J. L., Davis, J. M.…\n     \n      Arthritis care & research\n      2017 Dec 22\n    ",
         "  \n        1\n       citations    \n        Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation.\n       \n      Challa, D. N., Kvrgic, Z., Cheville, A. L., Crowson, C. S., Bongartz, T., Mason, T. G., Matteson, E.…\n     \n      Arthritis research & therapy\n      2017 Sep 28\n    ",
         "1\n       citations    \n        Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population.\n       \n      Davis, J. M., Lin, G., Oh, J. K., Crowson, C. S., Achenbach, S. J., Therneau, T. M., Matteson, E. L.…\n     \n      International journal of cardiology\n      2017 Apr 22\n    ",
         "2\n       citations    \n        Editorial: The Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis: Is It a Valid Measure of Disease Activity?\n       \n      Davis, J. M.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Apr 26\n    ",
         "47\n       citations  \n        25\n       mentions   \n        An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.\n       \n      Chen, J., Wright, K., Davis, J. M., Jeraldo, P., Marietta, E. V., Murray, J. A., Nelson, H., Matteso…\n     \n      Genome medicine\n      2016 Apr 23\n    ",
         "  \n        Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study.\n       \n      Zamora-Legoff, J. A., Achenbach, S. J., Crowson, C. S., Krause, M. L., Davis, J. M., Matteson, E. L.…\n     \n      Clinical rheumatology\n      2016 Mar 30\n    ",
         "1\n       citations    \n        Determinants of Disability in Rheumatoid Arthritis: A Community-Based Cohort Study.\n       \n      Krause, M. L., Crowson, C. S., Bongartz, T., Matteson, E. L., Michet, C. J., Mason, T. G., Persellin…\n     \n      The open rheumatology journal\n      2016 Feb 11\n    ",
         "1\n       citations    \n        Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis.\n       \n      Ungprasert, P., Thongprayoon, C., Davis, J. M.…\n     \n      Clinical rheumatology\n      2016 Feb 8\n    ",
         "  \n        Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: A meta-analysis.\n       \n      Ungprasert, P., Thongprayoon, C., Davis, J. M.…\n     \n      Seminars in arthritis and rheumatism\n      2015 Nov 28\n    ",
         "  \n        Acute Bilateral Pulmonary Opacities Associated With Use of Tocilizumab.\n       \n      Utz JP, Jinnur PK, Yi ES, Ryu JH, Midthun DE, Davis JM 3rd…\n     \n      J Clin Rheumatol\n      2015 Oct\n    ",
         "  \n        Toward Quality of Cardiovascular Preventive Care for Patients with Rheumatic Diseases.\n       \n      Davis, J. M.…\n     \n      The Journal of rheumatology\n      2015 Sep 4\n    ",
         "  \n        Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis.\n       \n      Deng, X., Crowson, C. S., Rajkumar, S. V., Dispenzieri, A., Larson, D. R., Therneau, T. M., Matteson…\n     \n      The Journal of rheumatology\n      2015 Jan 17\n    ",
         "1\n       citations    \n        Frequency of radiologic procedures in patients with rheumatoid arthritis.\n       \n      Venegas-Pont, M., Davis, J. M., Crowson, C. S., Gabriel, S. E., Matteson, E. L.…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2014 Dec 30\n    ",
         "5\n       citations  \n        1\n       mention   \n        Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007.\n       \n      Makol, A., Davis, J. M., Crowson, C. S., Therneau, T. M., Gabriel, S. E., Matteson, E. L.…\n     \n      Arthritis care & research\n      2014 May 14\n    ",
         "38\n       citations  \n        13\n       mentions   \n        Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study.\n       \n      Bongartz, T., Glazebrook, K. N., Kavros, S. J., Murthy, N. S., Merry, S. P., Franz, W. B., Michet, C…\n     \n      Annals of the rheumatic diseases\n      2014 Mar 29\n    ",
         "  \n        Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity.\n       \n      Davis, J. M., Knutson, K. L., Strausbauch, M. A., Green, A. B., Crowson, C. S., Therneau, T. M., Mat…\n     \n      Arthritis research & therapy\n      2013 Nov 26\n    ",
         "49\n       citations  \n        1\n       mention   \n        Rheumatoid arthritis and cardiovascular disease.\n       \n      Crowson, C. S., Liao, K. P., Davis, J. M., Solomon, D. H., Matteson, E. L., Knutson, K. L., Hlatky, …\n     \n      American heart journal\n      2013 Oct 8\n    ",
         "2\n       citations    \n        Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis.\n       \n      Crowson, C. S., Therneau, T. M., Davis, J. M., Roger, V. L., Matteson, E. L., Gabriel, S. E.…\n     \n      Arthritis and rheumatism\n      2013 Jul 3\n    ",
         "2\n       citations    \n        Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study.\n       \n      Myasoedova, E., Davis, J. M., Crowson, C. S., Roger, V. L., Karon, B. L., Borgeson, D. D., Therneau,…\n     \n      Arthritis and rheumatism\n      2013 Apr 5\n    ",
         "17\n       citations  \n        2\n       mentions   \n        My treatment approach to rheumatoid arthritis.\n       \n      Davis, J. M., Matteson, E. L.…\n     \n      Mayo Clinic proceedings\n      2012 Jul 7\n    ",
         "1\n       citations    \n        Contribution of obesity to the rise in incidence of rheumatoid arthritis.\n       \n      Crowson, C. S., Matteson, E. L., Davis, J. M., Gabriel, S. E.…\n     \n      Arthritis care & research\n      2012 Apr 20\n    ",
         "3\n       citations    \n        A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis.\n       \n      Davis, J. M., Knutson, K. L., Skinner, J. A., Strausbauch, M. A., Crowson, C. S., Therneau, T. M., W…\n     \n      Arthritis research & therapy\n      2012 Feb 2\n    ",
         "  \n        Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis.\n       \n      Krause, M. L., Davis, J. M., Knutson, K. L., Strausbauch, M. A., Strausbach, M. A., Crowson, C. S., …\n     \n      Clinical immunology (Orlando, Fla.)\n      2011 Jun 28\n    ",
         "11\n       citations    \n        The influence of rheumatoid arthritis disease characteristics on heart failure.\n       \n      Myasoedova, E., Crowson, C. S., Nicola, P. J., Maradit-Kremers, H., Davis, J. M., Roger, V. L., Ther…\n     \n      The Journal of rheumatology\n      2011 May 17\n    ",
         "13\n       citations    \n        A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis.\n       \n      Davis, J. M., Knutson, K. L., Strausbauch, M. A., Crowson, C. S., Therneau, T. M., Wettstein, P. J.,…\n     \n      Arthritis and rheumatism\n      2011 Mar 9\n    ",
         "7\n       citations    \n        The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.\n       \n      Crowson, C. S., Matteson, E. L., Myasoedova, E., Michet, C. J., Ernste, F. C., Warrington, K. J., Da…\n     \n      Arthritis and rheumatism\n      2011 Mar 2\n    ",
         "4\n       citations    \n        Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.\n       \n      Crowson, C. S., Myasoedova, E., Davis, J. M., Roger, V. L., Karon, B. L., Borgeson, D. D., Rodeheffe…\n     \n      Arthritis care & research\n      2011 Jan 13\n    ",
         "26\n       citations    \n        Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease.\n       \n      Crowson, C. S., Myasoedova, E., Davis, J. M., Matteson, E. L., Roger, V. L., Therneau, T. M., Fitz-G…\n     \n      The Journal of rheumatology\n      2010 Oct 19\n    ",
         "2\n       citations    \n        Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality.\n       \n      Myasoedova, E., Davis, J. M., Crowson, C. S., Gabriel, S. E.…\n     \n      Current rheumatology reports\n      2010 Jul 21\n    ",
         "10\n       citations    \n        Increased prevalence of diastolic dysfunction in rheumatoid arthritis.\n       \n      Liang, K. P., Myasoedova, E., Crowson, C. S., Davis, J. M., Roger, V. L., Karon, B. L., Borgeson, D.…\n     \n      Annals of the rheumatic diseases\n      2010 May 26\n    ",
         "9\n       citations    \n        Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells.\n       \n      Davis, J. M., Knutson, K. L., Strausbauch, M. A., Crowson, C. S., Therneau, T. M., Wettstein, P. J.,…\n     \n      Journal of immunology (Baltimore, Md. : 1950)\n      2010 May 25\n    ",
         "17\n       citations    \n        The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population.\n       \n      Davis, J. M., Roger, V. L., Crowson, C. S., Kremers, H. M., Therneau, T. M., Gabriel, S. E.…\n     \n      Arthritis and rheumatism\n      2008 Sep 2\n    ",
         "16\n       citations    \n        The widening mortality gap between rheumatoid arthritis patients and the general population.\n       \n      Gonzalez, A., Kremers, H. M., Crowson, C. S., Nicola, P. J., Davis, J. M., Therneau, T. M., Roger, V…\n     \n      Arthritis and rheumatism\n      2007 Oct 31\n    ",
         "30\n       citations    \n        Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.\n       \n      Kremers, H. M., Reinalda, M. S., Crowson, C. S., Davis, J. M., Hunder, G. G., Gabriel, S. E.…\n     \n      Arthritis and rheumatism\n      2007 Mar 3\n    ",
         "18\n       citations    \n        Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.\n       \n      Davis, J. M., Kremers, H. M., Crowson, C. S., Nicola, P. J., Ballman, K. V., Therneau, T. M., Roger,…\n     \n      Arthritis and rheumatism\n      2007 Mar 3\n    ",
         "2\n       citations    \n        Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases.\n       \n      Davis, J. M., Moder, K. G., Homburger, H. A., Ytterberg, S. R.…\n     \n      Medicine\n      2005 Jul 13\n    ",
         "1\n       citations    \n        Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis.\n       \n      Kent, P. D., Davis, J. M., Davis, M. D., Matteson, E. L.…\n     \n      Arthritis and rheumatism\n      2002 Sep 5\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[

      ],
      "memberships":[
         "\n  Edit\n     American College of Physicians - ACP Fellow",
         "\n  Edit\n     American College of Rheumatology - ACR Fellow"
      ],
      "clinical-trails":[

      ],
      "lectures":[

      ],
      "press-mentions":[

      ],
      "hospital-info":[
         "   \n        Mayo Clinic Hospital - Rochester\n       \n      Current Affiliation\n     \n        Rochester, MN\n    "
      ],
      "award-info":[
         "   \n      Fellow (FACR)\n     \n      American College of Rheumatology\n    "
      ],
      "support-grants":[

      ]
   },
   "P8":{
      "name":"\n          Jasvinder Singh, MD MPH\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/snaqutrcuf21jjipmcyo.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        510 20th St S\n       \n        Ste 820\n       \n        Birmingham, AL 35233\n        ",
      "phone":"\n      \n     \n      (205) 996-7438\n      ",
      "fax":"",
      "job-title":"\n            Professor, Medicine, University of Alabama School of Medicine\n          ",
      "summary":" \n        Jas is interested in improving patient outcomes in people suffering from arthritis and other rheumatic conditions. His research interests including studying behavioral interventions to improve key disease outcomes with an emphasis on patient-centered outcomes such as pain/function; using big data and performing pharmaco-epidemiology studies to understand new uses of approved medications; undertaking systematic reviews, meta-analyses and network meta-analyses; and evidence-based guideline development. Disease interests include gout, joint replacement, osteoarthritis, lupus and rheumatoid arthritis.\n       \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        University of Minnesota\n       \n      MPH, Epidemiology, 2001 - 2003\n    ",
         "   \n        Washington University\n       \n      Fellowship, Rheumatology, 1998 - 2000\n    ",
         "   \n        SUNY Upstate Medical University\n       \n      Residency, Internal Medicine, 1995 - 1998\n    ",
         "   \n        Delhi University College of Medical Sciences\n       \n      Class of 1993, MBBS, Distinction in Pharmacology\n    "
      ],
      "certifications&licences":[
         "   \n      AL State Medical License\n     \n      2009 - 2020\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    "
      ],
      "publications&presentations":[
         "     \n        Hospitalized Infections in People with Osteoarthritis: A National U.S. Study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      The Journal of rheumatology\n      2020 Aug 3\n    ",
         "     \n        Sjogren's syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: a U.S. cohort study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      BMC musculoskeletal disorders\n      2020 Jul 28\n    ",
         "     \n        Pop a Pill or Give myself a Shot? Patient perspectives of disease-modifying anti-rheumatic drug (DMARD) choice for rheumatoid arthritis (RA).\n       \n      Singh, J. A., Tornberg, H., Goodman, S. M.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2020 Jul 19\n    ",
         "     \n        Gout epidemiology and comorbidities.\n       \n      Singh, J. A., Gaffo, A.…\n     \n      Seminars in arthritis and rheumatism\n      2020 Jul 6\n    ",
         "     \n        Serious infections in people with systemic sclerosis: a national US study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Arthritis research & therapy\n      2020 Jul 1\n    ",
         "  \n        GRADE Equity Guidelines 4: Guidance on How to Assess and Address Health Equity Within the Evidence to Decision Process\n       \n      Jasvinder Singh, MD…\n     \n      Journal of Clinical Epidemiology\n      \n    ",
         "  \n        Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey.\n       \n      Singh, J. A., Edwards, N. L.…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2020 May 27\n    ",
         "  \n        A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.\n       \n      Singh, J. A., Green, C., Morgan, S., Willig, A. L., Darnell, B., Saag, K. G., Weiss, R., Cutter, G.,…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2020 May 27\n    ",
         "  \n        2020 American College of Rheumatology Guideline for the Management of Gout.\n       \n      FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello-Petersen, R., Guyatt, G., Abeles, A. M., Ge…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2020 May 12\n    ",
         "  \n        2020 American College of Rheumatology Guideline for the Management of Gout.\n       \n      FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello-Petersen, R., Guyatt, G., Abeles, A. M., Ge…\n     \n      Arthritis care & research\n      2020 May 12\n    ",
         "  \n        Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy.\n       \n      Craig, R. S., Goodier, H., Singh, J. A., Hopewell, S., Rees, J. L.…\n     \n      The Cochrane database of systematic reviews\n      2020 Apr 22\n    ",
         "  \n        Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study.\n       \n      Colantonio, L. D., Saag, K. G., Singh, J. A., Chen, L., Reynolds, R. J., Gaffo, A., Plante, T. B., C…\n     \n      Arthritis research & therapy\n      2020 Apr 18\n    ",
         "  \n        Assessment of a Satisfaction Measure for Use After Primary Total Joint Arthroplasty.\n       \n      Goodman, S. M., Mehta, B. Y., Kahlenberg, C. A., Krell, E. C., Nguyen, J., Finik, J., Figgie, M. P.,…\n     \n      The Journal of arthroplasty\n      2020 Mar 17\n    ",
         "  \n        Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2020 Mar 17\n    ",
         "  \n        Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA).\n       \n      Singh, J. A., Tornberg, H., Goodman, S. M.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2020 Mar 10\n    ",
         "  \n        Acute kidney injury after primary total hip arthroplasty: a risk multiplier for complication, mortality, and healthcare utilization.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Arthritis research & therapy\n      2020 Feb 23\n    ",
         "  \n        National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      PloS one\n      2020 Feb 19\n    ",
         "\n        3\n       mentions \n        3 NEW\n        \n        Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Annals of the rheumatic diseases\n      2020 Feb 7\n    ",
         "  \n        Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical Trials.\n       \n      Goodman, S. M., Mehta, B. Y., Mandl, L. A., Szymonifka, J. D., Finik, J., Figgie, M. P., Navarro-Mil…\n     \n      The Journal of arthroplasty\n      2020 Jan 19\n    ",
         "  \n        Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review.\n       \n      Kelly, A., Crimston-Smith, L., Tong, A., Bartlett, S. J., Bekker, C. L., Christensen, R., De Vera, M…\n     \n      The Journal of rheumatology\n      2019 Dec 17\n    ",
         "  \n        Socioeconomic status and healthcare access are associated with healthcare utilization after knee arthroplasty: A U.S. national cohort study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2019 Dec 8\n    ",
         "  \n        Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.\n       \n      Chaudhary, N. S., Bridges, S. L., Saag, K. G., Rahn, E. J., Curtis, J. R., Gaffo, A., Limdi, N. A., …\n     \n      Hypertension (Dallas, Tex. : 1979)\n      2019 Dec 4\n    ",
         "\n        2\n       mentions \n        2 NEW\n        \n        Association of Early Postoperative Pain Trajectories With Longer-term Pain Outcome After Primary Total Knee Arthroplasty.\n       \n      Singh, J. A., Lemay, C. A., Nobel, L., Yang, W., Weissman, N., Saag, K. G., Allison, J., Franklin, P…\n     \n      JAMA network open\n      2019 Nov 14\n    ",
         "  \n        Association of Race/Ethnicity With Hospital Discharge Disposition After Elective Total Knee Arthroplasty.\n       \n      Singh, J. A., Kallan, M. J., Chen, Y., Parks, M. L., Ibrahim, S. A.…\n     \n      JAMA network open\n      2019 Oct 31\n    ",
         "\n        90\n       mentions \n        90 NEW\n        \n        Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.\n       \n      Burstein, R., Henry, N. J., Collison, M. L., Marczak, L. B., Sligar, A., Watson, S., Marquez, N., Ab…\n     \n      Nature\n      2019 Oct 18\n    ",
         "  \n        How Systemic Sclerosis Affects Healthcare Use and Complication Rates after Total Hip Arthroplasty.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      The Journal of rheumatology\n      2019 Oct 17\n    ",
         "  \n        Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.\n       \n      Bursill, D., Taylor, W. J., Terkeltaub, R., Abhishek, A., So, A. K., Vargas-Santos, A. B., Gaffo, A.…\n     \n      Annals of the rheumatic diseases\n      2019 Sep 11\n    ",
         "  \n        Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2019 Aug 25\n    ",
         "  \n        Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort.\n       \n      Singh, J. A., Yang, S., Saag, K. G.…\n     \n      The Journal of rheumatology\n      2019 Aug 17\n    ",
         "  \n        Are the days of missed or delayed diagnosis of gout over?\n       \n      Singh, J. A.…\n     \n      Nature reviews. Rheumatology\n      2019 Aug 14\n    ",
         "  \n        Correction to: Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS).\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2019 Jul 31\n    ",
         "  \n        Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study.\n       \n      Qu, H., Hu, X., Singh, J. A.…\n     \n      Clinical rheumatology\n      2019 Jun 22\n    ",
         "  \n        Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      The Journal of rheumatology\n      2019 Jun 4\n    ",
         "  \n        Total knee arthroplasty outcomes in lupus: a study using the US National Inpatient Sample.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Rheumatology (Oxford, England)\n      2019 May 24\n    ",
         "  \n        Defining ranges for certainty ratings of diagnostic accuracy: a GRADE concept paper.\n       \n      Hultcrantz, M., Mustafa, R. A., Leeflang, M. M., Lavergne, V., Estrada-Orozco, K., Ansari, M. T., Iz…\n     \n      Journal of clinical epidemiology\n      2019 May 22\n    ",
         "  \n        Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.\n       \n      Singh, J. A., Fraenkel, L., Green, C., Alarcón, G. S., Barton, J. L., Saag, K. G., Hanrahan, L. M., …\n     \n      PLoS medicine\n      2019 May 9\n    ",
         "  \n        Lupus is associated with poorer outcomes after primary total hip arthroplasty.\n       \n      Singh, J. A.,Cleveland, J. D.…\n     \n      Lupus\n      2019 May 24\n    ",
         "  \n        Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample.\n       \n      Singh, J. A., Yu, S., Chen, L., Cleveland, J. D.…\n     \n      The Journal of rheumatology\n      2019 Apr 17\n    ",
         "  \n        Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.\n       \n      Chiarotto, A., Kaiser, U., Choy, E., Christensen, R., Conaghan, P. G., Cowern, M., Gill, M., de Wit,…\n     \n      The Journal of rheumatology\n      2019 Apr 3\n    ",
         "\n        3\n       mentions   \n        Gout and chronic pain in older adults: a Medicare claims study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2019 Mar 31\n    ",
         "  \n        Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      European heart journal\n      2019 Mar 29\n    ",
         "  \n        Gout and sexual function: patient perspective of how gout affects personal relationships and intimacy.\n       \n      Singh, J. A.…\n     \n      BMC Rheumatol\n      2019 Mar 20\n    ",
         "\n        2\n       mentions   \n        Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      BMC nephrology\n      2019 Mar 17\n    ",
         "\n        1\n       mention   \n        Cardiovascular Disease in Gout and theÂ\\xa0Protective Effect of Treatments Including Urate-Lowering Therapy.\n       \n      Gupta, M. K., Singh, J. A.…\n     \n      Drugs\n      2019 Mar 15\n    ",
         "  \n        Patient-Centered Outcomes and Key Study Procedure Finalization in the Pilot Feasibility Gout Randomized Trial: Comparative Feasibility Study in GOUt, CHerry Extract Versus Diet Modification (Mini-GOUCH).\n       \n      Singh, J. A., Willig, A. L., Darnell, B., Green, C., Morgan, S., Weiss, R., Saag, K. G., Cutter, G.,…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2019 Mar 15\n    ",
         "  \n        Patient perspectives in gout: a review.\n       \n      Singh, J. A.…\n     \n      Curr Opin Rheumatol\n      2018 Dec 24\n    ",
         "  \n        Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase.\n       \n      Lawrence Edwards, N.,Singh, J. A.,Troum, O.,Yeo, A. E.,Lipsky, P. E.…\n     \n      Rheumatology (Oxford)\n      2019 Mar 08\n    ",
         "  \n        Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.\n       \n      Maxwell, L. J., Beaton, D. E., Shea, B. J., Wells, G. A., Boers, M., Grosskleg, S., Bingham, C. O., …\n     \n      The Journal of rheumatology\n      2019 Feb 17\n    ",
         "  \n        OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.\n       \n      Boers, M., Beaton, D. E., Shea, B. J., Maxwell, L. J., Bartlett, S. J., Bingham, C. O., Conaghan, P.…\n     \n      The Journal of rheumatology\n      2019 Feb 17\n    ",
         "\n        4\n       mentions   \n        GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations.\n       \n      Schünemann, H. J., Mustafa, R. A., Brozek, J., Santesso, N., Bossuyt, P. M., Steingart, K. R., Leefl…\n     \n      Journal of clinical epidemiology\n      2019 Feb 11\n    ",
         "  \n        The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2019 Feb 10\n    ",
         "  \n        OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.\n       \n      Toupin-April, K., Barton, J. L., Fraenkel, L., Meara, A., Li, L. C., Brooks, P., de Wit, M., Stacey,…\n     \n      The Journal of rheumatology\n      2019 Feb 3\n    ",
         "  \n        Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.\n       \n      Beaton, D. E., Maxwell, L. J., Shea, B. J., Wells, G. A., Boers, M., Grosskleg, S., Bingham, C. O., …\n     \n      The Journal of rheumatology\n      2019 Feb 3\n    ",
         "  \n        Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital Perspective.\n       \n      Miller, G. D.,Singh, J. A.…\n     \n      Rheum. Dis. Clin. North Am.\n      2018 Nov 19\n    ",
         "\n        1\n       mention   \n        Self-reported sleep quality and sleep disorders in people with physician-diagnosed gout: an Internet cross-sectional survey.\n       \n      Singh, J. A.…\n     \n      Arthritis research & therapy\n      2019 Jan 27\n    ",
         "  \n        Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS).\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2019 Jan 24\n    ",
         "  \n        The Third Biennial 2018 OMERACT First-time Participant Program: A Qualitative and Quantitative Study.\n       \n      Sloan, V. S., Grosskleg, S., Wells, G., Singh, J. A.…\n     \n      The Journal of rheumatology\n      2019 Jan 17\n    ",
         "  \n        Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group.\n       \n      Kelly, A., Bartlett, S. J., de Wit, M. P., Beaton, D. E., Dawson, T., Evans, V., Gill, M., Hassett, …\n     \n      The Journal of rheumatology\n      2019 Jan 17\n    ",
         "  \n        Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.\n       \n      Andersen, K. M., Cheah, J. T., March, L., Bartlett, S. J., Beaton, D., Bingham, C. O., Brooks, P. M.…\n     \n      The Journal of rheumatology\n      2019 Jan 17\n    ",
         "  \n        Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.\n       \n      Nielsen, S. M., Tugwell, P., de Wit, M. P., Boers, M., Beaton, D. E., Woodworth, T. G., Escorpizo, R…\n     \n      The Journal of rheumatology\n      2019 Jan 17\n    ",
         "\n        20\n       mentions   \n        Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      BMC neurology\n      2019 Jan 7\n    ",
         "  \n        Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.\n       \n      Singh, J. A.,Guyatt, G.,Ogdie, A.,Gladman, D. D.,Deal, C.,Deodhar, A.,Dubreuil, M.,Dunham, J.,Husni,…\n     \n      \n      2018 Dec 01\n    ",
         "  \n        Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.\n       \n      Singh, J. A.,Guyatt, G.,Ogdie, A.,Gladman, D. D.,Deal, C.,Deodhar, A.,Dubreuil, M.,Dunham, J.,Husni,…\n     \n      Arthritis Care Res (Hoboken)\n      2018 Dec 01\n    ",
         "  \n        Gout and the risk of incident depression in older adults.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Psychiatry research\n      2018 Dec 16\n    ",
         "  \n        Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysis.\n       \n      Ramsubeik, K.,Ramrattan, L. A.,Kaeley, G. S.,Singh, J. A.…\n     \n      Ther Adv Musculoskelet Dis\n      2018 Dec 06\n    ",
         "\n        1\n       mention   \n        Gout and dementia in the elderly: a cohort study of Medicare claims.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      BMC geriatrics\n      2018 Nov 16\n    ",
         "  \n        Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims Data.\n       \n      Singh JA, Cleveland JD…\n     \n      Journal of general internal medicine\n      \n    ",
         "  \n        The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States.\n       \n      US Burden of Disease Collaborators, Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, Mullany E, …\n     \n      JAMA\n      \n    ",
         "  \n        Management of Gout.\n       \n      Singh JA, Saag KG…\n     \n      Annals of internal medicine\n      \n    ",
         "  \n        Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures.\n       \n      Yazdany J, Robbins M, Schmajuk G, Desai S, Lacaille D, Neogi T, Singh JA, Genovese M, Myslinski R, F…\n     \n      Arthritis care & research\n      \n    ",
         "  \n        Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT).\n       \n      de Wit M, Kirwan JR, Tugwell P, Beaton D, Boers M, Brooks P, Collins S, Conaghan PG, D'Agostino MA, …\n     \n      The patient\n      \n    ",
         "  \n        A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database.\n       \n      Altan A, Shiozawa A, Bancroft T, Singh JA…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      \n    ",
         "  \n        Age-related differences in the use of total shoulder arthroplasty over time: use and outcomes.\n       \n      Singh JA, Ramachandran R…\n     \n      The bone & joint journal\n      \n    ",
         "  \n        Do \"Evidence-Based Recommendations\" Need to Reveal the Evidence? Minimal Criteria Supporting an \"Evidence Claim\".\n       \n      Christensen R, Singh JA, Wells GA, Tugwell PS…\n     \n      The Journal of rheumatology\n      \n    ",
         "  \n        Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes.\n       \n      Singh JA, Ramachandran R…\n     \n      Journal of racial and ethnic health disparities\n      \n    ",
         "  \n        2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.\n       \n      Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, J…\n     \n      Annals of the rheumatic diseases\n      \n    ",
         "  \n        2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.\n       \n      Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, J…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      \n    ",
         "  \n        An internet survey of common treatments used by patients with gout including cherry extract and juice and other dietary supplements.\n       \n      Singh JA, Bharat A, Edwards NL…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      \n    ",
         "  \n        Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study.\n       \n      Bartels CM, Singh JA, Parperis K, Huber K, Rosenthal AK…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      \n    ",
         "  \n        Is the double contour sign specific for gout? Or only for crystal arthritis?\n       \n      Singh JA, Dalbeth N…\n     \n      The Journal of rheumatology\n      \n    ",
         "  \n        Veterans Affairs databases are accurate for gout-related health care utilization: a validation study.\n       \n      Singh JA…\n     \n      Arthritis research & therapy\n      \n    ",
         "  \n        Revision surgery following total shoulder arthroplasty: analysis of 2588 shoulders over three decades (1976 to 2008).\n       \n      Singh JA, Sperling JW, Cofield RH…\n     \n      The Journal of bone and joint surgery. British volume\n      \n    ",
         "  \n        Use of biologics in rheumatoid arthritis: current and emerging paradigms of care.\n       \n      Curtis JR, Singh JA…\n     \n      Clinical therapeutics\n      \n    ",
         "  \n        Comparison of patient-reported and clinician-assessed outcomes following total knee arthroplasty.\n       \n      Khanna G, Singh JA, Pomeroy DL, Gioe TJ…\n     \n      The Journal of bone and joint surgery. American volume\n      \n    ",
         "  \n        Patient understanding and satisfaction in informed consent for total knee arthroplasty: a randomized study.\n       \n      Johnson MR, Singh JA, Stewart T, Gioe TJ…\n     \n      Arthritis care & research\n      \n    ",
         "  \n        Gout in the Hmong in the United States.\n       \n      Wahedduddin S, Singh JA, Culhane-Pera KA, Gertner E…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      \n    ",
         "  \n        Repeat injections of intra-articular botulinum toxin a for the treatment of chronic arthritis joint pain.\n       \n      Singh JA, Mahowald ML, Kushnaryov A, Goelz E, Dykstra D…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      \n    ",
         "  \n        Quality of care for gout in the US needs improvement.\n       \n      Singh JA, Hodges JS, Toscano JP, Asch SM…\n     \n      Arthritis and rheumatism\n      \n    ",
         "  \n        Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases.\n       \n      Singh JA, Holmgren AR, Krug H, Noorbaloochi S…\n     \n      Arthritis and rheumatism\n      \n    ",
         "  \n        Long term effects of intra-articular botulinum toxin A for refractory joint pain.\n       \n      Mahowald ML, Singh JA, Dykstra D…\n     \n      Neurotoxicity research\n      \n    ",
         "  \n        Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases.\n       \n      Mitlyng BL, Singh JA, Furne JK, Ruddy J, Levitt MD…\n     \n      American journal of hematology\n      \n    ",
         "  \n        Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the veterans arthritis quality of life study.\n       \n      Singh JA, Nelson DB, Fink HA, Nichol KL…\n     \n      Seminars in arthritis and rheumatism\n      \n    ",
         "  \n        Health-related quality of life, functional impairment, and healthcare utilization by veterans: veterans' quality of life study.\n       \n      Singh JA, Borowsky SJ, Nugent S, Murdoch M, Zhao Y, Nelson DB, Petzel R, Nichol KL…\n     \n      Journal of the American Geriatrics Society\n      \n    ",
         "  \n        Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis.\n       \n      Singh JA, Holmgren AR, Noorbaloochi S…\n     \n      Arthritis and rheumatism\n      \n    ",
         "  \n        Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid-naïve patients.\n       \n      Singh JA, Pando JA, Tomaszewski J, Schumacher HR…\n     \n      The Journal of rheumatology\n      \n    ",
         "  \n        Immunohistochemistry of normal human knee synovium: a quantitative study.\n       \n      Singh JA, Arayssi T, Duray P, Schumacher HR…\n     \n      Annals of the rheumatic diseases\n      \n    ",
         "  \n        Talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals in sisters: a new syndrome?\n       \n      Singh JA, Williams CB, McAlister WH…\n     \n      American journal of medical genetics. Part A\n      \n    ",
         "  \n        Expert opinion on emerging urate-lowering therapies.\n       \n      Stamp LK, Merriman TR, Singh JA…\n     \n      Expert opinion on emerging drugs\n      2018-09-24\n    ",
         "  \n        Gout and the Risk of Incident Obstructive Sleep Apnea in Adults 65 Years or Older: An Observational Study.\n       \n      Singh JA, Cleveland JD…\n     \n      Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine\n      2018-09-15\n    ",
         "  \n        Correction to: Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.\n       \n      Arayssi T, Harfouche M, Darzi A, Al Emadi S, Alnaqbi KA, Badsha H, Al Balushi F, Dib C, Elzorkany B,…\n     \n      Clinical rheumatology\n      2018-09-06\n    ",
         "  \n        Gout and hearing impairment in the elderly: a retrospective cohort study using the US Medicare claims data.\n       \n      Singh JA, Cleveland JD…\n     \n      BMJ open\n      2018-08-20\n    ",
         "  \n        Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.\n       \n      Arayssi T, Harfouche M, Darzi A, Al Emadi S, A Alnaqbi K, Badsha H, Al Balushi F, Dib C, Elzorkany B…\n     \n      Clinical rheumatology\n      2018-08-10\n    ",
         "\n        1\n       mention   \n        Goals of gout treatment: a patient perspective.\n       \n      Singh, J. A.…\n     \n      Clinical rheumatology\n      2018 Aug 6\n    ",
         "  \n        Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis.\n       \n      Singh, J. A.,Cleveland, J. D.…\n     \n      Arthritis Res. Ther.\n      2018 Aug 05\n    ",
         "  \n        Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain.\n       \n      Singh, J. A.,Curtis, J. R.,Saag, K. G.…\n     \n      JAMA\n      2018 Aug 09\n    ",
         "  \n        Global Mortality From Firearms, 1990-2016.\n       \n      Naghavi, M.,Marczak, L. B.,Kutz, M.,Shackelford, K. A.,Arora, M.,Miller-Petrie, M.,Aichour, MTE.,Aks…\n     \n      JAMA\n      2018 Sep 01\n    ",
         "  \n        Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data.\n       \n      Singh JA, Cleveland JD…\n     \n      RMD open\n      2018-07-13\n    ",
         "  \n        Gout and the risk of age-related macular degeneration in the elderly.\n       \n      Singh JA, Cleveland JD…\n     \n      PloS one\n      2018-07-12\n    ",
         "  \n        Factors Associated with the Orthopaedic Surgeon’s Decision to Recommend Total Joint Replacement in Hip and Knee Osteoarthritis: An International Cross-Sectional Study of 1905 Patients\n       \n      Jasvinder Singh, MD…\n     \n      Osteoarthritis and Cartilage\n      2018 Jul 19\n    ",
         "  \n        The association of gout with incident giant cell arteritis in older adults.\n       \n      Singh JA, Cleveland JD…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2018-06-07\n    ",
         "  \n        Minimally Invasive Versus Open Primary Resection for Retroperitoneal Soft Tissue Sarcoma: A Propensity-Matched Study From the National Cancer Database.\n       \n      Gani, F., Goel, U., Blair, A. B., Singh, J. A., Overton, H. N., Meyer, C. F., Canner, J. K., Pawlik,…\n     \n      Annals of surgical oncology\n      2018 Jun 2\n    ",
         "  \n        Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients.\n       \n      Singh JA, Cleveland JD…\n     \n      Arthritis research & therapy\n      2018-06-01\n    ",
         "  \n        Association of Gout With Uveitis in Older Individuals.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      JAMA ophthalmology\n      2018 May 26\n    ",
         "  \n        Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout.\n       \n      Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edw…\n     \n      Arthritis care & research\n      2018-05-25\n    ",
         "  \n        Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities.\n       \n      Sun M, Vazquez AI, Reynolds RJ, Singh JA, Reeves M, Merriman TR, Gaffo AL, Los Campos G…\n     \n      Arthritis research & therapy\n      2018-05-03\n    ",
         "  \n        A novel method to combine assessment of benefit and harm: OMERACT 3x3 methodology applied to two active comparator trials.\n       \n      Boers M, Singh JA, Cofield SS, Bridges SL, Moreland LW, O'Dell JR, Wu H, Leatherman S, Curtis JR…\n     \n      Arthritis care & research\n      2018-04-25\n    ",
         "  \n        Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).\n       \n      Chalmers JR, Thomas KS, Apfelbacher C, Williams HC, Prinsen CA, Spuls PI, Simpson E, Gerbens LAA, Bo…\n     \n      The British journal of dermatology\n      2018-04-19\n    ",
         "\n        1\n       mention   \n        Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout.\n       \n      FitzGerald, J. D., Mikuls, T. R., Neogi, T., Singh, J. A., Robbins, M. L., Khanna, P. P., Turner, A.…\n     \n      Arthritis care & research\n      2018 Apr 13\n    ",
         "  \n        Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.\n       \n      Kelly, A., Tong, A., Tymms, K., March, L., Craig, J. C., De Vera, M. A., Evans, V., Hassett, G., Tou…\n     \n      Trials\n      2018 Mar 29\n    ",
         "  \n        Role of serum urate in neurocognitive function and dementia: new evidence contradicts old thinking.\n       \n      Singh, J. A.…\n     \n      Ann. Rheum. Dis.\n      2017 Sep 25\n    ",
         "  \n        Any sleep is a dream far away: a nominal group study assessing how gout affects sleep.\n       \n      Singh JA…\n     \n      Rheumatology (Oxford, England)\n      2018-02-23\n    ",
         "  \n        Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.\n       \n      Stamp L, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R…\n     \n      Seminars in arthritis and rheumatism\n      2018-02-21\n    ",
         "  \n        Correction to: Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials.\n       \n      Hoang, A., Goodman, S. M., Navarro-MillÃ¡n, I. Y., Mandl, L. A., Figgie, M. P., Bostrom, M. P., Padg…\n     \n      Arthritis research & therapy\n      2018 Feb 16\n    ",
         "\n        1\n       mention   \n        Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?\n       \n      Curtis, J. R., Yang, S., Singh, J. A., Xie, F., Chen, L., Yun, H., Muntner, P., Kent, S. T., Levitan…\n     \n      Arthritis care & research\n      2018 Feb 7\n    ",
         "  \n        Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends.\n       \n      Singh, J. A.,Yu, S.…\n     \n      Arthritis Care Res (Hoboken)\n      2017 May 04\n    ",
         "  \n        Epilepsy and psychosis: a practical approach.\n       \n      Maguire, M. J., Singh, J. A., Marson, A. G.…\n     \n      Practical neurology\n      2017 Dec 24\n    ",
         "  \n        Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements.\n       \n      Stamp LK, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R…\n     \n      The Journal of rheumatology\n      2017-12-15\n    ",
         "  \n        Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials.\n       \n      Hoang, A.,Goodman, S. M.,Navarro-Millán, I. Y.,Mandl, L. A.,Figgie, M. P.,Bostrom, M. P.,Padgett, D.…\n     \n      Arthritis Res. Ther.\n      2017 Dec 07\n    ",
         "  \n        Developing a core outcome-domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: the VAPAIN consensus statement on core outcome-domains.\n       \n      Kaiser, U.,Kopkow, C.,Deckert, S.,Neustadt, K.,Jacobi, L.,Cameron, P.,De Angelis, V.,Apfelbacher, C.…\n     \n      Pain\n      2018 Jan 05\n    ",
         "  \n        Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis.\n       \n      Young BL, Watson SL, Perez JL, McGwin G, Singh JA, Ponce BA…\n     \n      The Journal of rheumatology\n      2017-12-01\n    ",
         "1\n       citations    \n        EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report.\n       \n      Bottai, M., Tjärnlund, A., Santoni, G., Werth, V. P., Pilkington, C., de Visser, M., Alfredsson, L.,…\n     \n      RMD open\n      2017 Nov 28\n    ",
         "  \n        Response to: 'Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults' by Lee and Song.\n       \n      Singh JA, Cleveland J…\n     \n      Annals of the rheumatic diseases\n      2017-11-16\n    ",
         "1\n       citations  \n        2\n       mentions   \n        Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Rheumatology (Oxford, England)\n      2017 Nov 7\n    ",
         "  \n        Validation of a definition for flare in patients with established gout.\n       \n      Gaffo, A. L.,Dalbeth, N.,Saag, K. G.,Singh, J. A.,Rahn, E. J.,Mudano, A. S.,Chen, Y. H.,Lin, C. T.,B…\n     \n      \n      2017 Nov 22\n    ",
         "  \n        2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.\n       \n      Lundberg, I. E.,Tjärnlund, A.,Bottai, M.,Werth, V. P.,Pilkington, C.,Visser, M.,Alfredsson, L.,Amato…\n     \n      Ann. Rheum. Dis.\n      2017 Oct 29\n    ",
         "\n        1\n       mention   \n        Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study.\n       \n      Singh, J. A., Ramachandaran, R., Yu, S., Yang, S., Xie, F., Yun, H., Zhang, J., Curtis, J. R.…\n     \n      Arthritis research & therapy\n      2017 Oct 19\n    ",
         "  \n        2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.\n       \n      Lundberg, I. E.,Tjärnlund, A.,Bottai, M.,Werth, V. P.,Pilkington, C.,de Visser, M.,Alfredsson, L.,Am…\n     \n      \n      2017 Nov 07\n    ",
         "  \n        Medication adherence among patients with gout: A systematic review and meta-analysis.\n       \n      Scheepers, LEJM.,van Onna, M.,Stehouwer, CDA.,Singh, J. A.,Arts, ICW.,Boonen, A.…\n     \n      Semin. Arthritis Rheum.\n      2017 Dec 05\n    ",
         "  \n        Response to: \\'A response to Singh. \"Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?\"\\' by Valiyil and Schechter.\n       \n      Singh JA…\n     \n      Annals of the rheumatic diseases\n      2017-09-28\n    ",
         "  \n        Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults.\n       \n      Singh JA, Cleveland JD…\n     \n      Annals of the rheumatic diseases\n      2017-09-26\n    ",
         "  \n        Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives.\n       \n      Singh JA, Herbey I, Bharat A, Dinnella JE, Pullman-Mooar S, Eisen S, Ivankova N…\n     \n      Arthritis care & research\n      2017-09-26\n    ",
         "  \n        Patient Burden of Axial Spondyloarthritis.\n       \n      Strand, V., Singh, J. A.…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2017 Sep 25\n    ",
         "  \n        Patient Burden of Axial Spondyloarthritis.\n       \n      Strand, V., Singh, J. A.…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2017 Sep 25\n    ",
         "  \n        Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment.\n       \n      Darzi A, Harfouche M, Arayssi T, Alemadi S, Alnaqbi KA, Badsha H, Al Balushi F, Elzorkany B, Halabi …\n     \n      Health and quality of life outcomes\n      2017-09-21\n    ",
         "  \n        Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies.\n       \n      Nielsen, S. M.,Bartels, E. M.,Henriksen, M.,Wæhrens, E. E.,Gudbergsen, H.,Bliddal, H.,Astrup, A.,Kno…\n     \n      Ann. Rheum. Dis.\n      2017 Sep 04\n    ",
         "1\n       citations    \n        The burden of septic arthritis on the U.S. inpatient care: A national study.\n       \n      Singh, J. A., Yu, S.…\n     \n      PloS one\n      2017 Aug 16\n    ",
         "  \n        Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.\n       \n      Kleiber Balderrama C, Rosenthal AK, Lans D, Singh JA, Bartels CM…\n     \n      Arthritis care & research\n      2017-08-08\n    ",
         "  \n        Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.\n       \n      Tunis SR, Maxwell LJ, Graham ID, Shea BJ, Beaton DE, Bingham CO, Brooks P, Conaghan PG, D'Agostino M…\n     \n      The Journal of rheumatology\n      2017-08-01\n    ",
         "  \n        Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.\n       \n      Rasch LA, Boers M, Hill CL, Voshaar M, Hoogland W, de Wit M, Flurey C, Davis B, Hetland ML, Brahe CH…\n     \n      The Journal of rheumatology\n      2017-08-01\n    ",
         "  \n        Patient-Reported Outcomes Can Be Used to Streamline Post-Total Hip Arthroplasty Follow-Up to High-Risk Patients.\n       \n      Yao, J. J., Kremers, H. M., Schleck, C. D., Larson, D. R., Singh, J. A., Berry, D. J., Lewallen, D. …\n     \n      The Journal of arthroplasty\n      2017 Jul 8\n    ",
         "6\n       citations  \n        6\n       mentions   \n        2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.\n       \n      Goodman, S. M., Springer, B. D., Guyatt, G. H., Abdel, M. P., Dasa, V., George, M., Gewurz-Singer, O…\n     \n      The Journal of arthroplasty\n      2017 Jun 21\n    ",
         "17\n       citations  \n        28\n       mentions   \n        2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.\n       \n      Goodman, S. M., Springer, B. D., Guyatt, G. H., Abdel, M. P., Dasa, V., George, M., Gewurz-Singer, O…\n     \n      Arthritis care & research\n      2017 Jun 18\n    ",
         "3\n       citations  \n        20\n       mentions   \n        Clinical Practice Guidelines: Incorporating Input From a Patient Panel.\n       \n      Goodman, S. M., Miller, A. S., Turgunbaev, M., Guyatt, G. H., Yates, A. J., Springer, B. D., Singh, …\n     \n      Arthritis care & research\n      2017 Jun 18\n    ",
         "  \n        Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data.\n       \n      Singh JA, Cleveland JD…\n     \n      Annals of the rheumatic diseases\n      2017-06-05\n    ",
         "  \n        Health care utilization in patients with gout: a prospective multicenter cohort study.\n       \n      Singh, J. A., Bharat, A., Khanna, D., Aquino-Beaton, C., Persselin, J. E., Duffy, E. L., Elashoff, D…\n     \n      BMC musculoskeletal disorders\n      2017 Jun 2\n    ",
         "  \n        Do outcomes reported in randomised controlled trials of joint replacement surgery fulfil the OMERACT 2.0 Filter? A review of the 2008 and 2013 literature.\n       \n      Wall PDH, Richards BL, Sprowson A, Buchbinder R, Singh JA…\n     \n      Systematic reviews\n      2017-05-30\n    ",
         "  \n        The OMERACT First-time Participant Program: Fresh Eye from the New Guys.\n       \n      Sloan, V. S., Grosskleg, S., Pohl, C., Wells, G. A., Singh, J. A.…\n     \n      The Journal of rheumatology\n      2017 May 17\n    ",
         "  \n        Outcome Measures Used in Arthroplasty Trials: Systematic Review of the 2008 and 2013 Literature.\n       \n      Richards BL, Wall PDH, Sprowson AP, Singh JA, Buchbinder R…\n     \n      The Journal of rheumatology\n      2017-05-15\n    ",
         "  \n        Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.\n       \n      Singh JA, Hossain A, Mudano AS, Tanjong Ghogomu E, Suarez-Almazor ME, Buchbinder R, Maxwell LJ, Tugw…\n     \n      The Cochrane database of systematic reviews\n      2017-05-08\n    ",
         "1\n       citations  \n        2\n       mentions   \n        GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale.\n       \n      Welch, V. A., Akl, E. A., Guyatt, G. H., Pottie, K., Eslava-Schmalbach, J., Ansari, M. T., de Beer, …\n     \n      Journal of clinical epidemiology\n      2017 Apr 17\n    ",
         "  \n        GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence.\n       \n      Welch VA, Akl EA, Pottie K, Ansari MT, Briel M, Christensen R, Dans A, Dans L, Eslava-Schmalbach J, …\n     \n      Journal of clinical epidemiology\n      2017-04-04\n    ",
         "  \n        {\"__content__\"=>\"EULAR gout treatment guidelines by Richette .: uric acid and neurocognition.\", \"i\"=>{\"__content__\"=>\"et al\"}}\n       \n      Singh JA, Edwards NL…\n     \n      Annals of the rheumatic diseases\n      2017-03-27\n    ",
         "2\n       citations    \n        Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      BMC medicine\n      2017 Mar 23\n    ",
         "  \n        Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set.\n       \n      Singh, J. A., Dowsey, M. M., Choong, P. F.…\n     \n      BMC musculoskeletal disorders\n      2017 Mar 17\n    ",
         "2\n       citations  \n        3\n       mentions   \n        Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.\n       \n      Singh, J. A., Ramachandaran, R., Yu, S., Curtis, J. R.…\n     \n      BMC cardiovascular disorders\n      2017 Mar 16\n    ",
         "  \n        Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.\n       \n      Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, Lopez-Olivo MA, Suarez-…\n     \n      The Cochrane database of systematic reviews\n      2017-03-10\n    ",
         "  \n        Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.\n       \n      Spuls PI, Gerbens LAA, Simpson E, Apfelbacher CJ, Chalmers JR, Thomas KS, Prinsen CAC, von Kobyletzk…\n     \n      The British journal of dermatology\n      2017-03-02\n    ",
         "  \n        Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection.\n       \n      Burton MJ, Curtis JR, Yang S, Chen L, Singh JA, Mikuls TR, Winthrop KL, Baddley JW…\n     \n      The Journal of rheumatology\n      2017-03-01\n    ",
         "  \n        Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.\n       \n      Petkovic J, Barton JL, Flurey C, Goel N, Bartels CM, Barnabe C, de Wit MPT, Lyddiatt A, Lacaille D, …\n     \n      The Journal of rheumatology\n      2017-02-15\n    ",
         "  \n        Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.\n       \n      Strand V, Bergman M, Singh JA, Gibofsky A, Kivitz A, Young C…\n     \n      Clinical rheumatology\n      2017-02-13\n    ",
         "  \n        Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial.\n       \n      Singh, J. A., Shah, N., Green, C.…\n     \n      BMC musculoskeletal disorders\n      2017 Feb 2\n    ",
         "  \n        Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.\n       \n      Moradi-Lakeh, M.,Forouzanfar, M. H.,Vollset, S. E.,El Bcheraoui, C.,Daoud, F.,Afshin, A.,Charara, R.…\n     \n      Ann. Rheum. Dis.\n      2017 Feb 18\n    ",
         "  \n        Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease.\n       \n      Strand, V.,Singh, J. A.…\n     \n      Mayo Clin. Proc.\n      2017 Feb 25\n    ",
         "2\n       citations    \n        Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group.\n       \n      Singh, J. A., Dohm, M., Choong, P. F.…\n     \n      BMC musculoskeletal disorders\n      2017 Jan 28\n    ",
         "1\n       citations    \n        Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Final Core Domain Set for Total Hip and Total Knee Replacement Trials for Endstage Arthritis.\n       \n      Singh, J. A., Singh, J. A., Dowsey, M. M., Dowsey, M. M., Dohm, M., Dohm, M., Goodman, S. M., Goodma…\n     \n      The Journal of rheumatology\n      2017-01-15\n    ",
         "1\n       citations  \n        1\n       mention   \n        An underlying diagnosis of osteonecrosis of bone is associated with worse outcomes than osteoarthritis after total hip arthroplasty.\n       \n      Singh, J. A., Chen, J., Inacio, M. C., Namba, R. S., Paxton, E. W.…\n     \n      BMC musculoskeletal disorders\n      2017 Jan 11\n    ",
         "  \n        Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?\n       \n      Singh JA…\n     \n      Annals of the rheumatic diseases\n      2016-12-30\n    ",
         "  \n        Racial differences in health-related quality of life and functional ability in patients with gout.\n       \n      Singh, J. A., Bharat, A., Khanna, D., Aquino-Beaton, C., Persselin, J. E., Duffy, E. L., Elashoff, D…\n     \n      Rheumatology (Oxford, England)\n      2016 Dec 29\n    ",
         "  \n        Chasing crystals out of the body: will treat to serum urate target for gout help us get there?\n       \n      Singh JA, Uhlig T…\n     \n      Annals of the rheumatic diseases\n      2016-12-28\n    ",
         "  \n        The Association of Vibratory Perception and Muscle Strength With the Incidence and Worsening of Knee Instability: The Multicenter Osteoarthritis Study.\n       \n      Shakoor N, Felson DT, Niu J, Nguyen US, Segal NA, Singh JA, Nevitt MC…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016-12-07\n    ",
         "  \n        Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).\n       \n      Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Tugwell P, Wells GA…\n     \n      The Cochrane database of systematic reviews\n      2016-11-17\n    ",
         "  \n        Increasing comorbidity is associated with worsening physical function and pain after primary total knee arthroplasty.\n       \n      Hilton, M. E., Gioe, T. J., Noorbaloochi, S., Singh, J. A.…\n     \n      BMC musculoskeletal disorders\n      2016 Oct 9\n    ",
         "  \n        Does T'ai Chi Gait Reduce External Knee Adduction Moment?\n       \n      Liu, W.,Kovaleski, J. E.,Kepple, T. M.,Wolfe, J.,Decoux, B.,McCarthy, J. P.,Singh, J.,Lewis, C. E.…\n     \n      J Altern Complement Med\n      2016 Jun 28\n    ",
         "  \n        Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.\n       \n      Zhang, J.,Xie, F.,Yun, H.,Chen, L.,Muntner, P.,Levitan, E. B.,Safford, M. M.,Kent, S. T.,Osterman, M…\n     \n      Ann. Rheum. Dis.\n      2016 Jan 23\n    ",
         "3\n       citations    \n        Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis.\n       \n      Morillon, M. B., Stamp, L. K., Taylor, W. J., Fransen, J., Dalbeth, N., Singh, J. A., Christensen, R…\n     \n      BMJ open\n      2016 Sep 22\n    ",
         "  \n        Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials.\n       \n      Tarp S, Furst DE, Dossing A, Østergaard M, Lorenzen T, Hansen MS, Singh JA, Choy EH, Boers M, Suarez…\n     \n      Seminars in arthritis and rheumatism\n      2016-09-14\n    ",
         "2\n       citations    \n        Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis.\n       \n      Singh, J. A., Hossain, A., Kotb, A., Wells, G. A.…\n     \n      Systematic reviews\n      2016 Sep 14\n    ",
         "  \n        Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.\n       \n      Singh JA, Hossain A, Kotb A, Wells G…\n     \n      BMC medicine\n      2016-09-13\n    ",
         "4\n       citations  \n        1\n       mention \n        1 NEW\n        \n        Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis.\n       \n      Singh, J. A., Hossain, A., Kotb, A., Oliveira, A., Mudano, A. S., Grossman, J., Winthrop, K., Wells,…\n     \n      The Journal of rheumatology\n      2016 Sep 3\n    ",
         "1\n       citations    \n        Renal dosing of allopurinol results in suboptimal gout care.\n       \n      Neogi, T., Dalbeth, N., Stamp, L. K., Castelar, G., Fitzgerald, J., Gaffo, A. L., Mikuls, T. R., Sin…\n     \n      Annals of the rheumatic diseases\n      2016 Sep 2\n    ",
         "  \n        How often is the office visit needed? Predicting total knee arthroplasty revision risk using pain/function scores.\n       \n      Hightower, C. D., Hightower, L. S., Tatman, P. J., Morgan, P. M., Gioe, T. J., Singh, J. A.…\n     \n      BMC health services research\n      2016 Aug 25\n    ",
         "  \n        Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).\n       \n      Chalmers JR, Simpson E, Apfelbacher CJ, Thomas KS, von Kobyletzki L, Schmitt J, Singh JA, Svensson Å…\n     \n      The British journal of dermatology\n      2016-07-19\n    ",
         "  \n        Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure.\n       \n      Singh JA, Yu S…\n     \n      Annals of the rheumatic diseases\n      2016-06-13\n    ",
         "8\n       citations    \n        Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty.\n       \n      Singh, J. A., Schleck, C. D., Harmsen, S., Lewallen, D. G.…\n     \n      BMC musculoskeletal disorders\n      2016 Jun 12\n    ",
         "3\n       citations    \n        Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes.\n       \n      Singh, J. A., Ramachandran, R.…\n     \n      Journal of racial and ethnic health disparities\n      2016 Jun 9\n    ",
         "  \n        Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.\n       \n      Carmona-Moran CA, Zavgorodnya O, Penman AD, Kharlampieva E, Bridges SL, Hergenrother RW, Singh JA, W…\n     \n      International journal of pharmaceutics\n      2016-06-01\n    ",
         "  \n        Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.\n       \n      Singh JA, Hossain A, Tanjong Ghogomu E, Kotb A, Christensen R, Mudano AS, Maxwell LJ, Shah NP, Tugwe…\n     \n      The Cochrane database of systematic reviews\n      2016-05-13\n    ",
         "  \n        Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data.\n       \n      Singh JA, Yu S…\n     \n      Annals of the rheumatic diseases\n      2016-05-10\n    ",
         "  \n        Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.\n       \n      de Lautour, H.,Taylor, W. J.,Adebajo, A.,Alten, R.,Burgos-Vargas, R.,Chapman, P.,Cimmino, M. A.,da R…\n     \n      Arthritis Care Res (Hoboken)\n      2015 Sep 29\n    ",
         "  \n        Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context.\n       \n      Qu, H., Shewchuk, R. M., Alarcón, G. S., Fraenkel, L., Leong, A., Dall'Era, M., Yazdany, J., Singh, …\n     \n      Arthritis care & research\n      2016 Apr 10\n    ",
         "8\n       citations  \n        2\n       mentions   \n        Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations.\n       \n      Taylor, A. M., Phillips, K., Patel, K. V., Turk, D. C., Dworkin, R. H., Beaton, D. E., Clauw, D. J.,…\n     \n      Pain\n      2016 Apr 9\n    ",
         "  \n        Ms. A.M. Taylor, et al reply.\n       \n      Taylor, A. M.,Taylor, J. O.,Singh, J. A.,Conaghan, P. G.,Choy, E. H.,Tugwell, P. S.,Kaiser, U.,Stran…\n     \n      J. Rheumatol.\n      2016 Apr 03\n    ",
         "16\n       citations  \n        1\n       mention \n        1 NEW\n        \n        Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.\n       \n      Yun, H., Yang, S., Chen, L., Xie, F., Winthrop, K. L., Baddley, J. W., Saag, K. G., Singh, J. A., Cu…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Mar 19\n    ",
         "  \n        Racial/Ethnic Disparity in Rates and Outcomes of Total Joint Arthroplasty.\n       \n      Shahid, H., Singh, J. A.…\n     \n      Current rheumatology reports\n      2016 Mar 18\n    ",
         "  \n        Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: to worry or not to worry?\n       \n      Singh JA…\n     \n      Annals of the rheumatic diseases\n      2016-03-07\n    ",
         "3\n       citations    \n        A cross-sectional internet-based patient survey of the management strategies for gout.\n       \n      Singh, J. A., Shah, N., Edwards, N. L.…\n     \n      BMC complementary and alternative medicine\n      2016 Mar 5\n    ",
         "  \n        GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health.\n       \n      Schünemann HJ, Mustafa R, Brozek J, Santesso N, Alonso-Coello P, Guyatt G, Scholten R, Langendam M, …\n     \n      Journal of clinical epidemiology\n      2016-02-27\n    ",
         "  \n        Performance of Gout Impact Scale in a longitudinal observational study of patients with gout.\n       \n      Wallace, B., Khanna, D., Aquino-Beaton, C., Singh, J. A., Duffy, E. L., Elashoff, D., Khanna, P. P.…\n     \n      Rheumatology (Oxford, England)\n      2016 Feb 19\n    ",
         "3\n       citations    \n        Validation of the Mayo Hip Score: construct validity, reliability and responsiveness to change.\n       \n      Singh, J. A., Schleck, C. D., Harmsen, W. S., Lewallen, D. G.…\n     \n      BMC musculoskeletal disorders\n      2016 Jan 21\n    ",
         "14\n       citations  \n        1\n       mention   \n        Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).\n       \n      Singh, J. A., Yu, S.…\n     \n      Respiratory research\n      2016 Jan 8\n    ",
         "  \n        Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making.\n       \n      Singh JA, Qu H, Yazdany J, Chatham W, Shewchuk R…\n     \n      Arthritis research & therapy\n      2015-12-17\n    ",
         "  \n        Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative.\n       \n      Singh, J. A.,Dohm, M.,Sprowson, A. P.,Wall, P. D.,Richards, B. L.,Gossec, L.,Hawker, G. A.,Riddle, D…\n     \n      J. Rheumatol.\n      2015 Apr 03\n    ",
         "9\n       citations  \n        1\n       mention   \n        Current tobacco use is associated with higher rates of implant revision and deep infection after total hip or knee arthroplasty: a prospective cohort study.\n       \n      Singh, J. A., Schleck, C. D., Harmsen, W. S., Jacob, A. K., Warner, D. O., Lewallen, D. G.…\n     \n      BMC medicine\n      2015 Nov 21\n    ",
         "5\n       citations  \n        8\n       mentions   \n        When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.\n       \n      Fraenkel, L., Miller, A. S., Clayton, K., Crow-Hercher, R., Hazel, S., Johnson, B., Rott, L., White,…\n     \n      Arthritis care & research\n      2015 Nov 8\n    ",
         "490\n       citations  \n        7\n       mentions   \n        2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.\n       \n      Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E.…\n     \n      Arthritis care & research\n      2015 Nov 8\n    ",
         "390\n       citations  \n        60\n       mentions \n        2 NEW\n        \n        2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.\n       \n      Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Nov 8\n    ",
         "  \n        Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?\n       \n      Paxton, E. W.,Inacio, M. C.,Singh, J. A.,Love, R.,Bini, S. A.,Namba, R. S.…\n     \n      Clin. Orthop. Relat. Res.\n      2015 Apr 08\n    ",
         "  \n        Racial Disparities In total ankle arthroplasty Utilization and outcomes.\n       \n      Singh J, Ramachandran R…\n     \n      Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research\n      2015-10-20\n    ",
         "  \n        Effectiveness of Allopurinol In Achieving And Sustaining Target Serum Urate: An Analysis of A National Integrated U.S. Healthcare System.\n       \n      Singh J, Yang S…\n     \n      Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research\n      2015-10-20\n    ",
         "  \n        A Call for Evidence-based Decision Making When Selecting Outcome Measurement Instruments for Summary of Findings Tables in Systematic Reviews: Results from an OMERACT Working Group.\n       \n      Beaton DE, Terwee CB, Singh JA, Hawker GA, Patrick DL, Burke LB, Toupin-April K, Tugwell PS…\n     \n      The Journal of rheumatology\n      2015-09-15\n    ",
         "  \n        Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda.\n       \n      Maxwell LJ, Wells GA, Simon LS, Conaghan PG, Grosskleg S, Scrivens K, Beaton DE, Bingham CO, Busse J…\n     \n      The Journal of rheumatology\n      2015-09-15\n    ",
         "  \n        Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.\n       \n      Singh JA, Akhras KS, Shiozawa A…\n     \n      Arthritis research & therapy\n      2015-09-02\n    ",
         "3\n       citations    \n        Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.\n       \n      Vargas-Santos, A. B., da Rocha Castelar-Pinheiro, G., Coutinho, E. S., Schumacher, H. R., Singh, J. …\n     \n      PloS one\n      2015 Aug 15\n    ",
         "  \n        Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT.\n       \n      Phillips K, Taylor A, Mease PJ, Simon LS, Conaghan PG, Choy EH, Singh JA, Strand V, Gossec L, Kaiser…\n     \n      The Journal of rheumatology\n      2015-08-01\n    ",
         "  \n        Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique.\n       \n      Singh, J. A., Qu, H., Yazdany, J., Chatham, W., Dall'era, M., Shewchuk, R. M.…\n     \n      The Journal of rheumatology\n      2015 Jul 17\n    ",
         "  \n        Is Chronic Pain a Disease in Its Own Right? Discussions from a Pre-OMERACT 2014 Workshop on Chronic Pain.\n       \n      Taylor AM, Phillips K, Taylor JO, Singh JA, Conaghan PG, Choy EH, Tugwell PS, Kaiser U, Strand V, Si…\n     \n      The Journal of rheumatology\n      2015-07-01\n    ",
         "5\n       citations    \n        Investigational drugs for hyperuricemia.\n       \n      Shahid, H., Singh, J. A.…\n     \n      Expert opinion on investigational drugs\n      2015 Jun 16\n    ",
         "  \n        Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures.\n       \n      Petkovic J, Epstein J, Buchbinder R, Welch V, Rader T, Lyddiatt A, Clerehan R, Christensen R, Boonen…\n     \n      The Journal of rheumatology\n      2015-06-15\n    ",
         "5\n       citations  \n        1\n       mention   \n        Validity and sensitivity to change of three scales for the radiographic assessment of knee osteoarthritis using images from the Multicenter Osteoarthritis Study (MOST).\n       \n      Sheehy, L., Culham, E., McLean, L., Niu, J., Lynch, J., Segal, N. A., Singh, J. A., Nevitt, M., Cook…\n     \n      Osteoarthritis and cartilage\n      2015 May 25\n    ",
         "  \n        Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study.\n       \n      Burton MJ, Curtis JR, Yang S, Chen L, Singh JA, Mikuls TR, Winthrop KL, Baddley JW…\n     \n      Arthritis research & therapy\n      2015-05-22\n    ",
         "94\n       citations  \n        17\n       mentions   \n        Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis.\n       \n      Singh, J. A., Cameron, C., Noorbaloochi, S., Cullis, T., Tucker, M. D., Christensen, R., Ghogomu, E.…\n     \n      Lancet (London, England)\n      2015 May 16\n    ",
         "  \n        Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop.\n       \n      Busse JW, Bartlett SJ, Dougados M, Johnston BC, Guyatt GH, Kirwan JR, Kwoh K, Maxwell LJ, Moore A, S…\n     \n      The Journal of rheumatology\n      2015-05-15\n    ",
         "  \n        Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.\n       \n      Singh JA, Akhras KS, Shiozawa A…\n     \n      Arthritis research & therapy\n      2015-05-12\n    ",
         "  \n        Consensus on the Need for a Hierarchical List of Patient-reported Pain Outcomes for Metaanalyses of Knee Osteoarthritis Trials: An OMERACT Objective.\n       \n      Christensen R, Maxwell LJ, Jüni P, Tovey D, Williamson PR, Boers M, Goel N, Buchbinder R, March L, T…\n     \n      The Journal of rheumatology\n      2015-05-01\n    ",
         "22\n       citations  \n        5\n       mentions   \n        TNF-alpha inhibitors for ankylosing spondylitis.\n       \n      Maxwell, L. J., Zochling, J., Boonen, A., Singh, J. A., Veras, M. M., Ghogomu, E. T., Jandu, M. B., …\n     \n      The Cochrane database of systematic reviews\n      2015 Apr 19\n    ",
         "2\n       citations    \n        Are there racial disparities in utilization and outcomes after total elbow arthroplasty?\n       \n      Singh, J. A., Ramachandran, R.…\n     \n      Rheumatology international\n      2015 Mar 31\n    ",
         "  \n        Racial disparities in total ankle arthroplasty utilization and outcomes.\n       \n      Singh JA, Ramachandran R…\n     \n      Arthritis research & therapy\n      2015-03-21\n    ",
         "  \n        Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).\n       \n      Dueck, A. C.,Singh, J.,Atherton, P.,Liu, H.,Novotny, P.,Hines, S.,Loprinzi, C. L.,Perez, E. A.,Tan, …\n     \n      Osteoporos Int\n      2015 Mar 10\n    ",
         "  \n        Muscle Inflammation Susceptibility: A Prognostic Index of Recovery Potential after Hip Arthroplasty?\n       \n      Bamman, M. M.,Ferrando, A. A.,Evans, R. P.,Stec, M. J.,Kelly, N. A.,Gruenwald, J. M.,Corrick, K. L.,…\n     \n      Am. J. Physiol. Endocrinol. Metab.\n      2015 Feb 12\n    ",
         "  \n        Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.\n       \n      Grainger R, Dalbeth N, Keen H, Durcan L, Lawrence Edwards N, Perez-Ruiz F, Diaz-Torne C, Singh JA, K…\n     \n      The Journal of rheumatology\n      2015-02-01\n    ",
         "23\n       citations  \n        28\n       mentions \n        1 NEW\n        \n        Chondroitin for osteoarthritis.\n       \n      Singh, J. A., Noorbaloochi, S., MacDonald, R., Maxwell, L. J.…\n     \n      The Cochrane database of systematic reviews\n      2015 Jan 30\n    ",
         "4\n       citations  \n        4\n       mentions   \n        When gout goes to the heart: does gout equal a cardiovascular disease risk factor?\n       \n      Singh, J. A.…\n     \n      Annals of the rheumatic diseases\n      2015 Jan 22\n    ",
         "11\n       citations  \n        4\n       mentions   \n        Remembering the forgotten non-communicable diseases.\n       \n      Lopez, A. D., Williams, T. N., Levin, A., Tonelli, M., Singh, J. A., Burney, P. G., Rehm, J., Volkow…\n     \n      BMC medicine\n      2015 Jan 22\n    ",
         "  \n        Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration.\n       \n      Navarro-Millán, I.,Yang, S.,DuVall, S. L.,Chen, L.,Baddley, J.,Cannon, G. W.,Delzell, E. S.,Zhang, J…\n     \n      Ann. Rheum. Dis.\n      2015 Jan 23\n    ",
         "1\n       citations    \n        Gout-related inpatient utilization: a study of predictors of outcomes and time trends.\n       \n      Singh, J. A., Yu, S.…\n     \n      Arthritis research & therapy\n      2015 Jan 1\n    ",
         "8\n       citations  \n        2\n       mentions   \n        Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: a 13-year study of time trends.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      BMC musculoskeletal disorders\n      2014 Dec 19\n    ",
         "9\n       citations  \n        1\n       mention   \n        Antidepressants for people with epilepsy and depression.\n       \n      Maguire, M. J., Weston, J., Singh, J. A., Marson, A. G.…\n     \n      The Cochrane database of systematic reviews\n      2014 Dec 3\n    ",
         "  \n        Hospital Volume Predicts Outcomes and Complications after Total Shoulder Arthroplasty in the United States.\n       \n      Singh, J. A.,Ramachandran, R.…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Nov 06\n    ",
         "12\n       citations    \n        Trends in and disparities for acute myocardial infarction: an analysis of Medicare claims data from 1992 to 2010.\n       \n      Singh, J. A., Lu, X., Ibrahim, S. A., Cram, P.…\n     \n      BMC medicine\n      2014 Oct 25\n    ",
         "55\n       citations  \n        3\n       mentions   \n        The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.\n       \n      Schmitt, J., Spuls, P. I., Thomas, K. S., Simpson, E. L., Furue, M., Deckert, S., Dohil, M. A., Apfe…\n     \n      The Journal of allergy and clinical immunology\n      2014 Oct 6\n    ",
         "  \n        Rheumatoid arthritis is associated with higher 90-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: A cohort study.\n       \n      Singh, J. A.,Inacio, M. C.,Namba, R. S.,Paxton, E. W.…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Oct 11\n    ",
         "  \n        Patient-centered priorities for improving medication management and adherence.\n       \n      McMullen, C. K.,Safford, M. M.,Bosworth, H. B.,Phansalkar, S.,Leong, A.,Fagan, M. B.,Trontell, A.,Ru…\n     \n      Patient Educ Couns\n      2014 Dec 03\n    ",
         "18\n       citations    \n        Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings.\n       \n      Kuntz, J. L., Safford, M. M., Singh, J. A., Phansalkar, S., Slight, S. P., Her, Q. L., Lapointe, N. …\n     \n      Patient education and counseling\n      2014 Sep 30\n    ",
         "  \n        A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.\n       \n      Puhan MA, Schünemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, Kessels AG, Guyatt GH, G…\n     \n      BMJ (Clinical research ed.)\n      2014-09-24\n    ",
         "275\n       citations  \n        172\n       mentions   \n        Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.\n       \n      Murray, C. J., Ortblad, K. F., Guinovart, C., Lim, S. S., Wolock, T. M., Roberts, D. A., Dansereau, …\n     \n      Lancet (London, England)\n      2014 Jul 26\n    ",
         "11\n       citations    \n        The impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout.\n       \n      Singh, J. A.…\n     \n      Arthritis research & therapy\n      2014 Jun 26\n    ",
         "118\n       citations    \n        Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.\n       \n      Ng, M., Ng, M., Fleming, T., Fleming, T., Robinson, M., Robinson, M., Thomson, B., Thomson, B., Grae…\n     \n      Lancet (London, England)\n      2014-05-29\n    ",
         "  \n        Impaired response or insufficient dosage? Examining the potential causes of \"inadequate response\" to allopurinol in the treatment of gout.\n       \n      Stamp LK, Merriman TR, Barclay ML, Singh JA, Roberts RL, Wright DF, Dalbeth N…\n     \n      Seminars in arthritis and rheumatism\n      2014-05-09\n    ",
         "10\n       citations    \n        Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.\n       \n      Kassebaum, N. J., Bertozzi-Villa, A., Coggeshall, M. S., Shackelford, K. A., Steiner, C., Heuton, K.…\n     \n      Lancet (London, England)\n      2014 May 7\n    ",
         "231\n       citations \n        1 NEW\n       \n        7\n       mentions \n        1 NEW\n        \n        Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.\n       \n      Wang, H., Liddell, C. A., Coates, M. M., Mooney, M. D., Levitz, C. E., Schumacher, A. E., Apfel, H.,…\n     \n      Lancet (London, England)\n      2014 May 7\n    ",
         "  \n        Comorbidities in Patients with Crystal Diseases and Hyperuricemia.\n       \n      Sattui, S. E.,Singh, J. A.,Gaffo, A. L.…\n     \n      Rheum. Dis. Clin. North Am.\n      2014 Apr 08\n    ",
         "8\n       citations    \n        Depression in primary TKA and higher medical comorbidities in revision TKA are associated with suboptimal subjective improvement in knee function.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      BMC musculoskeletal disorders\n      2014 Apr 15\n    ",
         "4\n       citations    \n        Updating the OMERACT filter: discrimination and feasibility.\n       \n      Wells, G. A., Beaton, D. E., Tugwell, P., Boers, M., Kirwan, J. R., Bingham, C. O., Boonen, A., Broo…\n     \n      The Journal of rheumatology\n      2014 Apr 3\n    ",
         "6\n       citations    \n        Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of \"truth\": content, face, and construct validity.\n       \n      Tugwell, P., Boers, M., D\\'Agostino, M., Beaton, D. E., Boonen, A., Bingham, C. O., Choy, E., Conagha…\n     \n      The Journal of rheumatology\n      2014 Apr 3\n    ",
         "13\n       citations    \n        Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study.\n       \n      Singh, J. A.…\n     \n      Arthritis research & therapy\n      2014 Apr 1\n    ",
         "22\n       citations    \n        Bariatric surgery prior to total joint arthroplasty may not provide dramatic improvements in post-arthroplasty surgical outcomes.\n       \n      Inacio, M. C., Paxton, E. W., Fisher, D., Li, R. A., Barber, T. C., Singh, J. A.…\n     \n      The Journal of arthroplasty\n      2014 Mar 29\n    ",
         "2\n       citations    \n        Updating the OMERACT filter: core areas as a basis for defining core outcome sets.\n       \n      Kirwan, J. R., Boers, M., Hewlett, S., Beaton, D. E., Bingham, C. O., Choy, E., Conaghan, P. G., D'A…\n     \n      The Journal of rheumatology\n      2014 Mar 19\n    ",
         "6\n       citations    \n        Updating the OMERACT filter: implications for imaging and soluble biomarkers.\n       \n      D'Agostino, M., Boers, M., Kirwan, J. R., van der Heijde, D., Østergaard, M., Schett, G., Landewé, R…\n     \n      The Journal of rheumatology\n      2014 Mar 4\n    ",
         "  \n        Research priorities in gout: the patient perspective.\n       \n      Singh, J. A.…\n     \n      J. Rheumatol.\n      2014 Mar 04\n    ",
         "  \n        Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: a multicenter study.\n       \n      Singh, J. A.,Luo, R.,Landon, G. C.,Suarez-Almazor, M.…\n     \n      J. Rheumatol.\n      2014 Jan 17\n    ",
         "  \n        Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout.\n       \n      Taylor, W. J.,Redden, D.,Dalbeth, N.,Schumacher, H. R.,Edwards, N. L.,Simon, L. S.,John, M. R.,Essex…\n     \n      J. Rheumatol.\n      2014 Jan 17\n    ",
         "  \n        How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.\n       \n      Boers M, Kirwan JR, Gossec L, Conaghan PG, D'Agostino MA, Bingham CO, Brooks PM, Landewé R, March L,…\n     \n      The Journal of rheumatology\n      2014-03-01\n    ",
         "  \n        Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.\n       \n      Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, Conaghan PG, Bingham CO, Brooks P, L…\n     \n      Journal of clinical epidemiology\n      2014-02-28\n    ",
         "  \n        Editorial: Arthroplasty Outcomes Are Improving, but Why Isn't My Patient With Rheumatoid Arthritis Doing as Well?\n       \n      Singh, J. A.…\n     \n      \n      2014 Feb 08\n    ",
         "4\n       citations    \n        Predictors of pain medication use for arthroplasty pain after revision total knee arthroplasty.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Rheumatology (Oxford, England)\n      2014 Jan 25\n    ",
         "  \n        OMERACT 11: International Consensus Conference on Outcome Measures in Rheumatology.\n       \n      Simon, L. S.,Strand, V.,Bingham, C. O.,Singh, J. A.…\n     \n      J. Rheumatol.\n      2014 Jan 03\n    ",
         "  \n        Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study.\n       \n      Singh, J. A.…\n     \n      Br J Med Med Res\n      2013 Dec 10\n    ",
         "  \n        Risk of hospitalized bacterial infections associated with biologic treatment among U.S. Veterans with Rheumatoid Arthritis.\n       \n      Curtis, J. R.,Yang, S.,Patkar, N. M.,Chen, L.,Singh, J. A.,Cannon, G. W.,Mikuls, T. R.,Delzell, E.,S…\n     \n      Arthritis Care Res (Hoboken)\n      2014 Jan 29\n    ",
         "7\n       citations  \n        1\n       mention   \n        Update of strategies to translate evidence from cochrane musculoskeletal group systematic reviews for use by various audiences.\n       \n      Rader, T., Pardo, J. P., Stacey, D., Ghogomu, E. T., Maxwell, L. J., Welch, V. A., Singh, J. A., Buc…\n     \n      The Journal of rheumatology\n      2013 Dec 3\n    ",
         "29\n       citations    \n        Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalyses.\n       \n      Ghogomu, E. T., Maxwell, L. J., Buchbinder, R., Rader, T., Pardo, J. P., Johnston, R. V., Christense…\n     \n      The Journal of rheumatology\n      2013 Dec 3\n    ",
         "  \n        OMERACT Endorsement of Measures of Outcome for Studies of Acute Gout.\n       \n      Singh, J. A.,Taylor, W. J.,Dalbeth, N.,Simon, L. S.,Sundy, J.,Grainger, R.,Alten, R.,March, L.,Stran…\n     \n      J. Rheumatol.\n      2013 Dec 18\n    ",
         "  \n        Outcome Measures in Acute Gout: A Systematic Literature Review.\n       \n      Dalbeth, N.,Zhong, C. S.,Grainger, R.,Khanna, D.,Khanna, P. P.,Singh, J. A.,McQueen, F. M.,Taylor, W…\n     \n      J. Rheumatol.\n      2013 Dec 18\n    ",
         "3\n       citations    \n        Time trends in the characteristics of patients undergoing primary total knee arthroplasty.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Arthritis care & research\n      2013 Nov 20\n    ",
         "  \n        Underlying diagnosis predicts patient-reported outcomes after revision total knee arthroplasty.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Rheumatology (Oxford, England)\n      2013 Nov 8\n    ",
         "3\n       citations    \n        Patient-level improvements in pain and activities of daily living after total knee arthroplasty.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Rheumatology (Oxford, England)\n      2013 Oct 29\n    ",
         "  \n        Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm.\n       \n      O'Neill J, Rader T, Guillemin F, Boonen A, Christensen R, Lyddiatt A, Pardo JP, Welch V, Singh JA, T…\n     \n      The Journal of rheumatology\n      2013-10-15\n    ",
         "7\n       citations \n        1 NEW\n         \n        Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared to rheumatoid arthritis after primary hip arthroplasty: a cohort study.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      BMC medicine\n      2013 Sep 26\n    ",
         "  \n        Racial disparities in knee and hip total joint arthroplasty: an 18-year analysis of national medicare data.\n       \n      Singh, J. A.,Lu, X.,Rosenthal, G. E.,Ibrahim, S.,Cram, P.…\n     \n      Ann. Rheum. Dis.\n      2013 Sep 18\n    ",
         "1\n       citations    \n        Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: a cohort study.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Arthritis care & research\n      2013 Aug 9\n    ",
         "  \n        Folic acid supplementation for rheumatoid arthritis patients on methotrexate: the good gets better.\n       \n      Singh JA…\n     \n      The Cochrane database of systematic reviews\n      2013-07-22\n    ",
         "2\n       citations    \n        Medical comorbidity is associated with persistent index hip pain after total hip arthroplasty.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Pain medicine (Malden, Mass.)\n      2013 Jun 8\n    ",
         "3\n       citations    \n        Cerebrovascular disease is associated with outcomes after total knee arthroplasty: a US total joint registry study.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      The Journal of arthroplasty\n      2013 May 15\n    ",
         "  \n        Reply.\n       \n      Singh, J. A.,Saag, K. G.,Furst, D.…\n     \n      Arthritis Care Res (Hoboken)\n      2013 May\n    ",
         "6\n       citations  \n        4\n       mentions   \n        Mediation of smoking-associated postoperative mortality by perioperative complications in veterans undergoing elective surgery: data from Veterans Affairs Surgical Quality Improvement Program (VASQIP)--a cohort study.\n       \n      Singh, J. A., Hawn, M. T., Campagna, E. J., Henderson, W. G., Richman, J. S., Houston, T. K.…\n     \n      BMJ open\n      2013 Apr 23\n    ",
         "14\n       citations    \n        The relation between cancer patient treatment decision-making roles and quality of life.\n       \n      Atherton, P. J., Smith, T., Singh, J. A., Huntington, J., Diekmann, B. B., Huschka, M., Sloan, J. A.…\n     \n      Cancer\n      2013 Apr 6\n    ",
         "  \n        Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature.\n       \n      Jain, A.,Singh, J. A.…\n     \n      Immunotherapy\n      2013 Mar\n    ",
         "  \n        Patient-level clinically meaningful improvements in activities of daily living and pain after total hip arthroplasty: data from a large US institutional registry.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Rheumatology (Oxford, England)\n      2013 Feb 6\n    ",
         "27\n       citations  \n        3\n       mentions   \n        Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Rheumatology (Oxford, England)\n      2013 Jan 18\n    ",
         "17\n       citations  \n        2\n       mentions   \n        Racial and gender disparities among patients with gout.\n       \n      Singh, J. A.…\n     \n      Current rheumatology reports\n      2013 Jan 15\n    ",
         "  \n        Are gender, comorbidity, and obesity risk factors for postoperative periprosthetic fractures after primary total hip arthroplasty?\n       \n      Singh, J. A.,Jensen, M. R.,Harmsen, S. W.,Lewallen, D. G.…\n     \n      J Arthroplasty\n      2012 May 04\n    ",
         "7\n       citations  \n        5\n       mentions \n        1 NEW\n        \n        Use of botulinum toxin in musculoskeletal pain.\n       \n      Singh, J. A., Singh, J. A., Singh, J. A., Singh, J. A.…\n     \n      F1000Research\n      2013 Jan 1\n    ",
         "2333\n       citations \n        2 NEW\n       \n        86\n       mentions \n        1 NEW\n        \n        Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.\n       \n      Murray, C. J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K…\n     \n      Lancet (London, England)\n      2012 Dec 19\n    ",
         "1705\n       citations \n        1 NEW\n       \n        85\n       mentions \n        2 NEW\n        \n        Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.\n       \n      Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. …\n     \n      Lancet (London, England)\n      2012 Dec 19\n    ",
         "4\n       citations    \n        Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: a cohort study using an institutional joint registry.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Arthritis research & therapy\n      2012 Nov 20\n    ",
         "1\n       citations    \n        Emerging therapies for gout.\n       \n      Singh, J. A.…\n     \n      Expert opinion on emerging drugs\n      2012 Nov 7\n    ",
         "195\n       citations  \n        10\n       mentions   \n        2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.\n       \n      Khanna, D., Khanna, P. P., Fitzgerald, J. D., Singh, M. K., Bae, S., Neogi, T., Pillinger, M. H., Me…\n     \n      Arthritis care & research\n      2012 Oct 2\n    ",
         "5\n       citations    \n        Gout-related health care utilization in US emergency departments, 2006 through 2008.\n       \n      Garg, R., Sayles, H. R., Yu, F., Michaud, K., Singh, J. A., Saag, K. G., Mikuls, T. R.…\n     \n      Arthritis care & research\n      2012 Sep 6\n    ",
         "  \n        Ninety-day mortality in patients undergoing elective total hip or total knee arthroplasty.\n       \n      Singh, J. A.,Lewallen, D. G.…\n     \n      J Arthroplasty\n      2012 May 05\n    ",
         "  \n        Patient factors predict periprosthetic fractures after revision total hip arthroplasty.\n       \n      Singh, J. A.,Jensen, M. R.,Lewallen, D. G.…\n     \n      J Arthroplasty\n      2012 Feb 22\n    ",
         "15\n       citations    \n        Patient race and surgical outcomes after total knee arthroplasty: an analysis of a large regional database.\n       \n      Blum, M. A., Singh, J. A., Lee, G., Richardson, D., Chen, W., Ibrahim, S. A.…\n     \n      Arthritis care & research\n      2012 Aug 31\n    ",
         "  \n        Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacement.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Acta orthopaedica\n      2012 Aug 21\n    ",
         "  \n        Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.\n       \n      Saag KG, Mohr PE, Esmail L, Mudano AS, Wright N, Beukelman T, Curtis JR, Cutter G, Delzell E, Gary L…\n     \n      Contemporary clinical trials\n      2012-07-05\n    ",
         "15\n       citations    \n        Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.\n       \n      Singh, J. A., Cameron, D. R.…\n     \n      Journal of managed care pharmacy : JMCP\n      2012 Jun 8\n    ",
         "15\n       citations  \n        2\n       mentions   \n        Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.\n       \n      Strand, V., Khanna, D., Singh, J. A., Forsythe, A., Edwards, N. L.…\n     \n      The Journal of rheumatology\n      2012 Jun 5\n    ",
         "29\n       citations    \n        Total knee arthroplasty in morbidly obese patients treated with bariatric surgery: a comparative study.\n       \n      Severson, E. P., Singh, J. A., Browne, J. A., Trousdale, R. T., Sarr, M. G., Lewallen, D. G.…\n     \n      The Journal of arthroplasty\n      2012 May 5\n    ",
         "  \n        Developing a provisional definition of flare in patients with established gout.\n       \n      Gaffo, A. L.,Schumacher, H. R.,Saag, K. G.,Taylor, W. J.,Dinnella, J.,Outman, R.,Chen, L.,Dalbeth, N…\n     \n      Arthritis Rheum.\n      2012 May\n    ",
         "685\n       citations  \n        9\n       mentions   \n        2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.\n       \n      Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M., Moreland, L.…\n     \n      Arthritis care & research\n      2012 Apr 5\n    ",
         "  \n        Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.\n       \n      Navarro-Millán I, Singh JA, Curtis JR…\n     \n      Clinical therapeutics\n      2012-03-22\n    ",
         "2\n       citations    \n        Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trial.\n       \n      Singh, J. A.…\n     \n      BMC medicine\n      2012 Feb 10\n    ",
         "3\n       citations    \n        A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data.\n       \n      Singh, J. A., Kundukulam, J. A., Bhandari, M.…\n     \n      Pharmacoepidemiology and drug safety\n      2012 Jan 25\n    ",
         "16\n       citations    \n        Acetylcholinesterase inhibitors for schizophrenia.\n       \n      Singh, J. A., Kour, K., Jayaram, M. B.…\n     \n      The Cochrane database of systematic reviews\n      2012 Jan 20\n    ",
         "3\n       citations    \n        Adverse effects of smoking on postoperative outcomes in cancer patients.\n       \n      Gajdos, C., Hawn, M. T., Campagna, E. J., Henderson, W. G., Singh, J. A., Houston, T. K.…\n     \n      Annals of surgical oncology\n      2011 Nov 9\n    ",
         "20\n       citations  \n        1\n       mention   \n        Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty.\n       \n      Singh, J. A., Jensen, M. R., Harmsen, W. S., Gabriel, S. E., Lewallen, D. G.…\n     \n      Annals of the rheumatic diseases\n      2011 Oct 25\n    ",
         "4\n       citations    \n        The attributable risk of smoking on surgical complications.\n       \n      Hawn, M. T., Houston, T. K., Campagna, E. J., Graham, L. A., Singh, J. A., Bishop, M. J., Henderson,…\n     \n      Annals of surgery\n      2011 Aug 27\n    ",
         "8\n       citations    \n        OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health.\n       \n      Kirwan, J. R., Boonen, A., Harrison, M. J., Hewlett, S. E., Wells, G. A., Singh, J. A., Furst, D. E.…\n     \n      The Journal of rheumatology\n      2011 Aug 3\n    ",
         "26\n       citations    \n        OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group.\n       \n      Gossec, L., Paternotte, S., Bingham, C. O., Clegg, D. O., Coste, P., Conaghan, P. G., Davis, A. M., …\n     \n      The Journal of rheumatology\n      2011 Aug 3\n    ",
         "13\n       citations    \n        Biologicals for rheumatoid arthritis.\n       \n      Tugwell, P., Singh, J. A., Wells, G. A.…\n     \n      BMJ (Clinical research ed.)\n      2011 Jul 30\n    ",
         "35\n       citations    \n        Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans.\n       \n      Singh, J. A., Houston, T. K., Ponce, B. A., Maddox, G. E., Bishop, M. J., Richman, J. S., Campagna, …\n     \n      Arthritis care & research\n      2011 Jul 20\n    ",
         "2\n       citations    \n        Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Arthritis care & research\n      2011 Jul 13\n    ",
         "6\n       citations    \n        Patient-reported outcomes in chronic gout: a report from OMERACT 10.\n       \n      Singh, J. A., Taylor, W. J., Simon, L. S., Khanna, P. P., Stamp, L. K., McQueen, F. M., Neogi, T., G…\n     \n      The Journal of rheumatology\n      2011 Jul 5\n    ",
         "7\n       citations    \n        Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.\n       \n      Dalbeth, N., McQueen, F. M., Singh, J. A., MacDonald, P. A., Edwards, N. L., Schumacher, H. R., Simo…\n     \n      The Journal of rheumatology\n      2011 Jul 5\n    ",
         "21\n       citations  \n        1\n       mention   \n        Early postoperative mortality following joint arthroplasty: a systematic review.\n       \n      Singh, J. A., Kundukulam, J., Riddle, D. L., Strand, V., Tugwell, P.…\n     \n      The Journal of rheumatology\n      2011 Jul 5\n    ",
         "5\n       citations    \n        Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?\n       \n      Stamp, L. K., Khanna, P. P., Dalbeth, N., Boers, M., Maksymowych, W. P., Schumacher, H. R., Becker, …\n     \n      The Journal of rheumatology\n      2011 Jul 5\n    ",
         "1\n       citations    \n        Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials.\n       \n      Taylor, W. J., Singh, J. A., Saag, K. G., Dalbeth, N., MacDonald, P. A., Edwards, N. L., Simon, L. S…\n     \n      The Journal of rheumatology\n      2011 Jul 5\n    ",
         "24\n       citations    \n        Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database.\n       \n      Singh, J. A., Kwoh, C. K., Boudreau, R. M., Lee, G., Ibrahim, S. A.…\n     \n      Arthritis and rheumatism\n      2011 Jun 10\n    ",
         "  \n        Smoking and outcomes after knee and hip arthroplasty: a systematic review.\n       \n      Singh JA…\n     \n      The Journal of rheumatology\n      2011-06-01\n    ",
         "1\n       citations    \n        Responsiveness differences in outcome instruments after revision hip arthroplasty: what are the implications?\n       \n      Singh, J. A.…\n     \n      BMC musculoskeletal disorders\n      2011 May 25\n    ",
         "  \n        Editorial: current concepts in arthroplasty.\n       \n      Singh, J. A.…\n     \n      The open orthopaedics journal\n      2011 May 18\n    ",
         "  \n        Diagnosis and management of infected total knee arthroplasty.\n       \n      Kalore NV, Gioe TJ, Singh JA…\n     \n      The open orthopaedics journal\n      2011-03-16\n    ",
         "  \n        Biomarkers in arthroplasty: a systematic review.\n       \n      Mertens MT, Singh JA…\n     \n      The open orthopaedics journal\n      2011-03-16\n    ",
         "2\n       citations    \n        Minimally important differences of the gout impact scale in a randomized controlled trial.\n       \n      Khanna, D., Sarkin, A. J., Khanna, P. P., Shieh, M. M., Kavanaugh, A. F., Terkeltaub, R. A., Lee, S.…\n     \n      Rheumatology (Oxford, England)\n      2011 Mar 5\n    ",
         "277\n       citations \n        1 NEW\n       \n        11\n       mentions \n        1 NEW\n        \n        Adverse effects of biologics: a network meta-analysis and Cochrane overview.\n       \n      Singh, J. A., Wells, G. A., Christensen, R., Ghogomu, E. T., Maxwell, L., Macdonald, J. K., Filippin…\n     \n      The Cochrane database of systematic reviews\n      2011 Feb 18\n    ",
         "8\n       citations    \n        Botulinum toxin therapy for osteoarticular pain: an evidence-based review.\n       \n      Singh, J. A.…\n     \n      Therapeutic advances in musculoskeletal disease\n      2011 Feb 10\n    ",
         "3\n       citations    \n        Applying science in practice: the optimization of biological therapy in rheumatoid arthritis.\n       \n      Ramiro, S., Machado, P., Singh, J. A., Landewé, R. B., da Silva, J. A.…\n     \n      Arthritis research & therapy\n      2010 Nov 12\n    ",
         "42\n       citations    \n        Tocilizumab for rheumatoid arthritis: a Cochrane systematic review.\n       \n      Singh, J. A., Beg, S., Lopez-Olivo, M. A.…\n     \n      The Journal of rheumatology\n      2010 Oct 19\n    ",
         "  \n        A population-based study of trends in the use of total hip and total knee arthroplasty, 1969-2008.\n       \n      Singh, J. A.,Vessely, M. B.,Harmsen, W. S.,Schleck, C. D.,Melton, L. J.,Kurland, R. L.,Berry, D. J.…\n     \n      Mayo Clin. Proc.\n      2010 Sep 09\n    ",
         "85\n       citations    \n        Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale.\n       \n      Singh, J. A., Sloan, J. A., Atherton, P. J., Smith, T., Hack, T. F., Huschka, M. M., Rummans, T. A.,…\n     \n      The American journal of managed care\n      \n    ",
         "15\n       citations  \n        2\n       mentions   \n        Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial.\n       \n      Singh, J. A., Mahowald, M. L., Noorbaloochi, S.…\n     \n      The Journal of rheumatology\n      2010 Sep 3\n    ",
         "45\n       citations  \n        1\n       mention   \n        Tocilizumab for rheumatoid arthritis.\n       \n      Singh, J. A., Beg, S., Lopez-Olivo, M. A.…\n     \n      The Cochrane database of systematic reviews\n      2010 Jul 9\n    ",
         "21\n       citations    \n        Pessimistic explanatory style: a psychological risk factor for poor pain and functional outcomes two years after knee replacement.\n       \n      Singh, J. A., O'Byrne, M. M., Colligan, R. C., Lewallen, D. G.…\n     \n      The Journal of bone and joint surgery. British volume\n      2010 Jun 2\n    ",
         "33\n       citations    \n        Predictors of pain and use of pain medications following primary Total Hip Arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      BMC musculoskeletal disorders\n      2010 May 14\n    ",
         "  \n        Golimumab for rheumatoid arthritis: a systematic review.\n       \n      Singh JA, Noorbaloochi S, Singh G…\n     \n      The Journal of rheumatology\n      2010-05-01\n    ",
         "22\n       citations  \n        1\n       mention \n        1 NEW\n        \n        Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study.\n       \n      Boon, A. J., Smith, J., Dahm, D. L., Sorenson, E. J., Larson, D. R., Fitz-Gibbon, P. D., Dykstra, D.…\n     \n      PM & R : the journal of injury, function, and rehabilitation\n      2010 May 1\n    ",
         "31\n       citations    \n        Higher body mass index is not associated with worse pain outcomes after primary or revision total knee arthroplasty.\n       \n      Singh, J. A., Gabriel, S. E., Lewallen, D. G.…\n     \n      The Journal of arthroplasty\n      2010 Apr 24\n    ",
         "2\n       citations    \n        A national survey of Veterans Affairs rheumatologists for relevance of quality of care indicators for gout management.\n       \n      Singh, J. A., Alpert, M. D., Kerr, G. S.…\n     \n      Arthritis care & research\n      2010 Mar 18\n    ",
         "  \n        Pegloticase for chronic gout.\n       \n      Anderson A, Singh JA…\n     \n      The Cochrane database of systematic reviews\n      2010-03-17\n    ",
         "  \n        Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions.\n       \n      Singh, J.,Sloan, J. A.,Johanson, N. A.…\n     \n      J Am Acad Orthop Surg\n      2010 Feb 02\n    ",
         "51\n       citations    \n        Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity.\n       \n      Strand, V., Singh, J. A.…\n     \n      Drugs\n      2010 Jan 30\n    ",
         "40\n       citations  \n        1\n       mention   \n        Golimumab for rheumatoid arthritis.\n       \n      Singh, J. A., Noorbaloochi, S., Singh, G.…\n     \n      The Cochrane database of systematic reviews\n      2010 Jan 22\n    ",
         "38\n       citations    \n        Abatacept for rheumatoid arthritis: a Cochrane systematic review.\n       \n      Maxwell, L. J., Singh, J. A.…\n     \n      The Journal of rheumatology\n      2010 Jan 19\n    ",
         "  \n        A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.\n       \n      Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugw…\n     \n      CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne\n      2009-11-02\n    ",
         "40\n       citations  \n        2\n       mentions   \n        Abatacept for rheumatoid arthritis.\n       \n      Maxwell, L., Singh, J. A.…\n     \n      The Cochrane database of systematic reviews\n      2009 Oct 13\n    ",
         "36\n       citations    \n        Accuracy of Veterans Affairs databases for diagnoses of chronic diseases.\n       \n      Singh, J. A.…\n     \n      Preventing chronic disease\n      2009-09-15\n    ",
         "14\n       citations    \n        Variation in outcome measures in hip and knee arthroplasty clinical trials: a proposed approach to achieving consensus.\n       \n      Riddle, D. L., Stratford, P. W., Singh, J. A., Strand, C. V.…\n     \n      The Journal of rheumatology\n      2009 Sep 10\n    ",
         "33\n       citations    \n        Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty.\n       \n      Singh, J. A., Lewallen, D. G.…\n     \n      Clinical rheumatology\n      2009 Sep 4\n    ",
         "5\n       citations    \n        Mobile and fixed-bearing (all-polyethylene tibial component) total knee arthroplasty designs. A prospective randomized trial.\n       \n      Gioe, T. J., Glynn, J., Sembrano, J. N., Suthers, K., Santos, E. R., Singh, J. A.…\n     \n      The Journal of bone and joint surgery. American volume\n      2009 Sep 3\n    ",
         "10\n       citations    \n        Trial sample size, but not trial quality, is associated with positive study outcome.\n       \n      Singh, J. A., Murphy, S., Bhandari, M.…\n     \n      Journal of clinical epidemiology\n      2009 Sep 1\n    ",
         "14\n       citations    \n        Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty.\n       \n      Singh, J. A., Sloan, J. A.…\n     \n      Clinical rheumatology\n      2009 Jun 12\n    ",
         "16\n       citations    \n        The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.\n       \n      Sprangers, M. A., Sloan, J. A., Veenhoven, R., Cleeland, C. S., Halyard, M. Y., Abertnethy, A. P., B…\n     \n      Twin research and human genetics : the official journal of the International Society for Twin Studies\n      2009 May 22\n    ",
         "3\n       citations    \n        Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty.\n       \n      Singh, J. A.…\n     \n      Clinical rheumatology\n      2009 May 19\n    ",
         "  \n        Anakinra for rheumatoid arthritis: a systematic review.\n       \n      Mertens M, Singh JA…\n     \n      The Journal of rheumatology\n      2009-05-15\n    ",
         "  \n        Spondyloarthritis is associated with poor function and physical health-related quality of life.\n       \n      Singh JA, Strand V…\n     \n      The Journal of rheumatology\n      2009-04-15\n    ",
         "  \n        Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain.\n       \n      Mahowald ML, Krug HE, Singh JA, Dykstra D…\n     \n      Toxicon : official journal of the International Society on Toxinology\n      2009-04-05\n    ",
         "21\n       citations    \n        Quality of life and quality of care for patients with gout.\n       \n      Singh, J. A.…\n     \n      Current rheumatology reports\n      2009 Mar 20\n    ",
         "6\n       citations    \n        Effect of resistance exercise on bone mineral density in premenopausal women.\n       \n      Singh, J. A., Schmitz, K. H., Petit, M. A.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2009 Feb 17\n    ",
         "57\n       citations  \n        1\n       mention   \n        Anakinra for rheumatoid arthritis.\n       \n      Mertens, M. T., Singh, J. A.…\n     \n      The Cochrane database of systematic reviews\n      2009 Jan 23\n    ",
         "1\n       citations    \n        Health care utilization in patients with spondyloarthropathies.\n       \n      Singh, J. A., Strand, V.…\n     \n      Rheumatology (Oxford, England)\n      2009 Jan 20\n    ",
         "  \n        Can patients help with long-term total knee arthroplasty surveillance? Comparison of the American Knee Society Score self-report and surgeon assessment.\n       \n      Gioe TJ, Pomeroy D, Suthers K, Singh JA…\n     \n      Rheumatology (Oxford, England)\n      2008-12-23\n    ",
         "11\n       citations    \n        Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: a report of two cases.\n       \n      Singh, J. A., Mahowald, M. L.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2008 Oct 28\n    ",
         "19\n       citations    \n        Evaluation of an instrument assessing influence of Gout on health-related quality of life.\n       \n      Hirsch, J. D., Lee, S. J., Terkeltaub, R., Khanna, D., Singh, J. A., Sarkin, A. J., Harvey, J., Kava…\n     \n      The Journal of rheumatology\n      2008 Oct 18\n    ",
         "9\n       citations    \n        Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty.\n       \n      Singh, J. A., Sloan, J. A.…\n     \n      Rheumatology (Oxford, England)\n      2008 Oct 18\n    ",
         "41\n       citations    \n        Opportunities for improving medication use and monitoring in gout.\n       \n      Singh, J. A., Hodges, J. S., Asch, S. M.…\n     \n      Annals of the rheumatic diseases\n      2008 Aug 15\n    ",
         "  \n        Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.\n       \n      Singh JA, Strand V…\n     \n      Annals of the rheumatic diseases\n      2008-01-04\n    ",
         "29\n       citations  \n        1\n       mention   \n        Classification criteria in rheumatic diseases: a review of methodologic properties.\n       \n      Johnson, S. R., Goek, O., Singh-Grewal, D., Vlad, S. C., Feldman, B. M., Felson, D. T., Hawker, G. A…\n     \n      Arthritis and rheumatism\n      2007 Oct 2\n    ",
         "6\n       citations    \n        Effect of health-related quality of life on women and men's Veterans Affairs (VA) health care utilization and mortality.\n       \n      Singh, J. A., Murdoch, M.…\n     \n      Journal of general internal medicine\n      2007 Jul 5\n    ",
         "2\n       citations    \n        Ciprofloxacin-related acute peripheral neuropathy in a patient with lupus nephritis.\n       \n      Singh, J.…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      \n    ",
         "2\n       citations    \n        Leflunomide use during the first 33 months after food and drug administration approval: experience with a national cohort of 3,325 patients.\n       \n      Siva, C., Eisen, S. A., Shepherd, R. M., Cunningham, F. E., Fang, M. A., Finch, W., Salisbury, D., S…\n     \n      Arthritis and rheumatism\n      2003 Dec 16\n    ",
         "  \n        Hospitalized Infections in People with Osteoarthritis: A National U.S. Study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      The Journal of rheumatology\n      2020 Aug 3\n    ",
         "  \n        Sjogren's syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: a U.S. cohort study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      BMC musculoskeletal disorders\n      2020 Jul 28\n    ",
         "  \n        Pop a Pill or Give myself a Shot? Patient perspectives of disease-modifying anti-rheumatic drug (DMARD) choice for rheumatoid arthritis (RA).\n       \n      Singh, J. A., Tornberg, H., Goodman, S. M.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2020 Jul 19\n    ",
         "  \n        Gout epidemiology and comorbidities.\n       \n      Singh, J. A., Gaffo, A.…\n     \n      Seminars in arthritis and rheumatism\n      2020 Jul 6\n    ",
         "  \n        Serious infections in people with systemic sclerosis: a national US study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Arthritis research & therapy\n      2020 Jul 1\n    ",
         "  \n        GRADE Equity Guidelines 4: Guidance on How to Assess and Address Health Equity Within the Evidence to Decision Process\n       \n      Jasvinder Singh, MD…\n     \n      Journal of Clinical Epidemiology\n      \n    ",
         "  \n        Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey.\n       \n      Singh, J. A., Edwards, N. L.…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2020 May 27\n    ",
         "  \n        A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.\n       \n      Singh, J. A., Green, C., Morgan, S., Willig, A. L., Darnell, B., Saag, K. G., Weiss, R., Cutter, G.,…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2020 May 27\n    ",
         "  \n        2020 American College of Rheumatology Guideline for the Management of Gout.\n       \n      FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello-Petersen, R., Guyatt, G., Abeles, A. M., Ge…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2020 May 12\n    ",
         "  \n        2020 American College of Rheumatology Guideline for the Management of Gout.\n       \n      FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello-Petersen, R., Guyatt, G., Abeles, A. M., Ge…\n     \n      Arthritis care & research\n      2020 May 12\n    ",
         "  \n        Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy.\n       \n      Craig, R. S., Goodier, H., Singh, J. A., Hopewell, S., Rees, J. L.…\n     \n      The Cochrane database of systematic reviews\n      2020 Apr 22\n    ",
         "  \n        Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study.\n       \n      Colantonio, L. D., Saag, K. G., Singh, J. A., Chen, L., Reynolds, R. J., Gaffo, A., Plante, T. B., C…\n     \n      Arthritis research & therapy\n      2020 Apr 18\n    ",
         "  \n        Assessment of a Satisfaction Measure for Use After Primary Total Joint Arthroplasty.\n       \n      Goodman, S. M., Mehta, B. Y., Kahlenberg, C. A., Krell, E. C., Nguyen, J., Finik, J., Figgie, M. P.,…\n     \n      The Journal of arthroplasty\n      2020 Mar 17\n    ",
         "  \n        Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2020 Mar 17\n    ",
         "  \n        Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA).\n       \n      Singh, J. A., Tornberg, H., Goodman, S. M.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2020 Mar 10\n    ",
         "  \n        Acute kidney injury after primary total hip arthroplasty: a risk multiplier for complication, mortality, and healthcare utilization.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Arthritis research & therapy\n      2020 Feb 23\n    ",
         "  \n        National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      PloS one\n      2020 Feb 19\n    ",
         "\n        3\n       mentions \n        3 NEW\n        \n        Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Annals of the rheumatic diseases\n      2020 Feb 7\n    ",
         "  \n        Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical Trials.\n       \n      Goodman, S. M., Mehta, B. Y., Mandl, L. A., Szymonifka, J. D., Finik, J., Figgie, M. P., Navarro-Mil…\n     \n      The Journal of arthroplasty\n      2020 Jan 19\n    ",
         "  \n        Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review.\n       \n      Kelly, A., Crimston-Smith, L., Tong, A., Bartlett, S. J., Bekker, C. L., Christensen, R., De Vera, M…\n     \n      The Journal of rheumatology\n      2019 Dec 17\n    ",
         "  \n        Socioeconomic status and healthcare access are associated with healthcare utilization after knee arthroplasty: A U.S. national cohort study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Joint, bone, spine : revue du rhumatisme\n      2019 Dec 8\n    ",
         "  \n        Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.\n       \n      Chaudhary, N. S., Bridges, S. L., Saag, K. G., Rahn, E. J., Curtis, J. R., Gaffo, A., Limdi, N. A., …\n     \n      Hypertension (Dallas, Tex. : 1979)\n      2019 Dec 4\n    ",
         "\n        2\n       mentions \n        2 NEW\n        \n        Association of Early Postoperative Pain Trajectories With Longer-term Pain Outcome After Primary Total Knee Arthroplasty.\n       \n      Singh, J. A., Lemay, C. A., Nobel, L., Yang, W., Weissman, N., Saag, K. G., Allison, J., Franklin, P…\n     \n      JAMA network open\n      2019 Nov 14\n    ",
         "  \n        Association of Race/Ethnicity With Hospital Discharge Disposition After Elective Total Knee Arthroplasty.\n       \n      Singh, J. A., Kallan, M. J., Chen, Y., Parks, M. L., Ibrahim, S. A.…\n     \n      JAMA network open\n      2019 Oct 31\n    ",
         "\n        90\n       mentions \n        90 NEW\n        \n        Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.\n       \n      Burstein, R., Henry, N. J., Collison, M. L., Marczak, L. B., Sligar, A., Watson, S., Marquez, N., Ab…\n     \n      Nature\n      2019 Oct 18\n    ",
         "  \n        How Systemic Sclerosis Affects Healthcare Use and Complication Rates after Total Hip Arthroplasty.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      The Journal of rheumatology\n      2019 Oct 17\n    ",
         "  \n        Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.\n       \n      Bursill, D., Taylor, W. J., Terkeltaub, R., Abhishek, A., So, A. K., Vargas-Santos, A. B., Gaffo, A.…\n     \n      Annals of the rheumatic diseases\n      2019 Sep 11\n    ",
         "  \n        Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2019 Aug 25\n    ",
         "  \n        Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort.\n       \n      Singh, J. A., Yang, S., Saag, K. G.…\n     \n      The Journal of rheumatology\n      2019 Aug 17\n    ",
         "  \n        Are the days of missed or delayed diagnosis of gout over?\n       \n      Singh, J. A.…\n     \n      Nature reviews. Rheumatology\n      2019 Aug 14\n    ",
         "  \n        Correction to: Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS).\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2019 Jul 31\n    ",
         "  \n        Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study.\n       \n      Qu, H., Hu, X., Singh, J. A.…\n     \n      Clinical rheumatology\n      2019 Jun 22\n    ",
         "  \n        Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      The Journal of rheumatology\n      2019 Jun 4\n    ",
         "  \n        Total knee arthroplasty outcomes in lupus: a study using the US National Inpatient Sample.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Rheumatology (Oxford, England)\n      2019 May 24\n    ",
         "  \n        Defining ranges for certainty ratings of diagnostic accuracy: a GRADE concept paper.\n       \n      Hultcrantz, M., Mustafa, R. A., Leeflang, M. M., Lavergne, V., Estrada-Orozco, K., Ansari, M. T., Iz…\n     \n      Journal of clinical epidemiology\n      2019 May 22\n    ",
         "  \n        Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.\n       \n      Singh, J. A., Fraenkel, L., Green, C., Alarcón, G. S., Barton, J. L., Saag, K. G., Hanrahan, L. M., …\n     \n      PLoS medicine\n      2019 May 9\n    ",
         "  \n        Lupus is associated with poorer outcomes after primary total hip arthroplasty.\n       \n      Singh, J. A.,Cleveland, J. D.…\n     \n      Lupus\n      2019 May 24\n    ",
         "  \n        Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample.\n       \n      Singh, J. A., Yu, S., Chen, L., Cleveland, J. D.…\n     \n      The Journal of rheumatology\n      2019 Apr 17\n    ",
         "  \n        Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.\n       \n      Chiarotto, A., Kaiser, U., Choy, E., Christensen, R., Conaghan, P. G., Cowern, M., Gill, M., de Wit,…\n     \n      The Journal of rheumatology\n      2019 Apr 3\n    ",
         "\n        3\n       mentions   \n        Gout and chronic pain in older adults: a Medicare claims study.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      Clinical rheumatology\n      2019 Mar 31\n    ",
         "  \n        Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      European heart journal\n      2019 Mar 29\n    ",
         "  \n        Gout and sexual function: patient perspective of how gout affects personal relationships and intimacy.\n       \n      Singh, J. A.…\n     \n      BMC Rheumatol\n      2019 Mar 20\n    ",
         "\n        2\n       mentions   \n        Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population.\n       \n      Singh, J. A., Cleveland, J. D.…\n     \n      BMC nephrology\n      2019 Mar 17\n    ",
         "\n        1\n       mention   \n        Cardiovascular Disease in Gout and theÂ\\xa0Protective Effect of Treatments Including Urate-Lowering Therapy.\n       \n      Gupta, M. K., Singh, J. A.…\n     \n      Drugs\n      2019 Mar 15\n    ",
         "  \n        Patient-Centered Outcomes and Key Study Procedure Finalization in the Pilot Feasibility Gout Randomized Trial: Comparative Feasibility Study in GOUt, CHerry Extract Versus Diet Modification (Mini-GOUCH).\n       \n      Singh, J. A., Willig, A. L., Darnell, B., Green, C., Morgan, S., Weiss, R., Saag, K. G., Cutter, G.,…\n     \n      Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\n      2019 Mar 15\n    ",
         "  \n        Patient perspectives in gout: a review.\n       \n      Singh, J. A.…\n     \n      Curr Opin Rheumatol\n      2018 Dec 24\n    ",
         "  \n        Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase.\n       \n      Lawrence Edwards, N.,Singh, J. A.,Troum, O.,Yeo, A. E.,Lipsky, P. E.…\n     \n      Rheumatology (Oxford)\n      2019 Mar 08\n    ",
         "  \n        Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.\n       \n      Maxwell, L. J., Beaton, D. E., Shea, B. J., Wells, G. A., Boers, M., Grosskleg, S., Bingham, C. O., …\n     \n      The Journal of rheumatology\n      2019 Feb 17\n    ",
         "  \n        OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.\n       \n      Boers, M., Beaton, D. E., Shea, B. J., Maxwell, L. J., Bartlett, S. J., Bingham, C. O., Conaghan, P.…\n     \n      The Journal of rheumatology\n      2019 Feb 17\n    ",
         "\n        4\n       mentions   \n        GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations.\n       \n      Schünemann, H. J., Mustafa, R. A., Brozek, J., Santesso, N., Bossuyt, P. M., Steingart, K. R., Leefl…\n     \n      Journal of clinical epidemiology\n      2019 Feb 11\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[
         "  ACR Quality of Care Committee Member 2004 - 2008"
      ],
      "memberships":[
         "   American College of Rheumatology - ACR Fellow"
      ],
      "clinical-trails":[

      ],
      "lectures":[

      ],
      "press-mentions":[
         "   \n        Opioid Use Hospitalization Rates Increased for Patients with Common Rheumatic Diseases\n       \n      Medical Xpress\n       · November 10, 2019  ...this group is at risk of receiving opioids and potentially developing an opioid use disorder,\" says Jasvinder Singh, MD, MPH, Professor in the Division of Rheumatology and Clinical Immunology at the University of Al...",
         "   \n        Examining the Cardioprotective Benefits of Urate-Lowering Therapy in Gout\n       \n      Rheumatology Advisor\n       · June 14, 2019  ...with ULT) for cardioprotective purposes at this time in gout patients may be a bit premature,” said Jasvinder Singh, MD, MPH, Endowed Professor, Musculoskeletal Outcomes Research at the Division of Clinical Immunolo...",
         "   \n        JAK Inhibitor Tapering in Rheumatoid Arthritis: Implications for Patients in Sustained Remission\n       \n      Rheumatology Advisor\n       · January 23, 2019  ....7% recaptured their baseline LDA or remission status at 24 weeks after returning to the 4 mg dose. Jasvinder Singh MD, MPH, a rheumatologist at University of Alabama at Birmingham, stated in an accompanying editori...",
         "   \n        New PsA Guidelines from National Psoriasis and Rheumatology Orgs Recommend Treat-to-Target Approach\n       \n      Practical Dermatology\n       · December 04, 2018  ...because it encompasses all clinical scenarios, rather than one particular clinical situation,” says Jasvinder Singh, MD, MPH, a rheumatologist at the University of Alabama at Birmingham who served as principal inves..."
      ],
      "hospital-info":[
         "   \n        University of Alabama Hospital\n       \n      Current Affiliation\n     \n        Birmingham, AL\n    "
      ],
      "award-info":[
         "   \n      Arthritis Foundation�s Lee C. Howley, Sr. award\n     \n      Arthritis Foundation, 2018\n    ",
         "   \n      Max Cooper Award for Research Excellence\n     \n      University of Alabama at Birmingham (UAB), 2017\n    ",
         "   \n      Endowed Professor, Musculoskeletal Outcomes Research\n     \n      UAB Division of Clinical Immunology and Rheumatology, 2016\n    ",
         "   \n      Henry Kunkel Young Investigator Award\n     \n      American College of Rheumatology, 2016\n    ",
         "   \n      UAB Research Supplement Award for the 3rd rank at the Associate Professor level\n     \n      2013\n    ",
         "   \n      Best Doctors in America\n     \n      2011\n    ",
         "   \n      Best Paper\n     \n      Indian Rheumatology Association (IRA) Annual Meeting, 2005\n    ",
         "\n  Edit\n     \n      Selected Clinical Scholar\n     \n      Minneapolis Center for Epidemiological and Clinical Research, 2004\n    ",
         "\n  Edit\n     \n      Rheumatology fellow award\n     \n      American College of Rheumatology (ACR), 2001\n    ",
         "\n  Edit\n     \n      3rd highest grade in second professional examination, Medical School training\n     \n      1991\n    ",
         "\n  Edit\n     \n      Honors in Pharmacology during Medical School training\n     \n      1991\n    ",
         "\n  Edit\n     \n      Fellow (FACR)\n     \n      American College of Rheumatology\n    "
      ],
      "support-grants":[

      ]
   },
   "P9":{
      "name":"\n          Daniel Hal Solomon, MD\n          ",
      "profile_pic":"https://doximity-res.cloudinary.com/image/upload/t_profile_photo_320x320/fl_progressive,h_160,w_160,f_auto,dpr_1.0/hs8xu4ehcgcrj1js4ixs.jpg",
      "subspecialty":"\n            Rheumatology \n          ",
      "office":"\n        111 Cypress St\n        \n        Brookline, MA 02445\n        ",
      "phone":"\n      \n     \n      (857) 307-0896\n      ",
      "fax":"",
      "job-title":"\n            Professor, Medicine-Brigham & Women's Hospital, Harvard Medical School\n          ",
      "summary":" \n        Add Summary\n         \n            Attach Media\n            ",
      "education":[
         "   \n        Brigham and Women's Hospital\n       \n      Fellowship, Rheumatology, 1995 - 1998\n    ",
         "   \n        Brigham and Women's Hospital\n       \n      Residency, Internal Medicine, 1993 - 1996\n    ",
         "   \n        Boston University Medical Center\n       \n      Internship, Internal Medicine, 1992 - 1993\n    ",
         "   \n        Yale University School of Medicine\n       \n      Class of 1992\n    "
      ],
      "certifications&licences":[
         "   \n      MA State Medical License\n     \n      1994 - 2021\n    ",
         "   \n      American Board of Internal Medicine\n     \n      Rheumatology\n    "
      ],
      "publications&presentations":[
         "     \n        Cancer and the Risk of Suicide in Older Americans\n       \n      Daniel Solomon, MD…\n     \n      Journal of Clinical Oncology\n      \n    ",
         "     \n        The Performance of Matrix-Based Risk Models for Rapid Radiographic Progression in BRASS, a Cohort of Patients with Established Rheumatoid Arthritis\n        \n      Wiley\n      \n    ",
         "     \n        Pharmacological Management of Osteoporosis in Nursing Home Populations: A Systematic Review\n        \n      Wiley\n      \n    ",
         "     \n        Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States.\n       \n      Zhao, S. S.,Ermann, J.,Xu, C.,Lyu, H.,Tedeschi, S. K.,Liao, K. P.,Yoshida, K.,Moots, R. J.,Goodson, …\n     \n      Rheumatology (Oxford)\n      2019 May 14\n    ",
         "     \n        A tool for empirical equipoise assessment in multigroup comparative effectiveness research.\n       \n      Yoshida, K.,Solomon, D. H.,Haneuse, S.,Kim, S. C.,Patorno, E.,Tedeschi, S. K.,Lyu, H.,Hernández-Díaz…\n     \n      Pharmacoepidemiol Drug Saf\n      2019 May 28\n    ",
         "  \n        Prevalence and predictors for sustained remission in rheumatoid arthritis.\n       \n      Sung, Y. K.,Yoshida, K.,Prince, FHM.,Frits, M. L.,Cho, S. K.,Choe, J. Y.,Lee, H. S.,Lee, J.,Lee, S. …\n     \n      PLoS ONE\n      2019 Apr 20\n    ",
         "  \n        Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome.\n       \n      Kim, S. C.,Di Carli, M. F.,Garg, R. K.,Vanni, K.,Wang, P.,Wohlfahrt, A.,Yu, Z.,Lu, F.,Campos, A.,Bib…\n     \n      BMC Rheumatol\n      2019 Mar 20\n    ",
         "  \n        Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study.\n       \n      Kim, S. C.,Pawar, A.,Desai, R. J.,Solomon, D. H.,Gale, S.,Bao, M.,Sarsour, K.,Schneeweiss, S.…\n     \n      Semin. Arthritis Rheum.\n      2019 Apr 11\n    ",
         "\n        2\n       mentions   \n        Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled Trial.\n       \n      Solomon, D. H., Shao, M., Wolski, K., Nissen, S., Husni, M. E., Paynter, N.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2019 Feb 26\n    ",
         "  \n        The impact of smoking on response to TNF inhibitors in axial spondyloarthritis: methodological considerations for longitudinal observational studies.\n       \n      Zhao, S.,Yoshida, K.,Jones, G. T.,Hughes, D. M.,Tedeschi, S. K.,Lyu, H.,Moots, R. J.,Solomon, D. H.,…\n     \n      Arthritis Care Res (Hoboken)\n      2019 Feb 15\n    ",
         "  \n        Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation.\n       \n      Ljung, L.,Ueda, P.,Liao, K. P.,Greenberg, J. D.,Etzel, C. J.,Solomon, D. H.,Askling, J.…\n     \n      RMD Open\n      2019 Jan 10\n    ",
         "  \n        Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor.\n       \n      Ogdie, A.,Palmer, J. L.,Greenberg, J.,Curtis, J. R.,Harrold, L. R.,Solomon, D. H.,Kavanaugh, A.,Krem…\n     \n      J. Rheumatol.\n      2019 Jan 17\n    ",
         "  \n        Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.\n       \n      Pawar, A.,Desai, R. J.,Solomon, D. H.,Santiago Ortiz, A. J.,Gale, S.,Bao, M.,Sarsour, K.,Schneeweiss…\n     \n      Ann. Rheum. Dis.\n      2019 Jan 27\n    ",
         "  \n        Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study.\n       \n      Yoshida, K.,Solomon, D. H.,Haneuse, S.,Kim, S. C.,Patorno, E.,Tedeschi, S. K.,Lyu, H.,Franklin, J. M…\n     \n      Am. J. Epidemiol.\n      2018 Dec 06\n    ",
         "  \n        Comparison of denosumab vs. bisphosphonates in osteoporosis patients: A meta-analysis of randomized controlled trials.\n       \n      Lyu, H.,Jundi, B.,Xu, C.,Tedeschi, S. K.,Yoshida, K.,Zhao, S.,Nigwekar, S. U.,Leder, B. Z.,Solomon, …\n     \n      J. Clin. Endocrinol. Metab.\n      2018 Dec 12\n    ",
         "  \n        Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial.\n       \n      Zak, A.,Corrigan, C.,Yu, Z.,Bitton, A.,Fraenkel, L.,Harrold, L.,Smolen, J. S.,Solomon, D. H.…\n     \n      Rheumatology (Oxford)\n      2018 Jul 10\n    ",
         "  \n        Chronic Opioid Use in Rheumatoid Arthritis: Prevalence and Predictors.\n       \n      Lee, Y. C.,Kremer, J.,Guan, H.,Greenberg, J.,Solomon, D. H.…\n     \n      \n      2018 Nov 27\n    ",
         "  \n        Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis.\n       \n      Yu, Z.,Yang, N.,Everett, B. M.,Frits, M.,Iannaccone, C.,Coblyn, J.,Weinblatt, M.,Shadick, N.,Solomon…\n     \n      \n      2018 Apr 21\n    ",
         "  \n        Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.\n       \n      Solomon, D. H.,Glynn, R. J.,MacFadyen, J. G.,Libby, P.,Thuren, T.,Everett, B. M.,Ridker, P. M.…\n     \n      Ann. Intern. Med.\n      2018 Sep 23\n    ",
         "  \n        Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.\n       \n      Choudhry, N. K.,Isaac, T.,Lauffenburger, J. C.,Gopalakrishnan, C.,Lee, M.,Vachon, A.,Iliadis, T. L.,…\n     \n      JAMA Intern Med\n      2018 Aug 08\n    ",
         "  \n        Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings.\n       \n      Wohlfahrt, A.,Campos, A.,Iversen, M. D.,Gagne, J. J.,Massarotti, E.,Solomon, D. H.,Feldman, C. H.…\n     \n      PLoS ONE\n      2018 Jul 20\n    ",
         "  \n        Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus.\n       \n      Barbhaiya, M.,Feldman, C. H.,Guan, H.,Chen, S. K.,Fischer, M. A.,Solomon, D. H.,Everett, B. M.,Coste…\n     \n      Semin. Arthritis Rheum.\n      2018 Sep 13\n    ",
         "  \n        Subsequent Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.\n       \n      Sparks, J. A., Sparks, J. A., Lesperance, T., Lesperance, T., Accortt, N. A., Accortt, N. A., Solomo…\n     \n      Arthritis care & research\n      2018 May 26\n    ",
         "  \n        Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT.\n       \n      Wang, P., Smith, S. E., Garg, R., Lu, F., Wohlfahrt, A., Campos, A., Vanni, K., Yu, Z., Solomon, D. …\n     \n      RMD open\n      2018 Mar 21\n    ",
         "  \n        An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.\n       \n      Desai, R. J.,Franklin, J. M.,Spoendlin-Allen, J.,Solomon, D. H.,Danaei, G.,Kim, S. C.…\n     \n      PLoS ONE\n      2018 Mar 01\n    ",
         "  \n        Rheumatoid arthritis.\n       \n      Smolen, J. S.,Aletaha, D.,Barton, A.,Burmester, G. R.,Emery, P.,Firestein, G. S.,Kavanaugh, A.,McInn…\n     \n      Nat Rev Dis Primers\n      2018 Feb 09\n    ",
         "  \n        Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis.\n       \n      Hresko, A., Lin, T., Solomon, D. H.…\n     \n      Arthritis care & research\n      2018 Jan 10\n    ",
         "  \n        Outcomes of lupus and rheumatoid arthritis patients with primary dengue infection: A seven-year report from Brazil.\n       \n      de Abreu, M. M., Maiorano, A. C., Tedeschi, S. K., Yoshida, K., Lin, T., Solomon, D. H.…\n     \n      Seminars in arthritis and rheumatism\n      2017 Oct 25\n    ",
         "  \n        The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.\n       \n      Ruppert, K.,Cauley, J.,Lian, Y.,Zgibor, J. C.,Derby, C.,Solomon, D. H.…\n     \n      Osteoporos Int\n      2017 Oct 28\n    ",
         "3\n       citations  \n        5\n       mentions   \n        The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial.\n       \n      Solomon, D. H., Husni, M. E., Libby, P. A., Yeomans, N. D., Lincoff, A. M., Lϋscher, T. F., Menon, V…\n     \n      The American journal of medicine\n      2017 Aug 2\n    ",
         "  \n        Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) \n       \n      Ruschitzka, F.,Borer, J. S.,Krum, H.,Flammer, A. J.,Yeomans, N. D.,Libby, P.,Lüscher, T. F.,Solomon,…\n     \n      Eur. Heart J.\n      2017 Oct 12\n    ",
         "  \n        Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States: A Cohort Study of Publicly and Privately Insured Patients.\n       \n      Desai, R. J., Solomon, D. H., Jin, Y., Liu, J., Kim, S. C.…\n     \n      Journal of managed care & specialty pharmacy\n      2017 Jul 25\n    ",
         "  \n        Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement.\n       \n      Solomon, D. H., Shadick, N. A., Weinblatt, M. E., Zak, A., Frits, M., Franklin, J. M.…\n     \n      Arthritis research & therapy\n      2017 Jun 15\n    ",
         "  \n        Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries.\n       \n      Solomon, D. H., Shadick, N. A., Weinblatt, M. E., Frits, M., Iannaccone, C. K., Zak, A., Korzenik, J…\n     \n      BMC medical research methodology\n      2017 Apr 19\n    ",
         "  \n        Dr. Yoshida, et al reply.\n       \n      Yoshida, K., Kishimoto, M., Solomon, D. H.…\n     \n      The Journal of rheumatology\n      2016 Jun 3\n    ",
         "2\n       citations    \n        Validation of claims-based algorithms for gout flares.\n       \n      MacFarlane, L. A., Liu, C., Solomon, D. H., Kim, S. C.…\n     \n      Pharmacoepidemiology and drug safety\n      2016 May 28\n    ",
         "3\n       citations    \n        Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trial.\n       \n      Solomon, D. H., Lee, S. B., Zak, A., Corrigan, C., Agosti, J., Bitton, A., Harrold, L. R., Losina, E…\n     \n      Seminars in arthritis and rheumatism\n      2016 Apr 10\n    ",
         "\n        2\n       mentions   \n        Response to: 'Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomized trial?' by Giannopoulos and Deftereos.\n       \n      Solomon, D. H., Kim, S. C.…\n     \n      Annals of the rheumatic diseases\n      2016 Mar 2\n    ",
         "\n        2\n       mentions   \n        Potential confounding in colchicine and cardiovascular disease study.\n       \n      Solomon, D. H., Kim, S. C.…\n     \n      Annals of the rheumatic diseases\n      2016 Feb 14\n    ",
         "5\n       citations  \n        19\n       mentions   \n        Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.\n       \n      Sparks, J. A., Krumme, A. A., Shrank, W. H., Matlin, O. S., Brill, G., Pezalla, E. J., Choudhry, N. …\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Feb 13\n    ",
         "8\n       citations  \n        1\n       mention   \n        Brief Report: Utilization of the First Biosimilar Infliximab Since Its Approval in South Korea.\n       \n      Kim, S. C., Choi, N., Lee, J., Kwon, K., Eddings, W., Sung, Y., Song, H. J., Kesselheim, A. S., Solo…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Dec 15\n    ",
         "  \n        Effect of Milnacipran on Pain in Patients with Rheumatoid Arthritis with Widespread Pain: A Randomized Blinded Crossover Trial.\n       \n      Lee, Y. C.,Massarotti, E.,Edwards, R. R.,Lu, B.,Liu, C.,Lo, Y.,Wohlfahrt, A.,Kim, N. D.,Clauw, D. J.…\n     \n      J. Rheumatol.\n      2015 Dec 03\n    ",
         "7\n       citations    \n        Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.\n       \n      Katz, J. N., Smith, S. R., Collins, J. E., Solomon, D. H., Jordan, J. M., Hunter, D. J., Suter, L. G…\n     \n      Osteoarthritis and cartilage\n      2015 Nov 4\n    ",
         "3\n       citations    \n        Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.\n       \n      Kaushik, P., Solomon, D. H., Greenberg, J. D., Anderson, J. T., Reed, G. W., Pala, O., Sumbul-Yuksel…\n     \n      Clinical rheumatology\n      2015 Aug 6\n    ",
         "4\n       citations  \n        2\n       mentions   \n        An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score.\n       \n      Desai, R. J., Solomon, D. H., Weinblatt, M. E., Shadick, N. A., Kim, S. C.…\n     \n      Arthritis research & therapy\n      2015 Apr 17\n    ",
         "  \n        Risk of incident diabetes in patients with gout: A cohort study.\n       \n      Kim, S. C.,Liu, J.,Solomon, D. H.…\n     \n      \n      2014 Oct 22\n    ",
         "11\n       citations    \n        Arterial 18F-FDG uptake in rheumatoid arthritis correlates with synovial activity.\n       \n      Emami, H., Vijayakumar, J., Subramanian, S., Vucic, E., Singh, P., MacNabb, M. H., Corsini, E., Hoff…\n     \n      JACC. Cardiovascular imaging\n      2014 Sep 13\n    ",
         "1\n       citations    \n        Patterns of treatment among a cohort of older low-income adults starting new medications for osteoporosis.\n       \n      Solomon, D. H., Brown, E. M., Chandler, D., Bower, A., Barron, R., Mogun, H., Franklin, J. M.…\n     \n      Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA\n      2014 Jun 6\n    ",
         "3\n       citations    \n        Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?\n       \n      Losina, E., Burbine, S. A., Suter, L. G., Hunter, D. J., Solomon, D. H., Daigle, M. E., Dervan, E. E…\n     \n      Osteoarthritis and cartilage\n      2014 Feb 4\n    ",
         "7\n       citations  \n        1\n       mention   \n        Roles of nurse practitioners and physician assistants in rheumatology practices in the US.\n       \n      Solomon, D. H., Bitton, A., Fraenkel, L., Brown, E., Tsao, P., Katz, J. N.…\n     \n      Arthritis care & research\n      2013 Dec 18\n    ",
         "2\n       citations    \n        Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs.\n       \n      Solomon, D. H., Kremer, J. M., Fisher, M. C., Curtis, J. R., Furer, V., Harrold, L. R., Hochberg, M.…\n     \n      Seminars in arthritis and rheumatism\n      2013 Sep 10\n    ",
         "  \n        Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series.\n       \n      Mercer, E.,Norton, T.,Woo, S.,Treister, N.,Dodson, T. B.,Solomon, D. H.…\n     \n      Calcif. Tissue Int.\n      2013 Sep\n    ",
         "  \n        Rates of Bone Loss Among Women Initiating Antidepressant Medication Use in Midlife.\n       \n      Diem, S. J.,Ruppert, K.,Cauley, J. A.,Lian, Y.,Bromberger, J. T.,Finkelstein, J. S.,Greendale, G. A.…\n     \n      J. Clin. Endocrinol. Metab.\n      2013 Sep 3\n    ",
         "1\n       citations  \n        3\n       mentions   \n        Clinical problem-solving. A patient with migrating polyarthralgias.\n       \n      Casey, J. D., Solomon, D. H., Gaziano, T. A., Miller, A. L., Loscalzo, J.…\n     \n      The New England journal of medicine\n      2013 Jul 5\n    ",
         "  \n        Does motivational interviewing improve medication adherence?-Reply.\n       \n      Solomon, D. H., Iversen, M. D., Katz, J. N.…\n     \n      Archives of internal medicine\n      2013 Jun 12\n    ",
         "  \n        Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?\n       \n      Losina, E.,Daigle, M. E.,Suter, L. G.,Hunter, D. J.,Solomon, D. H.,Walensky, R. P.,Jordan, J. M.,Bur…\n     \n      Osteoarthr. Cartil.\n      2013 May\n    ",
         "  \n        Lifetime Risk and Age at Diagnosis of Symptomatic Knee Osteoarthritis in the US.\n       \n      Losina, E.,Weinstein, A. M.,Reichmann, W. M.,Burbine, S. A.,Solomon, D. H.,Daigle, M. E.,Rome, B. N.…\n     \n      Arthritis Care Res (Hoboken)\n      2013 May\n    ",
         "  \n        Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.\n       \n      Winthrop, K. L.,Baddley, J. W.,Chen, L.,Liu, L.,Grijalva, C. G.,Delzell, E.,Beukelman, T.,Patkar, N.…\n     \n      JAMA\n      2013 Mar 6\n    ",
         "  \n        Heart Failure Risk Among Patients with Rheumatoid Arthritis Starting a TNF Antagonist\n       \n      Solomon, D. H., Rassen, J. A., Kuriya, B., Chen, L., Harrold, L. R., Graham, D. J., Lewis, J. D., Li…\n     \n      Emergency Medicine Journal\n      2013 Nov 1\n    ",
         "  \n        Use of Disease-Modifying Antirheumatic Drugs During Pregnancy and Risk of Preeclampsia\n       \n      Daniel Solomon, MD…\n     \n      Wiley\n      2012 Nov\n    ",
         "  \n        Authors' reply.\n        \n      Am J Cardiol\n      2012 Jun 05\n    ",
         "16\n       citations  \n        1\n       mention   \n        Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey.\n       \n      Solomon, D. H., Ayanian, J. Z., Yelin, E. H., Shaykevich, T., Brookhart, M. A., Katz, J. N.…\n     \n      Arthritis care & research\n      2011 Oct 21\n    ",
         "4\n       citations    \n        Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments.\n       \n      Kim, S. Y., Solomon, D. H.…\n     \n      Arthritis research & therapy\n      2011 Oct 15\n    ",
         "  \n        Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis.\n       \n      Kawai, V.K., Grijalva, C.G., Arbogast, P.G., Curtis, J.R., Solomon, D.H., Delzell, E., Chen, L., Oue…\n     \n      Arthritis Care Res (Hoboken)\n      2011 Oct\n    ",
         "15\n       citations  \n        1\n       mention   \n        Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers.\n       \n      Iversen, M. D., Vora, R. R., Servi, A., Solomon, D. H.…\n     \n      Journal of geriatric physical therapy (2001)\n      2011 Sep 23\n    ",
         "27\n       citations    \n        Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: a review of their methodologies and results.\n       \n      Solomon, D. H., Mercer, E., Kavanaugh, A.…\n     \n      Arthritis and rheumatism\n      2011 Sep 8\n    ",
         "  \n        Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease.\n       \n      Micha, R., Imamura, F., Wyler von Ballmoos, M., Solomon, D. H., Hernán, M. A., Ridker, P. M., Mozaff…\n     \n      Am J Cardiol\n      2011 Nov 1\n    ",
         "  \n        The Economics of Improving Medication Adherence in Osteoporosis: Validation and Application of a Simulation Model.\n       \n      Patrick, A.R., Schousboe, J.T., Losina, E., Solomon, D.H.…\n     \n      J Clin Endocrinol Metab\n      2011 Sep\n    ",
         "  \n        Accuracy of identifying neutropenia diagnoses in outpatient claims data.\n        \n      Pharmacoepidemiol Drug Saf\n      2011 Jul\n    ",
         "  \n        Correlations of nursing home characteristics with prescription of osteoporosis medications.\n       \n      Parikh, S., Brookhart, M.A., Stedman, M., Avorn, J., Mogun, H., Solomon, D.H.…\n     \n      Bone\n      2011 May 1\n    ",
         "  \n        Patterns of medication use during pregnancy in rheumatoid arthritis.\n       \n      Kuriya, B., Hernández-Díaz, S., Liu, J., Bermas, B. L., Daniel, G., Solomon, D. H.…\n     \n      Arthritis Care Res (Hoboken)\n      2011 May\n    ",
         "  \n        Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study.\n       \n      Chan, P.K.…\n     \n      Rheumatology (Oxford)\n      2011 Aug\n    ",
         "20\n       citations  \n        8\n       mentions   \n        Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.\n       \n      Curtis, J. R., Larson, J. C., Delzell, E., Brookhart, M. A., Cadarette, S. M., Chlebowski, R. T., Ju…\n     \n      Medical care\n      2011 Mar 23\n    ",
         "  \n        Entering a new era of prevention in rheumatic disease.\n       \n      Costenbader, K. H., Solomon, D. H.…\n     \n      Current opinion in rheumatology\n      2011 Feb 3\n    ",
         "  \n        Patterns of drug use during pregnancy in rheumatoid arthritis.\n       \n      Kuriya, B., Hern&aacute;ndez-D&iacute;az, S., Liu, J., Bermas, B.L., Daniel, G., Solomon, D.H.…\n     \n      Arthritis Care Res (Hoboken)\n      2011-01-04\n    ",
         "  \n        The end of rheumatoid factor as we know it?\n       \n      Liao, K.P., Weinblatt, M.E., Solomon, D.H.…\n     \n      Arthritis Rheum\n      2010 Dec 15\n    ",
         "147\n       citations  \n        5\n       mentions   \n        The comparative safety of analgesics in older adults with arthritis.\n       \n      Solomon, D. H., Rassen, J. A., Glynn, R. J., Lee, J. L., Levin, R., Schneeweiss, S.…\n     \n      Archives of internal medicine\n      2010 Dec 15\n    ",
         "  \n        Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators.\n       \n      Demas, K.L., Keenan, B.T., Solomon, D.H., Yazdany, J., Costenbader, K.H.…\n     \n      Semin Arthritis Rheum\n      2010 Dec\n    ",
         "  \n        Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.\n       \n      Kim, S.Y., Schneeweiss, S., Katz, J.N., Levin, R., Solomon, D.H.…\n     \n      J Bone Miner Res\n      2010-11-18\n    ",
         "9\n       citations    \n        Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule.\n       \n      Solomon, D. H., Brookhart, M. A., Tsao, P., Sundaresan, D., Andrade, S. E., Mazor, K., Yood, R.…\n     \n      Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA\n      2010 Sep 30\n    ",
         "  \n        The complex relation between bisphosphonate adherence and fracture reduction.\n       \n      Patrick, A.R., Brookhart, M.A., Losina, E., Schousboe, J.T., Cadarette, S.M., Mogun, H., Solomon, D.…\n     \n      J Clin Endocrinol Metab\n      2010 Jul\n    ",
         "28\n       citations  \n        7\n       mentions   \n        Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.\n       \n      Schneeweiss, S., Patrick, A. R., Solomon, D. H., Dormuth, C. R., Miller, M., Mehta, J., Lee, J. C., …\n     \n      Pediatrics\n      2010 Apr 14\n    ",
         "  \n        Ambulatory visit utilization in a national, population-based sample of adults with osteoarthritis.\n       \n      Cisternas, M.G., Yelin, E., Katz, J.N., Solomon, D.H., Wright, E.A., Losina, E.…\n     \n      Arthritis Rheum\n      2009-12-15\n    ",
         "24\n       citations    \n        Confounder summary scores when comparing the effects of multiple drug exposures.\n       \n      Cadarette, S. M., Gagne, J. J., Solomon, D. H., Katz, J. N., Stürmer, T.…\n     \n      Pharmacoepidemiology and drug safety\n      2009 Sep 17\n    ",
         "  \n        An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes.\n       \n      Shrank, W.H., Patrick, A., Gleason, P.P., Canning, C., Walters, C., Heaton, A.H., Jan, S., Brookhart…\n     \n      Med Care\n      2009-09-01\n    ",
         "  \n        Measuring concurrent adherence to multiple related medications.\n       \n      Choudhry, N.K., Shrank, W.H., Levin, R.L., Lee, J.L., Jan, S.A., Brookhart, M.A., Solomon, D.H.…\n     \n      Am J Manag Care\n      2009-07-01\n    ",
         "  \n        Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trial.\n       \n      Shu, A.D., Stedman, M.R., Polinski, J.M., Jan, S.A., Patel, M., Truppo, C., Breiner, L., Chen, Y., W…\n     \n      Am J Manag Care\n      2009-07-01\n    ",
         "13\n       citations    \n        The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis.\n       \n      Solomon, D. H., Finkelstein, J. S., Shadick, N. A., LeBoff, M. S., Winalski, C. S., Stedman, M. R., …\n     \n      Arthritis and rheumatism\n      2009 May 30\n    ",
         "27\n       citations    \n        A cohort study of thiazolidinediones and fractures in older adults with diabetes.\n       \n      Solomon, D. H., Cadarette, S. M., Choudhry, N. K., Canning, C., Levin, R., Stürmer, T.…\n     \n      The Journal of clinical endocrinology and metabolism\n      2009 May 28\n    ",
         "  \n        Measuring quality of care for rheumatic diseases using an electronic medical record.\n       \n      Agnew-Blais, J. C.,Coblyn, J. S.,Katz, J. N.,Anderson, R. J.,Mehta, J.,Solomon, D. H.…\n     \n      Ann. Rheum. Dis.\n      2009 May\n    ",
         "  \n        More on reports of esophageal cancer with oral bisphosphonate use.\n       \n      Solomon, D.H., Patrick, A., Brookhart, M.A.…\n     \n      N Engl J Med\n      2009-04-23\n    ",
         "  \n        Clinical research in rheumatology: many promises and several disappointments.\n       \n      Solomon, D. H.…\n     \n      Current opinion in rheumatology\n      2009 Apr 3\n    ",
         "  \n        Rheumatology gone global.\n       \n      Solomon, D. H., Tyndall, A., Gabriel, S. E., Dougados, M.…\n     \n      Arthritis and rheumatism\n      2008 Sep 30\n    ",
         "  \n        Rheumatology gone global.\n       \n      Solomon, D. H., Tyndall, A., Gabriel, S. E., Dougados, M.…\n     \n      Annals of the rheumatic diseases\n      2008 Sep 16\n    ",
         "  \n        Osteoporosis medication use in nursing home patients with fractures in 1 US state.\n       \n      Parikh, S., Mogun, H., Avorn, J., Solomon, D.H.…\n     \n      Arch Intern Med\n      2008 May 26\n    ",
         "5\n       citations    \n        The relationship between cancer and rheumatoid arthritis: still a large research agenda.\n       \n      Love, T. J., Solomon, D. H.…\n     \n      Arthritis research & therapy\n      2008 May 23\n    ",
         "  \n        The risk of infection associated with tumor necrosis factor alpha antagonists: making sense of epidemiologic evidence.\n       \n      Solomon, D.H., Lunt, M., Schneeweiss, S.…\n     \n      Arthritis Rheum\n      2008 Apr\n    ",
         "  \n        Determining the best treatments for the right people in rheumatology.\n       \n      Solomon, D. H.…\n     \n      Current opinion in rheumatology\n      2008 Mar 20\n    ",
         "  \n        Classification criteria in rheumatic diseases: a review of methodologic properties.\n       \n      Johnson, S.R., Goek, O., Singh-Grewal, D., Vlad, S.C., Feldman, B.M., Felson, D.T., Hawker, G.A., Si…\n     \n      Arthritis Rheum\n      2007 Oct 15\n    ",
         "  \n        Patterns and predictors of statin use after coronary artery bypass graft surgery.\n       \n      Kulik, A., Levin, R., Ruel, M., Mesana, T.G., Solomon, D.H., Choudhry, N.K.…\n     \n      J Thorac Cardiovasc Surg\n      2007 Oct\n    ",
         "14\n       citations    \n        Cardiovascular risk and the thiazolidinediones: dÃ©jÃ\\xa0 vu all over again?\n       \n      Solomon, D. H., Winkelmayer, W. C.…\n     \n      JAMA\n      2007 Sep 13\n    ",
         "5\n       citations    \n        The medical license number accurately identifies the prescribing physician in a large pharmacy claims database.\n       \n      Brookhart, M. A., Avorn, J., Polinksi, J. M., Brown, T. V., Mogun, H., Solomon, D. H.…\n     \n      Medical care\n      2007 Aug 23\n    ",
         "  \n        Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.\n       \n      Schmajuk, G., Schneeweiss, S., Katz, J.N., Weinblatt, M.E., Setoguchi, S., Avorn, J., Levin, R., Sol…\n     \n      Arthritis Rheum\n      2007 Aug 15\n    ",
         "2\n       citations    \n        A call for evidence-based quality measures: a goal worthy of pursuit.\n       \n      Solomon, D. H., Gabriel, S. E.…\n     \n      Nature clinical practice. Rheumatology\n      2007 Jun 30\n    ",
         "  \n        Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries.\n       \n      Solomon, D.H., Stedman, M., Licari, A., Weinblatt, M.E., Maher, N., Shadick, N.…\n     \n      Arthritis Rheum\n      2007 Mar 15\n    ",
         "1\n       citations    \n        Not-so-surprising findings.\n       \n      Schneeweiss, S., Solomon, D. H.…\n     \n      CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne\n      2006 Jul 19\n    ",
         "  \n        Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review.\n       \n      Fischer, M.A., Cheng, H., Schneeweiss, S., Avorn, J., Solomon, D.H.…\n     \n      Med Care\n      2006 Jul\n    ",
         "  \n        Interactive voice response telephone calls to enhance bone mineral density testing.\n       \n      Polinski, J.M., Patrick, A., Truppo, C., Breiner, L., Chen, Y., Egan, C., Jan, S., Patel, M., Weiss,…\n     \n      Am J Manag Care\n      2006 Jun\n    ",
         "  \n        Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.\n       \n      Udell, J.A., Fischer, M.A., Brookhart, M.A., Solomon, D.H., Choudhry, N.K.…\n     \n      J Bone Miner Res\n      2006 May\n    ",
         "  \n        Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.\n       \n      Solomon, D. H., Avorn, J., Stürmer, T., Glynn, R. J., Mogun, H., Schneeweiss, S.…\n     \n      Arthritis Rheum\n      2006 May\n    ",
         "  \n        Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.\n       \n      Brookhart, M.A., Wang, P.S., Solomon, D.H., Schneeweiss, S.…\n     \n      Epidemiology\n      2006 May\n    ",
         "68\n       citations    \n        Identification of individuals with CKD from Medicare claims data: a validation study.\n       \n      Winkelmayer, W. C., Schneeweiss, S., Mogun, H., Patrick, A. R., Avorn, J., Solomon, D. H.…\n     \n      American journal of kidney diseases : the official journal of the National Kidney Foundation\n      2005 Aug 23\n    ",
         "  \n        Nonsteroidal antiinflammatory drugs and nonunion of humeral shaft fractures.\n        \n      Arthritis Rheum\n      2005 Jun 15\n    ",
         "  \n        Does practice make perfect?\n        \n      Arthritis Rheum\n      2005 Jun\n    ",
         "  \n        Development and assessment of indicators of rheumatoid arthritis severity: results of a Delphi panel.\n       \n      Cabral, D., Katz, J.N., Weinblatt, M.E., Ting, G., Avorn, J., Solomon, D.H.…\n     \n      Arthritis Rheum\n      2005 Feb 15\n    ",
         "  \n        Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions.\n        \n      Mayo Clin Proc\n      2005 Feb\n    ",
         "  \n        Coxibs, science, and the public trust.\n       \n      Donnelly, A.M., Tripp, C.S.…\n     \n      Arch Intern Med\n      2005 Jan 24\n    ",
         "  \n        Cardiovascular risk factors in women with and without rheumatoid arthritis.\n       \n      Solomon, D.H., Curhan, G.C., Rimm, E.B., Cannuscio, C.C., Karlson, E.W.…\n     \n      Arthritis Rheum\n      2004 Nov\n    ",
         "  \n        Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set.\n       \n      MacLean, C.H., Saag, K.G., Solomon, D.H., Morton, S.C., Sampsel, S., Klippel, J.H.…\n     \n      Arthritis Rheum\n      2004 Apr 15\n    ",
         "  \n        Which patients with knee problems are likely to benefit from nonarthroplasty surgery? Development of a clinical prediction rule.\n       \n      Solomon, D.H., Avorn, J., Warsi, A., Brown, C.H., Martin, S., Martin, T.L., Wright, J., Burgener, M.…\n     \n      Arch Intern Med\n      2004 Mar 8\n    ",
         "  \n        Underuse of osteoporosis medications in elderly patients with fractures.\n       \n      Solomon, D.H., Finkelstein, J.S., Katz, J.N., Mogun, H., Avorn, J.…\n     \n      Am J Med\n      2003 Oct 1\n    ",
         "  \n        Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectoris.\n       \n      Desai, A.S., Solomon, D.H., Stone, P.H., Avorn, J.…\n     \n      Am J Cardiol\n      2003 Aug 15\n    ",
         "  \n        Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.\n       \n      Solomon, D.H., Karlson, E.W., Rimm, E.B., Cannuscio, C.C., Mandl, L.A., Manson, J.E., Stampfer, M.J.…\n     \n      Circulation\n      2003 Mar 11\n    ",
         "  \n        Pharmacoepidemiology and rheumatic diseases: 2001-2002.\n       \n      Solomon, D.H., Avorn, J.…\n     \n      Curr Opin Rheumatol\n      2003 Mar\n    ",
         "  \n        Effectiveness of clinical pathways for total knee and total hip arthroplasty: literature review.\n       \n      Kim, S., Losina, E., Solomon, D.H., Wright, J., Katz, J.N.…\n     \n      J Arthroplasty\n      2003 Jan\n    ",
         "  \n        Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.\n       \n      Solomon, D.H., Katz, J.N., Jacobs, J.P., La Tourette, A.M., Coblyn, J.…\n     \n      Arthritis Rheum\n      2002 Dec\n    ",
         "  \n        Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?\n       \n      Mandl, L.A., Solomon, D.H., Smith, E.L., Lew, R.A., Katz, J.N., Shmerling, R.H.…\n     \n      Arch Intern Med\n      2002 Jul 8\n    ",
         "  \n        Cancer and the Risk of Suicide in Older Americans\n       \n      Daniel Solomon, MD…\n     \n      Journal of Clinical Oncology\n      \n    ",
         "  \n        The Performance of Matrix-Based Risk Models for Rapid Radiographic Progression in BRASS, a Cohort of Patients with Established Rheumatoid Arthritis\n        \n      Wiley\n      \n    ",
         "  \n        Pharmacological Management of Osteoporosis in Nursing Home Populations: A Systematic Review\n        \n      Wiley\n      \n    ",
         "  \n        Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States.\n       \n      Zhao, S. S.,Ermann, J.,Xu, C.,Lyu, H.,Tedeschi, S. K.,Liao, K. P.,Yoshida, K.,Moots, R. J.,Goodson, …\n     \n      Rheumatology (Oxford)\n      2019 May 14\n    ",
         "  \n        A tool for empirical equipoise assessment in multigroup comparative effectiveness research.\n       \n      Yoshida, K.,Solomon, D. H.,Haneuse, S.,Kim, S. C.,Patorno, E.,Tedeschi, S. K.,Lyu, H.,Hernández-Díaz…\n     \n      Pharmacoepidemiol Drug Saf\n      2019 May 28\n    ",
         "  \n        Prevalence and predictors for sustained remission in rheumatoid arthritis.\n       \n      Sung, Y. K.,Yoshida, K.,Prince, FHM.,Frits, M. L.,Cho, S. K.,Choe, J. Y.,Lee, H. S.,Lee, J.,Lee, S. …\n     \n      PLoS ONE\n      2019 Apr 20\n    ",
         "  \n        Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome.\n       \n      Kim, S. C.,Di Carli, M. F.,Garg, R. K.,Vanni, K.,Wang, P.,Wohlfahrt, A.,Yu, Z.,Lu, F.,Campos, A.,Bib…\n     \n      BMC Rheumatol\n      2019 Mar 20\n    ",
         "  \n        Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study.\n       \n      Kim, S. C.,Pawar, A.,Desai, R. J.,Solomon, D. H.,Gale, S.,Bao, M.,Sarsour, K.,Schneeweiss, S.…\n     \n      Semin. Arthritis Rheum.\n      2019 Apr 11\n    ",
         "\n        2\n       mentions   \n        Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled Trial.\n       \n      Solomon, D. H., Shao, M., Wolski, K., Nissen, S., Husni, M. E., Paynter, N.…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2019 Feb 26\n    ",
         "  \n        The impact of smoking on response to TNF inhibitors in axial spondyloarthritis: methodological considerations for longitudinal observational studies.\n       \n      Zhao, S.,Yoshida, K.,Jones, G. T.,Hughes, D. M.,Tedeschi, S. K.,Lyu, H.,Moots, R. J.,Solomon, D. H.,…\n     \n      Arthritis Care Res (Hoboken)\n      2019 Feb 15\n    ",
         "  \n        Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation.\n       \n      Ljung, L.,Ueda, P.,Liao, K. P.,Greenberg, J. D.,Etzel, C. J.,Solomon, D. H.,Askling, J.…\n     \n      RMD Open\n      2019 Jan 10\n    ",
         "  \n        Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor.\n       \n      Ogdie, A.,Palmer, J. L.,Greenberg, J.,Curtis, J. R.,Harrold, L. R.,Solomon, D. H.,Kavanaugh, A.,Krem…\n     \n      J. Rheumatol.\n      2019 Jan 17\n    ",
         "  \n        Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.\n       \n      Pawar, A.,Desai, R. J.,Solomon, D. H.,Santiago Ortiz, A. J.,Gale, S.,Bao, M.,Sarsour, K.,Schneeweiss…\n     \n      Ann. Rheum. Dis.\n      2019 Jan 27\n    ",
         "  \n        Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study.\n       \n      Yoshida, K.,Solomon, D. H.,Haneuse, S.,Kim, S. C.,Patorno, E.,Tedeschi, S. K.,Lyu, H.,Franklin, J. M…\n     \n      Am. J. Epidemiol.\n      2018 Dec 06\n    ",
         "  \n        Comparison of denosumab vs. bisphosphonates in osteoporosis patients: A meta-analysis of randomized controlled trials.\n       \n      Lyu, H.,Jundi, B.,Xu, C.,Tedeschi, S. K.,Yoshida, K.,Zhao, S.,Nigwekar, S. U.,Leder, B. Z.,Solomon, …\n     \n      J. Clin. Endocrinol. Metab.\n      2018 Dec 12\n    ",
         "  \n        Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial.\n       \n      Zak, A.,Corrigan, C.,Yu, Z.,Bitton, A.,Fraenkel, L.,Harrold, L.,Smolen, J. S.,Solomon, D. H.…\n     \n      Rheumatology (Oxford)\n      2018 Jul 10\n    ",
         "  \n        Chronic Opioid Use in Rheumatoid Arthritis: Prevalence and Predictors.\n       \n      Lee, Y. C.,Kremer, J.,Guan, H.,Greenberg, J.,Solomon, D. H.…\n     \n      \n      2018 Nov 27\n    ",
         "  \n        Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis.\n       \n      Yu, Z.,Yang, N.,Everett, B. M.,Frits, M.,Iannaccone, C.,Coblyn, J.,Weinblatt, M.,Shadick, N.,Solomon…\n     \n      \n      2018 Apr 21\n    ",
         "  \n        Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.\n       \n      Solomon, D. H.,Glynn, R. J.,MacFadyen, J. G.,Libby, P.,Thuren, T.,Everett, B. M.,Ridker, P. M.…\n     \n      Ann. Intern. Med.\n      2018 Sep 23\n    ",
         "  \n        Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.\n       \n      Choudhry, N. K.,Isaac, T.,Lauffenburger, J. C.,Gopalakrishnan, C.,Lee, M.,Vachon, A.,Iliadis, T. L.,…\n     \n      JAMA Intern Med\n      2018 Aug 08\n    ",
         "  \n        Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings.\n       \n      Wohlfahrt, A.,Campos, A.,Iversen, M. D.,Gagne, J. J.,Massarotti, E.,Solomon, D. H.,Feldman, C. H.…\n     \n      PLoS ONE\n      2018 Jul 20\n    ",
         "  \n        Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus.\n       \n      Barbhaiya, M.,Feldman, C. H.,Guan, H.,Chen, S. K.,Fischer, M. A.,Solomon, D. H.,Everett, B. M.,Coste…\n     \n      Semin. Arthritis Rheum.\n      2018 Sep 13\n    ",
         "  \n        Subsequent Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.\n       \n      Sparks, J. A., Sparks, J. A., Lesperance, T., Lesperance, T., Accortt, N. A., Accortt, N. A., Solomo…\n     \n      Arthritis care & research\n      2018 May 26\n    ",
         "  \n        Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT.\n       \n      Wang, P., Smith, S. E., Garg, R., Lu, F., Wohlfahrt, A., Campos, A., Vanni, K., Yu, Z., Solomon, D. …\n     \n      RMD open\n      2018 Mar 21\n    ",
         "  \n        An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.\n       \n      Desai, R. J.,Franklin, J. M.,Spoendlin-Allen, J.,Solomon, D. H.,Danaei, G.,Kim, S. C.…\n     \n      PLoS ONE\n      2018 Mar 01\n    ",
         "  \n        Rheumatoid arthritis.\n       \n      Smolen, J. S.,Aletaha, D.,Barton, A.,Burmester, G. R.,Emery, P.,Firestein, G. S.,Kavanaugh, A.,McInn…\n     \n      Nat Rev Dis Primers\n      2018 Feb 09\n    ",
         "  \n        Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis.\n       \n      Hresko, A., Lin, T., Solomon, D. H.…\n     \n      Arthritis care & research\n      2018 Jan 10\n    ",
         "  \n        Outcomes of lupus and rheumatoid arthritis patients with primary dengue infection: A seven-year report from Brazil.\n       \n      de Abreu, M. M., Maiorano, A. C., Tedeschi, S. K., Yoshida, K., Lin, T., Solomon, D. H.…\n     \n      Seminars in arthritis and rheumatism\n      2017 Oct 25\n    ",
         "  \n        The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.\n       \n      Ruppert, K.,Cauley, J.,Lian, Y.,Zgibor, J. C.,Derby, C.,Solomon, D. H.…\n     \n      Osteoporos Int\n      2017 Oct 28\n    ",
         "3\n       citations  \n        5\n       mentions   \n        The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial.\n       \n      Solomon, D. H., Husni, M. E., Libby, P. A., Yeomans, N. D., Lincoff, A. M., Lϋscher, T. F., Menon, V…\n     \n      The American journal of medicine\n      2017 Aug 2\n    ",
         "  \n        Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) \n       \n      Ruschitzka, F.,Borer, J. S.,Krum, H.,Flammer, A. J.,Yeomans, N. D.,Libby, P.,Lüscher, T. F.,Solomon,…\n     \n      Eur. Heart J.\n      2017 Oct 12\n    ",
         "  \n        Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States: A Cohort Study of Publicly and Privately Insured Patients.\n       \n      Desai, R. J., Solomon, D. H., Jin, Y., Liu, J., Kim, S. C.…\n     \n      Journal of managed care & specialty pharmacy\n      2017 Jul 25\n    ",
         "  \n        Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement.\n       \n      Solomon, D. H., Shadick, N. A., Weinblatt, M. E., Zak, A., Frits, M., Franklin, J. M.…\n     \n      Arthritis research & therapy\n      2017 Jun 15\n    ",
         "  \n        Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries.\n       \n      Solomon, D. H., Shadick, N. A., Weinblatt, M. E., Frits, M., Iannaccone, C. K., Zak, A., Korzenik, J…\n     \n      BMC medical research methodology\n      2017 Apr 19\n    ",
         "  \n        Dr. Yoshida, et al reply.\n       \n      Yoshida, K., Kishimoto, M., Solomon, D. H.…\n     \n      The Journal of rheumatology\n      2016 Jun 3\n    ",
         "2\n       citations    \n        Validation of claims-based algorithms for gout flares.\n       \n      MacFarlane, L. A., Liu, C., Solomon, D. H., Kim, S. C.…\n     \n      Pharmacoepidemiology and drug safety\n      2016 May 28\n    ",
         "3\n       citations    \n        Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trial.\n       \n      Solomon, D. H., Lee, S. B., Zak, A., Corrigan, C., Agosti, J., Bitton, A., Harrold, L. R., Losina, E…\n     \n      Seminars in arthritis and rheumatism\n      2016 Apr 10\n    ",
         "\n        2\n       mentions   \n        Response to: 'Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomized trial?' by Giannopoulos and Deftereos.\n       \n      Solomon, D. H., Kim, S. C.…\n     \n      Annals of the rheumatic diseases\n      2016 Mar 2\n    ",
         "\n        2\n       mentions   \n        Potential confounding in colchicine and cardiovascular disease study.\n       \n      Solomon, D. H., Kim, S. C.…\n     \n      Annals of the rheumatic diseases\n      2016 Feb 14\n    ",
         "5\n       citations  \n        19\n       mentions   \n        Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.\n       \n      Sparks, J. A., Krumme, A. A., Shrank, W. H., Matlin, O. S., Brill, G., Pezalla, E. J., Choudhry, N. …\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2016 Feb 13\n    ",
         "8\n       citations  \n        1\n       mention   \n        Brief Report: Utilization of the First Biosimilar Infliximab Since Its Approval in South Korea.\n       \n      Kim, S. C., Choi, N., Lee, J., Kwon, K., Eddings, W., Sung, Y., Song, H. J., Kesselheim, A. S., Solo…\n     \n      Arthritis & rheumatology (Hoboken, N.J.)\n      2015 Dec 15\n    ",
         "  \n        Effect of Milnacipran on Pain in Patients with Rheumatoid Arthritis with Widespread Pain: A Randomized Blinded Crossover Trial.\n       \n      Lee, Y. C.,Massarotti, E.,Edwards, R. R.,Lu, B.,Liu, C.,Lo, Y.,Wohlfahrt, A.,Kim, N. D.,Clauw, D. J.…\n     \n      J. Rheumatol.\n      2015 Dec 03\n    ",
         "7\n       citations    \n        Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.\n       \n      Katz, J. N., Smith, S. R., Collins, J. E., Solomon, D. H., Jordan, J. M., Hunter, D. J., Suter, L. G…\n     \n      Osteoarthritis and cartilage\n      2015 Nov 4\n    ",
         "3\n       citations    \n        Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.\n       \n      Kaushik, P., Solomon, D. H., Greenberg, J. D., Anderson, J. T., Reed, G. W., Pala, O., Sumbul-Yuksel…\n     \n      Clinical rheumatology\n      2015 Aug 6\n    ",
         "4\n       citations  \n        2\n       mentions   \n        An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score.\n       \n      Desai, R. J., Solomon, D. H., Weinblatt, M. E., Shadick, N. A., Kim, S. C.…\n     \n      Arthritis research & therapy\n      2015 Apr 17\n    ",
         "  \n        Risk of incident diabetes in patients with gout: A cohort study.\n       \n      Kim, S. C.,Liu, J.,Solomon, D. H.…\n     \n      \n      2014 Oct 22\n    ",
         "11\n       citations    \n        Arterial 18F-FDG uptake in rheumatoid arthritis correlates with synovial activity.\n       \n      Emami, H., Vijayakumar, J., Subramanian, S., Vucic, E., Singh, P., MacNabb, M. H., Corsini, E., Hoff…\n     \n      JACC. Cardiovascular imaging\n      2014 Sep 13\n    ",
         "1\n       citations    \n        Patterns of treatment among a cohort of older low-income adults starting new medications for osteoporosis.\n       \n      Solomon, D. H., Brown, E. M., Chandler, D., Bower, A., Barron, R., Mogun, H., Franklin, J. M.…\n     \n      Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA\n      2014 Jun 6\n    ",
         "3\n       citations    \n        Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?\n       \n      Losina, E., Burbine, S. A., Suter, L. G., Hunter, D. J., Solomon, D. H., Daigle, M. E., Dervan, E. E…\n     \n      Osteoarthritis and cartilage\n      2014 Feb 4\n    ",
         "7\n       citations  \n        1\n       mention   \n        Roles of nurse practitioners and physician assistants in rheumatology practices in the US.\n       \n      Solomon, D. H., Bitton, A., Fraenkel, L., Brown, E., Tsao, P., Katz, J. N.…\n     \n      Arthritis care & research\n      2013 Dec 18\n    "
      ],
      "journals":[

      ],
      "non-journals":[

      ],
      "committees":[

      ],
      "memberships":[
         "   American College of Rheumatology - ACR Fellow"
      ],
      "clinical-trails":[
         "  Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial \n    Start of enrollment: 2011-08-01\n   \n    Gravallese, E.M.,Kay, J.,Lo...\n  ",
         "  Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis \n    Start of enrollment: 2010-06-01\n   \n    Garg, R.K.,Massarotti, E.M....\n  ",
         "  Evaluating Ways to Improve Medication Use Among People With Osteoporosis \n    Start of enrollment: 2007-11-01\n   \n    Solomon, D.H.,Gleeson, T.\n  ",
         "  Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038) \n    Start of enrollment: 2004-09-01\n   \n    Solomon, D.H.\n  ",
         "  Randomized Controlled Testing of Osteoporosis Education \n    Start of enrollment: 2003-09-01\n   \n    Solomon, D.H.\n  "
      ],
      "lectures":[

      ],
      "press-mentions":[
         "   \n        Self-Management Education Programs in Chronic Disease: A Systematic Review and Methodological Critique of the Literature\n       \n      Archives of internal medicine\n       · August 09, 2023  ",
         "   \n        Podcast: Making Sense of the COVID-19 Infodemic\n       \n      Rheumatology Network\n       · August 13, 2020  ...s a possible treatment. In today’s edition of Overdrive, the podcast from Rheumatology Network, Dr. Daniel Solomon, editor-in-chief of Arthritis and Rheumatology, helps us make sense of the science. _____________ S...",
         "   \n        Denosumab Dosing Delays Tied to Increased Fracture Risk\n       \n      The Rheumatologist\n       · July 27, 2020  ...e uncertain that they can remain on the schedule alternative treatments should be considered,” says Daniel Solomon, MD, MPH, with the Division of Rheumatology, Brigham and Women’s Hospital and Harvard Medical Schoo...",
         "   \n        Low-Dose Methotrexate Linked to Increased Adverse Events in Some\n       \n      Healthcanal\n       · February 19, 2020  ...cornerstone drug for a variety of inflammatory diseases, especially for rheumatoid arthritis,\" said Daniel Solomon, MD, MPH, a rheumatologist in the Division of Rheumatology, Inflammation and Immunology at the Brig...",
         "   \n        Study Probes Side Effects of Long-Used Methotrexate\n       \n      WebMD\n       · February 18, 2020  ...cornerstone drug for a variety of inflammatory diseases, especially for rheumatoid arthritis,\" Dr. Daniel Solomon, a rheumatologist at Brigham and Women\\'s Hospital in Boston, said in a hospital news release. His t...",
         "   \n        ACR 2019: 50+ Arthritis Updates That Should Be on Your Radar\n       \n      CreakyJoints\n       · November 24, 2019  ...se as a chemotherapy drug (albeit in much higher doses). Harvard researchers, led by rheumatologist Daniel Solomon, MD, did an analysis on a large group of patients who did NOT have inflammatory arthritis taking me...",
         "   \n        11 Psoriatic Arthritis Complications You Need to Know About\n       \n      CreakyJoints\n       · August 16, 2019  ...percent. “It’s not entirely clear why the two conditions are often found in the same people,” says Daniel Solomon, MD, a rheumatologist at Brigham and Women’s Hospital and professor of medicine, at Harvard Medical...",
         "FDA Advisors Recommend Nintedanib for SSc Interstitial Lung Disease\n       \n      MDedge\n       · July 26, 2019  ",
         "Are NSAIDs Safe? New Findings Address Risk Factors\n       \n      University Health News\n       · December 22, 2018  ...ders about the safe use of commonly used analgesics, including celecoxib, ibuprofen, and naproxen,” Daniel Solomon, MD, MPH, chief, Section of Clinical Sciences, Division of Rheumatology and Division of Pharmacoepi...",
         "Injected Drug May Be New Weapon Against Gout\n       \n      Drugs.com\n       · September 18, 2018  ...gout attack risk, the researchers found. \"This was a very large effect,\" said study lead author Dr. Daniel Solomon, a rheumatologist with Brigham and Women\\'s Hospital in Boston. He acknowledged it was \"very surpris...",
         "New Evidence of a Preventative Therapy for Gout\n       \n      Medical Xpress\n       · September 17, 2018  ...en together although the underlying connection between the two remains unclear. When rheumatologist Daniel Solomon, MD, MPH, heard about a large, clinical study to determine if targeting inflammation among patients...",
         "Learning Sessions Help Rheumatologists Take Better Care of RA Patients, Study Says\n       \n      BioNews Feeds\n       · May 22, 2017  ...ing collaborative where teams work together using rapid cycle improvement methods to enhance care,” Daniel Solomon, MD, of the Division of Rheumatology at Brigham and Women’s Hospital and lead author of the study,...",
         "Trial Demonstrates Benefits of Learning Sessions for Managing Rheumatoid Arthritis\n       \n      Arthritis & Rheumatology\n       · May 17, 2017  ...borative where teams work together using rapid cycle improvement methods to enhance care,\" said Dr. Daniel Solomon, chief of the Section of Clinical Sciences in the Division of Rheumatology at Brigham and Women\\'s H...",
         "Bad News for Naproxen in RA\n       \n      MedPage Today\n       · November 14, 2016  ",
         "13-Country Precision Trial Looks at Cardiovascular Effects of Anti-Inflammatory Drug Use\n       \n      Medical Xpress\n       · November 14, 2016  ...about the safe use of commonly used analgesics, including celecoxib, ibuprofen and naproxen,\" says Daniel Solomon, MD, MPH, chief, Section of Clinical Sciences, Division of Rheumatology and Division of Pharmacoepi...",
         "The Comparative Safety of Analgesics in Older Adults with Arthritis\n       \n      JAMA Internal Medicine\n       · October 20, 2016  ",
         "Compliance with Osteoporosis Medications\n       \n      JAMA Internal Medicine\n       · October 20, 2016  ",
         "The Comparative Safety of Opioids for Nonmalignant Pain in Older Adults\n       \n      JAMA Internal Medicine\n       · October 20, 2016  ",
         "Arthritis & Heart Disease\n       \n      Arthritis Foundation\n       ",
         "Effects of Colchicine on Risk of Cardiovascular Events and Mortality Among Patients with Gout\n       \n      Annals of the Rheumatic Diseases\n       ",
         "Osteoporosis Telephonic Intervention to Improve Medication Regimen AdherenceA Large, Pragmatic, Randomized Controlled Trial\n       \n      JAMA Internal Medicine\n       · March 26, 2012  ",
         "Oxycontin and Similar Drugs up Fracture, Heart Attack Risk\n       \n      Health.com\n       · December 13, 2010  ",
         "More Studies Cast Doubt on Safety of Diabetes Drug\n       \n      NY Times\n       · September 12, 2007  ",
         "More Studies Cast Doubt on Safety of Diabetes Drug\n       \n      The New York Times\n       · September 12, 2007  "
      ],
      "hospital-info":[
         "   \n      Brigham And Womens Physicians Organization  ·  Boston, MA\n       \n    June 2015 - Present\n   ",
         "   \n        Brigham and Women's Hospital\n       \n      Current Affiliation\n     \n        Boston, MA\n    "
      ],
      "award-info":[
         "   \n      Fellow (FACR)\n     \n      American College of Rheumatology\n    "
      ],
      "support-grants":[
         "   Hydroxychloroquine To Improve Insulin Sensitivity In Rheumatoid Arthritis (R21AR057924) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Brigham And Women'S Hospital\n     2010–2011",
         "   Modifiable Disparities In Treatment For Rheumatoid Arthritis (R01AR056215) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Brigham And Women'S Hospital\n     2009–2011",
         "   Estimating And Communicating Risk About Biologic Dmards For Rheumatoid Arthritis (K24AR055989) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Brigham And Women'S Hospital\n     2008–2011",
         "   Improving Medication Adherence For Osteoporosis:Community Based Randomized CON (P60AR047782) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Brigham And Women'S Hospital\n     2007–2011",
         "   Osteonecrosis Of The Jaw In Non-Cancer Patients Using Bisphosphonates (R21DE018750) National Institute Of Dental &Craniofacial Research \n      Brigham And Women'S Hospital\n     2009–2010",
         "   Osteoporosis In Women With Rheumatoid Arthritis (M01RR002635) National Center For Research Resources \n      Brigham And Women'S Hospital\n     2006–2008",
         "   Osteoporosis In Women With Rheumatoid Arthritis (R21AG027066) National Institute On Aging \n      Brigham And Women'S Hospital\n     2005–2006",
         "   Randomized Controlled Testing Of Osteoporosis Education (K23AR048616) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Brigham And Women'S Hospital\n     2002–2006",
         "   Pain Medication Use &Risk Factors For Opioid Dependence (R01DA015507) National Institute On Drug Abuse \n      Brigham And Women'S Hospital\n     2002–2004",
         "   Why Is Cardiac Risk Increased In Rheumatiod Arthritis (R55AR048264) National Institute Of Arthritis And Musculoskeletal And Skin Diseases \n      Brigham And Women'S Hospital\n     2002"
      ]
   }
}